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1 Introduction and Objectives 
1.1 MITOCHONDRIA 
Mitochondria are essential organelles for eukaryotic cells. They are partially autonomous 
organelles, as they harbor their own DNA, RNA and protein synthesizing machinery. 
Furthermore, mitochondria are also capable of synthetizing some lipids on their own (Horvath & 
Daum, 2013). The mitochondrion is thought to have a bacterial evolutionary origin and it has 
become perhaps in the ultimate symbiont. This hypothesis is backed by substantial experimental 
evidence, including the similarities between the bacterial and mitochondrial DNA and the 
translational apparatus (Kutik et al, 2009). In addition, mitochondria also have a unique and quite 
complex membrane system, which is the basis for their numerous intricate functions (Harner et 
al, 2011). Concretely, these organelles are surrounded by an envelope composed by the outer 
(MOM) and inner (MIM) mitochondrial membranes.  
The MOM has been assumed to be relatively permeant to small molecules and ionic species. In 
contrast, the MIM is largely impermeable and forms the mayor barrier between the cytosol and 
the mitochondrial matrix. The MIM is considered to be the most protein-rich cellular membrane, 
containing proteins and protein complexes that are essential for the normal mitochondrial 
function. This MIM can be further divided into the inner boundary membrane (IBM), which is in 
continuous and close apposition to the MOM, and the cristae membrane (CM). Cristae are 
invaginations of the IBM that protrude to the matrix. Cristae and IBM are connected by narrow 
tubular structures called cristae junctions (CJ) (Reichert & Neupert, 2002). The space between 
the MOM and the MIM is called intermembrane space (IMS), and it is rather narrow in 
comparison to the space between cristae sheets, also called intracristae space (ICS). Furthermore, 
there are sites of firm interaction between MOM and IBM that may be necessary for the structural 
organization of mitochondrial membranes. These connections have been termed mitochondrial 
contact sites (CS) (Figure 1.1). 
With the appearance of the first transmission electron microscopy TEM-images of mitochondria, 
it was observed these organelles can assume a wide variety of morphologies. After some extensive 
studies, it was suggested that these mitochondrial membrane shape changes might not be random, 
but rather might reflect a novel regulatory mechanism of the organelle. Indeed, it is now assumed 
that mitochondrial functions can be affected by changes in mitochondrial membrane topology 
(Mannella, 2006a; Mannella, 2006b). Moreover, (Scorrano et al, 2002) proposed that the MIM 
topology could also be implicated in the apoptotic process. 
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Figure 1.1 Different components of mitochondria. This represents a cross section of a (non-existing) 
composite mitochondrion based on data from different organisms. Cristae are connected to the inner 
boundary via narrow tubular structures, called cristae junctions—only one of them is visible in this cross-
section. OM, outer membrane; IBM, inner boundary membrane; CM, cristae membrane; ICS, intracristal 
space. Image taken from (Reichert & Neupert, 2002). 
Specifically, they showed that tBID, a BCL2 family member protein (see at section 1.4), causes 
a rapid remodeling of the MIM, increasing the number of CJ and inverting the MIM curvature. 
This dramatic change in the MIM topology coincides with the enhanced mobilization of the 
internal cytochrome c (cyt c), a molecule that in the cytosol is directly associated with apoptotic 
cell death. Furthermore, it has been proposed that most of the cyt c is locked inside the cristae by 
the OPA1(Optic atrophy 1)-containing complexes located at the neck of the cristae and thus, 
disassembly of OPA1 complexes may be critical for the majority of cyt c to gain access to the 
IBM (Frezza et al, 2006). In this regard, it has been reported that the proapoptotic BCL2 family 
members BAX and BAK interact with mitochondrial CS during apoptosis to affect MOM 
permeability and induce activation of a novel MIM protease termed OMA1. These interactions 
between BAX/BAK and CS leads to enhanced OMA1 protease activity, resulting in accelerated 
autodegradation of OPA1 and thereby facilitating cyt c release and apoptotic pathway (Jiang et 
al, 2014). 
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1.2 MITOCHONDRIAL DYNAMICS 
Mitochondria are reticular organelles that have high plasticity for their dynamic structures and 
constantly undergo fission and fusion as well as movement through the cytoskeleton. As 
previously mentioned, mitochondrial morphology changes are determined by a balance between 
mitochondrial fusion and fission events, collectively known as mitochondrial dynamics. 
Perturbations on mitochondrial dynamics can have tremendous consequences on cell metabolism 
and therefore on cell life. Indeed, the importance of fission and fusion homeostasis has been 
highlighted by a number of diseases linked to an imbalance between these two processes. 
Mitochondrial fusion allows mitochondria to exchange their content including the mtDNA and 
proteins between individual mitochondria, whereas mitochondrial fission allows for 
mitochondrial biogenesis, and the segregation of damaged and inactive mitochondria by 
autophagic clearance (Diaz & Moraes, 2008). The main components of the mitochondrial fission 
and fusion machinery belong to the Dynamin superfamily. In mammals, outer membrane fusion 
is regulated by Mitofusins 1 and 2 (MTF1 and MTF2), while inner membrane fusion process is 
controlled by OPA1 and organelle division or fission is mediated by DRP1 (Figure 1.2). 
Interactions between mitochondria and the cytoskeleton are essential for normal mitochondrial 
morphology, motility and distribution. While microtubules and their motors have been established 
as important factors for mitochondrial transport, emerging evidence indicates that mitochondria 
interact with the actin cytoskeleton in many cell types (Boldogh & Pon, 2006). Moreover, close 
appositions between mitochondria and the ER have been observed by electron microscopy. The 
close contacts between these organelles are referred as mitochondria-associated ER membranes 
(MAM) (Giorgi et al, 2009; Vance, 1990). These contiguous membranes contain multiple 
phospholipid- and glycosphingolipid- synthesizing enzymes and support direct transfer of lipids 
between ER and mitochondria (Stone & Vance, 2000). MAMs play important roles in 
mitochondrial morphology and in many cellular functions ranging from lipid metabolism, to 
calcium signalling and apoptosis (Doghman-Bouguerra & Lalli, 2017). MAM regions are zones 
enriched in Inositol Triphosphate Receptors (IP3Rs), and are thus considered “hotspots” of Ca+2 
transfer from ER to mitochondria (Rizzuto et al, 1998). Remarkably, mitochondrial Ca+2 
accumulation may play a role in determining the outcome of the cell (Duchen et al, 2008) (Figure 
1.2). Indeed, studies several organisms have revealed that mitochondrial dynamics appear to be 
subject to regulation by the same proteins that regulate apoptosis, including BCL2 family proteins 
(Aouacheria et al, 2017). 
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Figure 1.2 MAM proteins involved in ER-mitochondria Ca2+signaling, lipid transfer and 
mitochondrial morphology. Some proteins localized in MAMs (IP3R, VDAC, GRP75) regulate Ca2+ 
release from the ER for an efficient mitochondrial Ca2+ uptake. MAMs play an important role in 
phospholipid shuttling between ER and mitochondria such as Cholesterol, PS, PE and CL. Mitochondrial 
morphology is regulated by Mitofusins 1/2, OPA1 and DRP1. Taken from (Doghman-Bouguerra & Lalli, 
2017). 
 
1.3 ROLE OF MITOCHONDRION IN CELL DEATH 
As described above, in healthy cells, the main function of mitochondria is the production of 
energy by oxidative phosphorylation and the maintenance of Ca+2 homeostasis. However, 
mitochondria are also actively implicated in cell death closely involved, among others, in necrotic 
and apoptotic processes. 
1.3.1 Necrotic cell death 
During classical necrotic death, the cell becomes physically or chemically stressed until the point 
that it cannot maintain its integrity and it finally swells, bursts and decomposes in a passive and 
unorganized manner. As a consequence, necrosis is typically associated with disruption of the 
plasma membrane, major organellar structural changes including mitochondrial swelling, release 
of intracellular contents and inflammation of the surrounding tissue. Thus, this type of cell death 
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is usually considered “non-programmed” and does not present specific biochemical markers 
(Kroemer et al, 2009). However, recent investigations have shown that under specific conditions 
necrotic death can occur in a genetically encoded and organized manner, rather than being an 
accidental process (Christofferson & Yuan, 2010; Galluzzi & Kroemer, 2008). This programmed 
necrosis process has also been termed necroptosis and involves activation of death receptors such 
as FAS or TNF, calcium cross-talk between ER and mitochondria, mitochondrial depolarization 
and ATP depletion, among other regulated events. Interestingly, certain BCL2 family members 
have been implicated in necroptosis regulation (Dorn, 2013; Whelan et al, 2010). 
A high m[Ca+2] in combination with other characteristics, such as, oxidative stress, high inorganic 
phosphate concentration (ATP depletion) and mitochondrial depolarization can lead to the 
opening of the mitochondrial permeability transition pore (mPTP). The mPTP is a pore whose 
exact structure is unknown, but it is thought to be composed by the adenine nucleotide translocator 
(ANT) in the MIM, the voltage dependent anion conductance (VDAC) in the MOM, and 
cyclophilin D, in the matrix, which confers sensitivity to the complex to cyclosporine A. Under 
pathological conditions, the mPTP is opened leading to a destruction of the mitochondrial 
potential, ATP consumption and energetic collapse, normally ending in a necrotic cell death 
(Duchen, 2000; Duchen, 2004; Krieger & Duchen, 2002; Osellame et al, 2012). 
1.3.2 Apoptotic cell death 
In addition to the role of mPTP in necrotic cell death, mitochondria are also actively implicated 
in apoptotic cell death. Apoptosis is a fundamental process of the entire animal kingdom 
(Metazoan), with millions of cells dying by apoptosis in the adult human body every second 
(Adams & Cory, 2007). Importantly, research done in apoptosis has also lead to the discovery 
that this type of cell death is not only essential for normal physiological developmental and 
homeostatic processes, but it is also crucial as a defensive strategy to remove infected, mutated, 
or damaged cells (Miura, 2011). Accordingly, defective apoptotic processes have been implicated 
in an extensive variety of human diseases (Adams & Cory, 2007; Strasser et al, 2011). 
Morphologically, a cell dying via apoptosis is characterized by rounding-up of the cell, cell 
shrinking (pyknosis), nuclear condensation and fragmentation (karyorrhexis), membrane 
blebbing (maintaining its integrity until the final stages of the process) and finally, the separation 
of the cellular components into apoptotic bodies. Another typical feature of an apoptotic cell is 
the redistribution of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma 
membrane, serving as a ‘come and- get-me’ signal to attract phagocytes to engulf the fragmented 
cell (Kroemer et al, 2005; Kroemer et al, 2009). The latter process allows rapid removal and 
clearance of apoptotic cells thereby avoiding immune activation and inflammation of surrounding 
tissue (Bevers & Williamson, 2010; Elliott & Ravichandran, 2010; Lauber et al, 2003).  
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In vertebrates, apoptosis can occur through two main pathways: the “extrinsic” or death receptor 
pathway and the “intrinsic” or mitochondrial pathway (Figure 1.3). Although the initial death 
signals are heterogeneous, both pathways ultimately lead to the activation of the executioner 
caspases (mainly caspases 3/7) that are responsible of the proteolytic cleavage of hundreds of 
different proteins within the cell, leading to the morphological features that define the apoptotic 
process (Green, 2005; Strasser et al, 2011).  
The extrinsic apoptotic pathway is triggered upon binding of extracellular death ligands of the 
tumour necrosis factor (TNF) superfamily (TNF α, Fas/CD95-L, TNF-related apoptosis-inducing 
ligand (TRAIL)) to their cognate cell surface receptor (TNF receptors), Fas, TRAIL receptor 
(TRAILR1 and TRAILR2)) (Fulda & Debatin, 2006; Lavrik et al, 2005; Walczak & Krammer, 
2000). Of note, in some cells, the extrinsic and intrinsic pathways are independent (Type I cells, 
for example lymphocytes), whereas in others, both pathways converge at the mitochondria (Type 
II cells, for example hepatocytes) through caspase-8-mediated cleavage of BH3-interacting 
domain death agonist (BID) (Czabotar et al, 2014; Fulda et al, 2002; Lee et al, 2016; Li et al, 
1998; Scaffidi et al, 1998)(Figure 1.3). 
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Figure 1.3 The mitochondrial and death receptor-mediated pathways to apoptosis. Diverse cytotoxic 
stimuli, including oncogenic stress and chemotherapeutic agents, as well as developmental cues, engage 
the mitochondrial pathway, which is regulated by BCL‑2 family members. These stimuli activate 
BH3‑only family members (initiators), which inhibit the pro-survival BCL‑2‑like proteins (guardians), 
thereby enabling activation of the pro-apoptotic effectors BAX and BAK, which then disrupt the 
mitochondrial outer membrane. The death receptor-mediated (or extrinsic) pathway of apoptosis is 
activated when certain death receptor ligands of the tumor necrosis factor (TNF) family (such as FAS 
ligand and TNF) engage their cognate death receptors (FAS and TNFR1, respectively) on the plasma 
membrane, leading to caspase 8 activation via FAS-associated death domain protein (FADD) and TNFR-
associated death domain protein (TRADD). The two pathways converge at activation of the effector 
caspases (caspase 3, caspase 7 and caspase 6). In addition, the truncated form of BID (tBID), which is 
generated by caspase 8‑mediated proteolysis of BID in the death receptor-mediated pathway, can engage 
the mitochondrial pathway to amplify the apoptotic response. Taken from (Czabotar et al, 2014). 
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1.3.3 Mitochondrial apoptotic pathway 
Most of cell death in vertebrates proceeds via the intrinsic or mitochondrial pathway (Green & 
Kroemer, 2004). This pathway can be activated by a variety of stress stimuli including radiation 
(UV and gamma), heat, viral virulence factors, growth-factor deprivation, DNA-damage, 
oxidative stress and the activation of some oncogenic factors (Plati et al, 2011).  
The crucial event in the intrinsic mitochondrial pathway is mitochondrial outer membrane 
(MOM) permeabilization (MOMP) that allows the release of apoptogenic factors sequestered in 
the IMS. In vertebrates, this event usually constitutes “the point of no return” of the apoptotic 
cascade (Green & Kroemer, 2004; Kroemer et al, 2007). So, MOMP typically leads to cell death 
irrespective of caspase activity by causing a progressive decline in mitochondrial function, 
although cells can survive this under certain circumstances, which may have pathophysiological 
consequences (Tait et al, 2010). MOMP  is regulated by the BCL-2 family proteins, which 
establish a complex interaction network within themselves and with other cellular factors to 
dictate whether or not MOMP ensues and therefore a cell dyes by apoptosis (Chipuk et al, 2010; 
Youle & Strasser, 2008). Other important apoptosis-related mitochondrial processes have been 
described to occur previous or in parallel to the MOMP, such as dissipation of membrane potential 
(∆m) (Zamzami et al, 1995) and alterations in mitochondrial structure and function (Petit et al, 
1995). 
The apoptogenic factors released from IMS play different roles in the intrinsic apoptotic pathway. 
Cyt c release, a small protein (12 kDa) loosely associated to the mitochondrial lipid cardiolipin 
(CL) in the MIM, is one of the key events of the mitochondrial-dependent apoptosis. Upon CL 
oxidation and MOMP, Cyt c can diffuse into the cytosol, where it promotes the assembly of the 
apoptosome, a molecular platform that includes: Cyt c, apoptosis protease activating factor 
(APAF-1), initiator caspase 9 and ATP/dATP. This multiprotein complex activates caspase-9 
resulting in the downstream caspase cascade activation (Garrido et al, 2006; Li et al, 1997; Liu et 
al, 1996; Ott et al, 2002; Saelens et al, 2004; Zou et al, 1997). In addition to Cyt c, MOMP allows 
intracytoplasmic release of two larger apoptogenic proteins termed SMAC/DIABLO (25kDa) and 
Omi/HtrA2 (37kDa). SMAC/Diablo and Omi/HtrA2 bind to and neutralize endogenous inhibitors 
of caspases (IAPs), thus favouring caspase activation (Saelens et al, 2004). Furthermore, 
Omi/HtrA2 has also been implicated in caspase-independent cell death due to its proteolytic 
activity (Saelens et al, 2004). Two additional apoptogenic proteins that are released from 
mitochondria as a consequence of MOMP are AIF (62 kDa) and Endo G (23 kDa) that, once 
released to the cytosol, translocate to the nucleus and mediate chromatin condensation and DNA 
fragmentation (Daugas et al, 2000; Li et al, 2001; Susin et al, 1999). 
The timing of the release of these multiple proteins from the IMS to the cytosol is under debate 
and depending on the cell type or apoptotic stimuli, the redistribution order of these apoptogenic 
factors can be different. In some studies, a differential release of Cyt c, SMAC/DIABLO and AIF 
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has been reported (Arnoult et al, 2002; Chauhan et al, 2001; Daugas et al, 2000; Modjtahedi et al, 
2006). However, other studies showed that Cyt c and SMAC/DIABLO are released 
simultaneously (Munoz-Pinedo et al, 2006; Rehm et al, 2003; Zhou et al, 2005).  
One potential explanation for the differences in apoptogenic protein release from mitochondria 
has been attributed to differences in their retention mechanisms within the mitochondria, 
processes closely related with the mitochondrial dynamics. For example, it has been proposed 
that 90% of the Cyt c is sequestered within the mitochondrial cristaes where it binds to the 
mitochondrial specific lipid CL. Thus, in order to induce Cyt c release, mitochondrial cristae has 
to be remodelled (Scorrano et al, 2002) and Cyt c has to be freed from CL (Ott et al, 2002). In the 
case of AIF, a non-caspase protease, it has to be cleaved to remove its anchorage-point from the 
MIM (Polster et al, 2005). In addition, or alternatively, the different timing of mitochondrial 
apoptogenic factors release could be due to creation of specific MOM pores selective for each (or 
some, but not all) apoptogenic protein(s) (Saito et al, 2000). Another controversial issue is that 
with the exception of Cyt c, genetic ablation of other mitochondrial proapoptotic factors has 
shown little effect on the apoptotic process (Irvine et al, 2005; Okada et al, 2002) (Figure 1.4). 
Of note, defects in mitochondrial apoptotic pathway have the potential to confer a survival 
advantage to cancer cells, contributing to the resistance of cancer cells to chemotherapy and 
radiotherapy (Hanahan & Weinberg, 2011). 
 
Figure 1.4 Scheme of structural changes in mitochondria during apoptosis: (a) MOMP, (b) cristae 
remodeling and (bottom) mitochondrial fragmentation. Taken from (Ugarte-Uribe & Garcia-Saez, 2017). 
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1.4 THE BCL-2 PROTEIN FAMILY 
Bcl-2 gene was the first apoptotic regulator to be identified in human follicular B-cell lymphoma 
and established the family name (Bakhshi et al, 1985). Since then, more than 20 BCL-2 related 
proteins have been identified in mammals, all of which share amino acid sequence homology in 
one to four regions designated BCL-2 homology domains (BH1, BH2, BH3, and BH4) (Chipuk 
et al, 2010; Youle & Strasser, 2008). In addition to BH domains, many BCL-2 family members 
possess C-terminal hydrophobic regions that serve to target and/or anchor them to intracellular 
membranes.  
Interestingly, BCL2 family proteins have been involved in several cellular processes such as 
mitochondrial dynamics (Aouacheria et al, 2017; Martinou & Youle, 2011), metabolic 
efficiency/cellular respiration (Alavian et al, 2011), calcium homeostasis (Szegezdi et al, 2006) 
and autophagy (Heath-Engel et al, 2008) among others. However, as previously mentioned, the 
main function of BCL-2 family proteins is MOMP regulation, which establish a complex 
interaction network within themselves and with many other cellular factors to dictate the cell fate 
(Chipuk et al, 2010; Youle & Strasser, 2008). Classicaly, depending on functional criteria and on 
their content of BH domains, BCL-2 family members were classified in three subgroups (Figure 
1.5):  
 Antiapoptotic BCL2-type proteins: contain all four BH domains and primarily inhibit 
apoptosis by preventing MOMP. They include BCL-2 itself, BCL-XL (B-cell 
lymphoma-extra-large), MCL-1 (myeloid cell leukemia-1), BCL-2-L2 (Bcl-2-like 
protein 2) commonly known as BCL-w, BCL2-A1 (Bcl-2-related protein A1) also 
known as A1(mouse)/BFL1(human) and BCL-B (Bcl-2-like protein 10). 
 Proapoptotic multidomain BAX-type proteins: These proteins contain BH1-3 
domains and directly cause MOM. They include BAX (BCL-2 Associated X protein), 
BAK (BCL-2 Associated Killer protein) and perhaps BOK (BCL2-related ovarian 
killer)/MTD (Matador). 
 Proapoptotic BH3-only proteins: Contain only the BH3 domain and promote MOMP 
by activating BAX-type proteins. They include BID, BIM (BCL-2-interacting mediator 
of cell death), PUMA (p53 up-regulated modulator of apoptosis), BAD (BCL-2 
antagonist of cell death), BIK (BCL-2-interacting killer), BMF (BCL.2-modifying 
factor), PMAIP1 (Phorbol-12-myristate-13-acetate-induced protein) commonly known 
as NOXA, and HRK (harakiri).  
Importantly, although the above classification is useful, it does not take into account the switch 
in phenotype observed for a number of BCL-2-type and BAX-type proteins under certain cell and 
environmental contexts (Basanez et al, 2001; Clem et al, 1998; Fannjiang et al, 2003; Landeta et 
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al, 2014; Lewis et al, 1999; Qi & Hardwick, 2008). Indeed, despite showing a high level of 
sequence and structure similarities, different members within the same subgroup of the BCL-2 
family can fulfill dissimilar physiological functions (Hardwick et al, 2012). Moreover, despite it 
is widely assumed that the BH4 distinguishes all anti-apoptotic BCL-2 family proteins from pro-
death members that lack a BH4, most multiple alignment programs fail when their BH4 domain 
of the original triumvirate (BCL-2, BCL-XL and BCL-W) is align with the putative BH4 of their 
anti-apoptotic homologs Mcl-1 and Bfl-1/A1 (Aouacheria et al, 2013).  Of note, in this thesis the 
terms domain and motif, referring to the BCL2 homology sequences, are used indistinctly. 
However, some authors argue that as a domain is associated with an autonomous folding unit of 
protein structure, and a motif is a sequence of conserved aminoacids that differentiates one family 
of proteins from another, BH domains should be redefined as a BH motifs (Aouacheria et al, 
2015).  
 
Figure 1.5 The BCL-2 protein family. Representation of the structural domains of representative 
members of each subfamily is shown. The BCL-2 family members can be classified as prosurvival proteins 
and proapoptotic members, in which there are two subgroups: multidomain effectors (BAX, BAK and 
perhaps BOK) and BH3-only proteins. Image taken from (Gimenez-Cassina & Danial, 2015). 
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1.4.1 Solution Structures of BCL-2 family proteins 
Given the difficulty of applying conventional structural techniques to study membrane proteins, 
most detailed structural information available to date corresponds to BCL2 family members in an 
aqueous environment. During the last two decades, X-ray crystallography and Nuclear Magnetic 
Resonance (NMR) have been applied to gain atomic-level structural information of BCL2 family 
proteins conformations.  
1.4.1.1 Multidomain-type folding 
Despite their functional heterogeneity all 3D structures of multidomain BCL2 family proteins 
solved to date revealed the same globular helical fold, with a central predominantly hydrophobic 
hairpin that is flanked on both sides by pairs of amphipathic helices. This peculiar folding is 
strikingly similar to the pore-forming domain of bacterial toxins such as the colicins and 
diphtheria toxin (Muchmore et al, 1996; Petros et al, 2004). Another important common feature 
is the presence of BH1, BH2 and BH3 domains shape a hydrophobic groove, which acts as the 
docking site for the BH3 domains of other BCL2 protein-binding partners (Liu et al, 2003b; 
Sattler et al, 1997). 
The first 3D structure resolved was the structure of a C-terminal truncated version of antiapoptotic 
BCLXL in complex with a long helical fragment of proapoptotic BIM (Figure 1.6A). Based on 
this structure, the canonical BH3 into groove interaction was firmly demonstrated, which has been 
particularly informative concerning how these two subfamilies engage in protein:protein 
interactions (Liu et al, 2003b). This interaction consists on, the hydrophobic match between four 
conserved hydrophobic residues (termed hereafter h1, h2, h3, and h4) localized in one side of the 
proapoptotic BIM BH3 peptide and in the canonical groove. In addition, BIM BH3 peptide 
contains several polar residues that interact with polar residues localized in the vicinity of the 
BCLXL hydrophobic groove (Figure 1.6B-C). According to the atomic structure, appeared to be 
particularly important a salt bridge established between an aspartate residue of the proapoptotic 
BH3 domain (D99 in BIM BH3) and an arginine residue of the antiapoptotic hydrophobic groove 
(R139 in BCL-XL). Thus, combination of hydrophobic and polar forces (including the salt bridge) 
triggers the BH3-into-groove interaction. Importantly, subsequent studies demonstrated that 
experimentally determined binding-specificities could be explained attending to sequence and 
structural diversities of the proapoptotic BH3 domains and hydrophobic grooves (Certo et al, 
2006; Chen et al, 2005; Dutta et al, 2010; Kuwana et al, 2005; Petros et al, 2004). 
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Figure 1.6 Details of the Interaction of BCLXL with BIM (PDB:1MAZ) (A) Structure of BIM BH3 
peptide in complex with C-terminal truncated BCLXL. (B) Hydrophobic interactions between BCLXL and 
BIM. The side chains of the conserved four BH3 hydrophobic residues from BIM are shown in yellow. The 
side chains of the BCLXL hydrophobic residues that interact with BIM are shown white. (C) Hydrophilic 
interactions between BCLXL and BIM. Side chains of BCLXL and BIM involved in H bonds and salt 
bridges are shown in white.  Taken from (Liu et al, 2003b). 
 
In this scenario, BCL2-type and BAX-type proteins are sharing both similar folding and 
interaction with their BH3-only counterparts, but the effect elicited upon BH3-ligand interaction 
is dissimilar. In 2013, Coleman and colleagues unearthed the termed “holy grail of BCL2 family 
proteins” revealing for the first time the atomic structure of truncated version of BAX bounded 
to BH3 peptide (Czabotar et al, 2013). Here, a new surface of interaction between BAX and BH3-
ligand was described (termed hereafter as “h0”), which is not present in the structured solved of 
BCL-2 type proteins (Figure 1.7). Remarkably, in this work was also described a cavity in BAX 
that is absent in its antiapoptotic family members, which according to the authors, explains the 
sequence of events that BAX-type proteins experiment to develop their pore forming activity 
including the separation of core (α2-α5) and latch (α6-α8) domains, oligomerization and 
membrane insertion (see also 1.7 and 1.8 sections).  
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Figure 1.7 BidBH3 peptide (magenta) projects four canonical hydrophobic residues (h1 through h4) 
into the canonical binding groove of BAX (green). (A) The h0 residues I82 and I83 make additional 
interactions with the BAX groove. Bid D95 forms a salt link to BAX R109 (cyan). Other BAX side-chains 
shown (cyan) are R94 (close to Bid I83) and I66 and Y164 (both close to Bid M97). (B) Cavity (orange, 
140A ° 3) in the hydrophobic core of BidBH3:BAX complex between α2, α5, and α8. The cavity is 
adjacent to BAX a2 residues L63 and I66 (side chains shown in gray). (C) Overlay of BidBH3:BAX with 
BimBH3:BCL-XL and zoom showing relative displacement of the BAX α2 and the contacts between 
hydrophobic residues on the BH3 domains of protein (h3 residues BCL-XL A93/BAX I66) and peptide 
(h4 residues Bid M97/Bim F159). PDB:4BD2, BH3:BAX and PDB:1MAZ, BH3:BCL:-XL. Adapted from 
(Czabotar et al, 2011). 
Importantly, the results obtained with this BAX variant lacking its TM domain could not 
reassemble, efficiently or completely, what is happening with full length protein. In the case of 
BAX, the helix 9 is located in the hydrophobic groove modulating its availability to BH3-ligands 
and therefore the TM must be dislodged to enable this canonical interaction (Suzuki et al 2000). 
Starting out from this premise, it was postulated that BAX, in the opposite side of the canonical 
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interaction site, has also a non-canonical groove or binding surface for BH3-ligands (Edwards et 
al, 2013; Gavathiotis et al, 2008; Leshchiner et al, 2013), that comprises mainly helices α3, α4 
and α5, forming a cleft between α1-α6. According to this model, full length BAX binds first BH3-
ligand in the non-canonical surface, which enables the release of TM domain and membrane 
targeting, and once in the membrane, it is the canonical groove which triggers BAX 
oligomerization and pore formation. Moreover, recently has been identified a compound that 
binds BAX in the junction of the α3–α4 and α5–α6 and sensitizes its activation allosterically, 
mobilizing the α1– α2 loop and BH3 motifs which are implicated in the activation and 
oligomerization of BAX, respectively (Pritz et al, 2017). In addition, same group have reported 
that the α1 of the antiapoptotic BCL2 is a non-canonical binding surface for BAX (Barclay et al, 
2015), adding an extra degree of complexity to anti/pro heterodimerization (Figure 1.8). 
 
Figure 1.8 BH3 binding sites: (A) BAX contains a series of surface grooves that regulate its proapoptotic 
activity, including the activating BH3 trigger (orange) and canonical (cyan) sites and the inhibitory BCL -
2 BH4 (yellow) and vMIA (purple) interaction pockets. (B) BFL1 (PDB= 2VM6) interacts with BAX-BH3 
via canonical site (cyan, left) and the analogous position of the non-canonical site (right, yellow). Adapted 
from (Pritz et al, 2017).  
1.4.1.2 BH3-only proteins 
Because recombinant mutant versions of most BH3-only proteins (e.g. BIM, BMF, PUMA and 
BAD) lacking their C-terminal regions do not have a well-defined 3D structure under 
physiological conditions, they have been classified as Intrinsically Unstructured Proteins. 
However, it has also been shown that these BH3-only proteins undergo a significant 
conformational transition upon binding to antiapoptotic members, where their BH3 domain 
switches from adopting an unstructured or partially structured to a well-ordered helix. This is 
consistent with the fact that synthetic peptides representing BH3 domains of almost all BH3-only 
proteins have been crystallized bound to antiapoptotic members (Day et al, 2005; Day et al, 2008; 
Hinds et al, 2007; Liu et al, 2003b; Petros et al, 2000). 
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Exceptionally, the BH3 only protein BID, shares multidomain folding with one central 
hydrophobic helix (α6) being surrounded by the remaining seven amphipathic helices (Chou et 
al, 1999; McDonnell et al, 1999). BID also contains a large unstructured loop between helices α2 
and α3 wherein a consensus sequence for caspase-8 cleavage is localized. The latter 
posttranslational modification markedly stimulates mitochondrial BID localization, BAX/BAK 
activation and MOMP (Gross et al, 1999).  
 
1.5 MECHANISM OF ACTION OF BCL-2 FAMILY 
PROTEINS DURING APOPTOTSIS: CONTENTIOUS 
ISSUES 
1.5.1 General overview of the MOMP process regulated by BCL-2 
family proteins 
Despite extensive research effort, many important mechanistic questions regarding apoptosis 
regulation mediated by BCL-2 family proteins remain to be answered: (i) How do different BCL-
2 family proteins target the MOM?;  (ii) How do BH3 only proteins and BCL2 type proteins 
regulate BAX-type proteins?; (iii) What is the role of the membrane and/or specific lipids in BCL-
2 family protein function?; (iv) What is the precise molecular pathway for BAX/BAK functional 
activation?  and (v) What is the nature of the BAX/BAK-driven pore and how is it regulated? 
1.5.2 How do different BCL-2 family proteins target the MOM? 
In healthy cells, many BCL-2 family proteins are found not only in the mitochondria but also in 
the cytosol, the ER and the nucleus. During apoptosis, most BCL-2 proteins translocate to or 
become enriched at the MOM, apparently to regulate its permeability. Additionally, non-MOM 
localizations of BCL-2 family members have also been connected to MOMP regulation, as well 
as to non-apoptotic functions of BCL-2 family proteins (Aouacheria et al, 2017; Hardwick et al, 
2012) . 
1.5.2.1 Cellular distribution of BCL2 multidomain family members  
BCL-2 family proteins have a heterogeneous distribution, that depends on the intrinsic nature of 
each specific family member, cell type and cellular conditions. Under healthy conditions, BCL2 
is an integral protein present in mitochondria, ER and nucleus (Hausmann et al, 2000; Hsu et al, 
1997; Lithgow et al, 1994). In the case of BCL-XL (Hausmann et al, 2000; Hsu et al, 1997) and 
BCL-W (Wilson-Annan et al, 2003), both exist partly in the cytosol and in the membrane and 
translocate to mitochondria during apoptosis. In particular, BCL-W is loosely associated to the 
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membrane, and its anchoring to the MOM is only triggered when a BH3-only protein binds to the 
hydrophobic groove of BCL-W (Wilson-Annan et al, 2003). The subcellular localization of MCL-
1 is even more complex: depending of the physiological cellular status and cell-type, MCL-1 has 
been localized to the mitochondria, the cytoplasm and the nucleus (Thomas et al, 2012). 
Concretely, BFL1 which does not contain a well-defined C-terminal transmembrane domain 
(TM), has a cytosolic fraction in healthy cell lysates and become inserted into the mitochondrial 
fraction in response to various apoptotic stimuli, following displacement of the C-terminal region 
by BH3-only proteins (Brien et al, 2009; Herman et al, 2008; Kucharczak et al, 2005). 
In the case of the multidomain proapoptotic proteins, BAX is mostly cytosolic (Suzuki et al, 2000) 
while BAK is inserted constitutively in the MOM and the ER (Breckenridge et al, 2003; Griffiths 
et al, 1999). This issue has been usually addressed to the nature of their TM domain. BAX 
possessed an amphipatic C-terminal domain, which tends to bind preferentially to its hydrophobic 
pocket rather than to insert in the membrane, whereas BAK has a hydrophobic one, with high 
tendency for MOM anchoring. Consistently, BAXTM-like mutations in the C terminal of full-
length BAK, becomes this protein much more soluble but still preserving its ability to translocate 
to MOM or liposomal membranes (Leshchiner et al, 2013).  
Many different mechanisms have been proposed to explain mitochondrial targeting of BCL-2 
multidomain proteins : 1)  Anchorage of the hydrophobic C-terminal helix into the MOM; 2) 
Interaction with other BCL-2 family partners; 3) Interaction with non-BCL-2 family proteins, 
including TOM/TIM complexes and enzymes that produce post-translational modifications and 
4) Interaction with mitochondrial lipids such as CL (Dorn & Maack, 2013).  
1.5.2.2 Anchorage of the hydrophobic C-terminal helix 
Among BCL-2 family members, the hydrophobicity of their C-terminal sequences has been 
frequently associated with their membrane targeting. Despite there is not a common feature the 
antiapoptotics BCL-2, BCL-XL, BCL-W and the proapoptotic BAK have a well-defined 
hydrophobic TM domain that constitutively target those proteins to the membrane. This 
hydrophobic tail is often flanked by basic residues that contribute to MOM localization, as it is 
observed for BCL-XL, whereas fewer basic residues favours ER localization as it is the case of  
BCL-2 (Kaufmann et al, 2003; Zhu et al, 1996). 
However, the hydrophobicity of the C- terminal cannot drive exclusively membrane targeting as 
MCL1 and BAX with an amphipatic TM domain, or BFL1, BOK and some BH3-only proteins 
which do not meet general criteria of TM sequences, still translocate to the membrane upon 
certain cellular conditions  (Lindsay et al, 2011).  
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1.5.2.3 Interaction with other BCL-2 family partners 
BAX translocation to the MOM is particularly important in the apoptotic pathway regulation, as 
traditionally has been considered an early step in the process of functional activation of the protein 
(Antonsson et al, 2001; Mikhailov et al, 2001; Nechushtan et al, 1999; Nechushtan et al, 2001; 
Valentijn et al, 2008). To date, three contrasting but not necessarily mutually exclusive models 
have been proposed to explain the mechanistic underpinnings of this process. 
The Cytosolic BH3-only interaction model postulates that selected BH3-only proteins such as 
BIM and PUMA, first bind to BAX non-canonical groove (α1/α6) at the cytosol. This 
protein:protein interaction triggers the release of BAX α9 from the canonical groove, thereby 
simultaneously allowing BAX translocation to the MOM together with exposition of BAX 
canonical BH3 binding-groove (Figure 1.8) (Edwards et al, 2013; Gavathiotis et al, 2010; 
Gavathiotis et al, 2008; Leshchiner et al, 2013; Walensky, 2013). 
The Combined BH3-only and MOM interaction model: Here, first BH3-only proteins bind to the 
MOM, and this protein:lipid interaction is a pre-requisite for  BAX recruitment to the 
mitochondria. Interaction of BH3-only proteins with BAX at the MOM level leads to 
disengagement of BAX´s C-terminal helix from the hydrophobic groove (Lovell et al, 2008; 
Wilfling et al, 2012).  
The Dynamic MOM interaction model or retrotranslocation postulates that in healthy cells, BAX 
is not only in the cytosol but it is also constitutively targeted to the MOM, maintaining a dynamic 
equilibrium between the two subcellular compartments. Some studies suggest that BAX is 
actively retrotranslocated from the MOM by several antiapoptotic proteins such as BCL2 or BCL-
XL (Edlich et al, 2011b; Todt et al, 2013), while others suggest that BAX retrotranslocation may 
occur independently to the presence of antiapoptotic and BH3-only proteins (Schellenberg et al, 
2013). Recently, has been demonstrated that BAX-homolog, BAK, is also in a antiapoptotic-
regulated dynamic equilibrium, but its hydrophobic C-terminal displaced the equilibrium to the 
membrane targeting (Todt et al, 2015). 
Within this last framework, it is conceivable that specific non BCL-2 related proteins or lipid 
factors present at the MOM may play a role in the reversible disengagement of BAX C-terminal 
hydrophobic helix. However, as some authors have been able to reproduce BAX`s 
retrotranslocation in vitro by using recombinant proteins and model membranes, the presence of 
other non-BCL2 proteins cannot be an essential requirement (Bleicken et al, 2017). Moreover, 
although the precise extent of BAX insertion in the MOM remains not well defined, this 
retrotranslocation process must require the removal of protein–lipid interactions, which 
theoretically should be thermodynamically unfavourable. Unless a molecular mechanism that 
provides energy for retrotranslocation is discovered, one could also reason that the dissociation 
of BAX from the membrane could proceed spontaneously via a low energy barrier accessible by 
thermal fluctuations (Cosentino & Garcia-Saez, 2017). 
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Regarding mitochondrial targeting of BH3-only proteins, one possibility is that they translocate 
to the MOM by binding to resident multidomain BCL-2 proteins (i.e. via protein:protein 
interactions) (Schinzel et al, 2004). Alternatively, considering that most BH3-only proteins 
contain a C-terminal hydrophobic domain similar to that found in multidomain proteins, BH3-
only proteins could also be targeted to the MOM via direct interaction with MOM lipids (Wilfling 
et al, 2012) and once in the MOM, the BH3 only proteins could attract to the multidomain family 
members. Remarkably, CL-binding domains have been identified in tBID and BAD (Gonzalvez 
et al, 2005; Gonzalvez et al, 2010; Hekman et al, 2006; Lutter et al, 2000; Petit et al, 2009). See 
also 1.6.2 section or lipid:BCL2-proteins interaction section. 
Of note, each type of BH3-only protein displays a distinct tissue distribution, and usually is the 
target of a particular signal transduction pathway. For example, in the case of BID, it is located 
in the cytosol adopting an inactive form (Chou et al, 1999; McDonnell et al, 1999; Wang et al, 
1996), then its cleavage by caspase-8 exposes a previously buried hydrophobic surface and 
reduces its negative molecular charge prompting its membrane targeting (Gross et al, 1999). BIM 
and BMF seem to be bound to cytoskeletal structures under healthy conditions, however during 
apoptosis, are translocated to the MOM (Puthalakath et al, 1999; Puthalakath et al, 2001). BAD 
is sequestered in the cytosol by 14-3-3 scaffold proteins, while upon dephosphorilation it is 
targeted to the MOM- or stays in cytosolic forming a complex with BCL-XL (Datta et al, 2002). 
1.5.3 Regulation of BAX/BAK permeabilization function 
The complex level of regulation needed to decide the cell fate of the cell is associated with an 
intricate interaction network of BCL-2 family proteins, among themselves, as well as with other 
cellular components. It is well known that BH3-only proteins discharge their pro-apoptotic 
functions through BAX-type proteins, while their activity is suppressed by anti-apoptotic BCL-
2-type proteins (Cheng et al, 2001; Zong et al, 2001). However, the exact hierarchy of these 
interactions and the role of other MOM factors remain controversial. 
Historically, largely based on solution binding studies between pro- and antiapoptotic family 
members, two seemingly opposing models emerged: the indirect and the direct activation models. 
Then, the MOM itself has been considered as one of the main regulators of BCL-2 family member 
interactions and functions. Thus, at least three non-mutually exclusive models exist to explain 
how interactions among the BCL-2 family proteins regulate MOMP and apoptosis (Figure 1.9).  
1.5.3.1 Indirect activation model 
In the indirect activation model or derepression model, the BCL-2 type proteins are continuously 
bounded to BAX-type proteins, and BH3-only proteins act by binding to and neutralizing BCL-2 
type proteins, thereby freeing BAX-type proteins to elicit MOMP (Chen et al, 2005; Willis et al, 
2005). The different affinities of soluble BH3 domain peptides for anti-apoptotic BCL-2 type 
proteins offered a potential explanation for the dissimilar lethality observed in BH3-only proteins. 
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Whereas BIM, PUMA and tBID bind avidly to all the pro-survival proteins, the rest of BH3-only 
proteins associate only with specific antiapoptotic. For example, NOXA binds only to MCL-1 
and BFL1, while BAD binds only to BCL-2, BCL-XL and BCL-W. Importantly, the promiscuous 
binders (e.g. BIM, BID and PUMA) are much more potent killers than those that cannot engage 
all the pro-survival proteins, but the combination of NOXA and BAD potently induces cell death 
(Chen et al, 2005). Indeed, based on the specific derepressors BAD and NOXA, BH3-like or BH3 
mimetic anticancer drugs have been designed. These structurally equivalent molecules, BAD-like 
ABT737 and NOXA-like S63845(Kotschy et al, 2016), retain the specific ability to block certain 
antiapoptotic proteins, which are one of the main reasons for chemotherapy resistance (Opydo-
Chanek et al, 2017a; Opydo-Chanek et al, 2017b; Vela & Marzo, 2015). 
 
Figure 1.9 Scheme of the models proposed to describe the regulation of the BAX/BAK 
permeabilization function. Antiapoptotic proteins are represented by BCL-XL (blue), multidomain 
proapoptotic proteins by BAX (green) and BH3 only proteins, sensitizers by BAD (yellow) and activators 
by tBID (red). (A) In the “Indirect model”, BH3-only proteins bind BCL-XL, releasing bound BAX that 
could self-activate in the absence of any other protein. (B) The direct model states that BH3 only proteins 
comprise two classes: the activators (here tBID) that are bound to antiapoptotic proteins, but once 
displaced by the sensitizers (BAD) could lead to activate directly BAX or BAK. (C) In the membrane 
model, the membrane is a regulating parameter of the interaction of the three subgroups of proteins. Taken 
from (Basanez & Hardwick, 2008). 
Another postulate of the indirect activation model is that BAX-type proteins are structurally active 
but remain inhibited under non-apoptotic conditions due to binding to antiapoptotic proteins. 
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Thus, once BAX-type proteins are liberated from their inhibitory interactions with BCL-2 type 
proteins they can lead to MOMP. Consistent with this view, in the absence of any other BCL2 
proteins, heat-activated BAX can promote cyt c release in isolated mitochondria or in MOM-like 
vesicles. In addition, BAX mutants harbouring specific substitutions in their BH3 domain that 
prevent their sequestration by BCL-2-type proteins, but not their homodimerization activity, 
provoke unrestrained apoptosis (Czabotar et al, 2011; Fletcher et al, 2008).  
However, the indirect activation model cannot explain the fact that only a minor portion of 
BAX/BAK is sequestered by antiapoptotic proteins in vivo. Moreover, mutants of BCL-2-type 
proteins that fail to bind BAX and BAK can be fully protective against cell death (Cheng et al, 
1996). Furthermore, we cannot exclude the possibility that other non BCL2 proteins are involved 
in BAX-mediated apoptosis and pore formation. 
1.5.3.2 Direct activation model 
The direct activation model states that BAX-type proteins are activated by binding to certain BH3-
only proteins such as tBID, and the BCL-2-type proteins primarily function by sequestering these 
activators from BAX/BAK. This model was first proposed to address the experimental 
observation that peptides representing the BID BH3 and BIM BH3 domains, unlike other BH3 
peptides (e.g. BAD and NOXA), seemingly suffice to activate the mitochondria-permeabilizing 
function of BAX/BAK (Kuwana et al, 2005; Letai et al, 2002; Wei et al, 2000). Therefore, BH3 
only proteins comprise two classes: those that directly activate BAX/BAK named “direct 
activators” such as tBID, BIM and PUMA; and those that displace the activator proteins from 
antiapoptotic proteins and activate BAX/BAK indirectly, known as “sensitizers” or “de-
repressors” such as BAD, NOXA or BMF. In agreement with this model, several groups showed 
that tBID efficiently activates the permeabilizing function of BAX and BAK in pure lipid 
membranes (Bleicken et al, 2010; Etxebarria et al, 2008; Kuwana et al, 2002; Lovell et al, 2008; 
Oh et al, 2010; Terrones et al, 2004).  
In this context, the main function of the anti-apoptotic proteins is to sequester the activator BH3 
only proteins BIM, BID and PUMA, thereby blocking their activation of BAX/BAK. In contrast 
to the well-established binding of the BH3-only protein to antiapoptotic members, the main caveat 
for the direct model was the difficulty to detect an interaction between the BH3-only proteins and 
BAX-type members. These and other observations led to a “hit-and-run” mechanism for 
BAX/BAK activation by selected BH3-only proteins (Dai et al, 2011; Eskes et al, 2000; Lovell 
et al, 2008; Wei et al, 2000), based on a transient interaction between BH3-only “ligands” and 
BAX-type “receptors”.  
Nevertheless, fluorescence resonance energy transfer (FRET) spectroscopy and fluorescence 
biocomplementation studies showed steady-state interaction between BAX and tBID measured 
in liposomes (Lovell et al, 2008) and in cells (Vela et al, 2013). In addition, recent structural 
studies provide strong support for a direct physical interaction between BH3 domains of selected 
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BH3-only proteins and BAX-type proteins. On the one hand, NMR studies of BIM and PUMA 
SABH peptides bound to full-length BAX in non-canonical surface between α1-α6 (Gavathiotis 
et al, 2010; Gavathiotis et al, 2008; Leshchiner et al, 2013; Walensky, 2013). On the other hand, 
X-Ray crystal structure of synthetic BID BH3 peptide bound to the canonical groove of 
BAX∆C21 (BAX lacking the tail-anchor sequence) (Czabotar et al, 2013) and BIM BH3 peptide 
bound to the canonical groove of truncated version of BAX-homolog, BAK (Moldoveanu et al, 
2013) were reported firmly confirming a canonical BH3-into-groove interaction. Importantly, 
from these studies an additional hydrophobic interaction (h5) was described near the N-terminus 
which could be the signature amino acid for distinguishing activator and sensitizer BH3 domains 
(Czabotar et al, 2013). In addition, combining size exclusion chromatography, double-electron 
resonance (DEER) and CHAPS, the oligomerization of BAX in solution upon BIM BH3 
activation has been reported, providing a functional activation of BAX in the absence of MOM 
or MOM-like membranes (Sung et al, 2015).  
Several caveats have been raised to this model. First, non-canonical BH3-binding site in BAX 
involves several specific residues (K21, R134, Q28, Q32 and E131) surrounding the hydrophobic 
surface. According to the authors, the SABH:BAX binding was shown to be specifically disrupted 
by K21E mutagenesis (Gavathiotis et al, 2010; Gavathiotis et al, 2008; Kim et al, 2009), but 
however, knock-in studies showed that BAXK21E mutant induces apoptosis as efficiently as wt 
BAX does in BAX/BAK DKO cells. Second, it remains to be proven that putative BH3-only 
activators other than BIM (Gavathiotis et al, 2008) and PUMA (Edwards et al, 2013), such as 
tBID, also bind the non-canonical groove of BAX to trigger its functional activation. Third, it 
remains to be rigorously shown that the binding interactions observed between the chemically 
modified BIM or PUMA SABH peptides and BAX in solution mirror the binding interactions 
occurring at the MOM level between the entire BIM or PUMA protein and BAX. Despite these 
caveats, Walensky L.D. and colleagues proposed a new model for BAX activation. The first step 
would consist in the union of BIM to the non-canonical groove of BAX at the cytosol, followed 
by release of BAX C-terminal domain allowing BAX MOM translocation, and enabling another 
BH3 interaction through the BAX canonical groove (Edwards et al, 2013; Leshchiner et al, 2013; 
Walensky, 2013).  
Finally, the structures obtained by X-Ray crystallography described above does not explain how 
direct activators might bind the full-length BAX, as its canonical groove is occupied by the C-
terminal helix 9. Alternatively, as mentioned before,  BAX may be in dynamic equilibrium 
between cytosol and membrane with the C-terminal anchorage being only transient (Schellenberg 
et al, 2013), thus, the canonical hydrophobic groove will be free for BH3 only binding. However, 
even if in the studies where the helix 9 is included (Sung et al, 2015), BAX activation requires a 
detergent (in order to mimic membrane lipophilic conditions) to dimerized.  
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1.5.3.3 Membrane models 
More recent models emphasize the role of the MOM in the BCL-2 family proteins interactome 
during apoptosis (Basanez & Hardwick, 2008; Billen et al, 2008; Leber et al, 2007; Leber et al, 
2010). According to the “Membrane-Embedded Model”, the association of BCL-2 proteins to the 
MOM causes conformational changes in these molecules that affect their binding interactions. 
Recent findings based on advance fluorescence microscopy techniques indicate that BCL-XL 
affinity for tBID is higher at the membrane level than in solution or that the presence of a 
membrane is necessary for tBID to interact with BAX (Garcia-Saez et al, 2009; Liu et al, 2012).  
Moreover, even if has been very controversial and nowadays has lost impact, some authors 
postulated that BH3 only proteins function as direct activators of BAX/BAK and can both activate 
or inhibit the role of the antiapoptotic proteins. In this way, BH3 only sensitizer proteins could 
bind to the hydrophobic groove of the antiapoptotic proteins inhibiting its prosurvival function. 
On the other hand, in some conditions interaction of BH3 only proteins with BCL-2 type proteins 
leads to membrane insertion of α5 of the latter proteins (Dlugosz et al, 2006; Leber et al, 2010; 
Peng et al, 2006). Based on these observations, it has been proposed that BCL-XL actually needs 
to be activated similarly to BAX to perform its antiapoptotic function, and BCL-XL and BAX 
compete with each other at different steps along the molecular pathways leading to their 
functional activation. In other words, BCL-XL would inhibit apoptosis by acting as a dominant-
negative version of BAX (Billen et al, 2008; Shamas-Din et al, 2013). 
On the other hand, a “Unified Model” was proposed based on the relative affinities of different 
BH3 domain chimeras for BCL-2 type proteins. Two types of inhibition interactions between 
MOM-localized antiapoptotic proteins and proapoptotic partners were proposed: interactions with 
BH3-only direct activator proteins (MODE 1) or interactions with activated effectors BAX/BAK 
(MODE 2). Both mechanisms could inhibit MOMP, but antiapoptotic binding to BAX/BAK is 
more efficient than binding BH3 only activators (Llambi et al, 2011). Since activated BAX/BAK 
can activate another BAX/BAK molecules (Gavathiotis et al, 2010), therefore inhibiting this auto-
activation process seems more efficient than sequestration of all the direct activator BH3 only 
proteins (Llambi et al, 2011). However, this assumption is on debate, as recently published in 
vitro studies by combining model membranes and recombinant proteins reveal that the inhibition 
interaction of BH3 only proteins by the BCL2-type proteins is much more efficient (Bleicken et 
al, 2017; Landeta et al, 2014).  
Finally, another increasingly recognized aspect that determines the binding interactions and 
functions of BCL-2 family proteins is the lipid composition of the MOM (Chipuk et al, 2012; 
Terrones et al, 2004; Terrones et al, 2008). Building in those observations, a “Lipid-Centric 
Model” has been proposed, where apoptosis-related lipids modulate the activation and action of 
BCL-2 family members, either through a direct and stereoselective interaction (Chipuk et al, 
2012), or via a bilayer-mediated effect (Basanez et al, 2012). Regarding the latter, it is conceivable 
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that the BH3-only protein cBID stimulates BAX permeabilizing function not only by direct 
binding via BH3-into-groove interactions, but also by altering the physical properties of the host 
bilayer via cBID:lipid interactions (Basanez et al, 2002; Bleicken et al, 2016; Terrones et al, 
2004). Upon protein adsorption at the bilayer/solution interface, these amphipathic helices can 
change lipid bilayer properties such as the intrinsic curvature and elasticity, which may alter the 
bilayer deformation energy associated with protein conformational changes (McIntosh & Simon, 
2006). Of note, lipid-mediated modes of BCL-2 family protein action could also be linked to 
mitochondrial dynamics (Basanez et al, 2012; Etxebarria et al, 2009; Montessuit et al, 2010). In 
stark support of the membrane relevance, recently, Oneil et al 2016 demonstrated in a study using 
a new cell line, knocked out for the most abundant BCL2 proteins, that BAX overexpression is 
sufficient to promote apoptosis (O'Neill et al, 2016). Moreover, in our group we have shown that 
membrane could modulate the interactome among BCL2 proteins as its composition can alter the 
activity of MCL1, which can inhibit BAX pore formation or promote itself a pore formation 
depending on the CL content (Landeta et al, 2014). 
 
1.6 THE MITOCHONDRIAL LIPID-FINGERPRINT AS A 
CELL FATE INDICATOR 
1.6.1 Mitochondrial lipids 
Mitochondria play a critical role in lipid metabolism and dynamics. Key steps as lipid 
degradation, fatty acid synthesis, together with essential reactions for the biosynthesis of 
significant levels of lipids occur in the mitochondria. Under normal conditions, the major 
components of mitochondrial membranes are glycerophospholipids and to a lesser extent 
sphingolipids and sterols which are important components of plasma membrane, Golgi apparatus, 
and lysosomal compartments, and are only found in trace amounts in mitochondrial membranes 
(van Meer et al, 2008). Of note, in cells involved in the biosynthesis of steroid hormones, 
mitochondria have a higher content of sterols (Strauss et al, 2003). 
The glycerophospholipid composition of mitochondrial membranes has been determined in yeast 
and mammalian cells, and although the exact composition determined in different studies varies 
(most likely because of differences in the growth conditions or in the purity of the analysed 
fractions), the relative abundance of different phospholipids remains within a relatively narrow 
range (Fleischer et al, 1967; Osman et al, 2011; van Meer et al, 2008). Thus, even if mitochondria 
are highly dynamic organelles, its lipid composition varies little among different cells, suggesting 
that major changes cannot be tolerated (Figure 1. 10). 
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Figure 1.10 Lipid composition of mitochondria in healthy cells. The lipid compositional data are 
expressed as a percentage of the total phospholipid in mammals (red) and yeast (green) mitochondria. PC: 
Phosphatidylcholine; PE: Phosphatidylethanolamine; PI: Phosphatidylinositol; PS: Phosphatidylserine; 
CL: Cardiolipin and R: remaining lipids Adapted from (van Meer et al, 2008). 
Regarding the relative abundance of glycerophospholipids at the MOM and MIM, a consensus 
exists for phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylinositol 
(PI). Moreover, it should be noted that the only asymmetrically distributed lipid is the CL. 
Originally, CL was thought to be present almost exclusively within the MIM, representing on 
average approximately ≈ 5% of the total lipid content of the MOM. However, subsequently it was 
shown that local CL concentrations at specific MOM domains known as the mitochondrial 
membrane contact sites (CS) can be as high as ≈25% (Ardail et al, 1990). Moreover, a recent 
study in yeast corroborates this CL-patches in the MOM lipid composition (Gebert et al, 2009). 
Because CL is the signature glycerophospholipid of mitochondria it is not surprising that CL is 
implicated in many mitochondrial functions in healthy cells, including maintenance of normal 
organelle ultrastructure, energy metabolism, protein import processes, and mitochondrial 
dynamics (Schlame & Ren, 2009; Tamura et al, 2009). However, as commented previously, far 
from being inert structural elements mitochondrial lipids can affect the function of specific 
mitochondrial proteins that are implicated in the apoptotic pathway, either through specific 
binding interactions or via changes in the physical properties mitochondrial membrane. 
1.6.2 BCL2-mediated apoptosis-related mitochondrial lipids 
MOM lipid composition is critical for the BCL-2 family proteins function, and therefore 
perturbation of the lipid composition in the mitochondria can lead to phenotypes associated with 
deregulated cell death (Canals & Hannun, 2013; Claypool & Koehler, 2012; Van Brocklyn & 
Williams, 2012). In this section, we describe the main characteristics of mitochondrial lipid 
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composition as well as proposed roles of apoptosis-related lipids in regulating the function of 
selected proapoptotic BCL-2 family members and mitochondrial proteins. 
1.6.2.1 Cardiolipin  
CL is the most specific lipid constituent of the mitochondrial membranes. CL is a unique 
phospholipid for at least three reasons. First, it is almost exclusively found in association with the 
MIM, the compartment in which it is synthesized. Second, CL is a double phosphoglycerolipid 
composed by two phosphatidyl residues bridged by a glycerol. Thus, it has two phosphate 
headgroups and four attached fatty acyl chains. Third, CL is a so-called structural phospholipid 
capable of acquiring lamellar and hexagonal structures (Figure 2.2, page 64). 
Structure 
CL is a phospholipid composed of two phosphatidyl moieties linked to a central glycerol group 
(Figure 1.11). The two phosphatidyl moieties are stereochemically non-equivalent, because one 
is in pro-R and the other is in pro-S position with respect to the central carbon atom of the glycerol 
bridge. The presence of two phosphate groups confers two negative charges, a fact that could be 
of importance for protein interactions (Claypool et al, 2008). 
Molecular species of CL derive from permutations of the four acyl chains. Eukaryotic CL have a 
unique fatty acid pattern, which is essentially restricted to C18 chains. However, there is an 
exception found in the yeast Saccharomyces cerevisiae, in which CL contains about equal 
amounts of oleoyl (18:1) and palmitoleoyl (16:1) residues. In the case of mammals, the dominant 
C18 chain is the linoleoyl (18:2). On the contrary, in bacteria CL containing mostly saturated and 
monoenoic acyl groups with 14-18 carbon atoms can be found (Schlame & Ren, 2009; Schlame 
et al, 2000). 
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Figure 1.11. Cardiolipin structure. The molecule consists of two sn-glycero-3-phosphate moieties linked 
by a glycerol group. Four acyl groups (X1,X2,Y1,Y2) are attached to the glycerophosphates. Both 
glycerophosphates carry obligate chiral centres in R conformation. The central glycerol carries a prochiral 
center (if X1=Y1 and X2=Y2) or a true chiral centre (if X1≠Y1 and X2≠Y2). As a result, the two 
glycerophosphates occupy different estereochemical positions. Image adapted from avatilipids.com and 
(Schlame & Ren, 2006). 
CL displays characteristic phase polymorphism, being able to form micellar, lamellar and 
hexagonal structures. Phase transitions from micellar to lamellar, and lamellar to hexagonal are 
favoured by the presence of divalent cations, low pH, high ionic strength and a high number of 
acyl groups. The importance of head group charges for phase behaviour are visible by the fact 
that ionic strength and the pH induce hexagonal structures. Another determining factor seems to 
be the volume of the hydrophobic moiety. For instance, dilysocardiolipin, which only contains 
two acyl chains, may form micellar and lamellar structures, whereas acylcardilipin, which 
contains an extra acyl chain compared to CL, always exists in hexagonal state. Hexagonal CL 
may play a role in membrane contact zones and other areas where the bilayer structure is perturbed 
(Ortiz et al, 1999). 
Biosynthesis and degradation 
The biosynthesis of CL begins with the formation of phosphatidic acid from glycerol-3-phosphate 
and activated fatty acids. Then, phosphatidic acid reacts with CTP to form the high-energy 
phosphoanhydride intermediate CDP-diacylglycerol, by the enzyme CDP-diacylglycerol 
synthase. This enzyme is localized to the ER, but can be also found in mitochondria. The activated 
phosphatidyl group is subsequently transferred to the sn-1 hydroxyl group of glycerol-3-
phosphate to yield phosphatidilglycerolphosphate (PG-P). The enzyme responsible to catalyse the 
formation of the PG-P is the phosphatidylglycerolphosphate synthase (Pgs1). It has been 
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observed, that deletion of the gene encoding this enzyme is not lethal, but seriously compromise 
mitochondrial function. Then, the PG-P is dephosphorylated to phosphatiydlglycerol by 
phosphatidylglycerolphosphatase enzymes. These enzymes are Gep4 in yeast and PTPMT1 in 
mammals. These enzymes are both anchored to the matrix side of the MIM. Loss of this enzymes 
leads to PG-P accumulation, destabilization of the respiratory chain supercomplexes and impaired 
cell growth. From here, the pathway diverges into prokaryotic and eukaryotic branches. In 
prokaryotes, phosphatidylglycerol receives a phosphatidyl group from another 
phosphatidylglycerol by transesterification. In eukaryotes, phosphatidylglycerol receives an 
activated phosphatidyl group from phosphatidyl-CMP, which is catalysed by CL synthase, which 
is a phosphatidyltransferas (Claypool & Koehler, 2012; Horvath & Daum, 2013; Schlame, 2008) 
(Figure 1.12). 
 
Figure 1.12. Overview of CL biosynthesis and remodelling. Image taken from (Claypool & Koehler, 
2012). 
CL requires continuous turnover to maintain the steady state. CL can be degraded by at least two 
enzymes; phospholipase A and phospholipase D. In 2006 a novel mitochondrial phospholipase D 
specific for CL and implicated in mitochondrial fusion was described (Choi et al., 2006). In this 
case, the product of CL hydrolysis is the fusogenic phospholipid phosphatidic acid (PA). Thus, 
mitochondrial phospholipase D could link mitochondrial dynamics to the CL metabolism. During 
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apoptosis the degradation of CL is linked to its oxidation. The mitochondrial respiratory chain is 
the main source of reactive oxygen species (ROS) and CL is a prime target due to its proximity 
to the ROS source and to its highly unsaturated acyl chains. Indeed, selective ROS-mediated CL 
peroxidation has been demonstrated to precede mitochondrial cyt c release during apoptosis 
(Kagan et al., 2005; Ott et al., 2007). 
CL during apoptosis 
Different lines of evidence indicate that during apoptosis the net content of CL at the MOM 
increases. Phospholipid transport between MOM and MIM has been proposed to occur at CS 
between both membranes (Ardail et al, 1991; Simbeni et al, 1991). Although the mechanism 
responsible for CL translocation from the MIM to the MOM during apoptosis is still unsettled, 
mitochondrial phospholipid scramblase-3 (PLS3) (Liu et al, 2003a; Liu et al, 2008), 
mitochondrial kinases (Epand et al, 2007) as for example nucleoside diphosphate kinase Nm23-
H4/NDPK-D (Schlattner et al, 2013), and specific BCL-2 family proteins such as tBID could be 
also implicated in this process due to a membrane remodelling and reordering of CL at the CS 
(Esposti et al, 2001; Gonzalvez et al, 2005; Gonzalvez et al, 2010; Heit et al, 2011; Jalmar et al, 
2013; Scorrano et al, 2002; Tyurin et al, 2007). In fact, the first set of evidence linking CL to 
apoptosis induction was the discovery that MOM-localized CL acts as a mitochondrial receptor 
for tBID (Lutter et al, 2000). Alternatively, considering that in the presence of Ca++ CL forms 
highly-curved inverted hexagonal HII structures (Gonzalvez & Gottlieb, 2007; Grijalba et al, 1999; 
Killian et al, 1994; Ortiz et al, 1999), calcium accumulation could cause significant stress in CL-
enriched regions of mitochondrial membranes, promoting the redistribution of CL itself to the 
surface of the mitochondria via CS (Schug & Gottlieb, 2009). 
In pure lipid model membranes, CL promoted association of tBID to the liposomes in a dose-
dependent manner (Lutter et al, 2001), and  independently of BAX translocation (Gonzalvez et 
al, 2010). In a cell line carrying a temperature-sensitive CL synthase gene, reduction of 
mitochondrial CL levels via temperature changes inhibited tBID targeting to the MOM (Lutter et 
al, 2000). Subsequently, tBID was found to localize preferentially at MOM CS by 
immunoelectron tomography and mitochondrial subfractionation (Lutter et al, 2001). On the other 
hand, caspase-8, the proteolytic enzyme that generates tBID, targets the mitochondria via 
interaction with CL, mediating BID cleavage, which also translocates to mitochondria (Gonzalvez 
et al, 2008; Jalmar et al, 2013). Indeed, masking CL is sufficient to block the accumulation of 
caspase-8 and tBID on apoptotic mitochondria, preventing Cyt c release (Heit et al, 2011)(Figure 
1.13). 
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Figure 1.13 Manifold roles of CL during apoptosis. (1) Cyt c binds to CL in the inner membrane. (2) 
Release of cytochrome c upon oxidation of CL. (3) Pro–caspase-8 (pro-8) binds to the surface of 
mitochondria and undergoes autocatalytic processing in a CL-dependent manner. (4 and 5) BID cleavage 
to truncated BID (tBID) by caspase-8 (4) and activation and oligomerization of BAX/BAK is stimulated 
by CL (5). (6) PLS-3 allows export of CL from the inner to the outer mitochondrial membrane (Osman et 
al, 2011). 
Additionally, accumulation of anionic lipids in certain cellular membranes can target polycationic 
motifs of proteins (Yeung et al, 2006). It is therefore conceivable that an increase in the anionic 
charge (principally CL) in the MOM during early stages of apoptosis (Heit et al, 2011), could 
lead to the recruitment of BCL-2 family proteins. Noteworthy, a specific binding pattern for CL 
has been proposed. Due to the observation of tight binding interactions with three residues (KKY, 
RKY, and HRN) in different crystal structures of proteins bound to CL, a “XXY” motif, where X 
is a positively charged and Y a polar residue, can be suggested as a preliminary CL binding motif. 
It is important to point out that these suggested motifs are nonlinear in amino acid sequence, so 
that residues from different subunits may contribute to CL binding (Palsdottir & Hunte, 2004). 
Also, due to the limited number of CL: protein structures available to date, caution should be 
exercised when assuming that the XXY motif constitutes a common CL-binding motif in 
mitochondrial proteins. 
In this regard, a putative CL-binding domain has been proposed for tBID consisting of lysines 
157 and 158 which might establish electrostatic interactions with the CL headgroup (Gonzalvez 
et al, 2010; Petit et al, 2009). Of note, it has also been described that other phospholipids as PC 
(Garofalo et al, 2003), PG and PE (Esposti et al, 2001) allow membrane translocation of tBID. 
Furthermore, it has also been proposed that CL promotes tBID association with the MOM by 
changing the physical properties of its lipid bilayer, rather than via a direct and specific tBID: CL 
interaction (Lutter et al, 2000). 
Different types of CL modifications have also been linked to apoptosis. For example, peroxidation 
of CL facilitates Cyt c detachment from the MIM, thereby allowing the presence of a “free” pool 
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of Cyt c at the intermembrane space, which can be released from mitochondria upon MOMP 
triggering (Kagan et al, 2005; Ott et al, 2002). CL peroxidation promotes BAX-driven liposome 
permeabilization and MOMP as well, apparently by changing membrane curvature (Mari et al, 
2008). During apoptosis, mitochondria accumulate monolysocardiolipin (MCL), a metabolic 
product of CL, which can interact with tBID and elicit membrane curvature changes (Esposti et 
al, 2003; Liu et al, 2005). In addition, a peptide representing the α6 helix of cBID has been 
described to (i) bind to mitochondria and CL-containing model membranes, and (ii) induce 
mitochcondrial lipid peroxidation and ROS production (Gonzalvez et al, 2010). 
During apoptosis, two other glycerolipids that accumulate in mitochondria before MOMP 
showing potential to induce membrane curvature changes are lysophosphatidylcholine (LPC) and 
diacylglycerol (DAG) (Crimi & Esposti, 2011).  Interestingly, LPC and DAG have been shown 
to modulate the membrane-permeabilizing function of BAX by altering the energetic proclivity 
for proteolipidic pore formation (Basanez et al, 2002; Terrones et al, 2004). 
1.6.2.2 Sphingolipids 
To date, much of the work on sphingolipids aimed to deciphering the complex biology of 
sphingolipids as glycosphingolipids and sphingomyelin, which play an important role in diverse 
processes, e.g. cell adhesion or signal transduction. More recently, ceramide (CER), ceramide-1-
P (CER-1P), sphingosine (Sph) and sphingosine-1-P (S1P) have been recognized as playing 
relevant physiological functions in the regulation of cell proliferation, migration and 
differentiation, regulation of angiogenesis and in the pathobiology of some diseases as 
autoimmune diseases, neurodegenerative diseases and cancer (Van Brocklyn & Williams, 
2012)(Gomez-Munoz, 2006). 
CER and CER-1P are antagonist molecules that can be interconverted by phosphorylation and 
dephosphorilation. Importantly, an appropriate balance between them seems to be crucial for 
tissue homeostasis, thus their dysregulation could end in pathological situations (Gangoiti et al, 
2010). CER have been reported to be involved in apoptosis, although these lipids are minor 
components of MOM under normal conditions (Goonesinghe et al, 2005; Obeid et al, 1993; 
Sandra et al, 2005; Siskind, 2005; Sorice et al, 2009). However, it is now well established that 
cellular CER levels increase in response to a variety of apoptotic stimuli as TNFα, FAS ligand or 
DNA damage (Cremesti et al, 2001; Obeid et al, 1993), with CER generation occurring prior to 
the activation of the apoptotic machinery (Selzner et al, 2001). CER has also been reported to 
produce alteration in bioenergetics, ROS production and permeabilization of MOM (Birbes et al, 
2001; Colombini, 2010; Siskind, 2005). The latter process could occur through formation of 
MOM channels exclusively composed of CER molecules, although this model has not gained 
general acceptance (Siskind, 2005; Siskind et al, 2002; Stiban et al, 2006).  
Regarding BCL-2 family proteins, CER production increases BAX translocation to mitochondria 
(Birbes et al, 2005) and stimulates MOMP driven by BAX/BAK, but the underlying mechanisms 
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are still under debate. On the one hand, the possibility has been raised that during apoptosis CER 
and BAX may form composite channels directly responsible for enabling the release of 
mitochondrial apoptogenic factors (Ganesan et al, 2010). BAK (but not BAX) has also been 
suggested to activate CER synthesis and the increase in CER levels would result  in subsequent 
synergistic channel formation at the MOM by CER and BAX/BAK, implying a non-redundant 
function for BAX and BAK in apoptosis and metabolism (Beverly et al, 2013; Siskind et al, 2010). 
On the other hand, it has been shown that sphingolipid metabolites other than CER cooperate with 
BAX-type proteins in promoting MOMP. Specifically, transfer of ER-localized CER to the 
mitochondria leads to production of S1P and hexadecenal (HEX), which in turn, are implicated 
in functional activation of BAK and BAX, respectively (Chipuk et al, 2012). Experiments using 
pharmacological inhibitors of sphingolipid enzymes together with reconstitution studies on 
isolated mitochondria suggest that the mitochondrion-specific sphingosine kinase 2 (producing 
S1P) and S1P lyase (producing HEX) stimulate apoptosis driven by BAK and BAX, respectively.  
Finally, the last group of apoptosis-related sphingolipids is that represented by gangliosides. GD3, 
a CER-based glycolipid, has been reported to accumulate in mitochondria in several cell lines in 
response to CER or TNFα treatment suggesting that GD3 contributes to the mitochondrial 
apoptotic pathway. In fact, exogenous addition of GD3 leads to caspase activation in intact cells, 
and treatment of isolated mitochondria with GD3 induces cytochrome-c release (Rippo et al, 
2000). However, little is known about the impact of this particular ganglioside on BCL-2 protein 
family function. 
1.6.2.3 Cholesterol 
Cholesterol (CHOL) plays an important role in the structure, physical properties and function of 
biological membranes. The CHOL/phospholipid mass ratio of MOM is normally kept between 
3% and 24% (Daum, 1985), although different tumour cells were reported to have higher levels 
of CHOL in their mitochondrial membranes (Baggetto et al, 1992; Crain et al, 1983). However, 
CHOL has been described to have dual roles in cell death regulation. This dual role apparently 
depends on the regulation of mitochondrial GSH (mGSH) stores, which in turn play a fundamental 
role in oxidative stress, CL maintenance and cell death susceptibility (Baulies et al, 2017; Montero 
et al, 2010). 
Mitochondrial CHOL is emerging as an important regulatory factor of MOMP and cell death 
(Garcia-Ruiz et al, 2009). Different mechanisms have been proposed to explain the antiapoptotic 
effect of CHOL. First, high levels of CHOL have been shown to protect mitochondria from large 
amplitude swelling (Graham & Green, 1970) and proton leaking across the MIM, as well as to 
modify the activities of a number of mitochondrial membrane proteins implicated in apoptosis 
(Colell et al, 2003). Second, evidence was gathered supporting that CHOL inhibits BAX 
membrane insertion, oligomerization, and Cyt c release (Lucken-Ardjomande et al, 2008; 
Montero et al, 2008), either by changing lipid lateral organization or through changes in the 
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membrane elastic properties (Garcia-Ruiz et al, 2009; Montero et al, 2008). The ability of CHOL 
to form ordered microdomains in mitochondrial membranes has been linked to both regulation of 
BCL-2 protein function and apoptosis modulation in intact cells (Garofalo et al, 2005). A putative 
CHOL recognition amino acid consensus (CRAC) motif has also been identified in BAX, 
corresponding to residues 113 to 119 of the BAX α5-helix (Martinez-Abundis et al, 2011). 
However, the CRAC motif is a relatively poor conserved sequence. In addition, BAK does not 
contain a well-defined CRAC motif. 
1.6.3 Lateral segregation of mitochondrial lipids 
In addition to specific lipid moieties, lipid may also form lipid domains in mitochondria 
functioning as signalling platforms for BAX-type protein insertion, oligomerization and pore 
formation at the MOM. Little is currently known about the lateral distribution of phospholipids 
in mitochondrial membranes. The non–bilayer forming lipids PE and CL laterally segregate into 
distinct domains in bacterial membranes lacking sterols and sphingolipids (Kawai et al, 2004; 
Mileykovskaya & Dowhan, 2000; Nishibori et al, 2005). In the case of CL, clusters of certain size 
but not individual CL molecules may stabilize the geometry of highly curved regions of the 
membrane (Schlame & Ren, 2009). In consequence, the high membrane curvature at cristae tips 
may impose geometric constraints that could lead to an enrichment of CL and PE (Osman et al, 
2011), which are also enriched in CS (Ardail et al, 1990; Simbeni et al, 1991). Moreover, recently 
was reported that the fluidity of the lipid bilayer increased and its mechanical stability decreased 
with CL concentration, indicating that CL decreases the packing of the membrane and CL 
promotes the formation of membrane areas with apposed double bilayers or nonlamellar 
structures, similar to those proposed for mitochondrial contact sites. Altogether, goes in favour 
that CL induces membrane alterations that support the role of CL in facilitating bilayer structure 
remodelling, deformation, and permeabilization (Unsay et al, 2013). In addition, BID or tBID 
may facilitate the assembly of CL-enriched microdomains by segregating together with CL or 
MCL (Esposti et al, 2003; Gonzalvez et al, 2005; Gonzalvez et al, 2010; Gonzalvez et al, 2008; 
Kudla et al, 2000; Manara et al, 2009).  
Consistent with these ideas, it has been recently proposed that CL provides an anchor and an 
activating platform for caspase-8/BID, resulting in a change in the fluidity of the membrane when 
these three components are present together (Gonzalvez et al, 2008; Jalmar et al, 2013). In sum, 
these data support the existence of spatially CL-enriched microdomains in mitochondria that 
could act as platforms for recruitment of BCL-2 proteins and could also affect other mitochondrial 
processes, such as fusion or fission, as well as the insertion or extraction of membrane proteins 
(Figure 1.14). 
Alternatively, or in addition, mitochondria may also contain lipid microdomains reminiscent of 
the lipid rafts of the plasma membrane (Garofalo et al, 2003). Under pro-apoptotic stimulation, 
raft-like microdomains were detected on mitochondria that apparently contribute to apoptosis-
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associated modifications and to late apoptogenic events (Garofalo et al, 2005; Garofalo et al, 
2003; Malorni et al, 2007). These raft-like domains were enriched in gangliosides (GD3, GM3) 
and CL, while showing a relatively low content of CHOL (Malorni et al, 2007; Sorice et al, 2009). 
Disruption of such raft-like microdomains by methyl-β-cyclodextrin prevented mitochondria 
depolarization, Cyt c release and apoptosis execution. Depending on the physiological status of 
the cells, these raft-like microdomains seem to be enriched in specific mitochondrial proteins, 
including the voltage-dependent anion channel-1 (VDAC-1),  the fission protein hFis1, and BCL-
2 family proteins such as tBID and BAX (Morales et al, 2007). 
 
Figure 1.14 Schematic drawing illustrating how cardiolipin-enriched raft-like microdomains are 
essential activating platforms for apoptotic signals on mitochondria. CL-enriched microdomains, 
between the mitochondrial inner and outer membranes, represent specialized of mitochondrial membrane 
tBID is recruited and causes BAX/BAK oligomerization (Sorice et al, 2009). 
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1.7 MEMBRANE-ASSOCIATED STRUCTURES OF BAX  
BAX and its homolog BAK are key regulators of the mitochondrial pathway of apoptosis. On cell 
stress BAX and BAK accumulate at distinct foci on the mitochondrial surface where they undergo 
a conformational change, oligomerize, and mediate cytochrome c release, leading to cell death. 
The molecular mechanisms of BAX and BAK assembly and mitochondrial permeabilization have 
remained a long standing question in the field. Recent structural and biophysical studies at several 
length scales have shed light on key aspects of BAX and BAK function that have shifted how we 
think this process occurs. These discoveries reveal an unexpected molecular mechanism in which 
BAX (and likely BAK) dimers assemble into oligomers with an even number of molecules that 
fully or partially delineate pores of different sizes to permeabilize the MOM during apoptosis. 
Given the difficulty of applying conventional structural techniques to study membrane proteins, 
most detailed structural information available corresponds to BCL-2 family members in aqueous 
environments. So that, the first puzzle with mechanistically relevant information describing BCL2 
family proteins interactoma is mainly based on studied that lack in the presence of the membrane. 
However, the complexity and heterogeneity of the membrane, including curvature, lipid 
composition etc., has been considered particularly relevant. Indeed, as was described above, 
membranes are one of the main regulators of the targeting and function of these family proteins, 
and therefore the study of BCL2 proteins in a membrane environment seems to be compulsory. 
In the last decade structural information on these molecules in their membrane-associated states 
has started to emerge, providing fundamental insight about the structural changes accompanying 
membrane translocation and insertion of BCL-2 proteins during apoptosis. 
1.7.1 Conformational changes of BAX during activation. 
Understanding the structural changes driving BAX-type proteins from an apoptosis-inactive 
conformation to a fully activated structure responsible for MOMP has been considered the “holy 
grail” of the apoptosis research (Youle & Strasser, 2008). In the following sections, the recent 
progress made in elucidating structurally how BAX mediate MOMP in apoptosis is explained. 
Proving information, from the conformational changes of BAX needed for its activation in the 
membrane, through its molecular assembly into oligomers, to the most recent findings about the 
supramolecular organization of BAX in model systems and cells, and finally their implication in 
the apoptotic pore formation. These events, are usually encompassed in the following subsections: 
1) Early activation steps (N-terminal and BH3 exposure), 2) Membrane insertion, 3) 
Oligomerization and 4) Supramolecular Structures and Pore Formation. 
1.7.1.1 Early activation steps 
Biochemical and structural studies have shown that upon apoptosis induction, BAX and BAK 
undergo profound structural rearrangements, including N-terminus and BH3 domain exposure. 
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Of note in order to enable this restructuration, the C-terminus must be released from the 
hydrophobic groove (Figure 1.15). 
N-terminal exposure and C-terminal insertion 
The N-terminus of BAX and BAK contains two regions, the N-segment (residues 1-15 and 1-23 
for BAX and BAK respectively) and the α1 helix. The N-segment in BAX is flexible and exposed 
to the solvent (Suzuki et al, 2000). During apoptosis the N-terminus of BAX undergoes 
conformational changes, accompanied by different ellipticity and partial rotation of the α1 helix. 
This conformational change has commonly been used as a marker in cellular assays to detect early 
steps in BAX/BAK activation (Dewson & Kluck, 2009; Dewson et al, 2009; Dewson et al, 2008; 
Griffiths et al, 2001; Kim et al, 2009; Lalier et al, 2007; Nechushtan et al, 1999). Most data come 
from studies based on the conformation-specific antibodies that recognized the exposure of the 
hidden epitope: 6A7/49F9 antibody for BAX and Ab-1 antibody in the case BAK (Czabotar et al, 
2013; Dewson et al, 2008; Griffiths et al, 2001; Kim et al, 2009; Peyerl et al, 2007). These 
structural rearrangements have also been addressed by structural studies in active BAX/BAK 
conformation, showing that upon tBID activation helix α1 is liberated from the remaining 
structure of BAX/BAK along with the loop that interconnects α1-α2 (Bleicken et al, 2010; Oh et 
al, 2010).  
 
Figure 1.15. Two proposed sequences of BAX conformation change during early activation steps 
during apoptosis. The non-activated form of BAX is represented as a globular molecule (orange) 
containing a hydrophobic surface groove (α3/α4; green) and a buried BH3 domain (α2; red). A BH3-only 
protein binds BAX to its non-canonical groove (solid arrow) and initiates BAX conformational changes. In 
this model, first, BAX exposes its N-terminal (α1) and then the BH3 domain. Finally, the exposure of these 
domains leads to the dislodgement of the C-terminal domain (α9). By contrast in the other model (dashed 
arrow), the sequence is the opposite. First, the C-domain in BAX is released from the canonical groove; in 
this manner BH3-only proteins could bind this groove. Once BAX is activated the BH3 domain is exposed 
and then the N-terminal region. In this drawing the insertion of the α5-α6 central hairpin has not been taken 
into account. Taken from (Westphal et al, 2011). 
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In the specific case of BAX, it has also been described that the α1 helix stabilizes helix 9 
engagement into the hydrophobic groove, concluding that the N-terminal exposure is correlated 
with insertion of the protein into the MOM (Kim et al, 2009; Nechushtan et al, 1999). However, 
recent studies suggest that BAX tail-anchoring to the MOM precedes the conformational change 
leading to exposure of BAX N-terminal epitope (Schellenberg et al, 2013). In stark contrast, BAX 
bound to liposomes led to N-terminal exposure but without membrane insertion (Yethon et al, 
2003). This controversial issue is particularly important in the understanding of BAX membrane 
activities and the mode of inhibition exercised by the antiapoptotic members.  
BH3 domain exposure 
Solution structures of BAX, BAK, BID and BCL-2 type proteins revealed that in all these 
molecules the hydrophobic face of helix α2 (BH3 domain) is oriented towards the protein interior 
(Moldoveanu et al, 2006; Suzuki et al, 2000). Complementarily, solution structures of synthetic 
peptides representing proapoptotic BH3 domains complexed with BCL-2 type or BAX-type 
proteins revealed that the same hydrophobic face of such peptides makes crucial interactions with 
the hydrophobic groove of multidomain binding partners. From here, it is reasonable to assume 
that if BH3-into-groove interactions are the core mechanism by which BCL-2 family proteins 
modulate MOMP, BAX/BAK/BID need to change conformation to expose their BH3 domains in 
order to engage in homo- or hetero-dimerization reactions (Cartron et al, 2005; Dewson et al, 
2008; Dewson et al, 2012; George et al, 2007; George et al, 2010; Munoz-Pinedo, 2012; Sattler 
et al, 1997; Simonen et al, 1997; Whelan et al, 2012; Willis et al, 2005). Consistently, the blockade 
of BAX/BAK BH3 domain by epitope-specific antibodies prevents BAX/BAK oligomerization 
and Cyt c release (Bleicken et al, 2010; Czabotar et al, 2013; Dewson et al, 2008; Dewson et al, 
2012; Moldoveanu et al, 2013). 
1.7.1.2 Membrane insertion of BAX  
Another aspect that has received considerable attention regarding the activation of BAX-type 
proteins is the insertion of distinct helical fragments into the membrane lipid bilayer. 
Glycosylation assays in vitro using BAX fragments and microsomal membranes showed that 
helices α1, α5, α6, and α9 are all inserted into the membrane adopting a transmembrane 
orientation, although α6 alone did not insert into the membrane (Garcia-Saez et al, 2004). 
Cysteine accessibility experiment using mitochondria isolated from cells overexpressing BAX 
indicated that BAX α5, α6, and α9 are inserted into the membrane, although this process was 
shown to be insufficient for MOMP induction (Annis et al, 2005). In addition, the sequence of 
events leading to this insertion remains unknown, although evidences suggest that BAX α5α6 
membrane insertion occurs prior to oligomerization and membrane permeabilization but after 
BAX:tBID interaction (Annis et al, 2005; Lovell et al, 2008; Weber et al, 2013). On the other 
hand, cross-linking studies with overexpressed BAX/BAK suggest that during MOMP the two 
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proteins only insert their C-terminal α9 helix into the membrane, while the rest of the molecule 
(including α5α6) maintains the solution globular fold (Dewson & Kluck, 2009).   
By contrast, rather than maintaining its globular fold, as previously said recently it has been 
proposed that BAX α5α6 separates from the core of the protein during the early activation step of 
the protein. Crystallographic data for truncated BAX in detergent solution have disclosed a novel 
conformational change on BAX activation that generates a ‘core’ (α2– α5) and a ‘latch’ (α6– α8) 
domain and induces transient exposure of the α2/BH3 domain. This rearrangement proceeds via 
partial unfolding of the hairpin comprising helices α5 and α6 and seems to be essential for BAX 
function (Czabotar et al, 2013) (Figure 1.16). 
 
Figure 1.16 Early activation steps in BAX-type proteins. (A), dimer of BAXΔC21, rainbow coloured 
(blue N terminus to red C terminus) in complex with BIDBH3 (magenta), illustrating domain swapping of 
helices α6–α8 (coloured orange and red) across the dotted line (PDB: 4BD2). (B), Putative intermediate 
in transition from monomeric BAXΔC21 to the structure in the left. Taken from (Czabotar et al, 2013). 
In the dimer the α2/BH3 domain of a BAX molecule binds to the canonical groove of another 
BAX and viceversa (BH3-in-groove interaction) (Figure 1.17). This allows the formation of a 
stable ‘symmetric’ dimerization domain, which supports a model initially proposed based on 
crosslinking and low-resolution structural studies (Bleicken et al, 2010; Dewson et al, 2012). This 
symmetric model was also confirmed using double electron–electron resonance (DEER) studies 
of the full-length protein, in solution (Sung et al, 2015) in a membrane environment (Bleicken et 
al, 2014) and by FRET microscopy in living cells (Gahl et al, 2014). 
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Figure 1.17. Model for BAX Activation and Dimerization at the Membrane. Proteins are illustrated in 
their surface representations. In its soluble form, BAX (cyan) retains a globular conformation where its 
transmembrane domain (α9 helix, blue) is kept in the BAX hydrophobic groove (α2–α5). On activation by 
BCL2 homology (BH)3-onlyproteins (yellow), BAX undergoes a series of conformational changes 
displacing α9 from the groove, which inserts in the membrane (grey), and dissociating in a core (α2–α5) 
and a latch (α6–α9) domain by unfolding of helices α5 and α6. Following activation, BAX engages in BH3-
in-groove dimerization with another activated BAX molecule (light green) while displacing the BH3-only 
activator from the hydrophobic groove. This leads to the formation of a symmetric dimer. Zoomed in 
cartoon representation appears the core domains PDB (4BDU), one monomer (M) coloured in yellow 
(BH3/α2) and in pale cyan (α3- α5) and a second monomer (M´) coloured in pale yellow (BH3/α2) and in 
cyan (α3- α5). Adapted from (Cosentino & Garcia-Saez, 2017; Czabotar et al, 2013). 
Since this model was proposed, same group proposed a mechanism in which apoptotic pore 
formation requires the insertion of BAX central helices into the mitochondrial outer membrane 
(Cosentino & Garcia-Saez, 2017; Subburaj et al, 2015; Westphal et al, 2014a; Westphal et al, 
2014b).This new approach rejected a longstanding ‘umbrella’ model, inferred on the grounds of 
structural similarities between soluble BAX and other α-pore-forming proteins like colicin and 
diphtheria toxin (Petros et al, 2004). In the umbrella model, α5 and α6 helices were assumed to 
insert as a transmembrane hairpin perpendicularly to the membrane while the other helices would 
lie on the membrane surface in an umbrella-like configuration. In the “in-plane model” α9 is a 
TM domain and other helices (including α5 and α6) insert only shallowly into the bilayer (Figure 
1.18A-B). However, the interpretation of how BAX domains are arranged with respect to such a 
membrane pore is unclear in this model. Complementarily, with small peculiarities but sharing 
the same tendency, DEER studies of membrane-bound full-length BAX provided additional 
information about the structure of active BAX dimers in the membrane (Bleicken et al, 2014). 
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While the α2– α5 core helices of BAX dimers retain a well-defined structure similar to the soluble 
one, helices α6–α9 adopt a more flexible conformation, which may play a role in membrane 
destabilization. This is the basis for a model where partial opening of helices α5 and α6 is essential 
for membrane permeabilization; these two pairs of helices assemble in the dimer as a ‘clamp’, 
with the dimerization domain (helices α2–α5) at the rim of a lipidic pore and the amphipathic α6 
helices lying on the surface, parallel to each other, on opposite sides of the membrane (Bleicken 
et al, 2014) (Figure 1.18C-D). In this “symmetric” model it is unclear how the C-terminal α9 
helices are oriented. They could be antiparallel, unless the structural symmetry of the dimer is 
broken. Despite this, if confirmed, this model would provide a firm explanation for how BAX 
molecules stabilize open pores at the membrane. 
 
Figure 1.18 Models of active dimeric BAX in the membrane. (A) In the in-plane models, α5 remains 
with α2–α4 in the core, where it contributes one face to a BH3:groove interface and the opposite to the 
membrane, whereas α6 disassociates from the α2–α5 core and collapses onto the membrane, presenting its 
polar face to the cytosol and its nonpolar face to the membrane. (B) Several of the in-plane helices may 
then slide into a nascent pore to promote its development or stabilize its wall. (C) Hypothetical clamp model 
for the topology of active BAX dimers at the MOM: the dimerization domain is at the rim of a pore induced 
by BAX in the membrane, with helices 5 and 6 lying on the membrane surface. The hypothetical symmetric 
and transmembrane location of the dynamic helices 9 is sketched. (D) Schematic top view of two adjacent 
BAX dimers in the pore based on the proposed structural model (C) and compatible with a transmembrane 
orientation of the dynamic helices 9. The coloured helix α6 in the dimer is above the membrane, while the 
α6 depicted in grey is laying spatially below the one coloured, so that the corresponding helix 6 is below 
the membrane plane. The possible locations of the dynamic N and C termini (NT, CT) of helices 9 are 
shown (D). Adapted from (Bleicken et al, 2014; Westphal et al, 2014a). 
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1.7.1.3 Oligomerization 
Some studies raise the question if oligomerization is essential for permeabilization. Based on a 
reconstituted system, Newmeyer and colleagues indicated that BAX oligomerization is not a pre-
requisite for BAX pore formation (Kushnareva et al, 2012). In agreement with this idea, Xu and 
colleagues found that a single molecule of BAX inserted in a nanodisc can form a small pore (Xu 
et al, 2013). However, multiple studies have suggested that that MOMP is accompanied by BAX 
and BAK homo-oligomerization, even if some aspects of this process are still controversial. It has 
been proposed that higher-order multimers of BAX/BAK are formed through engagement of other 
interaction surfaces, most prominently BAX/BAK α6 (Dewson et al, 2009; Ma et al, 2013). 
Another model for BAX oligomerization is the “head-to-tail” or asymmetrical model (Bogner et 
al, 2010; Zhang et al, 2010). Here, an activated BAX molecule with an exposed BH3 domain 
would bind to a second BAX molecule in the non-canonical groove pocket thereby explaining 
formation of higher-order BAX oligomers (Figure 1.19). 
 
Figure 1.19 Proposed models for BAX activation and oligomerization. BAX is represented as a 
globular blue molecule; the non-canonical groove is in green, the canonical groove in light blue and the 
BH3 domain as a small square in blue. (A) “BH3 in groove” or symmetric dimer. The BH3-only protein 
(red) can bind the non-canonical or the canonical groove and BAX molecule exposes its BH3 domain; this 
now could bind to the canonical groove of another activated BAX molecule. Thus, this model is based in 
the interaction of the BH3 domain into the canonical groove. In addition, it has been proposed that higher 
order oligomers could be formed by interactions of the α6 helix. (B) “Head-to-tail” or asymmetrical model. 
Here, a BH3 only protein activates a BAX molecule that exposes its BH3 domain; This BAX BH3 domain 
is able to activate another BAX molecule by the non-canonical groove thereby allowing the formation of 
higher order oligomers. 
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However, as explained before, according to the currently popular view, once the BH3 domain of 
a BAX/BAK molecule is exposed it engages the canonical binding groove of another activated 
BAX/BAK molecule, forming ‘‘BH3-in-groove’’ “symmetric” dimer (Bleicken et al, 2010; 
Bleicken et al, 2014; Dewson et al, 2009; Dewson et al, 2008; Dewson et al, 2012; Oh et al, 2010; 
Westphal et al, 2014a). Here, the existence of an additional interface would provide a rationale 
for how symmetric BAX and BAK dimers further assemble in higher-order oligomers. Several 
studies have implicated a role for helices α6 and α9 in BAX oligomerization (Dewson et al, 2012; 
Zhang et al, 2015). Dimerization via α9 (and probably α6) occurs downstream of BH3-in-groove 
dimerization, suggesting that it might represent the interaction site of symmetric dimers needed 
to form higher-order oligomers. Since α9 dimerization is not required for the passage of small 
molecules like cytochrome c but only for bigger ones like SMAC, the relative importance of 
interdimer contacts via helices α6 versus α9 remains unclear (Zhang et al, 2016). Recently, 
crosslinking and DEER results have reported a novel oligomerization site for BAK in isolated 
apoptotic mitochondria involving the α3/α5 interface, which, together with α6 (and hypothetically 
α9), stabilizes interactions of neighbouring BAK homodimers (Mandal et al, 2016). 
1.7.1.4 Supramolecular structures formed by BAX (and BAK) 
Historically and currently back in vogue, the formation of BAX/BAK clusters has been linked 
with apoptotic phenotype (Figure 1.20 A-B), (Nasu et al, 2016; Nechushtan et al, 2001; Uren et 
al, 2017) and recently, in the edge of these clusters, has been reported the formation of BAX 
assemblies associated with its apoptotic activity, in  form of semi-arcs, arcs and rings (Grosse et 
al, 2016; Salvador-Gallego et al, 2016)(Figure 1.21 A-B). In agreement with experiments on 
model membranes, BAX oligomers displayed a wide distribution of sizes (ranging from a few 
tens of nanometres to 100nm in diameter) and shapes, indicating that BAX-mediated MOMP 
involves flexible and diverse pores structures.  
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Figure 1.20 BAX/BAK supramolecular structures (I). Apoptotic clusters-A-B: (A) Cos-7 cells 
transiently expressing CFP-BAX together with the outer mitochondrial membrane marker, YFP-20, were 
treated with 1 µM STS for 5 h to induce apoptosis and then were examined by laser scanning confocal 
microscopy. CFP-BAX(red) was located in small punctate structures, whereas YFP-20 (green) was located 
in larger round mitochondrial-shaped structures. In overlay images, the BAX clusters appeared to be located 
next to or on top of the YFP-20–labelled structures. Bars, 25 µm . Taken from (Nechushtan et al, 2001). 
(B) Hypothesis of how growing clusters of BAK dimers induce membrane tension to rupture mitochondria. 
The top view of BAK dimers lying in-plane on the mitochondrial surface. The α2-α5 core is bounded by 
the large oval. Extending from the core are the membrane anchored C-terminal helices α6, α7 and α8. For 
simplicity, the α9 transmembrane domains that project into the membrane plane, and the flexible, solvent 
exposed N-termini of each dimer are not shown(left). Lipids and Bak dimers rearrange to bury exposed 
hydrophobic surfaces, yielding a variety of proteolipid (toroidal) ‘pores´(right). Taken from (Uren et al, 
2017). 
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Figure 1.21 BAX/BAK supramolecular structures (II). Apoptotic rings A-B. (A) Apoptotic 
mitochondria were decorated with antibodies against BAX (green) and Tom22 (red). The BAX signal was 
recorded in the STED mode. Shown are the individual colour channels as well as an overlay (from top to 
bottom) of several apoptotic mitochondria. We used Lagrange interpolation to double the number of pixels. 
Note that throughout this manuscript except for contrast stretching, no image manipulation was applied. 
Scale bar: 0.5 µm (C). Taken from (Grosse et al, 2016). (b) left: Illustration of the possible roles for the 
BAX non-random assemblies revealed by SMLM and AFM during apoptosis. Linear and arc clusters not 
perforating the membrane could correspond to BAX at initial stages of gathering on healthy mitochondria. 
They would evolve toward opening of membrane pores, where the protein is covering completely (full 
rings) or partially (arcs) the pore rim. We cannot exclude that a fraction of the linear and arc-shaped 
assemblies corresponds to BAX pores observed from different perspectives. The number of red spheres 
(BAX dimers) is illustrative and does not need to correlate with the actual number present in the structures. 
right: The mechanism by which BAX permeabilizes the membrane is mainly by releasing the curvature 
stress at the membrane edge. Full as well as partial coverage of the pore rim by BAX molecules could 
reduce line tension enough to stabilize the open pore state. The illustration shows an incomplete ring 
assembly of active BAX dimers adopting a clamp-like structure at the pore interface (Bleicken et al, 2014). 
Taken from (Salvador-Gallego et al, 2016). 
 
However, despite all the structural and apparently biologically relevant information, the question 
about the minimum number of BAX molecules able to form a functional pore at the MOM 
remains open. As previously commented, data from lipid nanodisks suggest that monomers or 
dimers are sufficient to stabilize membrane openings (Xu et al, 2013), which could grow with 
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additional BAX molecules. Moreover, due to the apparent impossibility of decoupling apoptotic 
process (loss of membrane potential, cyt c release, mitochondrial cristae remodelling etc.) the 
direct link between these structures and MOMP remains ill defined. Furthermore, another issue 
is the contribution of other MOM components to BAX-pore structures, including BAK (Zhou & 
Chang, 2008) and proteins involved in mitochondrial dynamics such as Drp1 and Mitofusins 
(Karbowski et al, 2002) MOMP have to be considered. 
1.7.2 Insights into the Assembly of BAX oligomers 
Deep structural changes induce a conformation of BAX that inserts extensively into the lipid 
bilayer and perforates it (Czabotar et al, 2014). This step is concomitant with BAX assembly into 
oligomers. Crosslinking and gel filtration studies have detected diverse oligomeric forms of BAX 
(Annis et al, 2005; Antonsson et al, 2001). However, none of these experimental approaches 
allowed precise determination of the oligomeric state of BAX during its activation and function 
in the membrane. 
Single-molecule imaging studies have recently elucidated key aspects of the molecular 
mechanism of BAX assembly in the membrane. Initially, BAX inserts in to the bilayer as a 
monomer, suggesting that BAX activation involves conformational changes that allow its 
membrane insertion but precede its dimerization, supporting a two-step activation process for 
BAX. However, probably due to the instability of this monomeric structure, BAX molecules 
quickly self-assemble into higher-order oligomers (Subburaj et al, 2015). Importantly, in 
equilibrium, BAX in the membrane is present as a mixture of species based on dimer units. In this 
scenario, the interdimer interactions are weaker than intra dimer ones, in line with a dynamic 
vision of BAX assembly where oligomerization is a reversible process that can be modulated, for 
example, by protein density at the membrane. Interestingly, same group have reported that BCL-
XL is able to disassemble preformed complexes (Subburaj et al, 2015). Although the exact 
molecular mechanism is not understood, this suggests that the assembly pathway of BAX can be 
a reversible process that can be regulated by other BCL2 members. This issue would explain the 
variety of oligomeric species found in previous studies and would be consistent with the formation 
of membrane pores that are tunable in size (Bleicken et al, 2013a; Bleicken et al, 2013b; Gillies 
et al, 2015). 
 
  
Chapter 1: Introduction and objectives   
 
46 
 
1.8 PORE FORMATION 
Since decades it is well established that BAX, BAK and perhaps BOK are the executioners of 
MOMP, but the nature of the membrane openings exerted by activated BAX/BAK has been a 
highly controversial issue. Different models have been proposed to explain how BAX-type 
proteins lead to MOMP. However, in the last 5 years the field converge in a pore constituted 
mainly, if not solely, of BAX (and BAK) dimmers with a proteolipidic nature and tunable size. 
However, there are still open question discussed below. These models can be divided in two 
groups: Indirect Models and Direct Models. 
1.8.1 Indirect models 
According to this view, BAX-type proteins induce MOMP by regulating the activity of 
endogenous mitochondrial channels. This model postulates that BAX permeabilizes  MOM via a 
physical interaction with the components of the mPTP (Permeability Transition Pore) found at 
mitochondrial contact sites (Kroemer et al, 2007). The mPTP is thought to be composed by the 
adenine-nucleotide translocator (ANT, located in the MIM), the voltage-dependent anion channel 
(VDAC, located in the MOM) and the cyclophilin-D (CyP-D, located into the matrix surface of 
the MIM) (Baines et al, 2005; Schinzel et al, 2004). mPTP opening allows the free flux of ions 
and water into the mitochondrial matrix, causing swelling of the organelle and rupture of the 
MOM; a phenomenon that is not usually detected in a cell dying by apoptosis. Moreover, mPTP-
induced cell death is generally considered to be necrotic rather than apoptotic (Nakagawa et al, 
2005; Tsujimoto et al, 2006). 
This hypothesis has been questioned and nowadays is almost totally relegated mainly due to 
knock-out studies showing that  each one of the postulated mPTP components (VDAC, ANT and 
Cyp-D) are not dispensable for MOMP and apoptotic cell death (Baines et al, 2005; Baines et al, 
2007; Kokoszka et al, 2004; Nakagawa et al, 2005; Whelan et al, 2012). In 2013, some authors  
suggest that the true component of the mPTP is dimeric ATPase, and therefore, it cannot be 
completely ruled out the mPTP, at least under some conditions (Giorgio et al, 2013). However, 
recent results describing supramolecular structures in both cellular and in vitro conditions support 
the idea that BAX (and BAK) are sufficient for the apoptotic pore formation. 
1.8.2 Direct models 
This model originated from the structural similarities found between BCL-2 proteins and bacterial 
pore-forming toxins (Petros et al, 2004).  Furthermore, different groups have shown that activated 
BAX and BAK can permeabilize pure lipid membranes in the absence of other mitochondrial 
components (Basanez et al, 1999; Basanez et al, 2002; Bleicken et al, 2010; Bleicken et al, 2013b; 
Kuwana et al, 2002; Martinez-Caballero et al, 2009; Roucou et al, 2002; Saito et al, 2000; Schafer 
et al, 2009; Terrones et al, 2004; Xu et al, 2013). 
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As mentioned before, different lines of evidence suggest that the central hairpin (α5α6) is 
responsible for its pore forming activity. Deletion of BAX α5α6 abolished BAX driven Cyt c 
release (Heimlich et al, 2004) and peptides corresponding to BAX α5 or α6 form pores similar to 
those elicited by activated full length BAX (Fuertes et al, 2010a; Garcia-Saez et al, 2005; Garcia-
Saez et al, 2006; Valero et al, 2011). 
Despite intense research, the nature and the exact mechanism by which BAX/BAK mediate MOM 
permeabilization remain controversial. Two distinct models have been proposed for the 
BAX/BAK pore; (i) a proteinaceous barrel-stave channel, and (ii) a proteolipidic pore (Figure 
1.22). 
1.8.2.1 Proteinaceous channels 
Proposed two decades ago and nowadays almost discarded, this model postulates that BAX or 
BAK induces MOMP generating a purely proteinaceous channel, as in the case of the peptide 
alamethicin or β-pore forming toxins (PFT). In the alamethicin channel, its helices adopt a 
transmembrane configuration and interact with each other as in the staves of a barrel, so that the 
lumen of the aqueous channel is formed by the peptide (He et al, 1996; Qian et al, 2008a) (Figure 
1.22A/C). In a similar way, pore-forming toxins such as pneumolysin or tetanolysin first 
oligomerize in the membrane in a structure named pre-pore and then, they insert a β-hairpin of 
each oligomer unit in a transmembrane fashion. In this PFT induced channel, the lumen of the 
pore is exclusively constituted by a huge β-barrel (Anderluh & Lakey, 2008). 
Following this line of reasoning, BAX has been proposed to be a component of a purely 
proteinaceous Mitochondrial Apoptosis-induced Channel (MAC) (Dejean et al, 2005). In kinetic 
and conductance studies it was estimated that MAC channel contains up to nine molecules of 
BAX (Martinez-Caballero et al, 2009), with a diameter in the range of 2.9 to 7.6 nm. MAC 
channel has been shown to be permeable to 10 and 17 kDa, but not 45 and 71 kDa Dextran 
(reviewed in (Dejean et al, 2010). By contrast, liposome permeabilization experiments indicated 
that a tetrameric BAX channel is the minimal stoichiometry required to allow Cyt c passage across 
liposomal membranes in the absence of any additional mitochondrial protein (Saito et al, 2000). 
However, neither the tetrameric BAX channel nor the MAC channel explains that BAX-driven 
MOMP allows the release of multiple, differently-sized mitochondrial proteins.  
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Figure 1.22 Barrel-stave vs. Proteolipidic pore model. Schematic representations of barrel-sate 
model (A) and proteolipidic model (B) are shown in a 3D view cut through the pore. Grey layers represent 
lipid headgroups of the bilayer, Br atoms located in the acyl chains are shown in red and protein helices 
by dark cylinders. The corresponding normalized electron density distributions of Br atoms of lipid 
bilayers containing alamethicin (C) and BAXα5 (D). Br atoms are distributed in the high-density region 
(yellow-red-black). Note that unlike in a proteinaceous channel, in a proteolipidic pore: (i) the surface of 
the pore is lined by lipid headgroups, (ii) membrane monolayers are bent at the edge of the pore, and (iii) 
the two leaflets of the bilayer become continuous. Taken from (Qian et al, 2008b).  
1.8.2.2 Proteolipidic pore 
The proteolipidic pore model was first proposed to explain the mode of action of magainin, a 23-
residue antimicrobial peptide (Ludtke et al, 1996; Matsuzaki et al, 1996). From a structural 
viewpoint, the toroidal pore and the barrel-stave pore differ in that in the toroidal pore the peptides 
always remain associated to the bilayer´s hydrophilic-hydrophobic interface, while in the barrel-
stave pore the peptides cross the bilayer from one side to the other (Figure 1.22 B/D).  In the 
toroidal pore model, the asymmetric insertion of peptide helixes exclusively into one of the 
membrane leaflets leads to an increase of membrane tension. When a threshold tension is reached, 
the bilayer structure becomes unstable, inducing lipids to fold into a highly curved pore where the 
membrane leaflet becomes continuous as a toroidal hole. Thus, as monolayers are in contact, they 
form a continuous structure with positive monolayer curvature in the perpendicular plane to the 
membrane and negative curvature in the plane of the membrane. The generated structure is known 
as a proteolipidic pore, in which the rim of the pore is formed by both lipids headgroups and 
protein molecules. The curvature stress could be alleviated by the localization of protein 
molecules at the edge of the pore and/or by peptide-generated membrane curvature (Fuertes et al, 
  Chapter 1: Introduction and objectives 
 
49 
 
2010b; Fuertes et al, 2011; Huang, 2000; Matsuzaki et al, 1996; Valcarcel et al, 2001; Yang et al, 
2001) (Figure 1.23). 
In other words, it is important to consider that membranes are non-covalent 2D assemblies kept 
together by the hydrophobic effect. This means that disrupting the continuity of the membrane 
bilayer has a high energetic cost. Therefore, it is not trivial how a protein would induce membrane 
opening. When membranes are under stress they are tensed, and beyond a certain threshold the 
planar assembly disrupts and a pore opens (Lee et al, 2004). The toroidal pore model proposes 
that lipids at such a pore rim bend to avoid exposure of the hydrophobic acyl chains to the aqueous 
environment (Ludtke et al, 1996). As a consequence, the two membrane leaflets form a continuous 
surface that is brought into contact by lipids at the curved pore edge. It is this high membrane 
curvature that is responsible for the high energy cost of maintaining the open pore conformation. 
The energy cost is directly proportional to the perimeter or length of the pore. For this reason, the 
driving force for toroidal pore closure is known as line tension (in contrast to membrane or surface 
tension, which is proportional to the area). To keep a toroidal pore stably open, the energy cost of 
the bent membrane at the pore edge needs to be reduced by stabilizing the curved structure 
(Karatekin et al, 2003). 
In the last years, several groups including ours have gathered different lines of evidence 
supporting that active forms of BAX forms toroidal pores of proteolipidic nature. BAX decreases 
planar membrane lifetime and form pores with variable conductance states (Basanez et al, 1999). 
In addition, the characteristics of the pore formed by BAX are affected by modifying the physical 
properties of the membrane with lipids with different intrinsic monolayer curvature (Basanez et 
al, 2002; Terrones et al, 2004). On the other hand, a peptide derived from the helix α5 of BAX 
forms pores with lipid molecules in the lumen as demonstrated by X-ray diffraction (Qian et al, 
2008b) (Figure 1.22B/D) and conductance experiments for this  peptide (Garcia-Saez et al, 2005) 
and BAX proteins (Basanez et al, 1999). These data are also in line with the transbilayer lipid 
movement coupled with the membrane permeabilization exerted by BAX (Epand et al, 2003; 
Garcia-Saez et al, 2006; Terrones et al, 2004).  
Moreover, BAX and BAK release high molecular-weight markers from liposomes (Bleicken et 
al, 2010; Kuwana et al, 2002; Schafer et al, 2009; Terrones et al, 2004; Terrones et al, 2008). In 
agreement with this, cryo-EM analysis of large unilamellar vesicles in presence of these proteins 
revealed membrane openings of heterogeneous range of sizes (25-100 nm). However, it was not 
possible to identify proteinaceous structures at the pore edges, in stark contrast to channel forming 
toxins (Tilley et al, 2005). 
Additional support for the proteolipidic pore model is based on the membrane inserting helices 
of BAX/BAK. As mentioned before, the pore forming domain of BAX/BAK that corresponds to 
α5α6 helices are positively charged and too short to span the bilayer, and these features are less 
compatible with the barrel-stave channels, which are largely restricted to peptides of neutral 
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charges and oriented perpendicular to the membrane. It has also  been proposed that α4-α5 may 
lie between the lipid headgroups, generating positive curvature and tension in the outer leaflet of 
that membrane leading to proteolipidic pore formation (Czabotar et al, 2013). 
 
Figure 1.23 Mechanism of pore formation by cationic amphipatic peptides. (A) Pore-forming peptides 
bind to lipid bilayers coupled to folding of the peptide (in this case as an α-helix). Peptides insert in the 
interface among the lipid headgroups, generating changes in the physical properties of the membrane as 
asymmetric area stretching and membrane thinning (∆h). (B) Membrane perturbations increases peptide 
binding and it has been postulated that peptides would stabilize membrane defects and reduce the energy 
barrier for pore formation. (C) Once the pore is formed, the initial pore is large. Thus, the peptides could 
diffuse through the pore and insert into the internal monolayer decreasing the line tension that tends to 
close the pore. (D) Nevertheless, the peptides at the edge or near the pore reduce the line tension, until 
equilibrium is reached where the pore is smaller. Adapted from (Fuertes et al, 2011). 
In the last years in combination with confocal techniques, additional atomic force microscopy 
(AFM) experiments on supported bilayers and electron microscopy of outer membrane vesicles 
(OMVs) and lipid nanodisks containing BAX confirmed protein enrichment at the rim of 
membrane pores of variable sizes where the pore wall was not completely covered by protein 
molecules (Kuwana et al, 2016; Salvador-Gallego et al, 2016; Xu et al, 2013) (Figure 1.24). 
Together, the evidence reveals an unexpected model for BAX (and probably BAK) mediated 
MOMP where oligomerization at the MOM induces the formation of heterogeneous toroidal pore 
structures that are flexible and evolve overtime leading to the release of apoptotic factors. 
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Figure 1.24 Recent evidences of the proteolipidic nature of BAX pore formation. (A) Cryoelectron 
microscopy (cryo-EM) image of gold-labelled BAX delineating a pore in the membrane of a vesicle. In the 
corresponding image, the pore is outlined in yellow and BAX in orange for visual purposes. Bar,40nm. 
Taken from (Kuwana et al, 2016) (B) Model of nanodisk structure (yellow) containing a single unit of 
BAX/BID peptide (blue surface) based on cryo-EM data. Taken from (Xu et al, 2013) (C) 3D AFM 
topography of a BAX arc (left) and ring (right). Both images reveal a circular dark hole that spans the lipid 
membrane (green). BAX molecules around the pore rim (magenta and white) protrude 3.97 ± 1.02 nm 
above the membrane plane, as confirmed by the height profiles shown below each image (corresponding to 
the white line in the 2D image insets). The topography of the arc structure reveals a pore only partially 
surrounded by BAX molecules, while lipids alone form the rest of the pore rim. Images are shown in a 42° 
tilted representation. Taken from(Salvador-Gallego et al, 2016). (D) Models for BAX (cyan) structures, 
including (left to right) lines, arcs, and rings, leading to pore formation in the membrane (grey). Taken from 
(Cosentino & Garcia-Saez, 2017). 
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1.9 MEMBRANE CONFORMATIONS AND FUNCTIONS 
OF THE ANTIAPOPTOTIC PROTEINS 
According to some authors, BCL-2 type proteins are anchored to the MOM via their C-terminal 
domain while maintaining the overall solution structure. This conformation would easily explain 
inhibitory interactions of BCL2-type proteins with proapoptotic partners at the MOM level, via 
the same  BH3-into-groove interactions described in solution-based studies (Day et al, 2005; Day 
et al, 2008; Hinds et al, 2007; Landeta et al, 2014; Liu et al, 2003b; Petros et al, 2000). 
By contrast, Andrews DW´s group and others gathered evidence that membrane insertion of  the 
helices α5 and α6 of BCL-2 and BCL-XL, prevented oligomerization of membrane bound BAX 
by hairpin-hairpin interactions (Billen et al, 2008; Dlugosz et al, 2006; Shamas-Din et al, 2013; 
Zhang et al, 2004). In line with these observations, biophysical studies with model membranes 
suggest that not only BCL-2 but also BCL-XL can insert α5α6 into the hydrophobic matrix of the 
lipid bilayer under certain experimental conditions (Garcia-Saez et al, 2004; Losonczi et al, 2000; 
Thuduppathy et al, 2006a). Regardless, it is important to point out that extensive membrane 
insertion of BCL-2 type proteins almost certainly eliminates the BH3-binding groove present in 
soluble structures of BCL-2-type proteins (Basanez & Hardwick, 2008).  
Other evidence links extensive membrane insertion of antiapoptotic proteins and a phenotypic 
switch linked with acquisition of BAX-like pore-forming activity (Basanez et al, 2001; Clem et 
al, 1998; Cheng et al, 1997; Menoret et al, 2010; Michels et al, 2004). Of note, pores formed by 
BCL-2 type proteins appear generally smaller than pores formed by BAX and BAK (Basanez et 
al, 2001; Bleicken et al, 2013b; Clem et al, 1998; Etxebarria et al, 2008; Garcia-Saez et al, 2009; 
Ko et al, 2007; Lei et al, 2006; Peng et al, 2009; Thuduppathy et al, 2006b; Valero et al, 2012).  
It has been argued that this is due to the fact that BCL-2-like proteins lack the oligomerization 
capability of BAX-type proteins (Bleicken et al, 2013b). However, it has also been described that 
certain BCL-2-type proteins oligomerize under exposure to mild heat, acidic pH, or specific 
detergents (Denisov et al, 2007; Feng et al, 2008; Jeong et al, 2004; O'Neill et al, 2006; Zhang et 
al, 2004). 
Moreover, in our group it has been reported that mitochondria specific lipid CL is able modulate 
the antiapoptotic capacity of MCL1 (Landeta et al, 2014). As the membrane content of CL is 
increased, MCL1 not only loses its inhibition capacity, but also is able to permeabilize model 
membranes. However, general aspects such as specificity, stoichiometry or the regulation of this 
new proapoptotic activity remains poorly understood. In this point it is worthy to mention that 
antiapoptotic overexpression has considered as the main cause of chemotherapeutic resistance. In 
this context, where the membrane plays a crucial role regulating BCL2 interactoma, membrane 
composition could become a key target in drug development.  
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1.10 INSIGHTS INTO THE OVERLOOKED BFL1 
B-cell lymphoma 2-related protein A1 (BCL2A1), also known as A1 in mouse and BCL2-related 
gene expressed in fetal liver in humans (BFL1), is one of the least studied antiapoptotic BCL2 
proteins. Although the BFL1 gene was discovered in the early 90s (Choi et al, 1995; Lin et al, 
1997; Orlofsky et al, 1991), BFL1 remains one of the least well understood BCL2 family proteins. 
In the following section I will describe the most relevant features attributed to BFL1, as follows: 
i) expression and regulation, ii) structure, iii) interaction partners, and iv) role in chemotherapeutic 
resistance and tumorigenesis. 
BFL1 expression and regulation 
In mouse, A1 is predominantly expressed in hematopoietic cells, but in humans it shows a more 
widespread distribution, including lung, small intestine testis and smooth muscles cells (Karsan 
et al, 1996b). The transcription of BCL2A1 gene is an extensively regulated process. Indeed, A1 
was found to be modulated by tumour necrosis factor (TNF)α and identified as a NF-κB target 
gene (Karsan et al, 1996a; Zong et al, 1999). Additional pathways such as CD40 and ERK 
signalling or antigen response are linked with A1 activities (Kater et al, 2004; Morgan et al, 2004). 
Moreover, A1 transcription can also be increased by extreme cellular oxygen levels (He et al, 
2005; Kim et al, 2005). Of note, A1 exerts an antiapoptotic activity under both cellular conditions 
hyperoxia and low levels of ROS.  
Structure 
Human BFL1 gene contains 3 exons that are differently transcribed to confer at least three 
different variants or isoforms of this protein. The most common mRNA of BFL1 is transcribed 
from exons 1 and 3, resulting in a 175 aminoacids protein. Several structures are available of 
human BFL1 in complex with BH3-peptides (3MQP with NOXA-BH3; 3I1H with BAK-BH3 
and 2VM6 with BIM-BH3). According to these structures, BFL1 consists in a central hydrophobic 
α-helix (α5) and four pairs of amphipatic α-helices (Herman et al, 2008). Moreover, as in the case 
of other BCL2-type proteins, BFL1 possess a BH3-binding hydrophobic groove constituted by 
BH1, BH2 and BH3 homology domains. Of note, BFL1 apparently possess two BH3-like 
domains in α2 and α3 helices, although the first one lacks an strictly conserved aspartic acid 
residue (Herman et al, 2008; Rautureau et al, 2012; Smits et al, 2008).  
The C-terminal helix of BFL1 (a9) is also atypical. This is because BFL1 present an amphipatic 
C-terminal helix that contributes to but is not absolutely required for BFL1 targeting to the MOM, 
while the rest of the BCL2-type proteins display a hydrophobic C-terminal helix that functions as 
transmembrane region that targets and anchors them to the MOM (Brien et al, 2009; Kucharczak 
et al, 2005). Moreover, unlike in other BCL2-type proteins, BFL1 α9 displays an autonomous 
proapoptotic activity (Valero et al, 2012).  In fact, BFL1 α5 and α9 have been identified as the 
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minimal motifs responsible for a proapoptotic pore-forming activity of the protein  (Kucharczak 
et al, 2005; Valero et al, 2012). 
Among the additional isoforms described for BFL1, the two most important are GRS or Glasgow 
rearranged sequence and BFL1-Short. GRS and A1 sequences differ only at two positions (N72T 
and Q107H). High expression levels of GRS were also observed in hematopoietic malignancies, 
such as chronic myeloid leukaemia and the Burkitt lymphoma cell line Raji (Kenny et al, 1997). 
BFL1-Short contain all 3 exons with an early stop codon forming a 163 aa protein, with nuclear 
rather than cytoplasmic/mitochondrial localization but conserving its antiapoptotic nature (Ko et 
al, 2003). 
Mouse BFL1 homolog, A1, contains two exons and four copies (A1-a, A1-b, A1-c and A1-d). 
The A1-a, -b and -d genes consisted of two exons, whereas the A1-c gene contained 1 bp insertion 
in the coding region which may result in an aberrant and truncated protein by frame-shift. With 
the exception of A1-c, the coding regions among A1 genes are highly conserved in both amino-
acid identity and 3D structure (Hatakeyama et al, 1998; Herman et al, 2008; Smits et al, 2008). 
BFL1 Interaction partners  
A common feature of the BCL2-type proteins is their ability to establish BH3-into groove 
interactions with their proapoptotic counterparts, including BAX-type and BH3 only proteins 
(Czabotar et al, 2014; Moldoveanu et al, 2014). However, the specific affinities exhibited by the 
different family members in solution and in the membrane are still under investigation. In this 
regard, BFL1 has been reported to bind both BAX and BAK in vitro and in cellulo, as well as the 
majority of BH3-only proteins, including BID, BIM, PUMA, BIK, HRK and NOXA.  Moreover, 
other non-BCL2 binding partners have been described for BFL1, such as the autophagy-related 
protein Beclin-1 and Nur77-derived BCL2-converting peptide (NuBCP-9). Interestingly, 
interaction with Nur77 unleashes a proapoptotic phenotype in BCL2, although  whether it remains 
to be determined whether the same is true for the case of BFL1 (Kathania et al, 2011; Kolluri et 
al, 2008)(Figure 1.25). 
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Figure 1.25 Interaction partners of BCL2A1. Binding by BCL2A1 can inhibit or neutralize pro-apoptotic 
multidomain BCL2 proteins (A) and BH3-only proteins (B). In addition, BCL2A1 can sequester Beclin-1 
(C). Binding by NuBCP-9 may inhibit the anti-apoptotic function of BCL2A1. Taken from (Vogler, 2012). 
 
Recently,  NOXA SABH-BH3 peptide has been identified as a high-affinity ligand of BFL1 
(Huhn et al, 2016). According to the authors, this new class of stapled peptides inhibitors confer 
a highly potent a specific BH3-like ligand that binds irreversibly to the antiapoptotic BFL1 via 
disulfide bonding, thereby blocking it antiapoptotic activity. Of note, BFL1 has described of 
probably as the one of most promiscuous prosurvival protein due to its structural plasticity, 
indeed, BFL1 is able to heterodimerize with several proapoptotic partners (Smits et al, 2008). In 
this context, having an specific BH3 peptide partner could be specially relevant in cancer therapy 
as they are other BH3 mimetic such as the BAD-like ABT-737 and the NOXA-like S63845 
(Kotschy et al, 2016).  
Mice knockout phenotype  
In 2017, a prominent  goal  to understand the biological role of BFL1 was achieved with the 
generation of all-A1-isoform KO mice by the group of Marco Herold in collaboration with 
Andreas Villunger´s group (Berberich & Hildeman, 2017; Schenk et al, 2017; Tuzlak et al, 2017). 
The generation of gene-deficient mice have facilitated the comprehension of the function of many 
BCL2 proteins, and therefore this A1 KO mice confers an invaluable tool to address the 
specificities of BFL1 functions in a physiologically relevant system.  
Surprisingly, the phenotype elicited by this new A1 all isoforms KO mice was similar to the wt, 
suggesting a functional redundancy of A1 with other antiapoptotic proteins in the control of T 
cell-dependent immune responses. Although different type of analysis were performed, these 
results are inconsistent with previous studies where mice lacking some (but not all) A1 isoforms 
behaved dissimilarly to the wt in apoptosis regulation under certain settings and cellular systems 
(Hamasaki et al, 1998; Xiang et al, 2001). Based on results obtained with the all-A1 KO cells, it 
has been postulated a model where BFL1 compensates the inhibition activity of MCL1 and BCL2, 
and immune cell survival is governed by collaboration among all the antiapoptotic members 
(Carrington et al, 2017). 
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The role of BFL1 in chemotherapeutic resistance and tumorigenesis 
Because of its function in the hematopoietic system it is not surprising that overexpression of 
BFL1 is frequently associated with different forms of leukaemia and lymphoma (Vogler, 2012). 
High expression levels of BFL1 in advanced tumour stages suggests that this protein may 
facilitate tumour progression. BFL1 contribution to tumorigenesis was demonstrated recently in 
anaplastic large cell lymphoma (Piva et al, 2006) and in squamous cell carcinoma (Kathpalia et 
al, 2006). Finally, BFL1 plays a critical role in chemotherapeutic resistance as the central function 
of BFL1 is to suppress apoptosis upon toxic stimulus and consequently to prevent cell death upon 
chemotherapy. In this regard, an excess of BFL1 has been shown to be resistant to etoposide 
(Wang et al, 1999), staurosporine (Shim et al, 2000) or cisplatin (Cheng et al, 2000). 
Despite extensive research effort there are still several unanswered question regarding the mode 
of BFL1 action, and its links to human physiology and pathology. In this thesis, we attempted to 
elucidate the detailed molecular mechanism by which BFL1 modulate MOM permeability.  
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1.11 OBJECTIVES 
The BCL2 protein family modulates the point of no return in the mitochondrial pathway of 
apoptosis that being the perforation of the MOM, which allows release of mitochondrial 
apoptogenic factors into the cytosol. Despite intense research effort, exactly how BCL2 family 
proteins operate at the MOM level remains incompletely understood. 
The general aim of this study is to advance in our knowledge of the molecular mechanisms of 
action of BCL2 family proteins at the membrane level. Our focus is in the prototypical 
proapoptotic BCL2 family member BAX, and the less well understood antiapoptotic BFL1 
protein. We combined studies in simplified model systems and in living cells, mainly using 
quantitative biophysical techniques. 
Specific Aims: 
1- To gain insight into inactive and active BAX membrane conformations. 
2- To elucidate the mechanism by which BFL1 inhibits apoptosis, by analysing three 
putative modes of action: (1) retrotranslocation of inactive BAX from the membrane into 
the cytosol (MODE-0), (2) heterodimerization with and neutralization of cBID at the 
membrane level (MODE-1), and (3) heterodimerization with and neutralization of 
activated BAX at the membrane level (MODE-2) 
3- To understand the role of the cardiolipin as a modulator of BFL1 and BCLXL membrane 
activities. 
 
 
  
 
 
  
  
 
 
 
 
 
 
CHAPTER 2: 
Experimental procedures 
  
 
  Chapter 2: Experimental procedures 
 
61 
 
2 Experimental procedures 
This chapter gathers general information about the experimental techniques used throughout the 
present thesis. The application of these techniques to specific purposes will also be briefly 
discussed within the corresponding section of the Results chapter. 
2.1 RECONSTITUTED MODEL SYSTEMS 
Given the inherent complexity of the molecular network controlling commitment to MOMP, one 
of the major challenges is elucidating the BCL-2 family protein interactions within intact cells at 
molecular level. In addition, as mentioned in the Chapter 1, these interactions could take place in 
two different environments: the cytosol or the membrane. Taking into account the difficulty of 
obtaining mechanistic information of BCL-2 proteins within dying cells, in this thesis we use 
simplified and compositionally-defined in vitro reconstituted systems consisting of pure lipid 
model membranes and purified proteins or peptides. The reductionist systems used in this thesis 
allows studying the interaction between proteins and lipids, side-lining the complexity of the 
biological membranes and having the opportunity of varying the composition and properties of 
the membrane in a controlled manner. 
2.1.1 Lipid component 
Biological membranes are enclosing double layers that organize within or around the cell, 
defining chemically or biochemically different environments. Being a physical barrier is not their 
only function, because due to their dynamic nature, biomembranes actively participate in 
reception and transduction of different cellular signals, as well as in other essential cellular 
processes, including oxidative phosphorylation and endo/exocytosis. 
2.1.1.1 Lipids: classification and properties 
Type of lipids 
Lipids are a highly varied group of amphipatic molecules compromising a polar headgroup and a 
hydrophobic moiety (usually acyl-chain-based). Lipids have the ability to self-assembly in 
complex structures as vesicles, being energetically favourable structures.  
The major groups of membrane lipids are phosphoglycerides, sphingolipids, glicolipids and 
sterols (Figure 2.1). 
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Phosphoglycerolipids 
Phosphoglycerolipids or phosphoglycerides are the most abundant lipids in biomembranes.  Their 
structure contains a glycerol backbone that could be linked to one or two acyl chains by an ester 
bound and one phosphate group. The later based on the variability of the headgroup can be 
derivatized to give different phosphoglycerolipids such as phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), phosphatidylglycerol (PG), 
phosphatidylserine (PS) or phosphatidic acid (PA). Due to the nature of the headgroup, these 
lipids can be anionic (PI, PG, PS and PA) or zwitteronic (PC and PE) at physiological pH. One 
of the mostly studied phospholipid in this thesis is cardiolipin (CL) that contains three glycerol 
molecules with four acyl chains and two phosphate groups that confer it an anionic nature. 
Sphingolipids  
Instead of a glycerol backbone, sphingolipids have sphingosine, a long-chain amino alcohol. In 
this group we can find from simplest structures to major structures: sphingosine, shingosine-1-P, 
ceramide, sphingomyelin etc. 
Other sphingolipids, instead of a sphingosine backbone, they contain a sphinganine; but this type 
of lipids is less abundant. 
Glycolipids 
Glycolipids are membrane components composed of lipids that are covalently bonded to 
monosaccharides or polysaccharides. Depending on the nature of their lipid backbone, there are 
two main groups: glycoglycerolipids (glycerolipid structure) and glycoshingolipids (shingolipid 
structure). These types of lipids are typically located in the extracellular monolayer. 
Sterols 
Sterols, also known as steroid alcohols, are a subgroup of the steroids, with the most familiar type 
of animal sterol being cholesterol. They are amphipathic lipids composed by a steroid ring and a 
small acyl chain. The hydrophilic part of the sterols consists in a hydroxyl group. Sterols and 
related compounds play essential roles in the physiology of eukaryotic organisms. For example, 
cholesterol forms part of the cellular membrane in animals, where it affects the cell membrane's 
fluidity and serves as secondary messenger in developmental signalling. 
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Figure 2.1. Scheme of structures of different type of lipids. Lipids are by far the chemically most diverse 
class of biomolecules. Beside the different headgroups, the length and saturation of the acyl chains 
multiply the possible combinations. Phosphoglycerolipids are represented by the predominant specie in 
egg PC (A) and cardiolipin (B). The sphingolipids are sphingosine-1-P (C) and the glycosphingolipid GD3 
(D). And finally, the structure of cholesterol (E) is shown. 
Lipid polymorphism 
The polymorphism of lipids is due to their effective molecular shape that depends on the 
compatibility of the volume of polar headgroup and the size of the hydrophobic tails. Therefore, 
the variety of lipid structures with different morphologies is referred to lipid polymorphism. The 
packing parameter (P) of a lipid can be defined as: 
𝑃 =
V
A. l
  
 eq. 2.1 
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where, V is the entire volume of the lipid, A is the area of the lipid headgroup at the lipid-water 
interface, and l is the length of the lipid. Lipids possessing a cross-sectional area of the headgroup 
similar to that of the acyl chain (P=1) adopt a “cylindrical” form and organize themselves into 
planar lipid bilayers. By contrast, lipids differing in headgroup and acyl-chain cross-sectional 
areas lead to positively-curved (P > 1) and negatively-curved (P < 1) non-bilayer lipid 
organizations. It is noteworthy that highly-curved nonbilayer lipid structures, are thought to occur  
in living cells at local sites of membrane fusion and fission (Mouritsen, 2011). 
 
Figure 2.2 Schematic illustration of the concept of lipid polymorphism, showing the lipid geometry 
and the predicted morphologies adopted by lipid self-assembly. Lipids with cylindrical geometry (P=1) 
aggregates favouring lamellar structures. Negatively curved lipids (P>1) could assembly forming inverted 
hexagonal (HII) and cubic phases. Finally, lipids with positive curvature formed micelles and Hexagonal 
(HI) structures. (Modified from (Mouritsen, 2011). 
The polymorphic behaviour of a particular lipid not only depends upon its specific chemical 
structure, but may also be affected by environmental parameters, such as temperature, water 
content, pH, salt concentration, and presence of divalent cations (Cullis & de Kruijff, 1979). 
2.1.1.2 Model membrane systems 
During the last decades, different model membrane systems have been developed to study the 
properties of pure lipids, lipid mixtures and protein-lipid interactions. According to the method 
of preparation and complexity, model membranes can be divided in: (a) lipid monolayers, (b) 
micelles, (c) lipid vesicles (liposomes) and d) supported lipid bilayers (SLB). 
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Lipid Monolayers 
A lipid monolayer is a monomolecular ﬁlm generated at the air/water interface. Due to their   
amphipathic character, lipids spread on top of a water surface orienting their polar headgroups in 
close contact with the water surface while moving their hydrophobic acyl chains towards the air. 
The terms “Langmuir ﬁlms” and “Langmuir balance” are also used, referring to the preparation 
and characterization of this type of model membranes (Langmuir, 1917). 
Langmuir balance measurement represents an important source for the characterization of lipid-
lipid and lipid-protein interactions. The advantages of this system over other models are that 
lateral pressure, molecular packing and lipid composition can be precisely controlled, as well as 
the absence of global membrane curvature or ﬂuctuation effects. In the present work, Langmuir 
balance-based approaches have been applied to the study of lipid-protein interaction (detailed 
procedure is shown in protocol 14). 
Micelles 
As previously was explained, due to the amphipatic nature of the lipids, these molecules tend to 
self-assembly in aqueous environments, orienting their polar headgroups and excluding their acyl 
chains to the solvent. In the case of micelles, the inner part of the structure is hydrophobic and is 
generally formed by fatty acids, detergents or lysophospholipids that have an inverted cone shape. 
The Critical Micellar Concentration (CMC) is defined as the concentration of monomeric 
surfactants above which can self-aggregate forming micelles. Here, we use lipid concentration 
above the CMC to form the micelles. It becomes a very important parameter to take into account 
when measuring the effects of specific lipids upon incubation with other model systems or in 
cells, because they can induce membrane permeabilization underneath the CMC. 
Liposomes 
Liposomes are synthetic vesicles in where an aqueous volume is entirely enclosed by a lipid 
bilayer. One of the principal advantages of liposomes is the fact that they allow easy manipulation 
of important parameters such as curvature, lipid composition, membrane fluidity, charge density 
and permeability. 
According to their shape and size, liposomes can be classified as follows: (a) Small Unilamellar 
Vesicles (SUVs), which contain a single lamella and display sizes ranging from 25-50 nm; (b) 
Large Unilamellar Vesicles (LUVs) have a mean diameter of 100-500 nm; (c) Multilamellar 
Large Vesicles (MLVs), which contain multiple lamellae, and display a wide range of sizes (100-
10.000 nm) (New, 1990); and finally, Giant Unilamellar Vesicles (GUVs) may attain micrometre 
ranged diameters, similar size as eukaryotic cells (Figure 2.3). 
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Figure 2.3 Size comparison of different type of liposomes. SUV: Small Unilamellar Vesicles. LUV: 
Large Unilamellar Vesicles; MLV: Multi-Lamellar; and GUV: Giant Unilamellar Vesicles. In the 
amplified circle the organization of the lipids within the bilayer is observed, that reflects the higher 
curvature in SUVs, and almost flat membranes as the size of the liposome is increased.  
Due to their small diameter; SUVs present high curvature stress, which induces lipid enrichment 
in the external monolayer compared to the inner one (Chapman, 1984). This curvature stress 
makes these vesicles a good membrane model for the study of membrane fusion/fission related 
processes (Nieva et al, 1989), which are subjected to such stress conditions in vivo. In the same 
way, their small size is of great advantage when using in samples for optical spectroscopy since 
they minimize light scattering artefacts. However, as diameter increases (LUV, MLV and GUV), 
the curvature in certain areas of the bilayer is almost zero (Mayer et al, 1986). 
Preparation of Multilamellar Vesicles (MLVs) 
MLVs generation is the simplest and fastest of all liposome formation methods. So starting from 
the preparation of MLV, we can form different types of liposomes by simple processes as freeze 
and thaw cycles (FT-MLV), extrusion (LUV) or sonication (SUV). 
MLVs contain between 7 and 10 concentric bilayers, each of them separated by a thin water layer. 
Their size is very heterogeneous, displaying an average diameter of around 700 nm but ranging 
from 100 to 10,000 nm. When treating vesicles with a solubilizing agent, or when looking at a 
protein effect upon binding to the vesicle, only the external bilayer is accessible (a 10% of the 
lipid concentration). A detailed protocol for multilamellar vesicle preparation used in the present 
work is described in Protocol 1. 
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Preparation of Freeze/Thaw Vesicles (FT-MLVs) 
Another variation of the MLV is the Freeze and Thaw Multilamellar Vesicle (FT-MLV). In this 
case the preparation was carried out as described in Protocol 2. 
 
Preparation of Large Unilamellar Vesicles (LUVs) 
Due to the low curvature stress and homogenous lipid distribution, LUVs represent a suitable 
model system for most studies. LUVs are prepared by mechanical extrusion of a FT-MLVs 
suspension through polycarbonate porous filters of the desired size (Mayer et al, 1986). A detailed 
LUV preparation protocol is given below (Protocol 3). 
Protocol 1 MLVs preparation 
1- Lipid stock preparation: Pure lipid stocks were usually dissolved into a 
chloroform/methanol (2:1 v/v) organic solution. The desired amount of lipid 
was pipetted from the stock in organic solution into a glass tube. 
2- Evaporation of the organic solvent: The organic solvent was evaporated under 
a nitrogen glass flow. Then, the tube was put into a vacuum desiccator for 2 
hours to completely remove the solvent. 
3- Generation of MLVs: Finally, the dried lipid film was hydrated with a selected 
buffer and resuspended by vigorous vortexing, generating MLVs. 
  SUVs preparation 
Generation of SUVs: Once MLVs are formed, sample is sonicated 10 sec on/10 
sec off for 10 min with a tip sonicator. 
 
 
Protocol 2 FT-MLV preparation 
1- Preparation of MLVs: see Protocol 1 
2- FT-MLV preparation: Formed MLVs were next subjected to 10 freeze/thaw cycles, 
in this process concentric bilayers were reduced in number, thus vesicles had a 
smaller size. 
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Preparation of Giant Unilamellar Vesicles (GUVs) 
Giant unilamellar vesicles (GUVs) are a powerful membrane model due to their size (10-100 m) 
which is comparable to a cell. This allows the imaging of spatially confined events at single 
vesicle, e.g. mechanical properties, lateral organization of bilayers or membrane/protein (even 
DNA) interactions (Apellaniz et al, 2010; Bernardino de la Serna et al, 2004; Bleicken et al, 
2013b; Garcia-Saez et al, 2010; Garcia-Saez et al, 2007; Schon et al, 2008; Steringer et al, 2012). 
The generation of giant vesicles was first described by (Reeves & Dowben, 1969),  consisting of 
the exposure of dry lipid films to aqueous solutions, where GUVs were spontaneously generated 
but with very low total lipid yield and a very heterogeneous size distribution. In 1986, a new 
method for GUV generation was developed by (Angelova, 1986; 1992), based on the exposure of 
dry lipid films to an aqueous solution under an electric field, being the most generally applied 
Protocol 3 LUV preparation 
1- Preparation of FT-MLVs: see Protocol 2 
2- Extrusion procedure: Once FT-MLVs were formed, to obtain unilamellar 
vesicles of a certain size, vesicles were extruded according to the method 
described in (Hope et al, 1985) The sample was extruded 10 times through 
polycarbonate filters (Nucleopore, San Diego, CA, USA) with the desired 
pore diameter (0.1-0.2µm) and with the help of a nitrogen gas flow of 200 
psi.  
3- Lipid peroxidation (optional): In order to induce lipid oxidation, LUVs 
(3mM) were incubated with CuCl2 (20µM) at 37oC under continuous 
stirring. Then, the reaction was stopped at required time (typically, 1-3h) 
by adding 100µM BHT and 100µM EDTA. Copper-induced oxidation was 
checked at 245 nm, according to (Schnitzer et al, 1998; Schnitzer et al, 
2007). Next, 25µL of liposome preparation were solubilized into 750 µL 
absolute ethanol and measured in an Uvikon 922 spectrophotometer 
(Kontron instruments, Groβ-Zimmern, Germany, using quartz cuvettes 
with absolute ethanol in the reference cell. 
                                                               SLB preparation 
SLB generation: In this thesis SLB are formed based on proteoLUVs that are 
fused by the addition of CaCl2, see a detailed explanation in protocol 18. 
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procedure in the present. This method is much faster than the previous one and higher amounts 
of homogeneous size vesicles can be obtained. Nevertheless, the electroformation method is 
strongly dependent on the lipid composition, ionic strength and pH and on the electric voltage 
and frequency conditions (Bagatolli, 2003). In this thesis, vesicle generation procedures have been 
applied to obtain giant vesicles in solution for direct microscopy measurements (see Protocol 4).  
 
Protocol 4 GUV preparation 
1- Preparation of lipid mixture: Pure lipid or lipid mixture stocks diluted into a 
chloroform/methanol (2:1 v/v) organic solution were prepared to a final 
1mM concentration. Depending on the experiment that was going to be 
carried out %0.05 DiI (1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindo-
carbocyanine Perchlorate, DiIC18, Invitrogen) or %0.2 Rho-DHPE (L-α-
Phosphatidylethanolamine-N-(lissamine rhodamine B sulfonyl ammonium 
salt, Avanti polar lipids) was added to the lipid mixture. 
2- Electroformation:  
- 6μl of the appropriate stock solution were added onto the surface 
of different platinum electrodes attached to specially designed 
Teflon chamber containing platinum-wires. Then, chamber was 
introduced into a high vacuum desiccator for 2 hours to remove 
any remaining solvent traces. 
- Next, the platinum wires were covered with 300-400µL buffer-
isosmotic sucrose solution. If the transition temperature for the 
lipid mixture of the study was higher than RT, the chamber and the 
sucrose solution need to be preheated. Importantly, in order to 
avoid thermal evaporation, chambers need to be sealed with a 
glass cover.  
- The platinum electrodes were connected to a generator and the 
function started with a sinus wave at a voltage of 2.5V and a 
frequency of 10Hz during 2h, so vesicles were generated attached 
to the platinum wires. Then, frequency was decreased to 2Hz for 
30min, and finally vesicles were gently detached from the Pt wires.  
For a detailed specification on buffer, generator type or microscopy conditions in a 
particular assay look for Experimental procedures in the corresponding chapters. 
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2.1.1.3 Characterization of model membrane systems 
Phospholipid concentration measurement 
Accurate measurements of phospholipids are difficult to make directly, consequently the most 
widely used method for determination of phospholipids is the measurement of phosphate content 
in the sample (Bartlett, 1959; Böttcher, 1961; Fiske, 1925). Briefly, phospholipid phosphorus is 
first hydrolysed with perchloric acid to inorganic phosphate. Next, ammonium molybdate is 
added to obtain phospho-molybdic acid. The phospho-molybdic acid is then quantitatively 
reduced to a blue-coloured compound by ascorbic acid, and sample absorbance is measured at 
812 nm. 
A more detailed explanation is described in Protocol 5. 
 
 
Protocol 5 Phospholipid concentration measurement 
1- Preparation of the samples: The phosphate calibration curve was prepared 
from a 1mM NaH2PO4 stock solution. Lipid sample was pipetted into 
separate tubes to be in the middle of calibration curve (approximately 50 
nmol lipid phosphorous). 
2- Digestion: 400µL of 70% perchloric acid (HClO4) was added to each tube and 
let them incubate for 45min at 205°C and then cooled down to room 
temperature. 
3- Colorimetric assay: 4mL of ammonium heptamolybdate based solution and 
500µL of ascorbic acid 10% were added, while mixing the samples with a 
vortex. Samples were incubated for 10-15min at 100°C. 
4- Absorbance measurement: Absorbance was measured at 812nm using an 
Ultrospec 500 pro spectrophotometer from Amersham Biosciences 
(Piscataway, NJ, USA). 
NOTE: The mitochondrial specific lipid CL, containing two phosphate groups and 
need to be weighted. Moreover, cholesterol as lack in phosphate group was 
quantified by a commercial kit from Biosystems®. 
  Chapter 2: Experimental procedures 
 
71 
 
Determination of vesicular size (Dynamic light Scattering) 
Vesicle size measurements were performed using the quasi-elastic light scattering (QELS) 
technique, commonly known as dynamic light scattering (DLS). This technique measures the 
fluctuations in the intensity of the scattered light of the sample due to the Brownian motion of the 
particles in solution. From this data, the diffusion coefficient of the particles in the sample can be 
determined, and this can be related to the hydrodynamic radius (RH) of the vesicle by the Stokes-
Einstein equation (see eq.2.7). 
For the measurement, we placed 50 µL of the sample, at a lipid concentration of 0.5mM, in 
standard acryl cuvettes. The samples were analysed in a Malvern Zeta-Sizer Nano ZS (Malvern, 
Instruments, UK) subjected to a He-Ne laser beam of 5mW ( = 633 nm). The light scattered by 
the sample was detected with a photomultiplier placed perpendicular to the beam. 
2.1.2 Protein component 
In this section, it is described the methodology used in the present thesis to obtain and validate, 
both structurally and functionally, different recombinant BCL-2 family members and their 
mutants. As well as, a brief description of BAX peptides used. Importantly, proteins are with 
lipids, a key piece of reconstituted systems. Therefore, in order to understand their precise 
biological role, their accurate characterization becomes fundamental.  
2.1.2.1 Site-directed mutagenesis 
In vitro site-directed mutagenesis is an invaluable technique for studying protein structure and 
function. In this work, site directed mutagenesis has been used mainly for generating residues 
susceptible to be modified by fluorescent dyes. 
The system used for site-direct mutagenesis (Stratagene’s QuikChange® Site-Directed 
Mutagenesis Kit) allows site-specific mutations in virtually any double-stranded plasmid, thus 
eliminating the need for subcloning. In addition, no specialized vectors, unique restriction sites, 
or multiple transformations are required. The process consists of different steps as described in 
Protocol 6. 
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Protocol 6 Site-directed mutagenesis 
1- Primers design: The primers were designed containing each specific 
mutation, flanked by unmodified nucleotide sequence. Ideally, primers 
should be between 25 and 45 bases in length, with a melting temperature 
(Tm) of ≥78°C, and a minimum GC content of 40%. In this thesis, primer 
design was performed by using Primer X web page and selected candidates 
were synthesized by Sigma-Aldrich. 
2- Plasmid preparation: Sample reactions were prepared as indicated in the 
User´s manual of Stratagene’s QuikChange® Site-Directed Mutagenesis Kit. 
1. 5μl 10× reaction 
buffer 
 5–50ng dsDNA 
template 
 125ng Oligonucleotide 
primer #1 (Fw) 
 125ng oligonucleotide 
primer #2 (Rv) 
 20mM dNTP mix 
 q.s  to 50μL 
ddH20 
 
2. 2.5 U PfuTurbo DNA 
polymerase 
 
Table 2.1. Concentrations required for sample preparation in a mPCR. 
(next page) 
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3- Thermal Cycling: 
Segment Cycles Temperature Time 
1 1 95° C 30 s 
2  16 95° 30s 
  55°C 1 min 
  72°C 1 min/kb 
of 
plasmid 
length 
3 1 4°C  
Table 2.2. Cycling Parameters for the QuikChange Site-Directed Mutagenesis 
Method. 
4- Digestion of the Amplification Products: 1 μl of the Dpn I restriction enzyme 
(10 U/μl) was added to each sample reaction and incubated at 37°C for 1h 
to digest methylated (parental) supercoiled dsDNA. 
5- Transformation of XL1-Blue Supercompetent Cells: XL1-Blue 
supercompetent cells, resistant to tetracycline, were thawed on ice and 50 
µL aliquots for each sample were put on sample tubes. 10 µL of DpnI-
treated DNA was added and the reactions were mixed and incubated on 
ice for 30 minutes. Transformation reactions were heated for 45 seconds 
at 42°C and then were placed on ice for 10 minutes. 1mL of Luria broth 
medium (10g tryptone, 5g yeast extract and 5g NaCl, per litre) was added 
and incubated for 37°C for 1 hour while shaking. Then samples were 
centrifuged, resuspended in a smaller volume and plated on agar plates 
containing the appropriate antibiotic for the plasmid vector. The 
transformation plates were incubated at 37°C for >16 hours. Finally, DNA 
plasmid was extracted by a QIAprep Spin Miniprep Kit®. 
6- Sequence determination: The mutated DNA samples were sent for 
sequencing to determine that the mutation had been inserted and no 
additional changes were made in the sequence of the plasmid. 
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In this thesis, different variants of the recombinant proteins have been used, objects of study, 
some of them have been made following the procedure explained above (Table 2.2), obtained 
from Addgene company and some other have been developed by TopGeneTech (Quebec, Canada) 
company. For example, to develop BFL1 monocysteine mutants, all endogenous cysteines were 
removed; C4S, C19S, C55S by consecutive substitutions. Of note, we conserved C19S/C55S 
construct, which preserves C4 and still enables its labelling, to add the L21A and R88D single 
mutations. Then, using 0cys mutant as the PCR template the following monocysteine mutants 
were developed: Y10C, S31C, S43C, A67C, N72C, Q73C, I100C, R105C, F121C and N129C 
among others. 
2.1.2.2 Expression and purification of proteins 
Recombinant protein utilization has greatly increased in recent years. Fusion proteins are simple 
and convenient to work with and, for many applications, a single purification step using a 
commercially available affinity chromatography is generally sufficient. In the present work, 
Glutathione S-transferase (GST), chitin and 6 Histidine ((His)6) tagged proteins have been used. 
Plasmids for bacterial expression 
Different plasmids were used for recombinant protein expression (Table 2.3): 
 Antiapoptotic proteins: Plasmids for human GST-BCL-XL lacking the C-terminal 24 
amino acids (BCL-XLΔC), chitin-BCL-XL version and human His6-tag BFL1 lacking 
the C-terminal 26 amino acids (BFL1∆C) have been used in this thesis. Particular 
features: The vector pGEX-6P-3 for expression of GST fusion proteins has a PreScission 
Protease target place LEVLFQ/GP. BCL-XL was kindly provided by Dr. Ana García-
Sáez. His6-tag BFL1∆C was obtained from Addgene (Plasmid #42399, which was 
deposited by Nicola Burgess-Brown). 
 Proapoptotic BAX: Plasmid for expression of human full-length BAX was kindly 
provided by of Dr. M Suzuki (NIH, Bethesda). The plasmid is a derivative of pTYB1 
vector (New England Biolabs, Canada), in which the cDNA of human full-length BAX 
was subcloned into NdeI/SapI sites of the vector. The resulting plasmid, pTYB1-BAX, 
encodes a fusion protein of BAX and a chitin binding domain plus a self-cleavage intein 
at its C-terminus, which is cleaved off to obtain BAX with neither any extra amino acid 
nor truncation (Suzuki et al, 2000).  
 BH3 only proteins: Plasmid for murine BID with an N-terminal His6-tag was kindly 
provided by Dr. B. Antonsson.  
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Next, a table summarizing plasmids characteristics is built in order to collect their peculiarities, 
including origin, tag, resistance and growth media. 
Protein 
insert 
Plasmid Description Resistance Purification 
media 
Human 
BAX 
pTYB1 A chitin binding domain plus a 
intein sealf-cleavage at the C 
terminal. 
Ampr TB 
 
Human 
BFL1∆C26 
pNIC28-
Bsa4 
A 6-histidine tag plus TEV 
protease cleavage at the N-
terminus. 
Kanr TB 
Human 
BCL-
xL∆C24 
pGEX-6P-
3 
A GST-tag plus a PreScission 
protease cleavage site at the N-
terminus. 
Ampr LB 
Human 
BCL-XL 
pTYB2 A chitin binding domain plus a 
intein sealf-cleavage at the C 
terminal. 
Ampr/chlor LB 
Murine BID pET23d A 6-histidine tag plus 
PreScission protease cleavage 
at the N-terminus. 
Ampr LB 
Table 2.3. Expression plasmids, bacterial strains and antibiotic resistances used for the different 
proteins purification. LB (Luria Broth; 10g tryptone, 5g yeast extract and 5g NaCl, per litre). TB (Terrific 
Broth, 24g Yeast extract, 12g peptone, 12.5g K2HPO4 and 2.3g KH2PO4). 
Protein expression and purification 
Protein expression and purification is a very diverse methodology, which is very dependent on 
the nature of recombinant protein. In the case of BCL2 family members, full-length version of 
some of this protein has achieved to be purified, while others have been purified in their C-
terminal lacking version which is much more soluble.  
Here, protein purification protocols differ mainly according to the affinity-tag, however, a general 
procedure is summarized in the next scheme and protocol 7. 
 
Figure 2.4. Simplified scheme of recombinant protein purification process 
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Protocol 7 Protein purification 
1- Transformation: BL21(DE3) CaCl2-competent bacteria for recombinant 
protein expression, were transformated with ≈100ng of plasmid, as 
explained in protocol 6.  
2- Next, a single colony of transformed bacteria was picked and placed into a 
flask containing 100mL of growth medium supplemented with the 
appropriated antibiotic (1000:1, hereafter medium*) and incubated in an 
orbital shaker at 37°C ON. Next, the medium was diluted 1:50 in 1L of 
medium* and incubated in an orbital shaker at 37°C.  
3- IPTG induction and cell harvesting: Once bacterial medium reached to the 
appropriated confluence/O.D. 600nm: 0.8-1a.u. (for BID and BCL-XL), 1.2-
1.5a.u. (for BAX) and 2-2.5a.u. (for BFL1ΔC), in order to promote protein 
expression, 1mM of IPTG was added, and bacteria were incubated at 18°C 
ON. Then, were collected by centrifugation (5,000 x g for 30min at 4°C) in a 
Beckman Coulter centrifuge using JLA-9,100 rotor and kept frozen for 
further purification. 
(next page) 
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4- Cell lysis:  Bacterial pellets were resuspended in bacterial lysis buffer A (see 
table 2.4) supplemented with freshly added lysozyme (final concentration 
of 1mg/ml, Sigma-Aldrich), bacterial protease inhibitors (without EDTA for 
His6-tagged proteins, Roche), and 2.5µg/ml RNAse (Sigma-Aldrich). The 
mixture was then incubated at 4ºC in an orbital shaker for 2h to allow 
disruption of the bacterial cell wall. Then, samples were disrupted by using 
an EmulsiFlex C5 from Avestin (≥17000psi on ice), or sonicated with a tip 
sonicator on ice 4 x (10on/10off/10sec). Next, the suspension was 
centrifuged at 30,000 x g for 30min at 4°C in a Beckman Coulter centrifuge 
using JA-25.50 rotor. Finally, the pellet was discarded and the supernatant 
was kept on ice for further purification steps. 
5- Affinity chromatography:  
- Purification of His6-tagged proteins: His6-tagged proteins were purified by 
affinity chromatography using “Ni-NTA Superflow beads” (Qiagen). Beads 
were first washed three times with distillate water and three more times 
with ten bed volumes of Buffer A (Table 2.4). Then, prefiltered bacterial 
supernatant was incubated with washed beads for 2h in an orbital-shaker 
at 4°C. Next, beads were packed in a column connected to a peristaltic 
pump, followed by a washing step of the column with 10 bed volumes of 
buffer A. Then, protein was eluted by using buffer B (Buffer A with 400mM 
imidazole, pH8) (Table 2.4) and fractions of 0.5mL were collected for SDS-
PAGE analysis and Coomassie blue staining.  
Additionally, in order to remove the 6HIS tag, protein enriched fractions 
were incubated with 10 µL (Stock: 10U/µL) of AcTEV protease (Invitrogen) 
ON at 4°C. Digested samples were incubated with 100µL of precleaned 
Ni-NTA beads for 2h at 4°C. Then, beads were centrifuged at 14,000rpm 
for 10min and supernatant, where cleavage-protein (BFL1∆C) is, was 
collected. 
(next page) 
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- Purification of GST-proteins: These GST fusion proteins were purified by 
affinity chromatography using “Glutathione Sepharose 4B beads” (GE 
Healthcare, Waukesha, WI, USA). First, beads were washed with buffer A 
(Table 2.4) as described earlier. Second, bacterial supernatant was mixed 
with washed beads and incubated for 2h in an orbital-shaker at 4°C. Then, 
beads were packed in a column connected to a peristaltic pump. After 
washing of the column with 10 bed volumes of buffer A (without Protease 
inhibitors), 30µL (Stock: 2000units/ml) of PreScission protease (GE 
Healthcare, Waukesha, WI, USA) in 5ml of buffer A were added to the 
column. Then, column is sealed and stored at 4°C ON for efficient 
protease cleavage. Finally, the cleaved protein was eluted from the 
column for SDS-PAGE analysis and Coomassie blue staining. 
Complementarily, for some experiments we eluted GST-proteins without 
proteolytic cleavage using 20mM of glutathione in buffer A. 
- Purification of chitin-proteins:  Human full-length BAX/BCLXL and its 
mutants were purified following procedure described in (Suzuki et al, 
2000). Beads were first washed three times with ten bed volumes of buffer 
A (Table 2.4). The bacterial supernatant was mixed with washed beads and 
the mixture was incubated overnight in an orbital-rotator at 4ºC to allow 
binding of the protein to chitin beads. Then, beads were packed in a 
column connected to a peristaltic pump. Next, the column was washed 
with 5 bed volumes of corresponding buffer B. The column was then 
sealed and stored at 4ºC during 48h to allow efficient intein self-cleavage. 
Next, elution fractions were subjected to electrophoresis followed by 
Coomassie Blue staining. 
5- Size exclusion chromatography (SEC): (see in the next section) 
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Fusion protein Buffer A Buffer B 
His6-tagged proteins 300mM NaCl, 20mM 
imidazole, 1mM MgCl2, 
50mMNa2HPO4/NaH2PO4. 
1mM TCEP, 10% glycerol 
(pH 8) 
 
Buffer A supplemented 
with 300mM imidazole. 
(pH 8)  
GST fusion proteins 150mM NaCl, 50mM Tris, 
1mM EDTA, 1mM TCEP, 
10% glycerol (pH 7.5) 
Buffer A supplemented 
with 20mM glutathione. 
(pH 7.5) 
Chitin-proteins 100mM NaCl, 20mM Tris, 
1mM EDTA, 1mM TCEP, 
10% glycerol (pH 8) 
Buffer A supplemented 
with 50-200mM DTT.  
(pH 8) 
  Table 2.4. Composition of purification buffers for affinity chromatography for each fusion protein. 
Size exclusion chromatography (SEC) 
The main application of Size Exclusion Chromatography (SEC) (also referred to as gel filtration) 
method is the fractionation of proteins or other molecules in solution based on their size and 
hydrodynamic radius. For that aim, a protein mixture is passed through a column packed with an 
inert porous matrix of spherical particles with determined pore sizes in an aqueous solution. 
Differences in the elution time of the proteins are due to different retention capacity in the pore 
matrix system (stationary phase). Therefore, small molecules will elute at higher volumes, 
whereas, larger proteins that cannot penetrate the pores will pass through the interparticle volume 
(mobile phase), eluting at earlier volumes. Maximum resolution can be obtained when the sample 
volume is 0.5% to 2% of the total volume of the column. Samples are isocratically eluted; no 
additional buffer is needed for the separation process, and separation can be performed within a 
broad pH, ionic strength and the medium accepts a variety of additives as detergents or urea. 
In this thesis, SEC has been used for different objectives, in this section it has been used as the 
last step of the purification process, in order to obtain a homogenous and monomeric population. 
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2.1.2.3 Protein fluorescent labelling 
For several studies such as Fluorescence Correlation Spectroscopy (section 2.2.2.3.), proteins 
must be labelled with fluorescent probes. For labelling, we use selected thiol-reactive dyes that 
can be conjugated with native cysteines present in the protein sequence or mutationally 
engineered for this aim. For FCS experiments, proteins were labelled with Alexa Fluor dyes that 
produce bright and photostable conjugates, Alexa fluor®-488-C5-maleimide and Alexa fluor®-
647-C2-maleimide (Invitrogen, Carlsbad, CA). Moreover, IANBD, a thiol-specific 
iodoacetamide derivative of NBD, was used for studying protein:protein and protein:lipid 
interactions. 
A general procedure for dye conjugation reaction (labelling) is described in Protocol 9. 
 
Protocol 8 SEC 
1- Sample preparation: Fractions enriched in recombinant protein were 
concentrated in Centricons (Millipore) up to the 250µL-volume. 
2- Gel filtration: Samples were loaded into a SuperdexTM 200 HR 10/30 or 
Superdex 75 HR 10/300 GL size exclusion columns (Amersham Pharmacia 
Biotech, Uppsala, Sweden), equilibrated in KHE buffer (100mM KCl, 10mM 
HEPES, 1mM EDTA, pH 7.5) with 1mM TCEP and 10% glycerol. In the particular 
case of BFL1, the equilibration buffer was; 300mM NaCl, 20mM HEPES, with 
1mM TCEP and 10% glycerol. Elution was performed at 0.3-0.5mL/min flow-
rate, at 4°C and monitoring UV absorbance at 280nm. 
3- Protein detection: Peak protein fractions were concentrated up to 10-200M 
by ultrafiltration in 3YM Microcons, and analyzed by SDS-PAGE and 
Coomassie-blue staining. 
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2.1.2.4 Protein non-fluorescent labelling  
For the topology assessment by using non-fluorescent probes, thiol-reactive PEG-Mal (Methoxil 
poliethileneglycol Maleimide) molecules (NANOCS) have been used. Theses probes can be 
conjugated with native cysteines present in the protein sequence or mutationally engineered for 
this purpose. Two different approaches were used to characterize the topology of different BCL2 
family proteins at the membrane level.  
First, the combination of monocysteine mutants with the relatively small probe 0.5kDa PEG-Mal, 
was used to obtain information about the implication of labelled residue (and its adjoining) in the 
protein membrane activities. Here, the labelling was performed as described in the protocol 9, but 
using 0.5kDa PEG-Mal probe instead of fluorescent dyes.  
Second, a bigger thiol-reactive probe (5kDa PEG-Mal) was used to study the solvent exposure of 
each monocysteine residue, stablishing afterwards, the accessibility pattern and protein topology 
in the equilibrium. The irreversible binding of this 5kDa probe to exposed monocysteines, adds 
an extra weight to the protein that could be detected as a shift by SDS-PAGE. In this particular 
case, the protein labelling is done after its incubation with model membranes, mitochondria or 
semi-intact cells in the presence/absence of other BCL2 proteins. Thus, samples containing 
monocysteine mutants were incubated with 0.25-1mM of 5kDa PEG-Mal for 30min at variable 
temperature (4°C, RT and 37°C) under continuous stirring. Then, samples were blocked by adding 
Protocol 9 Protein Fluorescent labeling 
1- Sample preparation: Protein was diluted (0.2-0.5mg) in 1mL KHE at pH 7 
containing 1mM of TCEP and incubated for 30min at 37°C to reduce 
disulfide bonds.  
2- Labeling procedure: 5-10 molar excess of dye Stock (20mM IANB in DMSO 
or Alexa Fluor 10mM in DMSO) were incubated with the protein sample 
overnight at 4°C while constant stirring and protecting them from light. 
3- Blocking reaction: Sample was centrifuged at 14,000rpm for 10min and the 
supernatant was loaded to a PD-10 Desalting column (GE Healthcare, 
Waukesha, WI, USA) previously equilibrated with KHE 1mM DTT. Here, 
conjugation reaction is blocked by DTT and labeled protein is separated 
from the non-conjugated free dye. 
4- Determination of the degree of labeling: see section 2.1.2.5 
Characterization of proteins. 
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5mM DTT/NEM. Finally, SDS-PAGE analysis and Coomassie blue staining or Western blotting 
was performed as described in the protein visualization section 2.1.2.5 and protocol 10). 
 
Figure 2.5. Topology assessment by using thiol-reactive PEG-Mal molecules (NANOCS). SDS-PAGE: 
(Left) coomassie blue staining. (right) Western blotting. 
 
2.1.2.5 Characterization of proteins. 
Protein concentration measurement 
Protein concentration was quantified using either the Bradford protein assay (Bradford et al., 
1976) or absorbance measurement at 280nm. What follows is a brief description of main 
characteristics of each procedure: 
 Bradford: Coomassie Brilliant Blue G-250 dye binds selectively to positively charge 
residues and aromatic residues, and this binding is accompanied by a shift in 
absorbance maximum from 465nm to 595nm. The working range of the technique is 
1-1500µg/ml protein and the assay was performed using the standard test tube protocol 
and a set of pre-diluted bovine serum albumin (BSA) protein assay standards. 
 Absorbance at 280nm: Proteins in solution absorb ultraviolet light with absorbance 
maxima at 280nm, due to the presence of amino acids with aromatic rings. Secondary, 
tertiary, and quaternary structure all affect absorbance, therefore factors such as pH, 
ionic strength, etc. can alter the absorbance spectrum. Following Lambert-Beer 
equation with a theoretically calculated extinction coefficient, we can estimate protein 
concentration. 
A= ε c l 
Eq. 2.1 
Where A is the absorbance, ε the extinction coefficient, c concentration and l cuvette 
length 
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 Determination of the degree of labelling: The degree of labelling can be calculated 
measuring the ratio of fluorescent dye and protein concentration. Fluorescent dye 
concentration can be measured by the absorbance value of the dye at the absorption 
maximum wavelength, and the protein concentration, following the methods 
explained above. If non-conjugated free dye is present, the degree can be 
overestimated, FCS measurements or MS Spectrometry can be done to confirm the 
results. Additionally, PEG-Mal labelling was calculated as the ratio between the 
intensity, assessed by Quantity One software (Fujifilm USA, Valhalla, NY), of shifted 
and non-shifted bands obtained from coomassie blue staining or WB. 
Visualization and Detection techniques 
There are a variety of methods for visualization and detection of proteins in-gel and on-
membranes. In this section, several gel stains used in this thesis are described and summarized in 
the protocol 10. 
 
Protocol 10 Protein detection 
The whole procedure can be divided in 2 steps: (1) gel electrophoresis and (2) 
visualization and detection. 
(1) Gel electrophoresis: samples were separated according to the method of 
Laemmli (Laemmli, 1970). In this method, are separated mainly according to 
the molecular weight by denaturing sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) in 10-15% polyacrylamide gels, with 20 mM Tris-Cl 
(pH 7.9), 100 mM NaCl, 70 mM EDTA, 2% (w/v) SDS as running buffer. 
(2) Visualization and detection:  
1- Fluorescence: Fluorescently-labeled proteins were directly visualized in a 
gel using a Molecular Imager Versadoc (Bio-Rad, PA, USA).  (next page) 
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2-Coomassie staining: Gels were stained with Coomassie solution (0.1% 
Coomassie R250, 10% acetic acid, 40% methanol) and then de-stained with 20% 
methanol, %10 glacial acetic acid. The reaction is based on the reversible 
electrostatic interaction of the colorant molecules with the amine groups of the 
protein. 
3- Silver Staining: Gels were stained by using Silver Stain Plus kit (BIORAD) and 
then de-stained by following kit instructions. 
4- Western blot (Immunoblotting): After gel electrophoresis, the procedure can 
be divided in three steps: 
- Transference: Proteins were transferred onto nitrocellulose membrane 
(Protran nitrocellulose membrane; Whatman Inc, NJ, USA) by 
electroblotting at 12V for 45min, in a Trans-Blot SD (Bio-Rad, PA, USA) using 
20mM Tris-HCl (pH 8), 100mM NaCl, 70mM EDTA, 15% MeOH as transfer 
buffer. 
- Blocking: To prevent nonspecific interactions, the membrane was blocked 
with 5% non-fat dry milk in PBS (137mM NaCl, 10mM Na2HPO4, 10mM 
NaH2PO4 pH7) and supplemented with 0.05% Tween 20 (PBS-T). Blocking 
was performed in an orbital shaker at room temperature for 1 hour.  
- Detection:  The membrane was incubated for 1h at RT or ON at 4oC in a 
1:2,000 with an appropriate primary antibody diluted in %2.5 non-fat dry 
milk PBS-T. After 3X10 min washes in PBS-T, the membrane was incubated 
in a 1: 5,000 dilution with the corresponding horseradish peroxidase (HRP) 
conjugated secondary antibody for 1h on a shaker at room temperature. 
Finally, detection was carried out using the chemiluminescent ECL-Plus 
Western blotting reagent (Pierce, Rockford, IL, USA) and visualized on 
Hyperfilm™ ECL™ (PerkinElmer Life Sciences, Boston, MA, USA). 
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Structure studies 
Circular Dichroism 
Circular dichroism (CD) is a technique used for determining the secondary (Far-UV CD) or 
tertiary (Near-UV CD) structure of biomolecules. In addition, it is also useful to study their 
conformational changes and stability, either in solution or in model membrane systems, such as 
detergents or lipid vesicles. The relatively small amount of sample required and the simple data 
analysis have made this technique widely used. However, its main drawback is that, in contrast 
to other techniques like X-ray diffraction or nuclear magnetic resonance (NMR), the three 
dimensional atomic structure of the sample cannot be determined. 
CD is a type of light absorption spectroscopy based on the differential absorption of the left and 
right circularly polarized components of linearly polarized radiation by optically active chiral 
molecules. The most abundant chromophores in proteins are the amide group and the side chains 
of aromatic amino acids, and the electronic transitions that produce upon absorption vary in 
wavelength and intensity, depending on their spatial localization. Thus, information about 
secondary and tertiary structure can be obtained. In the present work, CD has been used to study 
the structure of several BCL-2 family proteins either in solution to determine if purified proteins 
were well structured. 
The Far-UV CD spectra were collected using the following parameters a 1-nm step size over 260 
to 190nm wavelength range, speed 50nm/min; response 1s; bandwidth 2nm in a 
spectropolarimeter Jasco J-810 (Jasco Spectroscopic Co. Ltd., Hachioji City, Japan) equipped 
with a JASCO PTC-423S temperature control unit. Each measurement was the average of 20 
scans, which was background- subtracted. All samples were allowed to equilibrate for 10min prior 
to CD analysis. Taking into account Lambert-Beer´s law, the degrees of ellipticity () can be 
converted to mean residue molar ellipticity (deg·cm2·dmol-1): 
[𝜃] =
𝜃
(10. 𝑙. 𝑛. 𝑐)
 
 eq. 2.2 
where  are the degrees of ellipticity; l is the length of the pathway in cm; n, the number of peptide 
bounds and c the protein concentration in molar.  
Finally, secondary structure content was estimated from the far-UV spectra using CDPro software 
(http://lamar.colostate.edu/-sreeram/CDPro/main.html) (Sreerama & Woody, 2004b). This 
prediction program, based on databases containing CD spectra of proteins whose structure has 
been solved with atomic resolution techniques such as X-ray crystallographically or NMR, is an 
online interface for the use of several open source algorithms (including  CONTINLL, SELCON3 
and CDSSTR) for analysing protein CD spectra. 
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As mention before, CD is also a useful technique to follow the thermal stability of a protein at a 
characteristic wavelength under increasing temperature. In our case, the multidomain proteins are 
α-helical proteins, so the signal at the 222nm is registered continuously as a function of 
temperature. Comparing these curves at different conditions, we analysed whether differences in 
the melting temperature of the protein occurred.  
 
Figure 2.6 Representative circular dichroism spectra. -helix structures present a double minimum at 
222 and 208-210 nm and an intense maximum at 191-193 nm. The ratio between these intensities reflects 
the helicity of the peptides or proteins analysed. In contrast,  structures present a single minimum localized 
between 210 and 225 nm and a maximum between 190 and 200, depending on if they have a parallel or 
antiparallel arrangement. Finally, unordered structures, present a minimum around 200 nm and several 
weak bands between 220 and 230, either positive or negative. 
To assess the thermal stability of the BCL-2 proteins studied, sample components (proteins with 
or without liposomes) were incubated for 1h in PBS buffer 37°C prior to the beginning of 
measurements. CD data was collected at 222nm wavelength every 1°C from 25°C to 90°C. The 
midpoint of the melting transition was estimated using the first derivative converter available in 
the software of the CD instrument with a window of nine data points and a 2nd degree polynomial 
smoothing. 
Intrinsic tryptophan fluorescence spectroscopy 
The intrinsic fluorescence of aromatic amino acids can be applied for studying protein stability.  
Changes in the intrinsic tryptophan (Trp) fluorescence of proteins often occur upon 
conformational changes or ligand binding. In general, the quantum yield of tryptophan 
fluorescence increases in intensity (sometimes accompanied with a blue shift) when tryptophan 
is buried to a more hydrophobic environment, and decreases when it is exposed to an aqueous 
medium. Thus, is sensitive to a possible conformational change, and therefore tryptophan 
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fluorescence can be applied for determining changes caused by cahotropic agents, membrane-
interaction or ligand-binding, among others (Bakas et al, 1996; Ostolaza & Goni, 1995; Soloaga 
et al, 1998; Zhao & Kinnunen, 2002). A general procedure is described in Protocol 11. 
 
 
Differential scanning fluorimetry (DSF) 
DSF monitors thermal unfolding of proteins in the presence of a fluorescent dye and is typically 
performed by using a real-time PCR instrument. The fluorescent dyes that can be used for DSF 
are highly fluorescent in non-polar environments, such as the hydrophobic sites in unfolded 
proteins, compared to aqueous solution where their fluorescence is quenched. In recent time, the 
use of extrinsic fluorescent dyes such as ANS, Bis-ANS, Sypro-Orange and others has increased, 
because of their versatility, sensitivity and suitability for high-throughput screening. (Hawe et al, 
2008a; Hawe et al, 2008b; Semisotnov et al, 1991). 
In a DSF experiment, the fluorescence intensity is plotted as a function of the temperature; this 
generates a sigmoidal curve that can be described by a two state transition. The inflection point 
of the transition curve (Tm) is calculated applying Boltzmann fitting.  
 
 
 
Protocol 11 Intrinsic tryptophan fluorescence  
1- Sample preparation: First, sample components (protein, drugs, liposomes…) 
were incubated for 10min prior the measurement at RT while stirring in 750µL 
KHE.  
2- Fluorescence measurement: Spectra were recorded in an 8100 Aminco-Bowman 
luminescence spectrometer (Spectronic Instruments, Rochester, NY, USA) 
between 305nm and 405nm (4nm bandpass) at a scan rate of 1 nm/s, using an 
excitation wavelength of 295 nm (4nm bandpass). The slit widths for excitation 
and emission were kept at 4nm, with the experiment conducted at RT. The 
contribution of the buffer or liposomes alone was subtracted as blank. 
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           Figure 2.7. Diagram of a typical thermal shift assay 
 
 
 
 
 
Protocol 12 DSF/ ANS Fluorescence 
1- Sample preparation: Protein (1µM final concentration) was diluted in 1mL KHE 
at pH 7,4 containing 10µM of 8-Anilinonaphthalene-1-sulfonic acid (ANS). 
2- Fluorescence measurement: Emission fluorescence were recorded in a 
FLUOROLOG HORIBA JOBIN YVON coupled with a peltier LFI 3551, at 
λEM=485±nm, between 60°C and 95°c (1°C/min increase), using an excitation 
wavelength of 350 nm (4nm bandpass).  
NOTE: For these experiments is particularly important to seal the cuvette with a 
lid to avoid thermal evaporation.  
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2.1.2.6 Synthetic peptides. 
The synthetic peptides used in this thesis emulate some of the alpha helixes present in the 
proapoptotic BAX. All synthetic peptides (>90%purity assessed by HPLC) were purchased from 
Biomatik (Wilmigton, DL, USA). 
Name Sequence 
BAX α5 peptide FNWGRVVALFYFASKLVLKALCT 
BAX α6 peptide VPELIRTIMGWTLDFLRERL 
BAX α7-8 peptide LGWIQDQGGWDGLLSYFG 
 
Table 2.5 Different peptides sequences of the BAX alpha helixes. 
Peptide concentration measurement 
The bicinchoninic acid (BCA) assay (Smith et al, 1985) was performed using the standard test 
tube protocol and a set of pre-diluted bovine serum albumin (BSA) protein assay standards.  This 
BCA method employs the reduction of Cu2+ to Cu1+ by protein in alkaline medium and this creates 
a purple-coloured product that absorbs at 562nm. The working range of the technique is 5 µg/ml-
2 mg/ml. Importantly, unlike the Coomassie dye-binding methods, the universal peptide backbone 
also contributes to colour formation, helping to minimize variability caused by protein 
compositional differences. 
2.2 METHODS RELATED TO RECONSTITUTED MODEL 
SYSTEMS 
2.2.1 Protein-lipid interaction: membrane-association  
Numerous approaches have been used to assess the interactions of proteins and lipids, those that 
have been used in the present thesis are described in the following sections. 
2.2.1.1 Binding of proteins to liposomes 
In order to have an observable effect on a membrane, the protein must first associate with it. A 
commonly used method to determine protein-lipid interaction is studying the binding of proteins 
to liposomes. The protocol used in this type of experiments involved incubation of the protein (or 
the combination of them) with liposomes and separation of lipid-associated from lipid-free 
fractions. This model membrane system is compiled in protocol 13. 
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2.2.1.2 Lipid Monolayers experiment 
Lipid monolayer experiments are based on the measurement of the water surface tension by means 
of a suspended solid probe that is slightly introduced into the gas-liquid interface. The forces 
generated by surrounding molecules (surface active compounds as lipids or proteins) produce an 
excess cohesive energy called the surface free energy that can be related to the forces detected by 
the probe which can be further related with surface pressures (π). 
Typically, lipid monolayer experiments are used in two types of experiments. In the first one, the 
two-dimensional lipid density can be controlled by compressing the monolayer, obtaining 
compression isotherms. This type of experiments allows determining phase transitions and the 
collapse pressure. 
In the second type of experiment, the one used in this work to assess BAX α helixes capacity to 
penetrate in the monolayer, the area of the interface is maintained constant and the changes in 
surface pressure (π), due to the addition of a protein or peptide, are registered as a function of 
time (Brockman, 1999; Fidelio et al, 1986). By comparing the values of π under different 
conditions (lipid composition, the temperature, the ionic strength of the medium, etc.), one can 
obtain information about the parameters influencing the interaction. 
Protocol 13            Binding of BCL2 proteins to liposomes 
1- Sample preparation: Proteins and liposomes were first incubated in KHE 
buffer at 37°C for 1h while shaking.  
2- Sucrose gradient float-up centrifugation: Following incubation of the 
proteins with the liposomes at 37°C, the sample is adjusted to 1.4M sucrose 
using sucrose stock solution prepared in KHE and loaded at the bottom of a 
discontinuous sucrose gradient (medium layer of 0.8M, upper layer of 0.5M 
sucrose). The sample is centrifuged at 4°C for 3 hours at 500,000 x g in a 
Beckman Optima TLX Benchtop ultracentrifuge (Beckman Coulter Miami, 
FL, USA), using a TLA 120.2 rotor. During ultracentrifugation, due to their 
lower density, liposomes and liposome-bound proteins float up to the top 
fraction of the gradient whereas free protein remains at the bottom (a total 
of 4 samples). 
3- Protein detection: Finally, proteins were detected by immunoblotting or by 
fluorescence detection and integrated densities were measured using 
Quantity One software (Fujifilm USA, Valhalla, NY). 
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Figure 2.8. Schematic representation of the process of protein insertion into a lipid monolayer. The 
initial pressure of the monolayer is adjusted to the desired value (πi). The protein inserts into the monolayer 
increasing the surface pressure until reaching the equilibrium (πf). Δπ is then calculated using Δπ= πf- πi. 
A particularly useful parameter to study the monolayer-penetrating capacity of a protein is to 
determine its critical pressure (πC), this is the value of π at which ∆π becomes zero or in other 
words, the minimum surface pressure at which the protein is no longer able to penetrate the 
monolayer. This parameter can be calculated by plotting the increase of pressure (∆π) as a 
function of the initial surface pressure (π0), being the exclusion pressure the value when equation 
turns zero. It is to be stressed that cell membranes are proposed to have a surface pressure of 
around 30 mN/m (Janmey & Kinnunen, 2006). However, this value is controversial and can 
largely vary. Lipid monolayer experiments are described in Protocol 14. 
 
Protocol 14  Lipid Monolayer experiments 
1- Monolayer preparation: After calibration of the Langmuir balance, a small 
volume of the lipid mixture (1mM in chloroform) was spread onto 1,25mL KHE 
buffer to form a monolayer with a given initial surface pressure (0). 
2- Protein injection and surface pressure measurement: Once the surface 
pressure of the monolayer was stabilized, the protein solution was injected into 
the water subphase through a small hole drilled at an angle through a trough. 
Changes in surface pressure () were measured as a function of time, using a 
Kibron µTrough S tensiometer (Helsinki, Finland). 
Note: It is important to point out that proteins could also move to the water/air 
interphase, generating an increase of surface pressure without a lipid monolayer. 
Therefore, first we have to determine which minimum protein concentration can be used 
in which the increase of surface pressure is constant in the absence of lipid monolayer. 
This will determine above which initial surface pressure we can start measuring in the 
presence of lipid monolayer. 
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2.2.1.3 31P nuclear magnetic resonance (31P-NMR) 
NMR is based on the fact that atomic nuclei oriented by a strong magnetic field absorb radiation 
at characteristic frequencies that depends on the type of nucleus and the environment. The 
parameters that can be measured on the resulting spectral lines can be interpreted in terms of 
molecular structure. The neutrons and protons composing an atomic nucleus have an intrinsic 
quantum property of spin or angular momentum (L) and associate nuclear magnetic moment (µ). 
Both momentums are vectorial magnitudes. The angular momentum can be expressed as in the 
(eq. 2.3) where I is the spin.  
L=[I(I+1)ђ]1/2 
eq. 2.3 
The spin of any nucleus with an odd mass number A is half-integral, e.g. 1H, 13C, 15N, 19F, 31P. 
These nucleuses generate magnetic dipoles. On the other hand, the spin of any nucleus with and 
even mass number A and odd charge number Z is integral, e.g.  2H, 14N. These nucleuses do not 
represent spherical symmetry of charge; their observation is more difficult by RMN. Finally, the 
spin, and hence the magnetic moment, of any nucleus with both A and Z even is zero. This rule 
is important since the observation of resonance hinges on the existence of magnetic moment is 
unobservable in most abundant isotopes of biological elements. 
In absence of a magnetic field the µ of the different nuclei can adopt any direction. When the 
nucleuses are placed in a magnetic field (B0), however, the angular momentum tends to align in 
the direction of the field. Only two orientations defining two energy levels are possible for a 
nuclear spin ½, parallel or antiparallel to B0. 
For a transition from one energetic level to the other, an absorption or emission of a quantum of 
radiation (h) is required. Resonant absorption will occur when electromagnetic radiation of the 
correct frequency to match this energy difference is applied. The absorption will occur when: 
∆E=h=γ B0/2 
0= γ B0/2 
eq. 2.4 
where 0 is the Larmour frequency, which typically corresponds to the radio-frequency range of 
the electromagnetic spectrum. It is this resonant absorption that is detected in NMR. 
Several aspects of membrane structure and dynamics can be studied by NMR, such as the 
orientation and motility of hydrocarbon chains, the environment of polar head groups, lipid flip-
flop, etc. In this thesis, 31P-RMN of MLV dispersions of phospholipids has been used to directly 
assess whether these peptides disrupt the membrane lipid bilayer structure. When lipids are 
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organised in a bilayer, fast axial reorientation of lipids about their long axis results in partial 
averaging of the chemical shift anisotropy giving rise to characteristic spectra with a low field 
shoulder and a high field peak (Killian, 1998). In the hexagonal phase, the phospholipids are 
arranged in long tubes, with their headgroups surrounding an aqueous channel, the lipids now 
also undergo fast reversed asymmetry. Other phase that can be adopted by lipids is the cubic 
phase. This consist of interwoven networks of aqueous channels where lipids undergo complete 
motional averaging leading to an isotropic 31P-RMN signal (Killian, 1998). 
The 31P-NMR spectrum of MOM-like liposomes showed the high-field peak and low-field 
shoulder typical of a planar bilayer arrangement of membrane lipids. Therefore, changes in the 
intensity of this peak or the appearance of other peaks (around the chemical shift position of 
phospholipids experiencing isotropic motion) could be indicative of highly curved non-bilayer 
type lipid dispositions 
 
Protocol 15   31P-NMR experiments 
1- Sample preparation: Samples for 31P NMR were prepared by dispersing 15 
µmol of dry MOM-like lipid mixtures in 0.5 ml of KHE buffer alone or 
containing the peptide of interest (0.15 µmol). Multilamellar vesicle 
suspensions were freeze-thawed 3 times in liquid N2 to disperse the added 
proteins in the lipid membranes, and the liposomes were spun down in an 
Eppendorf centrifuge (14000 g, 15 min, 4 °C). Pellets were loaded directly 
into 5-mm Pyrex NMR tubes. 
2- NMR measurement: High power, proton noise-decoupled 31P NMR spectra 
were recorded at 25 °C on a Bruker AV-500 spectrometer operating at 
202.4 MHz using 5-mm broadband inverse probes with z-gradient 
equipment. 1024 free induction decays were averaged using a 2-s recycle 
delay. Spectra were processed and evaluated using TOPSPIN 1.3 (Bruker) 
and plotted with 80-kHz line broadening. 
Of note: These experiments were carried out in the NMR service of the 
university of the Basque country (UPV/EHU) 
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2.2.1.4 COMPUTATIONAL TOOLS 
Main biophysical characteristics of BAX-derived peptides were determined by MPEx (Snider et 
al, 2009) and Heliquest (Gautier et al, 2008). Monte Carlo (MC) simulations of the interaction of 
peptide molecules with MOM-like membranes were performed using the MCPep (Gofman et al, 
2012a) web server. The web server´s output includes the free energy of peptide-membrane 
association, the energetically favourable peptide-membrane depth of penetration and tilt, and 
snapshots of example simulations with the centroid conformation of the largest cluster (in PDB 
format). 
MPEx: designed for examination of membrane protein sequences using hydropathy-plot methods 
popularized by Kyte and Doolittle (1982). That is, it is based on sliding-window analysis that 
represents an amino acid sequence as a sequence of numbers representing physical or statistical 
properties of the amino acid sequence. The most common physical property is hydropathy, which 
is based upon the free energy of partitioning of amino acids between water and membrane. The 
whole-residue partitioning scales predict with considerable accuracy the transmembrane (TM) 
segments of membrane proteins of known structure as shown by (Jayasinghe et al, 2001), 
Heliquest: this program calculates the physicochemical properties and amino acid composition 
of an alpha-helix and screens databank to identify protein segments possessing similar features. 
This server is also dedicated to mutating helices manually or automatically by genetic algorithm 
to design analogues of defined features (Gautier et al, 2008). 
MCPep Server: The helical content of the peptide is calculated based on the conformations 
obtained from the simulations. A residue is defined to be in an α-helical region if the rotational 
angles of its two adjacent bonds lay within the interval typical for an α-helix (-120°±30°) (Kessel 
et al, 2003). The percentage of conformations where a residue is found in the helical state is 
calculated and presented in the output files. The rotational angles of the peptide's ends cannot be 
defined, and the two residues at the N-terminal and the two residues at the C-terminal are 
neglected. 
2.2.2 Protein-protein interaction in solution and lipid environment 
2.2.2.1 Oligomerization assays 
According to current models, a crucial step in the activation of BAK/BAX is their 
oligomerization. However, this homo-oligomerization capacity that is frequently associated with 
apoptotic phenotype, has also been described for some antiapoptotic proteins. In this work, the 
oligomeric degree of the BFL1 was examined with three different approaches: gel filtration 
assays, cross-linking assay and by total internal reflection microscopy (TIRFm). 
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Gel filtration assay 
In this section, size exclusion chromatography (SEC) or gel filtration have been used to determine 
the oligomeric state of BFL1 in the presence/absence of CL enriched model membranes. SEC can 
provide valuable information of membrane protein quaternary structure. Typically, the protein of 
interest is first extracted from the membrane using non-denaturing detergents of small micellar 
size (CHAPS, octylglucoside…), and then the sample is subjected to gel filtration 
chromatography. Based on the observation that CHAPS (but not other detergents such as 
octylglucoside, or TX-100) does not induce the oligomerization of many BCL2 family proteins 
including BFL1, we chose this detergent to extract inserted BFL1 from the liposomal membrane. 
The protocol is described in Protocol 16. 
 
Crosslinking assay 
For determining the oligomeric state of BFL1 (intermolecular crosslinking), a cysteine modifying 
agent has been used to link cysteines present in BFL1. This agent is the redox catalyst copper (II) 
(1,10-phenanthroline)3 (CuPhe), that is formed by the mixture of 1,10-phenanthroline 
monohydrate (Sigma-Aldrich) and anhydrous copper(II) sulphate (Cu(II)SO4; Sigma-Aldrich). 
CuPhe enhances the rate air-oxidation of all sulfhydryl groups present in the cysteines at neutral 
pH. The crosslinking is effective only over an extremely short distance, as the disulphide bond is 
about 2.05 Å in length. Briefly, the procedure is detailed in Protocol 17. 
Protocol 16         Oligomerization assay by SEC 
1- Sample preparation: Samples (protein alone or in the presence of liposomes) 
were incubated in a final volume of 100µL in KHE at 37°C for 30 minutes while 
stirring. Then CHAPS was added to a final concentration of 3% and incubate 
the mixture at 4°C for 30 minutes. 
2- Gel filtration: Samples were loaded into a SuperdexTM 75 HR 10/30 size 
exclusion column (Amersham Pharmacia Biotech, Uppsala, Sweden), 
equilibrated in KHE buffer with 3% CHAPS. Elution was performed at 
0.5ml/min flow-rate, at 4°C and monitored by UV absorbance at 280nm. 
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2.2.2.2 Total internal Reflection Fluorescence (TIRF) 
Total internal reflection fluorescence (TIRF) microscopy (also called evanescent wave 
microscopy) provides a means to selectively excite fluorophores in an aqueous or cellular 
environment very near a solid surface (within ≤100nm) without exciting fluorescence from 
regions farther from the surface. Fluorescence excitation by this thin zone of electromagnetic 
energy (called an evanescent field) results in images with very low background fluorescence, 
virtually no out of focus fluorescence, and minimal exposure of cells to light at any other planes 
in the sample (Figure 2.9A). The unique features of TIRF have enabled numerous applications in 
biochemistry and cell biology, such as i) Selective visualization of cell/substrate contact regions, 
ii) Micromorphological structures and dynamics on living cells, iii) Long-term fluorescence 
movies of cells during development in culture and iv) protein oligomerization states among others 
(Figure 2.9B-E). (Axelrod, 2001a; Axelrod, 2001b; Subburaj et al, 2015). 
Protocol 17             Oligomerization assay by cross-linking 
1- CuPhe complex preparation: The CuPhe stock was 30mM CuSO4 and 100mM 
1,10-phenanthroline in 4:1 water/ethanol. 
2- Sample crosslinking: Samples (proteins in the presence or absence of 
liposomes) are incubated at 37° for 30 minutes in KH (KHE without EDTA), 
and for disulphide bond formation CuPhe stock is added and diluted 100-
fold into the sample, let them incubate at 4°C for 30 minutes or some 
minutes at room temperature. 
3- Blocking the reaction: The oxidation was blocked by adding 20mM EDTA to 
chelate copper and 20mM N-ethylmaleimide (NEM) to block unreacted 
cysteine residues.  
4- Protein detection: Samples were analyzed by non-reducing SDS-PAGE gels 
and detected by coomassie blue staining or immunoblotting using anti-HIS 
antibody. 
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Figure 2.9. General scheme of TIRF experiment. (a) Simplified scheme of evanescent wave exciting 
specifically the focal plane due to laser incidence degree. (b) Schematic representation of the experimental 
setup showing a supported lipid bilayer with BFL1g bound to it. (c) Epifluorescence image of BFL1g 
molecules immobilized on a supported lipid bilayer. Scale bar, 1µm. Each particle was detected and the 
fluorescence intensity measured over time. Detected particles are shown in circles to help visualization. 
(d,e) Fluorescence intensity of two representative individual particles showing photobleaching steps 
(arrow). Adapted from (Subburaj et al, 2015). 
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In this thesis, the TIRF microscopy was performed in Ana Garcia-Saez ´s lab (Tubingen, 
Germany), under the supervision of Dr Katia Consentino. Concretely, we used this technique in 
order to assess homo-oligomerization degree of BFL1 in model membranes. Here combining SLB 
(Protocol 18) and recombinant- Alexafluor488-labelled (protocols 7 y 9) BFL1ΔC (C19S, C55S). 
 
Microscope settings and stoichiometry analysis 
As experiments were developed in collaboration with Dr Katia Cosentino. Microscope settings 
and date analysis were based on (Subburaj et al, 2015) but optimised according to sample 
peculiarities exhibited by BFL1 in pure CL vesicles. In brief, samples were excited on a modified 
Protocol 18   SLB formation 
1- LUV preparation: pure CL LUV in PBS (1mM) were formed as described 
in protocol 3.   
2- BFL1-LUV binding and homo-oligomerization: 0.5-1.5nM of BFL1ΔC-a488 
were incubated with 1mM LUV for 1h at 37o (final volume of 150µL). 
3- CaCl2 for membrane fusion:  proteoLUVS were incubated in a 
precleaned-chamber* in the presence of CaCl2 (3mM, 0.5µL of 1M stock) 
at 37o for 2 min. 
4- Washing: Isosmotic PBS (300µL) was added and subsequently removed 
for at least 10 times, in order to remove free CaCl2 and non-fused LUVs. 
5- Data acquisition and analysis. 
 
*Importantly, chambers need to be cleaned with piranha solution (3:1 
mixture of concentrated sulfuric acid and hydrogen peroxide), in order 
to constitute homogeneous supported lipid bilayers. This cleaning 
procedure was specifically done to remove organic residues and to 
enhance the hydrophilicity of the glass surface. Slides were thoroughly 
rinsed with deionized water and sonicated with deionized water for 
5min. Before further usage, they were dried using a clean nitrogen 
stream. Individual slides were glued on the upper part of the 
measurement chamber (Lab-Tek 155411, Nunc, original borosilicate 
coverglass was manually removed) using glue. Once cleaned, chambers 
can be stored in MQ water for as much one week. 
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Zeiss Axiovert 200M epifluorescence microscope at 37 oC using a diode laser (iBeam smart 488, 
Toptica, Germany) via a X100, numerical aperture=1.46 Apochromat objective (Zeiss) for an 
illumination time till=1ms and a delay of 90 ms between frames (number of frames=500) with an 
intensity of 5 kWcm-2 (measured at the sample). 
As for the stoichiometry analysis, the images acquired were used for the stoichiometry analysis 
based on the fluorescence intensity of the particles. For this purpose, individual particles with a 
single photobleaching step were detected via a threshold and their fluorescence intensity was 
estimated by fitting with a Gaussian. The estimated values were used to build a histogram of the 
distribution of fluorescence intensities that was fitted a Gaussian that provided the mean intensity 
µ and s.d. σ of a single fluorophore. In our experimental data Nmax is 6 and therefore we restricted 
our fittings up to hexamers. For determining the stoichiometry of BFL1, ≈500 individual particles 
were detected and analysed for each experiment. The distribution of the fluorescence intensity of 
all the particles was fitted with a sum of six Gaussians using obtained µ and σ values.  
2.2.2.3 Fluorescence correlation spectroscopy (FCS) 
The biological function of molecules depends not only on their structure, but also on their mobility 
and dynamic properties, which are strongly influenced by the environment. Using single molecule 
techniques requires no synchronization of underlying molecular kinetics, because just observing 
a single member of the system we can study that configuration at any given time. Thus, the main 
advantage of single-molecule techniques is that one can study individually the distribution of the 
mechanism of action of biological molecules (Haustein & Schwille, 2004). For instance, we can 
distinguish if changes in the measured parameter are observed only for a subpopulation in the 
system (Johnson et al, 2005). The low concentrations needed similar to physiological conditions, 
and application to equilibrium systems are additional important advantages of this system. 
Fluorescence correlation spectroscopy (FCS), a single-molecule-based technique, allows inherent 
averaging of thousands of single-diffusion events, allowing precise estimation of diffusion 
coefficients and particle concentrations through the comparison of the fluctuations in fluorescence 
intensity of a system in equilibrium in a very small measurement volume (Schwille, 2001). At 
thermal equilibrium, the fluctuations in fluorescence intensity quantified by FCS could be due to 
the diffusion of fluorophores through the focal volume or changes in their emission properties 
due to chemical reactions and/or photo-dynamic processes. Consequently, not only diffusion 
coefficients, dye concentrations and particle sizes can be measured, conformational changes and 
molecular interactions can be also assessed by this technique (Bacia et al, 2006; Haustein & 
Schwille, 2004; Kahya, 2006). 
During the last years, FCS has been successfully employed for the study of membrane dynamics 
and protein/lipid interactions (Betaneli & Schwille, 2013; Bleicken et al, 2017; Bleicken et al, 
2013b; Garcia-Saez et al, 2009; Ries et al, 2009; Steringer et al, 2012). In this work, FCS was 
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used for the study of the interactions among BCL-2 family proteins, specially BFL1 interaction 
network, in solution and at different membrane compositions. 
The FCS setup (Figure 2.10) combines a confocal microscopy system with fluorescence 
correlation/cross-correlation capabilities. In general, this setup consists of an inverted microscope 
in combination with high numerical aperture objective (f.e. 40x NA 1.2 UV-VIS-IR C-Apocromat 
water-immersion objective, Zeiss, Germany), several lasers for excitation (f.e. Ar-ion (488 nm), 
HeNe (561 nm) or HeNe lasers (633 nm)) and several detection channels with fiber-coupled 
avalanche photo diodes (ADPs) to achieve efficient detection. The incoming laser light is 
reflected by the dichroic mirror and focused by the microscope objective to a spot of 
approximately 0.3-0.5μm diameter. The photons emitted within the focal volume of the sample 
passes the dichroic filter and finally through a pinhole that is inserted into the image plane which 
reduces the detection volume in the z-direction, resulting in a measurement volume ranging 
femtoliters. For detection, APDs with single-photon sensitivity are usually used. This 
configuration allows high signal/noise ratio when using fluorophore concentrations from 0.1nM 
to 1μM. The fluorescence trace can be then correlated with a hardware or a software correlator. 
 
Figure 2.10 Scheme of a typical FCS setup. Optical setup is based on an inverted laser-scanning 
microscope. The sample is excited by a laser beam and the emitted photons are spectrally filtered and 
passed through a pinhole, limiting the detection volume in z-direction, and finally, the detector is an 
avalanche photodiode coupled to an autocorrelator. Diffusion and binding of proteins in solution are 
measured by FCS, using a fixed detection volume. In contrast, for the measurements in the membrane, 
scanning FCS is used and the focal volume is perpendicular to the plane of the membrane (Garcia-Saez et 
al, 2009). 
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In principle, the autocorrelation function, G(τ), is a measure of the self-similarity of the 
fluorescence signal after a lag time (τ), hence, it resembles the conditional probability of finding 
a molecule in the focal volume at a later time, τ, given it was there at time 0 (Figure 2.11A). The 
characteristic decay time of the autocorrelation function is related to the time that the fluorophore 
spends within the focal volume, which depends on the mobility of the particle: The larger the 
diffusion coefficient, the faster the decay. The mathematical tool that relates the fluorescence 
signal with itself (auto-correlation) at different times can be calculated as: 
𝐺(𝜏) =
⧼𝛿𝐹(𝑡) . 𝛿𝐹(𝑡 +  𝜏)⧽
⧼(𝐹(𝑡)⧽2
 
 eq. 2.5 
where, G  is the autocorrelation function, F is the fluorescence intensity as a function of time t, 
and τ is the correlation time. The angular brackets refer to time averaging, so that δF(t)= F(t)-F(t). 
To obtain the parameters of interest, the correlation curve obtained is fitted with a mathematical 
model based on the characteristics of the system that gives rise to the fluorescence fluctuations, 
like diffusion of the fluorophore and triplet state. This model also considers the size and the shape 
of the focal volume, the molecular brightness of the fluorophore, and its concentration as a 
function of position and time. For FCS experiments in solution, a function that models the 3D 
Brownian motion of fluorescently labelled particles is used (Table 2.6). Then, the diffusion time, 
τD, is related to the diffusion coefficient D: 
 𝜏𝐷 =  
𝜔0
2
4 𝐷
⁄  
eq.2.6 
The waist radius of the focus, ω0, is calibrated by the fitting of the autocorrelation curve obtained 
in the same experimental conditions for a dye (f.e. free Alexa488 or Alexa647) of known diffusion 
coefficient. 
In general, protein molecules diffusing in solution are assumed to approximate a spherical shape, 
using the Einstein-Stokes relationship, we could calculate the hydrodynamic radius (R) of each 
particle in the system, once the diffusion coefficient of each particle is estimated: 
𝐷 =
𝑘𝛽 𝑇
6 𝜋 𝜂 𝑅
 
eq.2.7 
where, kβ is the Boltzmann constant, T is temperature in degrees Kelvin, η is viscosity of solution 
in which particle is diffusing, and R is the hydrodynamic radius of the spherical particle. 
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In most cases, the triplet state population of the fluorophore contributed to the fluorescence 
fluctuations and it can be taken into account by an additional factor as Table 2.6 shows. 
A powerful variation of FCS is the dual-colour fluorescence-correlation spectroscopy where two 
species labelled with spectrally different dyes (to avoid cross talk and thus false positives) are 
studied (Bacia et al, 2006; Haustein & Schwille, 2004). In this way, the two fluorophores are 
excited within the same focal volume using two overlapping laser beams, and photons are detected 
using different spectral channels with signals Fg(t) and Fr(t), in this case for the green and red 
species respectively. If two species interact they will diffuse together in the focal volume, and 
simultaneous fluorescence fluctuation will be recorded. The analysis of the latter in both channels 
yields a cross-correlation function that gives us information of the concentration of the complex: 
𝐺𝑔𝑟(𝜏) =
⧼𝛿𝐹𝑔(𝑡) . 𝛿𝐹𝑟(𝑡 +  𝜏)⧽
⧼𝐹𝑔(𝑡)⧽ ⧼𝐹𝑟(𝑡)⧽
 
eq.2.8 
The degree of complex formation (%CC) can be calculated by comparing the amplitude G(0) of 
the auto- and cross-correlation curves: 
%𝐶𝐶𝑔𝑟/𝑟 =  
𝐶𝑔𝑟
𝐶𝑔𝑟 +  𝐶𝑟 
=  
𝐺𝑔𝑟 (0)
𝐺𝑟 (0)
 𝑎𝑛𝑑 %𝐶𝐶𝑔𝑟/𝑔 =
𝐶𝑔𝑟
𝐶𝑔𝑟 +  𝐶𝑔 
=  
𝐺𝑔𝑟 (0)
𝐺𝑔 (0)
   
eq.2.9 
where, Cgr, Cr  and Cg are the concentrations of the complex gr (the complex formed by green-
labeled and red-labeled species), and the forms g (green specie) and r (red specie), respectively. 
Therefore, %CC can be express with respect to the amount of red particles or green particles.  
For measurements in the membrane, dual color scanning FCS (SFCCS) was performed, which 
allows the measurement of the interaction of different species in the membrane (Figure 2.11B). 
In the case of GUV samples, the detection volume is repeatedly scanned perpendicularly through 
the equator of the membrane. In this two-focus SFCCS variant, two parallel lines are scanned 
through the membrane in an alternating fashion at distance d. This distance can be measured by 
repeatedly scanning over a film of dried fluorophores and measuring the distance between the 
bleached traces in a high-resolution LSM image. This setup eliminates the need to calibrate the 
detection volume. The intersections of these two lines with the membrane give rise to two 
intensity traces F1(t) at focus 1 and F2(t) at focus 2, from which the auto-correlation and also the 
spatial cross-correlation curve of the fluorescence in the two foci can be calculated: 
𝐺12(𝜏) =
⧼𝛿𝐹1(𝑡) . 𝛿𝐹2(𝑡 +  𝜏)⧽
⧼𝐹1(𝑡)⧽ ⧼𝐹2(𝑡)⧽
 
 eq.2.10 
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Modelling the spatial cross correlation function to a two-dimensional diffusion of a fluorescently 
labelled particle in a Gaussian elliptical detection area is given in Table 2.6. Once the distance d 
is known, the concentration C, the diffusion coefficient D, and the waist of the laser focus ω0 can 
be determined directly by fitting the data without any additional calibration. The photons in the 
two foci are not collected within the same time window, but with a delay td, which is usually given 
by the scan period, so during fitting data td has to be taken into account. When two spectral 
channels are employed, the red and the green auto and cross-correlation curves can be calculated. 
By globally fitting the auto-correlation curves, the spatial-cross-correlation and the cross-
correlation curves, we can estimate the total concentration of green and red particles, as well as 
the concentration of the complex (Garcia-Saez et al, 2009). 
Diffusion type Model function 
3D diffusion 
𝐺3𝐷(𝜏) =
1
𝑁
(1 +
𝜏
𝜏𝐷
)
−1 1
√1 +   
𝜏
𝜏𝐷 . 𝑆2
 
3D diffusion with 
triplet 
𝐺3𝐷 +  𝑇(𝜏) = [1 + 𝑇(1 − 𝑇)
−1 exp (−
𝜏
𝜏𝑇
)] 𝐺3𝐷(𝜏) 
2D diffusion for 
two foci SFCS 𝐺12(𝜏) =
1
𝐶𝜋𝑆𝜔0
2 
(1 +
4𝐷𝜏
𝜔0
2 )
−1 2⁄
(1 +
4𝐷𝜏
𝜔0
2 𝑆2
)
−1 2⁄
exp (−
𝑑2
𝜔0
2 +  4𝐷𝜏
) 
 
Table 2.6. Model functions for fitting of FCS data. Here G is the autocorrelation curve, N is the average 
number of particles in the detection volume, τ is the lag time and τD is the diffusion time. τT corresponds to 
the triplet time, ωO is the waist of the detection volume, T is the fraction of fluorophores in the triplet state 
within the detection volume and S is the structure parameter. The terms introduced to correct for 3D 
diffusion are also valid for two components. In the 2D diffusion model, d represents the distance between 
the two foci. 
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Figure 2.11 Principles of the FCS and scanning FCS. (A) Fluorescent molecules diffusing through the 
detection volume give rise to fluctuating fluorescence intensity. The auto-correlation curve (green and red 
squares) measures the self-similarity of these fluctuations and is used to determine the concentrations and 
diffusion coefficients. The cross-correlation curve (blue squares) compares the intensity fluctuations in the 
red and the green channels. (B) In scanning FCS, the detection volume is repeatedly scanned 
perpendicularly through a vertical membrane (A). The individual scans can array as pseudo-images, in 
which vertical axis represents the time. The fluorescence intensity observed corresponds to the membrane 
(B). The membrane fluctuations observed can be corrected for by shifting each line scan to obtain a straight 
line (C). The combination of dual-focus FCS with dual-color FCS results does not require calibration of 
the detection volume if the distance d is known, distance between the two detection volumes. Altogether, 
these data is used to calculate the auto- and cross-correlation curves of both particles and the complex at 
the membrane of an individual GUV (Adapted from (Ries et al, 2010)). 
The FCS experiments of this work were performed in Ana Garcia-Saez´s lab (Tubingen, 
Germany) using a Confocor 3 module in a LSM710 microscope with a C-Apochromat 40x 1.2 
water immersion objective (Zeiss, Oberkochen, Germany) at 22°C. For the FCS experiments, 
briefly, first of all the microscope setup should be aligned and calibrated, then data acquisition 
can be carried out. Depending in the FCS variant used the protocol differs (see Protocols 19 and 
20). 
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Protocol 19  FCCS in solution 
1- Setup alignment and calibration: In order to obtain a proper alignment, the 
calibration measurement is performed by the simultaneous addition of two 
dyes spectrally similar to the fluorophores (Alexa-488 and Alexa-633). As 
follows: 
a. The excitation lasers were turned on around 30min prior to the 
measurement, to allow stabilization of the light source. 
b. An observation chamber containing 200µL of 50nM of dyes solution were 
placed in the microscope, and FCS mode was setup. In the Light Path 
window, the lasers were selected to a power of 0.5% (the same conditions 
were used in the data acquisition) 
c. The sample was focused using the Count rate window. To avoid 
aberration of the cover slide, the detection volume should be at least 
150µm above the glass surface. In addition, the position of the correcting 
ring in the objective was optimized to maximize the counts per molecule 
in the detection volume. 
d. A calibration measurement was performed: 30s x 3 times at 0.5% laser 
power (the same conditions were used in the data acquisition for 
comparison).  
e. The data obtained for the calibration sample was fitted with a 3D diffusion 
for 1 component and triplet. The triplet state, diffusion time and 
structural parameters should be similar to those obtained in previous 
measurements or similar to those published. If these parameters are far 
from the expected values, the system is not correctly aligned, so the 
calibration procedure should be repeated. 
2. FCCS measurement: Once the system was aligned, the measurements 
of the samples in solution were carried out. Proteins of study were 
diluted at different concentrations (typically 200nM) and were let to 
incubate in solution for a defined time, and FCS experiment was carried 
out as in the calibration procedure.  
3. Fitting procedure: The fittings of the auto-correlation and cross-
correlation were performed with a software written in MATLAB 
(Mathworks) to the models above described (2C 3D).  
 
 ( 
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Protocol 20   SFCCS in GUV membrane 
1- Sample preparation:  GUVs were electroformed (see section Preparation of 
GUVs, Protocol 4). Then, an 8-well observation chamber (Lab-Tek® eight-
chambered No. 1.0 borosilicate cover glass from Nalge Nunc International, 
Rochester, NY, USA) was blocked with 10mg/mL BSA (non-fatty acid bovine 
serum albumin, Sigma Aldrich) to prevent attractive interactions between 
GUV and the glass substrate. After 1h of incubation, the observation 
chamber was extensively rinsed with Milli-Q water. The desired buffer with 
an osmolarity matching the glucose solution was added and the labelled 
BCL-2 proteins were added at low concentrations. Finally, an approximate 
volume of 80μL of electroformed GUV was transferred to the buffer with a 
micropipette. Of note, tip must be cut in order to widen the opening 
avoiding a possible GUV rupture. Sample preparation was incubated until 
the proteins bound to the membrane (≈2h). Of note, the membrane was 
not labeled with any fluorophore to avoid possible crosstalk in the 
measurements (more detailed procedures are described in Model 
membrane systems section, GUV preparation subsection). 
2- SFCCS setup: The microscope was aligned as explained for FCCS in solution 
experiments and then the SFCCS setup of the microscope was selected 
(laser potency used was 0.1-0.5%, depending on the brightness of the 
sample). 
3- SFCCS measurement: The equator plane of a GUV was selected and an 
image was taken. Then the membrane of interest was zoomed and the 
central horizontal line of the scanning square was lined perpendicular to 
the membrane. The Imaging setup was selected: track every line, frame size 
32x times 2y, both directions, Speed 13 and with these settings the scan 
time was 1.68 msec. While scanning was performing the photon counter (a 
hardware correlator Flex 02-01D/C (http://correlator.com) was detecting 
the photon arrival times.  
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2.2.3 Detection of functional and structural activation in lipid 
environment 
2.2.3.1 Fluorimetric measurements of vesicular contents release 
A common experimental approach using model systems to study the bilayer perturbations 
generated by membrane active peptides and proteins relies on the measurement of the 
fluorescence changes of vesicle-encapsulated fluorescent probes (Basanez et al, 2001; Ellens et 
al, 1985; Ladokhin et al, 1997). Two different applications of this idea have been used throughout 
this thesis. 
ANTS/DPX release 
In this assay, the fluorescent probe ANTS (8-aminonaphtalene-1,3,6-trisulfonic acid sodium salt) 
and its quencher DPX (p-xylenebis(pyridinium)bromide) are co-encapsulated in the aqueous 
compartment of the liposomes. By entrapping both ANTS and DPX inside the vesicles, their close 
proximity allows DPX to quench ANTS fluorescence by collision. Upon addition of a membrane-
perturbing agent, both molecules “leak out” and are diluted into the external medium where they 
hardly interact, inducing an increase of ANTS fluorescence. Thus, by monitoring ANTS 
fluorescence, vesicle bilayer permeabilization, can be followed in time (Figure 2.12). This 
approach was initially developed (Ellens et al, 1985) to measure vesicle fusion, an inverse 
4- Data analysis: The data analysis was performed with software written in 
MATLAB (Mathworks). The photon stream was binned in 2 µs bins and 
arranged it as matrix such that every row corresponded to one-line scan. The 
membrane movements were corrected by calculating the maximum of a 
running average over several hundred-line scans and shifting it to the same 
column. The fitting was done by an average over all rows with a Gaussian and 
only the elements of each row between -2.5 σ and 2.5 σ to construct the 
intensity trace were added. The autocorrelation and spectral and spatial 
cross-correlation curves from the intensity traces were computed and 
excluded irregular curves resulting from instability and distortion. The 
resulting auto- and cross-correlation functions were fitted with a nonlinear 
least-squares global fitting algorithm to the analytical models described 
above. Finally, cross-correlation percentages (CC%) calculated from FCCS 
measurements were corrected for labeling degree of the proteins used in 
each experiment. 
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situation in which both molecules were entrapped into separate vesicle populations. The 
procedure is detailed in Protocol 21. 
 
Protocol 21       Vesicular contents release 
ANTS/DPX release: 
1- ANTS/DPX encapsulated LUV preparation: LUVs were prepared as 
explained in protocol 3 with an additional step. In this case, lipid film is 
hydrated with a buffer containing tfluorescent probes: 12.5mM ANTS, 
45mM DPX, 20mM NaCl and 5mM Hepes, pH 7.4, 200-220mosm/Kg. After 
the extrusion, LUV containing the probes were separated from the 
unencapsulated probes by a PD-10 Desalting column (GE Healthcare, 
Waukesha, WI, USA) that was eluted with 5mM Hepes and 100mM NaCl 
(pH 7.4, 200-220mosm/Kg) and the lipid concentration is measured. 
2- Sample preparation: 150M ANTS/DPX loaded LUV (unless otherwise 
specified) and small amounts of proteins (nM range) are monitored along 
the time at different temperatures and constant stirring. 
3- Fluorescence measurement: The sample is excited at 355nm (slits 4nm) 
and the fluorescence emission is monitored at 520nm in an 8100 Aminco-
Bowman luminescence spectrometer (Spectronic Instruments, 
Rochester, NY, USA).  
4- Calculations of the percentage of content release: The extent of marker 
release was quantified on a percentage basis according to the following 
equation:  
%Leakage =
(Ft−F0)
(F100−F0)
∗ 100 
eq.2.11 
 
where Ft is the measured fluorescence of protein-treated LUV at time t, F0 
is the initial fluorescence of the LUV suspension before protein addition, 
and F100 is the fluorescence value after complete disruption of LUV by 
addition of C12E8 (final concentration, 0.5mM). 
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Figure 2.12 Schematic overview of the ANTS/DPX leakage assay. Upon incorporation of the surfactant 
into the membrane, vesicle enclosed ANTS and DPX are externalized through membrane defects, (?) in the 
picture. An increase on ANTS fluorescence is observed. Triton X-100 is generally added for complete 
vesicle solubilization into mixed vesicle lipid/surfactant/Triton X-100 micelles that gives the 100 % leakage 
value (i.e. maximum ANTS fluorescence). In our case, C12E8 detergent was used. 
 
2.2.3.2 GUV permeabilization 
Single vesicle study of the internalization of different dyes to the inside of GUVs is an invaluable 
tool to provide a deeper insight into the mechanism of pore formation by peptides and proteins  
(Apellaniz et al, 2010; Bleicken et al, 2013b; Fuertes et al, 2010a; Lee et al, 2008; Schon et al, 
2008; Tamba & Yamazaki, 2009). Taking into account that biological systems are intrinsically 
heterogeneous, this method gives us the opportunity to study the pore forming mechanism at 
single vesicle level, contrary to bulk experiments in LUVs, in which the information obtained is 
an average of the processes of the overall population. In the present work, confocal microscopy 
in GUVs has been applied to the characterization of the inhibition capacity of BFL1 in MOM-
like GUV and its permeabilization activity triggered in pure CL vesicles. The procedure is detailed 
in Protocol 22. 
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Protocol 22     GUV permeabilization assay 
1- GUV preparation: GUVs were electroformed as explained in the Protocol 
4. 
2- Sample preparation: An 8-well observation chamber (Lab-Tek® eight-
chambered No. 1.0 borosilicate cover glass from Nalge Nunc 
International, Rochester, NY, USA) was filled with 700µL of a blocking 
solution (10mg/mL fatty acid free BSA, Sigma Aldrich) for 1h. Next, 
observation chamber was extensively rinsed with Milli-Q water. Then, 
320µL of the desired buffer with an osmolarity matching the glucose 
solution was added to the chamber. In addition, BCL-2 proteins and 
different fluorophore permeabilization markers were added. Different 
combination of markers has been used during this thesis: Cyt c-
A488/Allophycocyanin (APC) (300nM each) with or without free Alexa-
555 (1µM). All the components were mixed gently by pipetting. 
Subsequently, an approximate volume of 80μL of electroformed GUV 
were transferred to the buffer (Note: The end of a micropipette tip is cut 
to widen the opening and to avoid rupture of GUV in suspension. 
Moreover, GUVs are mixed gently the sucrose suspension in the 
electroformation chamber and then GUVs should be added slowly on the 
top of the buffer in the observation chamber. Incubation conditions were 
2h for a typical permeabilization experiments. 
3- Measurements: Then observation chamber was placed on the confocal 
fluorescence microscopy. The measurements were performed at 25°C 
and the microscope used was a commercial LSM710 inverted confocal 
fluorescence microscope with a C-Apochromat 40x 1.2 water immersion 
objective (Zeiss, Oberkochen, Germany). Excitation light came from an Ar-
ion (488 nm), HeNe (561 nm) or HeNe lasers (633 nm). A spectral beam 
guide was used to separate emitted fluorescence. Images were processed 
with ImageJ (http://rsbweb.nih.gov/ij/), and data analysis was as 
described below. 
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Image analysis 
a) End-point permeabilization mechanism. 
The study of the end point permeabilization mechanism, characterized by the final properties of 
the process: total extent permeabilization and the distribution of the degree of filling for the dyes 
at single-GUV level, giving us the information of possible size of the pore and if that mechanism 
is “all or none” or “graded”. The analysis was done as described in (Bleicken et al, 2013b; Fuertes, 
2011; Fuertes et al, 2010a). 
The degree of GUV filling was calculated as:  
%𝐺𝑈𝑉 𝑓𝑖𝑙𝑙𝑖𝑛𝑔 =
(𝐹𝑖𝑛 − 𝐹0)
(𝐹𝑜𝑢𝑡 − 𝐹0)
 .100  
 eq. 2.12 
where Fin and Fout are the average fluorescence intensities inside and outside a GUV, and F0 is 
the background fluorescence inside the GUV at time 0 for a given dye. In image analysis the 
fluorescence is related to the arbitrary grey values. We arbitrarily set the threshold for a non-
permeabilized GUV to <20% of dye leak-in. In these approaches several hundred (>50 for each 
condition) of GUVs were analysed per experiment. 
b) Binding Profile 
GUV permeabilization reproduces the final pore formation and content release (or incorporation 
in this case) elicited by the BCL2 proteins. Importantly, the amount of protein required to 
permeabilize GUV, and cooperativity between the labelled BCL2 proteins constitutes a very 
profitable information to gain insight protein:lipid and protein:protein interactions. For this 
purpose, we take advantage of ImageJ plugin denominated Radial Profile, which give use 
information of the presence of the fluorescently labelled protein in the GUV membrane. 
Remarkably, even if FCS or its membrane variant SFCCS is a much more sensitive technique, 
with this approach we obtain a quantitative information extremely rapidly. Moreover, we can 
combine permeabilization and membrane binding assays. 
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Figure 2.13. Experimental setups of the study of membrane binding and pore formation at the 
equilibrium. (A) In the study of the pores at the equilibrium, non-labelled BAX/cBID are mixed with 
FITC-a488/APC dyes in the presence of MOM-like GUVs and incubated 2h at RT. (B) Binding profile 
experiment. Alexa 488/647-labelled BCL2 proteins, are incubated with GUV and their membrane binding 
is assessed after 2h incubation. 
2.2.3.3 Fluorescence spectroscopy techniques 
Fluorescence spectroscopy has long been considered one of the most useful biophysical 
techniques available to scientists studying the structure and function of proteins. Furthermore, 
protein fluorescence can provide a variety of information, such as the extent of rotational motional 
freedom, the exposure of amino acid side chains to quenchers, and intra-molecular distances. In 
this thesis, NBD dye was used in order to characterize the structure adopted by pore forming BAX 
and BFL1 at the membrane level during their activation process. 
NBD fluorescence spectroscopy 
The study of the structure adopted by BCL2 membrane proteins in their biological locus has been 
considered as one of the outstanding task in the field. Here, we adapt to our system a method that 
combines fluorescently dyed monocysteine mutants in the presence of model membranes and 
specific fluorescent quenchers that allow us to scrutinize the controversial topology of these 
proteins in both healthy and apoptotic conditions. For this purpose, we first obtain several 
monocysteine mutants spreads along the structure of BAX and BFL1. Then, as described 
previously we labelled them with NBD and validate their structure and function as described in 
the protocol 10, 12-13 and 23 respectively. Remarkably, NBD election as a fluorescent dye was 
not arbitrary. This particular dye has several properties that ensures its adequacy. 
First, this fluorescent dye is extremely sensitive to the polarity of the environment, small changes 
in pH or the electrostatic environment is detected as a shift in the maximum emission wavelength 
and in the fluorescence intensity. Moreover, its relatively small size is less prominent to interfere 
with the protein structure or function. Furthermore, it intermediate hydrophobicity enables the 
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study of the labelled protein in the presence of model membranes, because as it happens with 
other more hydrophobic dyes like acrylodan or coumarin, a very hydrophobic dye could trigger 
an unspecific membrane insertion. 
In NBD experiments, when NBD-labelled residue moves from an aqueous milieu (i.e. the surface 
of a soluble protein) to a hydrophobic environment (i.e. the nonpolar interior of the membrane or 
a protein), its emission intensity increases while its wavelength of maximum emission shifts to 
the blue (Figure 2.14). In addition, since the protein is labelled with a unique NBD moiety at a 
single location in the protein, this approach provides a methodology to characterize the structural 
changes that occur at specific sites of the protein when it is associated to the membrane. 
 
Figure 2.14: Site-specific NBD fluorescence. left, Chemical structure of IANBD. λex and λem are 
maximum fluorescence excitation (ex) and emission (em) wavelengths of IANBD in water. right, Changes 
in the fluorescence of the NBD moiety of NBD-labelled Perfringolysin O upon binding to cholesterol-
containing liposomes. Taken from (Heuck et al, 2000). 
 
Protocol 23                 NBD Fluorescence experiments 
1. Sample components (NBD-protein or NBD-protein plus liposomes) are 
incubated for 10-30 min at RT/37°C prior to beginning of measurements 
at RT/37°C.   
2. NBD spectra are recorded in an 8100 Aminco-Bowman luminescence 
spectrometer between 500 nm and 640 nm (5 nm bandpass) at a scan 
rate of 1 nm/s, using an excitation wavelength of 465 nm (4 nm 
bandpass). The slit widths for excitation and emission were kept at 4 nm, 
with the experiment conducted at 37°C in a 1cmXcm quartz cuvette 
under constant stirring. The contribution of the buffer or liposomes 
alone was subtracted as blank. 
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Fluorescence attenuation by doxyl-lipids 
The movement of a labelled residue into a nonpolar milieu could result from: (i) its burial in the 
nonpolar interior of a protein; (ii) its movement into a nonpolar interface between two proteins or 
(iii) its exposure to the nonpolar core of the membrane. The non-polar membrane interior can be 
distinguished from the other two possibilities by examining the NBD quenching ability of 
doxylated-lipids containing nitroxide (NO) collisional quenching moieties that are restricted to 
locations within the nonpolar core of the bilayer.  
When an excited fluorescent dye collides with some molecules and ions, its excitation energy is 
lost and no fluorescent photon is emitted. This phenomenon, termed collisional quenching of 
fluorescence, provides a direct method for determining accessibility. If the dye and quencher 
moiety are able to contact each other dynamically, emission intensity and lifetime will decrease. 
Whereas, if dye and quencher are in different compartments or locations (e.g. aqueous versus 
nonaqueous), the presence of the quencher in the sample will not affect/reduce dye emission. This 
approach has been used to demonstrate directly that specific residues within Clostridium 
perfringens, Perfringolysin O (PFO) toxin are exposed to and in contact with the nonpolar interior 
of the membrane (Heuck & Johnson, 2002; Ramachandran et al, 2002; Shepard et al, 1998) 
(Figure 2.15).  
Liposomes used for this lipophilic quenching experiments were prepared as explained in Protocol 
3, but substituting 25% mol PC for nitroxide-labelled phospholipid, 1-palmitoyl-2-stearoyl-(x-
doxyl)-sn-glycero-3-phosphocholine (x-doxyl-PC, where x is equal to 5 or 12 and indicates the 
location of the quencher in the acyl chain of the phospholipid). Data from fluorescence quenching 
experiments were then normalized to the fluorescence emission from protein in LUVs lacking 
nitroxylated lipids. Interestingly, the combination of lipids with the quencher at different positions 
in the acyl chain proffers information about the depth of its membrane insertion. 
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Figure 2.15: Quenching of NBD fluorescence by nitroxide moieties located at different depths in the 
membrane bilayer. Left, Chemical structure of 5-doxyl-PC and 14-doxyl-PC lipids, used in this study. 
The nitroxide moiety is highlighted in red. Structures were taken from Avanti Polar Lipids. Right, 
Representative emission spectra for NBD-dynamin before and after incubation with PIP2-containing 
liposomes (no quencher) or PIP2-containing liposomes that also contain indicated nitroxide-labeled 
phospholipids. Taken from (Ramachandran & Schmid, 2008). 
Fluorescence attenuation by IP 
In parallel, in order to obtain the complete picture, we attenuate the NBD fluorescence of those 
residues that are exposed to the solvent by using IP. Fluorescence quenching or attenuation by IP 
was obtained after addition of 200mM KI + 0.2mM Na2SO4. Unless otherwise stated, proteins 
and LUVs were incubated for 1 h before NBD fluorescence measurements. As it has done with 
nitroxilated lipids the fluorescence ratio between IP treated and non-treated NBD samples is 
plotted, obtaining this way information about the solvent exposure of the target residues.  
 
2.3 EX-VIVO EXPERIMENTS  
2.3.1  MITOCHONDRIA ASSAYS  
2.3.1.1  Isolation of mitochondria from cultured cells  
The point of no return in the mitochondrial pathway of apoptosis is MOMP, which allows the 
release of a variety of mitochondrial apoptogenic factors from the intermembrane space into the 
cytosol, such as cytochrome c or SMAC/DIABLO. Therefore, we studied the BCL2 interactoma 
by the capacity to bind to MOM and their ability to induce/inhibit cytochrome c release. Indeed, 
obtaining highly enriched mitochondria preparations is critical to evaluate the function of BCL2 
proteins as these organelles are often halfway between model membranes and cells. Thus, isolated 
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mitochondria enable the study of recombinant BCL2 proteins in their biological locus, the MOM 
(Frezza et al, 2007).   
 
 
Cytochrome-c release experiments: A classical method to assess MOMP induction by a purified 
protein is to examine its capacity to release cyt c from isolated mitochondria (Arnoult, 2008; 
Bossy-wetzel and Green, 2000). Briefly, mitochondria at a protein concentration of 1 mg/ml were 
incubated with the protein of interest for 30 min at 30-37°C in release buffer (RB buffer, 125 mM 
KCl, 10 mM Hepes-KOH (pH 7.4), 0.5 mM EGTA). Then, samples are centrifuged for 10 min at 
14000x g to separate released cyt c from mitochondria-enclosed cyt c. Finally, the cyt c content 
              Protocol 24   Mitochondrial isolation from cultured cells  
1. Cell harvesting: Cells from 3-4 confluent T175 flasks were collected by 
scrapping in 30-40ml PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 
mM KH2PO4, pH 7.4) and centrifuged during 5 min at 4°C (950xg, hereafter 
all the centrifugations were done at 4°C). The supernatant was discarded 
and the pellet resuspended in 4ml ice-cold Mitochondrial Isolation Buffer 
(MIB) containing 210 mM mannitol, 70 mM sucrose, 10 mM Hepes (pH 7.5), 
1mM EDTA and freshly added protease inhibitors (Roche).  
2. Cell homogenization: The cell suspension was after transferred to a pre-
cooled 5ml glass-teflon Elvehjem potter (Sigma-Aldrich) for 
homogenization. In the first homogenization 20 strokes were done, then it 
was centrifuged for 10 min at 1500x g and the supernatant (SN1) was 
recovered, while the pellet was resuspended again in 2ml cold MIB. This 
resuspended pellet was homogenized for a second time with 20 strokes 
and it was then centrifuged for 10 min at 1500x g. The supernatant (SN2) 
was recovered and the pellet was resuspended in 1 ml cold MIB. It was 
again homogenized with 20 strokes and centrifuged for 10 min at 1500x g. 
The supernatant (SN3) was recovered and the pellet was then discarded.  
3. Mitochondria isolation: Next, SN (1, 2 and 3) were collected and 
mitochondria were isolated by centrifugation (10 min, 7000x g). The 
supernatant was discarded and the pellet, which contains mitochondria, 
was resuspended in 200 μL cold MIB.  
4. Concentration measurement: Mitochondria concentration was 
determined by Bradford assay, normally obtaining 200μL at ≈4-6 mg/ml.  
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of each fraction is determined in a semi-quantitative manner by SDS-PAGE and immunoblotting 
using mouse BD Pharmigen (Franklin Lakes, NJ U.S.A) anti cyt c antibody clone 7H8.2C12. 
 
2.3.2 EUKARYOTIC CELL PROCEDURES  
2.3.2.1 Cell culture  
Wildtype (WT) and SV40 transformed BAX-/-BAK-/- double knockout (DKO) mouse embryonic 
fibroblasts (MEFs) were kindly provided by Dr. I Marzo (University of Zaragoza, Spain). WT 
and DKO HCT 116 cells were kindly provided by Prof. Ana García-Sáez (University of Tubingen, 
Germany). MEFs were grown in Dulbecco's Modified Eagle Medium and HCT116 cells in 
McCoy5A media (Invitrogen, U.S.A); both supplemented with 10% fetal bovine serum 
(Invitrogen), 1% Penicylin-Streptomicyn-Ionomycin solution (Invitrogen) in an atmosphere of 
5% CO2 at 37°C.  
2.3.2.2 Plasmids for eukaryotic cell transient transfection  
cDNA of human full-length BFL1 from Addgene (plasmid #36973, deposited by: Bill Sugden) 
was PCR-amplified with PfuTurbo Polymerase as explained in 2.1.2.1.1. In both cases, restriction 
sites were introduced in the forward and reverse primers respectively. Purified PCR products were 
digested with KpnI and XhoI (NEB) during 1 hour at 37C, subjected to gel purification and then 
ligated into a previously digested and dephosphorylated pCI-neo vector from Promega (WI, 
U.S.A) which carries the human cytomegalovirus (CMV) immediate early enhancer/promoter 
region to promote constitutive expression of cloned DNA inserts in mammalian cells. Several 
clones were checked for the presence of insert and DNA was sequenced using T7 promoter 
primer. Purified and digested PCR products were also ligated to a previously digested pEGFP-C3 
vector. Moreover, once BFL1 was inserted GFP-BFL1 was used as a template to obtain L21A 
and R88D mutants. Furthermore, same protocol was used earlier in the lab to insert proapoptotic 
BAX and its 1-2/L-6 variant in pCi-neo vector and pEGFP-C3 vector from Promega. 
2.3.2.3 Transient cell transfection  
Cells were transfected using jetPRIME® (Polyplus Transfection, France) following steps 
described inhttp://www.polyplus-transfection.com. The detailed procedure is described in 
Protocol 25.  
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2.3.2.4 Cell fixation, permeabilization and immunofluorescent staining 
Immunofluorescence (IF) is a powerful technique that utilizes fluorescent-labelled antibodies to 
detect specific target antigens. Applications include the evaluation of cells in suspension, cultured 
cells, tissue, beads, and microarrays for the detection of specific proteins. IF techniques can be 
used in both, fresh and fixed samples. In IF, antibodies are chemically conjugated to fluorescent 
dyes. These labelled antibodies bind to the antigen of interest, which allows for antigen detection 
through IF techniques such as: flow cytometry or fluorescence or confocal microscopy. Moreover, 
cell fixation immobilizes antigens while retaining cellular and subcellular structure and 
permeabilization allows for access of antibodies to all subcellular compartments.  A general 
fixation, permeabilization and immunofluorescent staining procedure are described in protocol 
26. 
 
 
Protocol 25   Transient cell transfection 
The following conditions are given for a 6-well plate. For other culture formats visit  
the manufactures website: http:// www.polyplus-transfection.com.  
1. Cell seeding: 300.000 cells per well were seeded into 2 ml growth medium 
20h before the transfection.  
2. Medium removal: 1-3h before transfection we substitute cells medium for 
one without antibiotic. 
3. Mixture preparation (per well): 2 μg DNA were diluted into 200 μL jetPRIME 
buffer and mixed by vortexing (the mixture was incubated for 10 min at RT). 
Then, 4 μL jetPRIME were added, vortexed for 10 seconds and spin down 
briefly (the mixture was incubated for 20 min at RT). 
4. DNA adding: 200 μL transfection mix per well was added, drop wise, onto the 
cells in serum containing medium and distributed evenly.  
The plates were gently rocked back and forth and from side to side.  
Protein expression analysis: Protein expression was analyzed after 18 h (GFP BAX, GFP 
BAK and GFP BOK in BAX-/- BAK-/- DKO MEF cells) or 48h (GFP BOK in Hela cells).  
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2.3.2.5 Subcellular fractionation assays  
Mitochondrial-share comprehends a sophisticated network that connects different cellular 
compartments including ER. Thus, isolated mitochondria are deficient in all these membranes 
that historically have been related with BCL2 function and MOMP. So that, using digitonin (a 
cholesterol dependent detergent) we are able to isolate cellular membranes from the cytosol. Of 
note, due to its differential lipid composition the integrity of plasmatic membrane which is 
enriched in cholesterol, is disrupted. The main aim of this assay is to isolate mitochondria and its 
associated membranes from cultured cells.  
For this purpose, cells are first harvested and then permeabilized by resuspending them on 
permeabilization buffer (PB, 20 mM HEPES/KOH pH7.5, 100 mM sucrose, 2.5 mM MgCl2, 100 
mM KCl, 0.025% digitonin, protease inhibitor cocktail) for 10min on ice. Next, cells were 
centrifuged at 2,000x g, saving the supernatant (cytosol). Depending on the experiment cytosols 
and pellets (mitochondrial enriched membranes) are directly analysed by western blotting to 
assess the subcellular localization. Complementarily, the cytochrome c release of these pellet 
fractions can be analysed, as described in the protocol 24 for isolated mitochondria. 
Protocol 26          Immunofluorescent staining  
 
1. Cell fixation and permeabilization: cells were seeded on a coverslip and 
depending on experiments requirements, were also transiently transfected 
as explained in protocol 25. Next, cells were fixed using 4% formaldehyde 
diluted in PBS for 20 min at RT. Then, cells were first washed with PBS and 
then permeabilized by the addition of cold acetone (-20°C) for 10 minutes, 
and washed again three times with PBS.  
2. Blocking and incubation with antibodies: Coverslips containing fixed and 
permeabilized cells were incubated for 45min with 3% BSA in 0.1% Triton X-
100 containing PBS (PBST). Then, cells were incubated with the primary 
antibody (1:200 in 3% BSA in PBST) in a humidified chamber for 1 h RT. The 
solution was then decanted and cells washed three times with PBST 
followed by incubation with the secondary antibody (1:400 in 3% BSA-PBST) 
for 1h at RT in darkness. Finally, secondary antibody was removed and cells 
were washed three times with PBST.  
3. Mounting: Coverslips were mounted on the slides using a drop of mounting 
medium (Fluorsave).  
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Moreover, this methodology also permits to assess whether the protein of interest is periferically 
attached or inserted in the membrane by incubating membrane fractions with sodium carbonate 
(pH 11.5). In brief, we incubate the membranes with 0.1 M Na2CO3 (pH 11.5) on ice during 20 
min. Then pH was neutralized with 0.1 M HCl and incubated for further 5 min. Next, buffer A 
(400 mM Tris HCl, 100 mM MgSO4, 10 mM CaCl2 and DNAase) was added and samples were 
incubated for 10 min at 37°C. Finally, in order to separate the supernatant (containing soluble and 
peripherally inserted proteins) and the pellet (containing membrane attached proteins) were 
centrifuged at 13,000x g for 10 min at 4°C. Obtained fractions were then analysed by western 
blotting using an antibody against the protein of interest.  
2.3.2.6 FRAP/FLIP experiments for retrotranslocation assessment 
The proapoptotic Bcl-2 protein BAX, is predominantly found in the cytosol of nonapoptotic cells 
and is commonly thought to translocate to mitochondria following an apoptotic stimulus. The 
current model for BAX activation is that BH3 proteins bind to cytosolic BAX, initiating 
mitochondrial targeting and outer-membrane permeabilization. Recently, has been described that 
BAX is constitutively targeted to mitochondria but in nonapoptotic cells is constantly translocated 
back to the cytosol by BCL-XL mediated BH3 into groove recognition (Edlich et al, 
2011a))(Schellenberg et al, 2013). In this thesis it has been examined whether BFL1 is able to 
retrotranslocate BAX from the mitochondria to the cytosol as BCL-XL does. This question could 
have been efficiently elucidated by the use of FRAP/FLIP.  
Fluorescence recovery after photobleaching (FRAP) is particularly advantageous to directly 
assess the dynamic equilibrium between intracellular organelles such as cytosol and mitochondria 
(Edlich et al, 2011a; Schellenberg et al, 2013; Todt et al, 2015; Todt et al, 2013). In a typical 
FRAP experiment fluorescent molecules are irreversibly photobleached in a small area of the cell 
by high intensity illumination with a focused laser beam. Subsequently, diffusion of the 
surrounding non-bleached fluorescent molecules into the bleached area leads to recovery of 
fluorescence. In FRAP experiments, the images are analysed and processed to generate a kinetic 
plot of photobleaching by displaying the temporal fluorescence changes in the bleached region of 
the cell. The ideal fluorescent probe for use in photobleaching studies should be highly fluorescent 
(high quantum yield), but only moderately susceptible to photobleaching. This permits bleaching 
within realistic time frames, but limits bleaching during image acquisition. Green fluorescent 
protein is the most widely used fluorescent probe for cellular studies because of its stability, low 
cytotoxicity, because it does not bleach significantly at low light intensities, does not seem to be 
damaging to the cell after undergoing irreversible photobleaching, it can be readily expressed in 
several cell types where it is fused to a particular protein, and in many cases tagging a protein of 
interest with GFP has no significant influence on the function and localization of the protein under 
investigation (Ishikawa-Ankerhold et al, 2012; White & Stelzer, 1999). 
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Fluorescence Loss in Photobleaching (FLIP) is a complementary technique to FRAP, which 
has been used to reveal the connectivity between different compartments in the cell or the mobility 
of a molecule within the whole compartment (Cole et al, 1996; Ellenberg et al, 1997). FLIP 
experiments differ from FRAP and iFRAP (irreversible FRAP) by the repetitive bleaching of the 
same region in the specimen, thereby preventing recovery of fluorescence in that region. In FLIP 
experiments the repetitive bleaching occurs adjacent to the unbleached ROI. The loss in 
fluorescence in the region of interest (ROI) defines the mobile fraction of the fluorescently 
labelled protein. Conversely, the incomplete loss in fluorescence defines the immobile fraction of 
fluorescently-labelled protein that does not move into the continuously photo-bleached area. The 
observation that molecules do not become bleached suggests that they are isolated (immobilized) 
in distinct cellular compartments. FLIP experiments are very useful to demonstrate the 
connectivity and fluxes between different regions of the cell and thus is an ideal and direct method 
for studying the exchange of molecules between two compartments (e.g., compartments that are 
separated by lipid bilayers). The continuity of cellular structures, such as the Golgi apparatus, the 
endoplasmic reticulum, mitochondria etc. have all been studied using FLIP (Cole et al, 1996; 
Nehls et al, 2000; Phair & Misteli, 2000). 
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Protocol 27   FLIP experiments  
1. Cell transfection: BAX/BAK DKO HCT116 cells were seeded on 1µ-Slide 8 
Well ibitreat (ibidi) in McCoy’s 5A medium, grown for 20 hr, transfected 
with EGFP-BAX (± non-labelled pCi-BFL1) and EGFP-BAX 1-2/L-6 (± non-
labelled pCi-BFL1) and EGFP-BFL1 (± non-labelled pCi-BAX) plasmids as 
explained in 2.3.2.3, and incubated for 6h-16 h at 37ºC with 5% CO2. 
2. Mitochondrial dying: cells were incubated with mitotracker-far red for 30 
min prior to analysis. Then, we substituted the media for McCoy’s 5A 
medium with 10mM HEPES and without phenol red and incubated 30 min 
at 37ºC with 5% CO2. 
3. Live imagining and Settings: Confocal analysis was performed on a Zeiss 
confocal LSM710 microscope equipped with 63X oil objective and laserlines 
to excite at 488, 561 or 633. A single spot with a diameter of 1,3 µm within 
the nucleus was repeatedly bleached with two iterations of 100% power of 
a 488 nm laser line (100% output). The diameter of a single ROI 0,52µm. 
Two images were collected after each bleach pulse, with 30 s between 
bleach pulses. After collecting 60 images, two separate measurements on 
the mitochondria were taken to analyze the fluorescence loss. Unbleached 
control cells were monitored for photobleaching due to image acquisition. 
The rate of loss in fluorescence on the mitochondria was calculated from 
fluorescence intensity measurements using the Zeiss LSM software. The 
fluorescence intensities were normalized by setting the initial fluorescence 
to 100% signal.  
NOTE 1: In FRAP/FLIP experiments is particularly important to open the pinhole 
to the maximum, (11.56 airy units= 8,4µm diameter section) 
NOTE 2: In order to ensure the presence of both plasmids and maximize the 
retrotranslocation effect, the plasmid ratio between GFP-tagged:non-labelled 
was 1:3). Protein expression amounts was assessed by WB. 
NOTE 3: GFP-BAX 1-2/L-6 appears to be much more sensible to phototoxicity, 
so that experiments with this construct were done at lower times in order to 
decrease protein expression 
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3 Structural details of BAX membrane conformations 
 
 
3.1 ABSTRACT 
Despite intensive research effort, how the paradigmatic proapoptotic protein BAX forms lethal 
apoptotic pores at the mitochondrial outer membrane (MOM) remains incompletely understood. 
Here, biophysical tools and minimalist model systems were used to identify the specific regions 
in BAX driving apoptotic pore formation, and to gain more insight into underlying mechanisms. 
Fluorescence mapping revealed that fully active BAX adopts a BH3-in-groove dimeric 
conformation in MOM-like membranes, with BAX α4-α5 helices belonging to its core domain 
inserting deeper into the membrane lipid bilayer than BAX α6-α8 helices belonging to its latch 
domain. In our reconstituted systems, antiapoptotic BCLXL formed canonical heterodimeric 
BH3-in-groove complexes with BAX, and blocked membrane insertion of BAX core α4-α5 
helices, but not BAX latch α6-α8 helices. Moreover, poly(ethylene glycol) (PEG) conjugation 
(PEGylation) at multiple individual sites along the BAX core, but not latch domain, potently 
inhibited BAX pore-forming activity. Additional combined computational and experimental 
evidence revealed that the BAX core α5 helix displays a bilayer-destabilizing membrane 
interaction mode that is absent in BAX latch α6-α8 helices. Based on this collective set of 
evidence, it is proposed that membrane insertion of the BAX core, but not latch domain, is critical 
for BAX apoptotic pore formation. 
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3.2 INTRODUCTION 
BAX is a key proapoptotic member of the BCL2 family which kills cells by forming an atypical 
pore at the mitochondrial outer membrane (MOM) (Cosentino & Garcia-Saez, 2017). This 
apoptotic pore is essential for allowing the release of cytochrome c (cyt c) and other mitochondrial 
apoptogenic factors into the cytosol, and is considered the pivotal step in the mitochondrial 
apoptotic pathway (Czabotar et al, 2014). It is well established that BAX exists in an inactive 
conformation in healthy cells, and that functional BAX activation is tightly regulated by two other 
factions of the BCL2 family (Cosentino & Garcia-Saez, 2017; Czabotar et al, 2014). On the one 
hand, proapoptotic BH3-only proteins such as cBID trigger activation of BAX at the MOM 
through a complex set of conformational changes culminating with formation of the BAX 
apoptotic pore. On the other hand, antiapoptotic BCL2-type proteins, including BCL2 itself and 
BCLXL, principally act by sequestering proapoptotic BCL2 family partners in stable protein 
complexes at the MOM, thereby blocking apoptotic pore formation.   
According to current knowledge, apoptotic pore formation relies in two distinct but interlinked 
biochemical activities of BAX: (1) homo-oligomerization, which is mainly mediated through 
BAX:BAX protein-protein interactions, and (2) perturbation of membrane structure, which 
primarily, if not solely, occurs through BAX:lipid interactions. Structural and functional studies 
have provided important insight into this dual activity of BAX. Early NMR studies revealed that 
inactive BAX forms a tight globular helical bundle fold comprising nine α-helices (Suzuki et al, 
2000). One critical feature of the inactive BAX structure is the presence of an extended 
hydrophobic groove mainly comprising the BAX α3-α5 region that is also present in its close 
homologue BAK, as well as in all antiapoptotic BCL2-type molecules. Such canonical BCL2 
hydrophobic grooves share the capacity to act as “receptors” for binding proapoptotic “BH3-
ligand” domains, although other non-canonical protein:protein interaction modes between BCL2 
family proteins have also been identified (Czabotar et al, 2014; Moldoveanu et al, 2014). 
Importantly, both the canonical BAX “receptor” groove and the BAX “BH3-ligand” domain 
(BAX α2) remain masked in the inactive BAX conformation, and together constitute the so-called 
BAX core domain (Czabotar et al, 2014).  Another salient characteristic of the inactive BAX 
conformation is the presence of hidden hydrophobic residues with potential for membrane 
interaction and/or perturbation that are localized in multiple helices of the protein.  
It is becoming clear that following binding by BH3-only activating ligands such as cBID, the 
BAX core domain (α2-α5) dissociates from the so-called BAX latch domain (α6-α8), as well as 
from the BAX N-terminal (α1) and C-terminal (α9) helices (Alsop et al, 2015; Czabotar et al, 
2013). Nevertheless, the specific regions in the BAX molecule that drive apoptotic pore formation 
via BAX:BAX and BAX:lipid interactions remain ill defined. The X-ray crystal structure of a 
truncated GFP-BAX fusion construct comprising the entire BAX core domain provided strength 
to the view that the assembly of a BH3-in-groove BAX dimer is a key step in the molecular 
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pathway for BAX activation5. However, it remains unclear whether this crystallographic BAX 
core dimer structure faithfully represents the fully activated conformation adopted by BAX in a 
membrane environment. In fact, under certain apoptotic conditions, alternative BAX dimeric 
conformations have been described at the MOM level (Gahl et al, 2014; Zhang et al, 2016). 
Additionally, how dimeric BAX species grow into higher-order multimers is not well understood, 
since multiple different interdimer interfaces have been identified in BAX and its close 
homologue BAK (Aluvila et al, 2014; Bleicken et al, 2014; Dewson & Kluck, 2009; Dewson et 
al, 2012; Mandal et al, 2016; Sung et al, 2015; Zhang et al, 2016).  Indeed, even the molecularity 
of BAX/BAK required to form functional apoptotic pores remains undetermined (Basanez et al, 
2012; Nasu et al, 2016; Salvador-Gallego et al, 2016; Subburaj et al, 2015). 
From the perspective of BAX:lipid interactions implicated in apoptotic pore formation, initial 
studies attributed a critical role to insertion of the BAX α5-α6 region into the MOM lipid bilayer 
as a transmembrane (TM) helical hairpin, akin to proteinaceous channel-like models proposed to 
explain the action of colicins (Youle & Strasser, 2008). Recent work, however, challenged this 
view by providing evidence that upon functional BAX activation, the BAX α5 and α6 helices: (i) 
dissociate from each other, rather than maintaining a hairpin configuration; and (ii) adopt a 
surface-parallel, rather than TM orientation (Czabotar et al, 2013; Westphal et al, 2014a). Based 
in these observations a new model emerged where the concerted shallow insertion of BAX α5 
and α6 helices into the MOM elicits the formation of a proteolipidic apoptotic pore through 
destabilization of the MOM lipid bilayer structure. It has also been proposed that additional 
helices of the BAX core (α4)(Czabotar et al, 2013) and latch (α7, α8)(Bleicken et al, 2014; 
Westphal et al, 2014a) domains, as well as the C-terminal BAX α9 helix8 actively drive BAX 
proteolipidic pore formation through shallow membrane insertion and bilayer destabilization. 
However, despite the proteolipidic nature of the BAX apoptotic pore has been debated for more 
than a decade (Basanez et al, 1999; Basanez et al, 2012; Cosentino & Garcia-Saez, 2017; Czabotar 
et al, 2013; Kuwana et al, 2002; Lovell et al, 2008; Qian et al, 2008b; Terrones et al, 2004; Youle 
& Strasser, 2008), the exact membrane topology of individual BAX helices, and the extent to 
which membrane immersion of defined BAX regions contributes to BAX pore formation are still 
incompletely delineated. On top of this, the specific BAX:lipid and BAX:BAX interactions 
targeted by antiapoptotic proteins such as BCLXL to block BAX apoptotic pore formation are 
currently under investigation (Andreu-Fernandez et al, 2017; Czabotar et al, 2014; Czabotar et al, 
2013; Landeta et al, 2014; Lee et al, 2016; Lovell et al, 2008; Llambi et al, 2011; Shamas-Din et 
al, 2013).  
In this chapter, physiologically-relevant model systems and biophysical and biochemical tools are 
used in order to analyse the membrane topology of individual helices of BAX core and latch 
domains, as well as their specific contribution to BAX pore-forming activity. Concretely, 
fluorescence mapping studies were used to gain insight the structural details of BAX 
conformation in the membrane when its activated by cBID. Moreover, not only it was also studied 
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the regulatory effect exerted by the antiapoptotic BCLXL but also BAX:BCLXL interaction 
surface  during the inhibition process. 
 
3.3 MATERIALS AND METHODS. 
In this section materials and methods required in this chapter are detailed briefly, a more extended 
explanation and specific information is described in the second chapter: general materials and 
methods. 
Chemicals and reagents.  
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL, USA). N,N'-Dimethyl-N-
(Iodoacetyl)-N'-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Ethylenediamine (NBD), 1, 3, 6, 
aminonaphtalene-tri-sulfonate (ANTS) and p-xilene-bis-dipicolyinicacis (DPX) were purchased 
from Molecular Probes (Eugene, OR, USA). Methoxy PEG maleimide of 550 Da average 
molecular weight (PEG05k) was obtained from Nanocs (New York, NY, USA). Synthetic 
peptides (>90% purity) were purchased from Biomatik (Wilmigton, DL, USA). All other reagents 
were from Sigma (St. Louis, MO, USA). 
Liposome preparation.  
MOM-like lipid mixtures (PC/PE/PI/CL 50/35/10/15, mol/mol) were co-dissolved in 
chloroform/methanol (2:1), and organic solvents were removed by incubation under vacuum for 
2h. Dry lipid films were resuspended in 100mM KCl, 10mM Hepes, 0.1mM EDTA (KHE buffer), 
except in experiments were 20 mM KCl, 10 mM Hepes pH 7.0, 0.1 mM EDTA, 12.5 mM ANTS 
and 45 mM DPX was used. Liposomes were then subjected to 5 freeze/thaw cycles, and 
subsequently extruded 10 times through two polycarbonate membranes of 0.2-µm pore size 
(Nucleopore, San Diego, CA) to obtain large unilamellar vesicles (LUVs).  
Purification and labeling of BCL2 family proteins.  
Recombinant BAX and BCLXL proteins were generated from the vector pTYB1 (New England 
Biolabs, Ipswich, MA), cells were lysed by passage through a French pressure cell, the intein tag 
was removed by DTT treatment, and the proteins were further purified as previously described in 
the material and method chapter and in (Subburaj et al, 2015; Suzuki et al, 2000). Caspase-8-
cleaved BID (cBID) and BCLXLΔC were expressed and purified as described earlier in the 
material and method chapter and in (Landeta et al, 2014; Terrones et al, 2004). All proteins were 
>90% pure as evaluated by Coomassie-stained SDS-PAGE. Mutant DNAs were generated by 
PCR-based mutagenesis using the Quickchange mutagenesis kit (Stratagene, San Diego, CA, 
USA) or purchased at GenTech (Montreal, Canada). All constructs were verified by sequencing. 
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In a typical labeling reaction, NBD dissolved in DMSO or PEG05k dissolved in KHE were added 
to a 1 ml sample containing 0.5 mg of a monocysteine BAX variant, at a labeling reagent/BAX 
molar ratio of 10:1. Samples were incubated overnight at 4oC, and subsequently eluted over a PD-
10 column (GE Healthcare, Pittsburgh, PA, USA) equilibrated with KHE+1mM TCEP.  
Cyt c release and BAX immunodetection assays.  
BAX-/-/BAK-/-DKO mouse embryonic fibroblasts (MEFs) were harvested by scrapping, and 
homogenized with a glass-Teflon Potter-Elvehjem homogenizer in mitochondrial isolation buffer 
(210 mM mannitol, 70 mM sucrose, 10 mM Hepes (pH 7.5), 1 mM EDTA, and protease 
inhibitors). After removing heavy membrane fractions by two consecutive centrifugations at 700g 
for 10 min at 4oC, mitochondria-enriched fractions were pelleted by centrifuging the resultant 
supernatant at 14000g for 10 min at 4oC. Mitochondria (50 µg total protein) were incubated with 
recombinant BAX variants (100 nM) with or without cBID (10 nM) in 125 mM KCl, 5 mM 
KH2PO4, 2 mM MgCl2, 1 mM DTT, and 10 mM HEPES-KOH, pH 7.2, for 30 min at 30oC. 
Samples were then centrifuged at 14000g for 10 min, and supernatant and pellet fractions were 
subjected to 15% SDS-PAGE and immunoblotting using anti-cyt c 7H8.2C-12 or anti-Bax 
554104 monoclonal antibodies (BD-Biosciences, San Jose, CA, USA).  
Steady-state fluorescence spectroscopy.  
Fluorescence intensity and spectral analyses were done in an 8100 Aminco-Bowman 
luminescence spectrometer (Spectronic Instruments, Rochester, NY), in a thermostatically 
controlled 4x4-mm quartz cuvettes, at 25 °C. The folding properties of all mutants were examined 
by monitoring the intrinsic tryptophan (Trp) fluorescence spectra of each BAX mutant compared 
with the wt BAX. Trp spectra were recorded between 310 nm and 410 nm at a scan rate of 1 nm/s, 
using an excitation wavelength of 290 nm (slits 4nm). NBD fluorescence spectra in the presence 
of MOM-like LUVs (200 µM) and proteins of choice were recorded between 500 nm and 650 nm 
at a scan rate of 1 nm/s, using an excitation wavelength of 465 nm (slits 4nm). The fluorescence 
emission maximum (λmax) values were determined from the first derivative of the smoothed 
spectra. To minimize vesicle light scattering, a 475nm cut-off filter was placed in the emission 
light path. In all cases, the signal from solvent blank (buffer or LUVs in buffer) was subtracted 
from the sample fluorescence. FQ=Dox was obtained using MOM-like LUVs containing 25 
mol% Dox-lipid substituting equivalent amounts of PC. FQ=I- was obtained after addition of 200 
mM KI + 0.2 mM Na2SO4, and sample fluorescence in the absence of quencher (F0) was obtained 
from equivalent samples to which 200 mM KCl + 0.2 mM Na2SO4 was added. Release of LUV-
encapsulated ANTS/DPX was monitored with λex=350 nm, and λem=520 nm (slits, 8 nm). The 
extent of marker release was quantified on a percentage basis according to the equation: (Ft-
F0/F100-F0) x100 where Ft is the measured fluorescence of protein-treated LUVs at time t, F0 is the 
initial fluorescence of the LUV suspension before protein addition, and F100 is the fluorescence 
value after complete disruption of LUVs by addition of C12E8 detergent (0.5 mM).  
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DSF Measurements.  
Fluorescence measurements were made by using a Qiagen Rotor Gene RT-PCR instrument 
(Valencia, CA) and an Applied Biosystems 7500 instrument (Life Technologies, Carlsbad, CA). 
Solutions for the DSF measurements were prepared on the day of measurement using stock 500 
μM dye solutions, 50 μM stock protein solutions, and the PBS buffer described above. The final 
solutions contained 4 % (by vol.) DMSO and 20 μM dye with protein concentrations of 1.0μM, 
2.0 μM, and 5.0 μM. Each sample tube was loaded with 25 μL of the protein/dye mixture for 
analysis. Two replicates of each protein concentration were measured for each experiment. 
Measurements made on the Rotor Gene instrument were set up such that the samples would 
initially equilibrate at 25 °C and then increased up to 99 °C in steps of 0.5 °C, holding the 
temperature at each step between 15 s and 80 s. The base scan speed of the instrument is 3.5K/min. 
However, because of the hold times at each temperature step, the effective scan rate of the system 
is much lower. The effective scan rate is the change in temperature divided by the total time of 
the scan. For example, a DSF run with a temperature profile from 25 °C to 99 °C (T = 74 K) and 
a base scan rate of 3.5 K/min will take approximately 21.1 minutes to complete. Holding each 0.5 
K interval for 30 seconds, will add an additional 74 minutes to the run, making the effective scan 
rate of 0.778 K/min or 47 K/hr. At each temperature step of the scan, fluorescence measurements 
were made for each sample, using the excitation and emission settings appropriate for the dye 
(4,4′-Dianilino-1,1′-binaphthyl-5,5′-disulfonic acid dipotassium salt (bis-ANS) λexc =365 λem= 
485). The tfm values are calculated as the midpoint of the fluorescence transition. Before 
transition midpoints were determined, a baseline approximation was subtracted from the 
fluorescence. The baseline approximation was of the dye alone with no protein. This was done to 
be consistent with the generally accepted DSF model in which this temperature corresponds to 
the point where the protein is halfway unfolded. The 2 μM and 5 μM protein concentrations gave 
the most consistent results, and the data presented are the average of these two protein 
concentrations. 
Monolayer surface pressure measurements.  
Measurements were carried out with a MicroTrough-S system from Kibron (Helsinki, Finland) at 
25 °C with constant stirring. The MOM-like lipid mixture, dissolved in chloroform, was gently 
spread over the surface and kept at a constant surface area. The desired initial surface pressure, 
πi, was attained by changing the amount of lipid applied to the airwater interface. After 10 min to 
allow for solvent evaporation, the protein was injected through a hole connected to the subphase. 
The change in surface pressure, Δπ, was recorded as a function of time until a stable signal was 
obtained. The linear plot of Δπ as a function of πi can be extrapolated to a πi of 0 to give the 
critical pressure, πc, which is a measure of the relative “penetration capacity” of a protein into the 
monolayer. 
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31P-NMR Measurements.   
Samples for 31P NMR were prepared by dispersing 15 µmol of dry MOM-like lipid mixtures in 
0.5 ml of KHE buffer alone or containing the peptide of interest. Multilamellar vesicle 
suspensions were freeze-thawed 3 times in liquid N2 to disperse the added proteins in the lipid 
membranes, and the liposomes were spun down in an Eppendorf centrifuge (14,000 rpm, 15 min, 
4 °C). Pellets were loaded directly into 5-mm Pyrex NMR tubes. High power, proton noise-
decoupled 31P NMR spectra were recorded on a Bruker AV-500 spectrometer operating at 202.4 
MHz using 5-mm broadband inverse probes with z-gradient equipment. 1024 free induction 
decays were averaged using a 2-s recycle delay. Spectra were processed and evaluated using 
TOPSPIN 1.3 (Bruker) and plotted with 80-kHz line broadening. 
Computer simulations.  
Main biophysical characteristics of BAX-derived peptides were determined by MPEx (Snider et 
al, 2009) and Heliquest (Gautier et al, 2008). Monte Carlo (MC) simulations of the interaction of 
peptide molecules with MOM-like membranes were performed using the MCPep web server 
(Gofman et al, 2012a). The web server´s output includes the free energy of peptide-membrane 
association, the energetically favorable peptide-membrane depth of penetration and tilt, and 
snapshots of example simulations with the centroid conformation of the largest cluster (in PDB 
format). 
 
3.4 RESULTS 
3.4.1 Active-BAX membrane topology assessment 
3.4.1.1 Structural and functional analysis of recombinant BAX monocysteine 
mutants.   
Minimalist systems comprising recombinant purified proteins and model membranes have 
provided invaluable information about different structural and functional aspects of BCL2 family 
proteins (Bleicken et al, 2014; Lovell et al, 2008; Nasu et al, 2016; Salvador-Gallego et al, 2016; 
Subburaj et al, 2015). Here, a set of recombinant BAX monocysteine mutants located at strategic 
positions along the BAX α2-α8 helices was generated aiming to map the membrane topology and 
role in BAX apoptotic pore formation of specific regions of BAX core and latch domains. The 
three-dimensional NMR solution structure of inactive, monomeric BAX is shown in Figure 3.1A, 
with residues mutated to cysteine (Cys) highlighted as black spheres and BAX helical segments 
colored according to the following scheme: BAX α2, green; BAX α3, brown; BAX α4, blue; BAX 
α5, pink; BAX α6, orange; and BAX α7-α8, cyan.  
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First, the structural integrity of BAX variants was assessed by examining the net wavelength of 
maximum emission (λmax) for their tryptophan (Trp) residues. As shown in Figure 3.1B, the Trp 
λmax values for all monocysteine BAX mutants were similar to that of wild-type (wt) BAX 
indicating that the BAX variants preserve the global folding pattern of the native protein. The 
only exception was the BAXF116C variant showing a 6 nm blue-shift in Trp λmax. Considering 
that the F116 residue is localized at the very core of the BAX molecule (Fig. 3.1A), it is not 
surprising that the F116C substitution significantly perturbs the native BAX structure. Moreover, 
in order to confirm globular folding they were validated, at least one monocysteine mutant per α-
helix, by a more sensitive fluorimetric technique, differential scanning fluorimetry (DSF), 
obtaining similar results Figure 3.1C.  
To test whether Cys mutations affect the apoptotic function of this set of recombinant purified 
BAX proteins, it was measured their capacity to release mitochondrial cyt c. Similarly to wt BAX, 
all BAX variants displayed minimal cyt c release in the absence of cBID, whereas in the presence 
of cBID all BAX mutants displayed near complete cyt-c-releasing activity (Figure 3.1D). Here 
also the BAXF116C mutant was an exception, showing negligible cyt c release with or without 
cBID. Further immunoblotting analyses indicated that cBID-activated BAX variants targeted to 
mitochondria similarly to the native protein, albeit this assay proved less sensitive to that of cyt c 
release (Figure 3.1D).  
Based on this collective set of results, it is concluded that all monocysteine BAX variants preserve 
the structural and functional integrity of the parent molecule, with the exception of BAXF116C 
which was not examined further. 
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Figure 3.1. Characterization of BAX mutants. (A) Inactive BAX structure showing cysteine mutation 
sites (black spheres). (B) Trp fluorescence spectra of BAX proteins. (C) DSF fluorescence spectra of BAX 
proteins (D) Cyt-c-releasing and mitochondrial-localizing activities of BAX proteins. 
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3.4.1.2 Assessing the active structure of BAX at the membrane level by 
fluorescence mapping.   
Fluorescence spectroscopy coupled to site-directed fluorescence labeling is a powerful approach 
to study conformations of membrane-associated proteins. In this approach, a fluorescent dye is 
covalently attached to the sulfhydryl group of a protein containing a single Cys residue positioned 
at a strategic site. NBD was chosen as the fluorescent probe in this study because it is a relatively 
small and uncharged dye, and its spectral properties are dramatically different in aqueous and 
nonaqueous environments (Alder et al, 2008; Lovell et al, 2008; Saksena et al, 2009). For 
example, when NBD moves from a polar environment (i.e. the hydrophilic surface of a protein) 
to a nonpolar environment (i.e. the hydrophobic interior of the membrane or a protein), its 
fluorescence emission intensity (F) increases while its λmax shifts to the blue.  
Typical emission scans for selected NBD-labelled BAX mutants in the presence of MOM-like 
liposomes with or without cBID treatment are shown in Figure 3.2A (continuous and dotted lines, 
respectively). Upon treatment with cBID, most mutants exhibited notable increases in F and blue-
shifts in λmax indicating transfer of NBD probes to more hydrophobic environments (Figure 
3.2A, arrows). Quantitative assessment of the magnitude of NBD-BAX spectral changes induced 
by cBID suggests that the different sites in membrane-active BAX can be grouped in the following 
three broad categories (Figure 3.2B): (1) sites which go through prominent changes in F (filled 
bars) and are placed in hydrophobic microenvironments as assessed by their low λmax values 
(empty bars); i.e., R89 and F100 in BAX α4, and F105, L120, and C126 in BAX α5; (2) sites 
which undergo small to negligible changes in F and localize to hydrophilic microenvironments 
according to their high λmax values; i.e., M74 and D84 in BAX α3, G138 in BAX α6, D154 in 
BAX α7, and D159 in BAX α8; and (3) sites which experience rather similar changes in F ranging 
from moderate to notable and localize to microenvironments of middle polarity judging by their 
intermediate λmax values; i.e., T56 and C62 in BAX α2, R94 in BAX α4, I133, R147, and L148 
in BAX α6, W151 in BAX α7, and F165C in BAX α8.  
 
Figure 3.2 Fluorescence mapping of membrane active BAX topology. (A) Emission spectra of NBD-
BAX variants (200 nM) with (continuous lines) or without (dotted lines) cBID (50 nM). (B) Filled bars: 
NBD intensity ratios for cBID-activated to inactive NBD-BAX variants. Empty bars: NBD λmax for cBID-
activated NBD-BAX variants. Data are mean ± S.E.M. (n ≥3). 
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Although the spectroscopic approach described above provides valuable information, alone it 
does not allow distinguishing whether an NBD probe shifts to a nonpolar environment by 
becoming exposed to the hydrophobic interior or the interface of the lipid bilayer, or by moving 
into a hydrophobic site within a proteinaceous structure. To further evaluate the membrane 
topography of each NBD probe in active BAX variants, a series of collisional quenching 
experiments were performed. First, the lipophilic quenching agents 1-palmitoyl-2-stearoyl-5-
doxyl-sn-glycero-3-phosphocholine (Dox5) and 1-palmitoyl-2-stearoyl-14-doxyl-sn-glycero-3-
phosphocholine (Dox14) were used, two phospholipid derivatives with a NO group localized 
within the bilayer hydrophobic phase, close to the glycerol backbone and the bilayer midplane, 
respectively (Kyrychenko & Ladokhin, 2013). 
 The left Panel in Figure 3.3 is a histogram showing the extent of quenching by doxylated lipids 
for the set of monocysteine BAX mutants incubated with MOM-like liposomes and cBID. As can 
be seen, NBD probes attached to R89, F100, F105, L120, and C126 sites in cBID-activated BAX 
were substantially quenched by both Dox5 and Dox14, with the former lipid eliciting stronger 
quenching than the latter one. Thus, in active BAX, this set of residues localized in the BAX core 
α4-α5 region are placed within the hydrocarbon phase of the lipid bilayer but without reaching 
the bilayer midplane. By contrast, NBD attached to other sites in the BAX core domain (T56, 
C62, M74, D84, and R94) and a group of sites localized in the BAX latch domain (G138, R147, 
D154, D159) showed minimal quenching by either Dox5 or Dox14 indicating these residues do 
not penetrate into the hydrocarbon phase of the lipid bilayer when BAX acquires its active 
conformation. Lastly, a set of sites localized in the BAX latch domain (I133, L148, W151, and 
F165) displayed moderate quenching by Dox5 and negligible quenching by Dox14, suggesting 
these residues are peripherally attached to the membrane surface in cBID-activated BAX.  
Next, the Dox5 quenching results for sites in the BAX core domain were mapped into the BH3-
in-groove BAX dimer crystal structure (Czabotar et al, 2013) (Figure 3.3, Right). It is readily 
apparent that NBD sites showing strong quenching by Dox5 localize to the “bottom” part of the 
dimeric BAX core crystal structure expected to provide a lipophilic surface in the molecule (red 
spheres)(Czabotar et al, 2013), while NBD sites showing weak quenching by Dox5 are distributed 
along regions of the dimeric BAX core crystal structure expected not to interact with membrane 
lipids (black spheres). Thus, Dox5 quenching results obtained with cBID-activated BAX in 
MOM-like LUV fit nicely into this crystallographic BAX core dimer structure. On the other hand, 
mapping the Dox5 quenching results obtained for sites in the BAX latch domain into structural 
models for BAX α6, α7 and α8 helices reveals a potential lipophilic surface along one face of 
each of these three helices.  
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Figure 3.3. Left: Dox-quenching ratios for cBID-activated NBD-BAX variants. Right: BAX structures 
depicting Dox5-exposed (red spheres) and -unexposed (black spheres) residues. Data are mean ± S.E.M. 
(n ≥3). 
Next, it was examined the same cBID-activated NBD-BAX mutants for quenching by the 
hydrophilic quencher I- (Figure 3.4, Left). NBD attached to sites R89, F100, F105, L120, and 
C126 in BAX α4-α5 displayed modest to minimal quenching by I-, consistent with the notion that 
these residues of the BAX core domain are buried within the membrane interior in cBID-activated 
BAX (Figure 3.3). On the other hand, NBD attached to multiple sites in BAX α3 (D74, M84) and 
BAX α6-α8 (G138, R147, L148, D154, D159, F165) showed substantial quenching by I- 
supporting that all these residues of the BAX core and latch domains are at least partially solvent-
exposed when BAX acquires its active conformation. The exceptions were I133 and W151 
residues in the latch domain which showed more modest quenching by I-. Lastly, NBD attached 
to sites T56 and C62 in BAX α2, and R94 in BAX α4 displayed weak quenching by I-, which 
combined with their low quenching by Dox5 and Dox14 (Figure 3.3, Left) indicates that these 
three residues belonging to the BAX core domain are buried within a proteinaceous structure in 
active BAX.  
 
Figure 3.4 Left: I--quenching ratios for cBID-activated NBD-BAX variants. Right: BAX structures 
depicting solvent-exposed (black spheres) and -unexposed (red spheres) residues. Data are mean ± S.E.M. 
(n ≥3). 
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Mapping I- quenching results for sites in the BAX core domain into the BH3-in-groove BAX 
dimer crystal structure also revealed a general agreement between experimental results and the 
distribution of BAX residues according to this structural model, as follows (Figure 3.4, Right). 
First, all residues in the BAX α4-α5 region expected to be hidden within the lipophilic surface at 
the “bottom” part of the dimeric BAX core structure scored as “buried” by the I- quenching 
approach. Of note, R89 in the putative lipophilic surface of BAX α4 scored as “solvent-exposed”, 
yet this residue displayed relative small quenching levels by I- (Figure 3.4, Left). Second, residues 
M74 and D84 in BAX α3 that strongly scored as “solvent-exposed” by the I- quenching method 
localize to surface-exposed regions in the dimeric BAX core crystal structure. Third, residues T56 
and C62 in BAX α2 and R94 in BAX α4 scoring as “buried” by the I- quenching approach localize 
to the protein:protein interface between the two BAX monomers in the dimeric BAX core crystal 
structure (red spheres with white stars). On the other hand, the mapping of I- quenching results 
for sites in the BAX latch domain into structural models for BAX α6, α7 and α8 helices, together 
with the data shown in Figure 3.4, supports the notion that the entire latch region of the activated 
BAX molecule adopts a peripheral disposition at the membrane displaying a lipophilic surface 
along one face of its component helices.  
Overall, fluorescence mapping of active BAX topology in MOM-like membranes indicates that 
the BAX core domain adopts a BH3-in-groove dimeric structure presenting a lipophilic surface 
in the BAX α3-α4 region, while the BAX latch domain provides another lipophilic surface along 
one side of its constituent α6-α8 helices. In addition, the combined results also reveal that the 
BAX core α4-α5 helices penetrate deeper into the membrane hydrocarbon core than the BAX 
latch α6-α8 helices, but without adopting a TM orientation. 
 
3.4.1.3 BCLXL blocks membrane insertion of BAX core, not latch domain.   
Next, it was also analysed the effect of antiapoptotic BCLXL on NBD-BAX fluorescence changes 
elicited by cBID. Of note, for these experiments the cBIDM97A mutant was used which displays 
negligible binding to BCLXL but preserves intact BAX activation capacity (Lee et al, 2016). 
Importantly, it is also considered the ongoing debate on whether antiapoptotic proteins neutralize 
BAX exclusively through canonical BH3-in-groove heterodimeric interactions, or also via 
additional non-canonical protein-protein binding interactions (Andreu-Fernandez et al, 2017; 
Basanez et al, 2012; Czabotar et al, 2014; Czabotar et al, 2013; Landeta et al, 2014; Lee et al, 
2016; Llambi et al, 2011; Shamas-Din et al, 2013). In the former case, BCLXL is expected to 
exert its inhibitory action only before the BAX BH3-in-groove dimerization process has taken 
place, while in the latter scenario BCLXL is predicted to remain at least partially active even after 
BAX has become previously dimerized. When BCLXL was added before cBIDM97A had activated 
BAX, the antiapoptotic protein prominently inhibited the NBD fluorescence increase observed at 
most sites in the BAX core, but not latch domain (Figure 3.5A, filled Bars). On the other hand, 
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when BCLXL was added after cBIDM97A had activated BAX, insignificant changes were observed 
in the NBD fluorescence of all BAX variants examined (Figure 3.5A, empty bars).  
To directly test whether BCLXL differentially inhibits membrane insertion of BAX core and latch 
helices, the effect of BCLXLΔC on Dox5-mediated quenching of NBD-BAX variants was 
assessed. Indeed, BCLXLΔC markedly inhibited the quenching elicited by Dox5 in multiple 
NBD-BAX variants localized at the BAX core domain (BAXR89C-NBD, BAXF100C-NBD, BAXL120C-
NBD, and BAXC126-NBD), but not the BAX latch domain (BAXI133C-NBD, BAXL148C-NBD, BAXW151C-
NBD, and BAXF165C-NBD) (Figure 3.5B).  
To try to further discriminate between canonical and non-canonical mechanisms of BCLXL-
mediated BAX inhibition, the BCLXLΔCR139D and BCLXLΔCL17A variants were expected to 
disrupt the canonical and the BCL2-like non-canonical BCLXL:BAX binding interfaces, 
respectively (Figure 3.5C)(Barclay et al, 2015; Czabotar et al, 2013). Interestingly, the canonical 
BCLXLΔCR139D mutant completely lost the ability of native BCLXLΔC to inhibit cBID-mediated 
BAX activation as determined by measurements of mitochondrial cyt c release (Figure 3.5D), 
vesicular ANTS/DPX release (Figure 3.5E), and NBD-BAX fluorescence changes (Figure 3.5F). 
In contrast, the BCL2-like non-canonical BCLXLΔCL17A mutant preserved all these inhibitory 
activities displayed by the parent protein (Figure 3.5D-F).  
Thus, can be concluded that antiapoptotic BCLXL inhibits both BAX core membrane insertion 
and BAX apoptotic pore formation via heterodimeric BH3-in-groove interactions. 
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Figure 3.5 Mode of BCLXL inhibition. (A) Intensity ratios of NBD-BAX variants treated with cBIDM97A 
and BCLXL (500 nM) (F+BCLXL) to those without BCLXL (F-BCLXL). BCLXL was added together with 
BAX+cBIDM97A (filled bars) or afterwards (empty bars). (B) Dox5-quenching ratios for NBD-BAX 
variants treated with cBIDM97A and BCLXLΔC (5000 nM, QDox5+BCLXLΔC) to those without BCLXLΔC 
(QDox5-BCLXL). (C) Representation of BCLXLΔC:BAX BH3 complex highlighting canonical/non-
canonical surfaces. (D) Cyt c release by BAX, cBIDM97A, and BCLXLΔC proteins. (E) ANTS/DPX release 
by BAX (200 nM), cBIDM97A (50nM), and BCLXLΔC proteins (5000 nM). (F) As in Panel A. Data are 
mean ± S.E.M. (n ≥2). 
 
3.4.1.4 PEGylation of multiple sites at the BAX core, but not latch domain, blocks 
BAX apoptotic pore formation.   
Next, in order to analyse the specific contribution of individual BAX core and latch residues to 
BAX apoptotic pore formation using a site-specific BAX PEGylation approach was used (Dozier 
& Distefano, 2015). To this aim, the modification of the different BAX monocysteine mutants 
with the small hydrophilic reagent methoxy PEG maleimide of 550 Da (PEG05k) was performed 
to yield a set of mono-PEGylated BAXPEG05k variants, and then compared the membrane-
permeabilizing activity of each BAX mutant with or without site-specific PEGylation.  
Chapter 3: BAX membrane topology   
 
142 
 
The rationale behind this experimental approach is that conjugation of a hydrophilic PEG05k 
molecule at a specific site in BAX should obstruct the localization of that particular BAX residue 
to the hydrophobic interior of the membrane or a BAX oligomerization interface, thereby 
potentially inhibiting BAX-induced membrane permeabilization.  
Notable differences were observed in the permeabilization of MOM-like LUV elicited by cBID-
activated BAX depending on the site of BAX PEGylation (Figures 3.6A, B). At the BAX core 
domain, PEGylation of all sites in BAX α2 and the BAX α4-α5 region potently inhibited BAX-
induced liposome permeabilization, whereas PEGylation of BAX α3 sites had a more modest 
impact on BAX permeabilizing activity. Site-specific PEGylation at the BAX latch domain had a 
generally weaker effect on BAX permeabilizing activity.  
The relative impact of site-specific BAX PEGylation on BAX-induced membrane 
permeabilization was mapped into BAX structural models (Fig. 3.6C, Right). This representation, 
together with those shown in Figure 3.2-3.4, illustrates that (i) the BAX sites where PEGylation 
strongly inhibits BAX-induced membrane permeabilization basically comprise BAX residues at 
the core domain implicated in BAX:BAX BH3-in-groove interaction (C62, R94) and BAX α4-
α5 membrane insertion (R89, F100, F105, L120, C126); whereas (ii) the BAX sites where 
PEGylation weakly inhibits BAX-induced permeabilization essentially represent BAX residues 
localized at the solvent-exposed, non-interacting BAX core α3 helix (M74, D84), or at the 
peripherally membrane-attached BAX latch α6-α8 domain (I133, G138, R147, L148, W151, 
D159, F165). 
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Figure 3.6: Contribution of BAX core and latch domains to membrane permeabilization. (A) 
ANTS/DPX release by cBID-activated BAX variants conjugated/unconjugated with PEG05k. (B) Ratios 
of ANTS/DPX release by BAX variants conjugated with PEG05k to BAX unconjugated with PEG05k. (C) 
BAX structures depicting residues strongly (red spheres) or weakly (black spheres) inhibiting BAX pore 
formation. Data are mean ± S.E.M. (n ≥3). 
 
3.4.1.5 BAX core α5 peptide displays membrane activities that are absent in BAX 
latch α6 and α7-α8 peptides.   
As an additional approach to try to determine the role of BAX core and latch helices in BAX 
apoptotic pore formation, they were examined different membrane activities of synthetic peptides 
representing BAX α5, α6, and α7- α8 regions. First, it was determined the main biophysical 
properties of BAX α5, α6, and α7- α8 regions using MPEx and Heliquest (Gautier et al, 2008; 
Snider et al, 2009). The BAX core α5 region showed higher mean hydrophobicity (<H>), lower 
mean hydrophobic moment (anphipaticity, <µH>), and more positive net charge (z) than the BAX 
latch α6 and α7-α8 regions (Figure 3.7A).  
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Next, the capacity of BAX-derived peptides to penetrate into MOM-like lipid monolayers was 
assessed (Figure 3.7B). For BAX α5 and BAX α6 peptides, the change in lipid monolayer surface 
pressure (Δp) upon peptide addition decreased linearly as a function of increasing initial surface 
pressure (π0), giving critical surface pressure (πc) values of 34.8 mN/m and 25.6 mN/m, 
respectively. Considering that typical πc values for lipid bilayer membranes are in the range of 
25-30 mN/m(Marsh, 1996), these data suggest that the BAX α5 peptide displays a superior 
capacity to penetrate into the MOM lipid bilayer compared to the BAX α6 peptide. In parallel, 
the membrane-permeabilizing ability of BAX-derived peptides was analysed. As shown in Figure 
3.7C, the BAX α5 peptide induced ANTS/DPX release from MOM-like LUV in a dose-dependent 
manner, while the BAX α6 and BAX α7-α8 peptides were much less active in this experimental 
system.  
 
Figure 3.7 Membrane activities of BAX-derived peptides (1). (A) Biophysical characteristics of BAX-
derived peptides. (B) Monolayer insertion of BAX-derived peptides. (C) ANTS/DPX release by BAX-
derived peptides (0.1 µM, 1 µM, and 5 µM). Data are mean ± S.E.M. (n ≥2). 
Similarly, the BAX α5 peptide induced a dose-dependent depletion of cyt c in BAX/BAK DKO 
mitochondria, whereas the BAX α6 and BAX α7-α8 peptides virtually did not release any 
mitochondrial cyt c at any concentration tested (Figure 3.8A). 31P-NMR studies were also 
conducted to directly assess whether these peptides disrupt the membrane lipid bilayer structure. 
The 31P-NMR spectrum of MOM-like liposomes showed the high-field peak and low-field 
shoulder typical of a planar bilayer arrangement of membrane lipids (Figure 3.8B). Addition of 
the BAX α5 peptide to MOM-like liposomes led to a profound change in the shape of the 31P-
NMR spectrum: the bilayer-type signal markedly decreased while a prominent peak appeared 
around the chemical shift position of phospholipids experiencing isotropic motion, which is 
typical for highly curved non-bilayer type lipid dispositions. By contrast, the BAX α6 and BAX 
α7-α8 peptides did not significantly alter the 31P-NMR spectrum of MOM-like liposomes.  
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Figure 3.8 Membrane activities of BAX-derived peptides (2). (A) Cyt c release by BAX-derived 
peptides. (B) Effect of BAX-derived peptides on lipid bilayer structure. Data are mean ± S.E.M. (n ≥2). 
Collectively, these results strongly suggest that the BAX core α5 helix displays an intrinsic 
capacity to insert into the MOM lipid matrix, destabilize the MOM lipid bilayer structure, and 
breach the MOM permeability barrier, while the BAX latch α6-α8 helices lack such membrane 
activities. 
 
3.4.1.6 Computational simulations reveal dissimilar membrane interaction modes 
for the BAX core α5 helix, the BAX latch α6-α8 helices, and the BAX C-
terminal α9 helix.   
Finally, coarse-grained Monte Carlo (MC) simulations of peptides in association with MOM-like 
lipid bilayer membranes using the MCPep web server was perfomed (Gofman et al, 2012a). 
Although this computational model captures only certain characteristics of the complex peptide-
lipid system, it allows obtaining quantitative information of thermodynamic parameters reflecting 
the mode of peptide-membrane interaction; in particular, the peptide´s membrane-association free 
energy (ΔGtotal), favored membrane orientation (Tilt), and preferred membrane penetration depth 
(Zcenter).  Moreover, the MC simulation model has been previously tested for a variety of peptide 
and protein fragments in membrane environments, and reproduced available empirical data and 
results obtained with explicit molecular dynamics simulations with reasonable success (Gofman 
et al, 2012a; Gofman et al, 2012b; Gofman et al, 2010).  
As a control, they were first examined three experimentally well-studied case examples in this 
computational system (Figure 3.9A): (1) the prototypical TM domain of glycophorin A 
(Harrington & Ben-Tal, 2009); (2) the N-terminal H0 helix of endophilin A1 localizing at the 
level of the phospholipid phosphate groups (Gallop et al, 2006); and (3) melittin, a potent pore-
forming and bilayer-destabilizing cytolitic peptide that localizes at the upper region of the 
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hydrocarbon phase of the lipid bilayer (Lee et al, 2013). Indeed, for each one of these example 
cases analysed, the MCPep simulation successfully reproduced the expected peptide-membrane 
interaction mode (Figure 3.9A, and Table 3.1).  
 
Figure 3.9. Peptide-membrane association modes assessed by MC simulations. (A) Example 
peptides; (B) BAX-derived peptides. Red rectangles represent phospholipid headgroups. 
Peptide/Quality ΔGtotal (kT) Zcenter (Å) Tilt (degrees) 
Glycophorin A 
(TM) 
-40.8±0.3 2.8±0.4 21.3±0.7 
Endophilin H0 -7.7±0.1 22.4±0.7 68.3±0.6 
Melittin -22.9±0.2 18.5±0.3 79.4±0.5 
BAX α5 -26.1±0.3 18.1±0.1 78.9±0.3 
BAX α6 -3.7±0.4 36.2±0.7 58.0±0.4 
BAX α7-α8 -0.8±0.5 45.3±0.6 53.8±0.4 
BAX α9 -17.7±0.1 0.8±0.1 11.5±0.4 
 
Table 3.1: Thermodynamic characteristics of interaction between different peptides and MOM-like 
membranes. 
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All values are reported as means ± standard error. ΔGtotal, the total free energy of peptide-
membrane association; Zcenter, the average distance of the peptide´s centre of mass to the 
membrane midplane; Tilt, the angle between the N´-to-C´ vector of the peptide´s helical core and 
the membrane normal. 
Then, it was examined the membrane-interaction modes of BAX α5, α6, α7-α8, and α9 peptides 
by MCPep (Figure 3.9B, and Table 3.1). Remarkably, the BAX core α5 peptide displayed a 
membrane-interaction mode very similar to that of the melittin peptide, by localizing into the sub-
surface region of the membrane with a membrane-association free energy of -26.1 kT, its 
geometrical center at an average distance of 18.1 Å from the membrane midplane, and its principal 
axis nearly parallel to the membrane surface. By contrast, the BAX latch α6 and α7-α8 peptides 
interacted very weakly with the membrane (ΔGtotal < 5kT), and for the most part, remained in the 
aqueous phase (Z > 30 Å). Lastly, the most energetically favored disposition for the BAX C-
terminal α9 peptide was the TM orientation.  
Thus, the dissimilar membrane interaction modes of the BAX core α5 peptide and the BAX latch 
α6 and α7-α8 peptides disclosed by MCPep simulations concur with experimental results showing 
that the former peptide, but not the latter ones, possesses intrinsic membrane-inserting, pore-
forming and bilayer-destabilizing activities (Figures 3.7 and 3.8). MCPep computational results 
also qualitatively agree with fluorescence mapping studies showing that membrane active BAX 
inserts the core α5 helix deeper into the lipid bilayer than the latch α6-α8 helices (Figure 3.2-3.4). 
 
3.4.2 Assessing inactive BAX membrane structure in model 
membranes and in situ in the MOM 
Recent information indicates that functional activation of BAX/BAK at the MOM level requires 
interaction with mitochondrial membrane lipids in addition to selected BH3-only proteins 
(Hollville & Martin, 2012; Zhang & Saghatelian, 2013). Therefore, as the conformational 
rearrangements that many BCL2 family proteins apparently undertake to become functionally 
active occur in a lipid bilayer environment, the interaction with mitochondrial membrane lipids, 
especially the CL, has been gaining attention. In fact, a growing body of evidence indicates that 
the BCL2-regulated MOM permeabilization pathway is a lipid-assisted process, but exactly how 
specific mitochondrial lipids impact on BCL2 family proteins is poorly understood (Crimi & 
Esposti, 2011; Osman et al, 2011).  
Previous studies in our lab (Dr Ane Landajuela´s thesis) using site-specific fluorescence labelling 
and fluorescence spectroscopy of NBD-BAX monocysteine mutants revealed that inactive BAX 
does not breach the membrane permeability barrier and peripherally interacts with CL-containing 
liposomes. Nevertheless, this peripheral membrane interaction induces localized structural 
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changes in BAX through a previously unidentified surface of the molecule, most prominently 
including C-terminal BAX α7-α9 helices and flanking regions. Those model membrane studies 
also detected exposure of N-terminal residues of BAX, akin to the conformational changes 
observed during early stages of the BAX activation process. Interestingly, functional regions 
potentially implicated in BAX intramembranous oligomerization (BH3 domain, canonical BH3-
binding groove, and α6 helix), or membrane perforation (central α5 helix) remained basically 
unaltered upon BAX membrane association. 
As a continuation of those studies, here we used the same set of monocysteine BAX mutants and 
SCAM (Single Cysteine Accesibility Methodology) to assess conformation of BAX in MOM-
like model membranes and in isolated BAX-/-/BAK-/- DKO mitochondria. Of note, our SCAM 
analysis enables the study of membrane BAX structural details in a label-free environment, 
avoiding possible NBD induced artifacts or aberrations. In this structural characterization 
protocol, it was analysed the cysteine accessibility to PEG-Mal5kDa, a 5kDa molecule that binds 
both specifically and irreversibly to exposed cysteines adding to the bounded molecule an extra 
weight. This modification is detected as a shift in the BAX band by SDS-PAGE, combined with 
coomassie blue staining for the studies in liposomes or an anti-BAX western blotting when we 
analyse the topology in the mitochondria. The effects exerted by membrane binding/insertion on 
the set of 27 monocysteine BAX mutants is shown in Figure 3.10 and summarized in Figure 3.11. 
Moreover, Figure 3.10 also includes the structural location and the theoretical exposure of each 
individual residue. 
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Figure 3.10 SCAM analysis of BAX conformation in different environments. (A-H) Right, Structural 
model generated in PyMol depicting individual amino acid residues along BAX structure substituted by 
cysteines (PDB=1F16). Top-left: SCAM analysis of BAX with or without Mito-like LUVs; Bottom-left, 
SCAM analysis of BAX with or without isolated mitochondria. 
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Figure 3.11 Quantitative SCAM analysis of BAX conformations. The ratio between label/non-label 
BAX monocysteine mutants in the presence (grey bars) absence (black bars) of model membranes. (n=3, 
S.D.). *, ** and ***: p= <0.001, <0.025 and <0.05 respectively. 
 
As shown in Figures 3.10 and 3.11, the exposure pattern obtained for BAX in solution is basically 
consistent with BAX solution NMR structure. However, SCAM analyses indicated that upon 
interaction with MOM-like LUVs of isolated mitochondria BAX undergoes localized 
conformational changes that are basically consistent with previous results generated in our lab 
using NBD-BAX mutants and fluorescence spectroscopy, where BAX interacts with the 
membrane via its C-terminal α7-α9 helixes and flanking regions. Moreover, specific residues 
surrounding the canonical groove that have been implicated in BAX dimerization and 
retrotranslocation. Concretely, canonical C62 (in the α2/BH3 domain) and R89 (in α4) experiment 
a decrease in the exposure in Mito-like LUVs and in isolated mitochondria. One possible 
interpretation of SCAM results is that the MOM lipid bilayer contributes to release BAX α9 from 
the canonical groove (Figure 3.12). It is also compatible with the view that interaction with the 
MOM facilitates BAX dimerization by increasing the accessibility of BAX BH3 domain and BAX 
canonical groove. 
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Figure 3.12. Schematic representation of BAX topology according to SCAM results (A) in solution 
and (B) in Mito-like and MOM. CL= Cardiolipin PL: Phospholipid. 
 
Complementarily, BAX membrane topology was analysed in membranes lacking mitochondrial 
specific lipid CL. In coherence with previous studies in our lab, BAX maintains its solution 
folding in the presence of this specific membranes (Figure 3.13). Thus, mitochondrial membrane 
lipids, specially the CL, could modulate BCL2 proteins membrane topology, and possibly their 
interaction network. 
 
Figure 3.13 Analysis of BAX interaction with CL-lacking LUV assessed by SCAM. The ratio between 
label/non-label BAX monocysteine mutants in the presence (grey bars) absence (black bars) of model 
membranes. 
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Altogether. this set of results, combined with the findings that BAX bound to CL-containing 
liposomes or MOM remains monomeric, does not breach the membrane permeability barrier, 
leads us to propose that the membrane-associated form of BAX described in this study represents 
an early conformational state of the protein along the pathway of its functional activation. We 
name this configuration the “lipid-primed” conformation of BAX. 
 
3.5 DISCUSSION 
How BCL2 family proteins modulate apoptosis through MOM permeability changes has been 
intensively studied during the last two decades (Basanez et al, 2012; Cosentino & Garcia-Saez, 
2017; Czabotar et al, 2014; Czabotar et al, 2013; Youle & Strasser, 2008). However, a 
comprehensive view of this fundamental process regulating cell fate is still lacking. In this 
chapter, using a variety of biophysical and biochemical techniques applied to minimalist in vitro 
reconstituted systems, it is provided new insight into how BAX and BCLXL regulate the 
formation of mitochondrial apoptotic pores through specific protein:protein and protein:lipid 
interactions.  
This work adds significantly to a growing number of studies indicating that the BAX BH3-into-
groove dimerization process plays a fundamental role in BAX-elicited apoptotic pore formation 
(Bleicken et al, 2014; Czabotar et al, 2013; Sung et al, 2015; Zhang et al, 2016). Not only it is 
shown that the BAX BH3-in-groove dimeric conformation persists in the fully active 
conformation of BAX rather than merely being and intermediate in the molecular pathway for 
BAX activation (Figure 3.2-3.4); this site-specific BAX PEGylation analyses also revealed that 
PEGylation of multiple individual BAX core residues implicated in BAX BH3-in-groove 
dimerization effectively block the BAX pore-forming activity (Figure 3.6). By contrast, these 
studies do not support the so-called BAXα2α3α4 dimeric structure for fully active BAX, although 
it cannot be discarded that BAX may transiently adopt this alternative dimeric structure at early 
stages of its functional activation pathway (Zhang et al, 2016). Concerning high-order BAX 
multimers, our site-directed fluorescence BAX mapping and PEGylation studies are consistent 
with the view that BAX BH3-in-groove dimers can grow into higher-order BAX multimeric 
species with optimal membrane-permeabilizing activity through multiple BAX interdimer 
interfaces (Aluvila et al, 2014; Bleicken et al, 2014; Dewson & Kluck, 2009; Dewson et al, 2012; 
Mandal et al, 2016; Sung et al, 2015; Zhang et al, 2016). In this scenario, the lower stability of 
such BAX interdimer interfaces would preclude their detection by the steady-state fluorescence 
analyses used here, while PEGylation of a single BAX interdimer interface would not be sufficient 
to efficiently block BAX multimerization and pore formation. 
Another ongoing debate in the BCL2 research field pertains to the precise mechanisms through 
which antiapoptotic BCL2-type proteins inhibit BAX activation and action (Czabotar et al, 2014; 
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Landeta et al, 2014; Llambi et al, 2011; Moldoveanu et al, 2014; Shamas-Din et al, 2013). 
According to canonical models, antiapoptotic proteins neutralize proapoptotic partners via 
heterodimeric BH3-in-groove complexes that in principle, should be formed before BAX BH3-
in-groove homodimers had been assembled. On the other hand, non-canonical models postulate 
that antiapoptotic proteins can use binding interfaces other than their canonical groove to form 
inactive complexes with BAX-type proteins, conceptually even after the building-up of BAX 
BH3-in-groove homodimers had occurred. In this regard, our combined results showing the 
differential effects exerted by the sequential addition of BCLXL on BAX topology, the inhibition 
of BAX α5 membrane insertion by BCLXL, as well as the opposite effects of canonical and non-
canonical BCLXLΔC mutants on BAX membrane activities (Figure 3.5), support the notion that 
BCLXL principally acts by sequestering the BAX BH3 domain into its canonical groove thereby 
blocking BAX BH3-in-groove homodimerization. Nevertheless, these results do not exclude that 
the recently described non-canonical BCLXL α9:BAX α9 surface contributes to form neutralizing 
BCLXL:BAX complexes (Andreu-Fernandez et al, 2017).  
Another important finding is that BAX apoptotic pore formation is driven by lipid interactions 
established by BAX α4-α5 helices, but not BAX α6-α8 helices, despite both the core and latch 
domains of BAX associate with the membrane lipid bilayer when the protein acquires its active 
conformation. Empirical and computational data indicate that the primary origin of this dissimilar 
behavior of BAX core and latch helices is their differential membrane penetration degrees: BAX 
α4-α5 localize to the upper region of the hydrocarbon core of the lipid bilayer, whereas BAX α6-
α8 localize to a more superficial region of the membrane interface. This is in line with current 
knowledge on the membrane penetration-depth of pore-forming helical peptides such as melittin, 
which in that way produce the optimal surface tension and curvature stress within the membrane 
required to destabilize its lipid bilayer structure and open a proteolipidic pore therein (Kozlov et 
al, 2014; Lee et al, 2013; Zemel et al, 2008). It appears reasonable to propose that other specific 
features of the BAX BH3-in-groove structure, such as its dimeric and curved nature, may also 
contribute to BAX-mediated destabilization of the membrane lipid bilayer structure. The finding 
that BCLXL selectively inhibits membrane insertion of BAX α4-α5 helices, but not BAX α6-α8 
helices, further supports that interaction of the BAX core domain with membrane lipids drives 
BAX apoptotic pore formation, while the BAX latch domain merely plays a passive role in this 
process.  
These results prompt to reconsider certain assumptions made in recent models proposed to explain 
proteolipidic pore formation by BAX-type proteins. Specifically, in the so-called “clamp model” 
the insertion of the BAX latch α6-α8 region into the MOM lipid bilayer was considered a key 
determinant for BAX proteolipidic pore formation (Bleicken et al, 2014). However, in that study 
the degree of membrane insertion of BAX α6-α8 helices and the contribution of the BAX latch 
region to BAX pore-forming activity were not explicitly examined.  Similarly, the so-called “in-
plane” model postulated that shallow membrane insertion of multiple BAX helices, including 
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those of the latch domain, drives BAX proteolipidic pore formation (Westphal et al, 2014a). 
However, in the latter study, the topological analyses of the BAX latch domain were limited to 
the BAX α6 helix, and BAX α6 membrane topology was assessed using a biochemical technique 
with lower spatial resolution than the one used here. Nevertheless, our results are not necessarily 
incompatible with the proposal of the “in-plane” model stating that the BAX latch domain plays 
an active role in BAX apoptotic pore expansion by sliding into the lumen of a nascent BAX 
proteolipidic pore in such a manner that decreases its line tension (Westphal et al, 2014a). The 
intrinsic curvature of the dimeric BAX core domain may also contribute to enrichment of BAX 
molecules at the pore edge (Kuwana et al, 2016), thereby reducing pore line tension as proposed 
in the “clamp” model (Bleicken et al, 2014; Subburaj et al, 2015).  
Finally, it was further characterized the inactive monomeric BAX membrane conformation, in 
both model membranes and in isolated mitochondria. This “lipid-primed” conformation of BAX 
displays some similarities, but also notable differences, with available high-resolution structures 
of BAX in lipid-free environments, which have been linked to early stages of the BAX activation 
process (Czabotar et al, 2013; Walensky & Gavathiotis, 2011) (Figures 3.10-3.12 and 1.7 
respectively).  
The most noticeable similarity is the “unlatching” of BAX C-terminal helices revealed by X-Ray 
crystal structures of domain-swapped BAX dimers (Czabotar et al, 2013). As regards to the 
“unlatched” BAX structure described by Czabotar et al., considering the diminishment of 
PEG5kDa exposure are much more prominent in multiple residues localized within or at the 
vicinity of BAX α7α8α9, together with the fact that α8 is a short amphipatic helix preceded by 
two glycines with potential for high conformational flexibility, it appears reasonable to propose 
that upon membrane binding at least the entire BAXα8 is detached from the core of the molecule 
and translocates to the membrane surface. In support of this possibility, according to previous 
studies of our lab (Dr Ane Landajuela´s thesis) with NBD-BAX and doxylated lipid, the F165 
residue which is originally oriented towards the protein interior in soluble BAX, penetrates into 
the bilayer interior in the lipid-primed conformation of BAX. 
On the other hand, based on the modest or negligible changes observed for residues 133 and 138 
when BAX binds to membranes, it appears much less likely that BAXα6 is detached from the 
core of the molecule in the “lipid-primed” conformation of BAX. This is contrasting to the 
“unlatched” BAX structure found in membrane-free environments, where the three helices α6, α7 
and α8 are completely dislodged from the rest of the molecule (Czabotar et al, 2013). Finally, the 
“lipid-primed” BAX conformation described here is clearly incompatible with the “BH3-in-
groove” symmetric BAX dimer structure reported by Czabotar et al., since several residues 
directly implicated in BAX dimerization (T56 and R94) according to this X-ray structure do not 
undergo significant changes. Moreover, SCAM analysis suggest that in the “lipid-primed” 
conformation (i) the overall integrity of BAX canonical BH3-binding groove is retained, and (ii) 
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the orientation of the BAX molecule with respect to the membrane is optimal for allowing 
insertion of proapoptotic BH3 domains into BAX canonical groove.  
In conclusion, this study provides novel structural and mechanistic information on structural 
details of BAX membrane topology and how BCLXL and lipids modulate the topology and the 
formation of lethal mitochondrial pores. These experimental approaches that can precisely 
monitor the structure and function of specific regions of BAX at the membrane level which may 
impact on the development of therapeutics that target this protein, and could potentially be used 
with other BCL2 family members as well. 
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4 BFL1 modulates apoptosis at the membrane level 
through a bifunctional and multimodal mechanism  
 
 
4.1 ABSTRACT 
BFL1 is a poorly understood apoptosis-regulatory BCL2 family protein that acts at the 
mitochondrial outer membrane (MOM) level through a complex protein:protein and protein:lipid 
interaction network. In this chapter, was carried out a comprehensive analysis on the mode of 
BFL1 action based on quantitative studies performed in both cellular and minimalist model 
systems, and taking into account the role of the MOM environment. On the one hand, it is shown 
that in membranes with nonapoptotic lipid compositions BFL1 displays three distinct 
antiapoptotic modes, all of which are based on canonical heterodimerizing interactions between 
BFL1 and its proapoptotic BCL2 family binding partners. On the other hand, these studies 
revealed that apoptotic-like membranes obstruct the three antiapoptotic activities of BFL1 and 
unleash a prodeath activity that is based on noncanonical homooligomerization and pore 
formation of the protein. Moreover, they were also identified mechanistic similarities and 
dissimilarities between BFL1 and BCLXL, the paradigmatic antiapoptotic BCL2 family protein.  
Based on these findings can be proposed that BFL1 modulates apoptosis through a bifunctional 
and multimodal mechanism of action that is susceptible to regulation by the MOM lipid 
composition.   
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4.2 INTRODUCTION 
Apoptotic programmed cell death plays an essential role in many human cell physiological 
processes and pathologies. During apoptosis, cellular stress signals converge in the mitochondria 
to induce mitochondrial outer membrane permeabilization (MOMP) (Czabotar et al, 2014). 
MOMP typically represents the point of no return in the mitochondrial apoptotic pathway and it 
is mainly regulated by BCL2 family proteins. Members of this protein family are typically divided 
in three groups based on their general impact in cell viability and the presence of up to four 
conserved BCL2 homology (BH) motifs: (i) BCL2-type apoptosis repressors, which contain all 
four BH motifs and primarily function by inhibiting MOMP (BCL2, BCLXL, BFL1, and others); 
(ii) BAX-type apoptosis effectors, which contain BH1-BH3 motifs and directly elicit the MOMP 
once they are activated (BAX, BAK and perhaps BOK); and (iii) BH3-only apoptosis activators  
(BID, BIM, NOXA, and others), which instigate the function of BAX-type effectors (Chen et al, 
2005; Letai et al, 2002). Despite the relevance of the above classification, many unanswered 
questions exist concerning the molecular mechanisms by which BCL2 family proteins exert their 
biological function. Chief among them is to elucidate the exact pattern of interactions comprising 
the BCL2 interactome and their precise structural nature (Basanez et al, 2012; Czabotar et al, 
2014; Delbridge et al, 2016)(Basanez et al, 2012; Czabotar et al, 2014; Delbridge et al, 
2016)(Basanez et al, 2012; Czabotar et al, 2014; Delbridge et al, 2016)(Basanez et al, 2012; 
Czabotar et al, 2014; Delbridge et al, 2016)(Basanez et al, 2012; Czabotar et al, 2014; Delbridge 
et al, 2016)(Basanez et al, 2012; Czabotar et al, 2014; Delbridge et al, 2016)(Basanez et al, 2012; 
Czabotar et al, 2014; Delbridge et al, 2016)(Basanez et al, 2012; Czabotar et al, 2014; Delbridge 
et al, 2016)(Basanez et al, 2012; Czabotar et al, 2014; Delbridge et al, 2016)(Basanez et al, 2012; 
Czabotar et al, 2014; Delbridge et al, 2016)(Basanez et al, 2012; Czabotar et al, 2014; Delbridge 
et al, 2016), particularly taking into account the mitochondrial outer membrane (MOM) 
environment. This is important in view of the high complexity and diversity of protein:protein 
interactions involving BCL2 family members, and also considering that during apoptosis most, if 
not all, BCL2 family proteins are targeted to the MOM via a C-terminal Tail-Anchor (TA) motif 
(Lindsay et al, 2011). 
From a structural viewpoint, it is remarkable that despite their opposing biological functions, 
antiapoptotic and proapoptotic multidomain BCL2 family members share the same globular 
folding solution, characterized by eight amphipatic helices surrounding a central hydrophobic 
helix (Muchmore et al, 1996; Suzuki et al, 2000). Moreover, all multidomain BCL2 family 
proteins display an elongated hydrophobic groove mostly comprising BH1 and BH2 motifs that 
serves as a receptor-site for binding BH3 motifs of ligand partners. Solution-based structural and 
biochemical studies revealed that this canonical BH3:groove interaction mechanism relies in 
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engagement of several hydrophobic residues of the BH3 ligand into corresponding hydrophobic 
binding pockets on the receptor groove, together with formation of a salt bridge between strictly 
conserved Asp and Arg residues at the BH3 ligand and BH1 receptor sites, respectively (Czabotar 
et al, 2013; Moldoveanu et al, 2013). However, since the canonical BH3:groove interface has 
been principally characterized in membrane-free environments, it may not represent the main or 
exclusive protein:protein interaction surface through which BCL2 family proteins modulate the 
apoptotic process once they are localized in the MOM. Consistent with this notion, in recent years 
an increasing number of non-canonical interaction surfaces have been identified in a variety of 
BCL2 family proteins (Andreu-Fernandez et al, 2017; Barclay et al, 2015; Gavathiotis et al, 
2008). Two prominent examples are the BH4 and TA motifs of BCL2 and BCLXL which can 
mediate heterodimeric interactions with BAX implicated in apoptosis repression. However, it 
remains to be clarified whether non-canonical interactions universally contribute to apoptosis 
inhibition by BCL2-type proteins.  
In fact, despite intense research effort, a consensus view is still missing on how BCL2-type 
proteins inhibit apoptosis via protein:protein interactions. Early models proposed that BCL2 and 
its close homologues repress apoptosis by forming stable neutralizing heterodimers either with 
proapoptotic BAX-type effectors (direct model), or with BH3-only activators (indirect 
model)(Korsmeyer et al, 1993). Subsequent models shifted towards a bimodal interaction mode 
of action where antiapoptotic proteins stably sequester the two classes of proapoptotic molecules, 
rather than only one of them (Chen et al, 2015; Leber et al, 2007; Llambi et al, 2011). At the same 
time, these bimodal models differed regarding specific features of the BCL2 interaction network.  
For example, the embedded-together model emphasized that the MOM environment is critical to 
expose otherwise hidden non-canonical surfaces in BCL2-type repressors that are generally 
required for their interaction with and neutralization of BAX-type effectors and BH3-only 
activators. The unified model ascribed less prominent roles to the MOM and to non-canonical 
interactions in the BCL2 interactome, and further proposed that BCL2-type repressors invariably 
bind BAX-type effectors strongly than BH3-only activators. The interconnected hierarchical 
model gave no particular importance to the MOM and to non-canonical interactions, and 
postulated that in the course of the apoptotic process, repressors always sequester activators 
before and with higher affinity than effectors. In addition, recent studies uncovered a distinct 
antiapoptotic mode of action for BCLXL which is not appropriately integrated in any of the 
bimodal interaction models described above(Edlich et al, 2011b; Schellenberg et al, 2013; Todt 
et al, 2015; Todt et al, 2013). Here, even under nonapoptotic conditions, BCLXL keeps BAX 
inactive using a retrotranslocation activity mediated through canonical and non-canonical 
BCLXL:BAX interactions of transient nature. Importantly, it remains to be clarified whether or 
not the BAX retrotranslocation activity recently discovered for BCLXL constitutes a general 
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antiapoptotic mode of action for all BCL2-type proteins. On top of this, another long-standing 
and often overlooked issue in the BCL2 research field is the capacity of every antiapoptotic 
protein examined to date to promote –rather than inhibit- apoptosis under defined conditions, 
although the exact mechanisms and molecular interactions underlying the proapoptotic functions 
of BCL2-type proteins are incompletely understood (Basanez et al, 2012; Basanez et al, 2001; 
Cheng et al, 1997). 
BFL1 is one of the least extensively studied BCL2-type proteins. It is accepted that BFL1 plays 
a key role in preventing apoptosis under specific physiological settings and that BFL1 represents 
a promising target for therapeutic intervention against selected types of human cancer, akin to 
BCL2 and BCLXL. In fact, BFL1 is a recognized contributing factor for chemoresistance to 
diverse anticancer agents, including navitoclax recently approved by the FDA. However, the 
molecular mode of action of BFL1 is much less well understood than those of BCL2 and BCLXL. 
In this chapter, a thorough analysis of the mechanism of BFL1 action at the molecular level is 
performed, using a multidisciplinary analysis based on quantitative biophysical techniques 
applied to cellular and minimalist model systems, and paying special attention to the potential 
role of the membrane environment in the pattern and nature of BFL1 protein:protein interactions.   
These studies revealed that BFL1 displays three distinct antiapoptotic modes in the presence of a 
membrane environment, all of which are exclusively elicited through canonical heterodimerizing 
interactions between BFL1 and its proapoptotic partners. Additionally, it is described a novel 
proapoptotic mode of action of BFL1 unleashed by the mitochondrial lipid cardiolipin (CL) and 
mediated by non-canonical homooligomerization and membrane poration activities of the protein. 
Here, common and distinguishing features between the molecular mechanisms of action of BFL1 
and BCLXL were also identified. Based on these collective findings, it is proposed a new 
bifunctional and multimodal model for apoptosis regulation by BCL2-type proteins.  
 
4.3 MATERIALS AND METHODS 
In this section materials and methods required in this chapter are detailed briefly, a more extended 
explanation and specific information is described in the second chapter: general materials and 
methods. 
Chemicals and reagents.  
Phosphatidylcholine (PC), Phospatidylethanolamine (PE), Phosphatidylinositol (PI), 18:1 DGS-
NTA (Ni) and Heart-Cardiolipin (CL) were from Avanti Polar Lipids (Alabaster, AL, USA). DiD, 
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DIO and Hoechst 33342 (Invitrogen). Alexa Fluor 488 C5 Maleimide and Alexa Fluor 647 C2 
Maleimide were from (Thermofisher). 1, 3, 6, aminonaphtalene-tri-sulfonate (ANTS) and p-
xilene-bis-dipicolyinicacis (DPX) were purchased from Molecular Probes (Eugene, OR, USA). 
All other reagents were from Sigma (St. Louis, MO, USA). 
Retrotranslocation assays: FLIP measurements and plasmids. 
FLIP experiments were done based on (Edlich et al, 2011a) and as explained in the general 
materials and methods chapter. First, BAX/BAK DKO HCT116 cells were seeded on 1µ-Slide 8 
Well ibitreat (ibidi) in McCoy’s 5A medium, grown for 20 hr, transfected, and incubated for 6h-
16h at 37oC with 5% CO2. Confocal analysis was performed on a Zeiss confocal LSM710 
microscope equipped with 63X oil objective and laserlines to excitate at 488, 561 or 633. For 
GFP-BAX translocation assay, the cells were incubated with mitotracker-far red for 30 min prior 
to analysis. Then, we substituted the media for McCoy’s 5A medium with 10mM HEPES and 
without phenol red and incubated 30 min at 37oC with 5% CO2. Then, a single spot with a diameter 
of 1,3 µm within the nucleus was repeatedly bleached with two iterations of 100% power of a 488 
nm laser line (100% output). The diameter of a single ROI was 0,52µm. Two images were 
collected after each bleach pulse, with 30 s between bleach pulses. After collecting 60 images, 
two separate measurements on the mitochondria were taken to analyse the fluorescence loss. 
Unbleached control cells were monitored for photobleaching due to image acquisition. The rate 
of loss in fluorescence on the mitochondria was calculated from fluorescence intensity 
measurements using the Zeiss LSM software. The fluorescence intensities were normalized by 
setting the initial fluorescence to 100% signal. Plots are shown as normalized fluorescence over 
time. GFP-BFL1 plasmid was generated by PCR-based sequence amplification and posterior 
insertion in pEGFP-C3 (from EGFP-BAK, a generous gift from Richard Youle (Addgene plasmid 
# 32564), whereas plasmids of non-labelled BAX and cBID were inserted in pCi-neo-myc 
vectors. Furthermore, GFP‐BAX WT and GFP‐BAX‐1‐2/L‐6 plasmids were provided thankfully 
by N. Brady and F. Edlich, respectively. Finally, we thank Dr. Frank Essmann and Prof. Klaus 
Schulze‐Osthoff for providing the Bax-/-/Bak-/- DKO HCT116 cells. 
Purification and labelling of recombinant BCL2 family proteins.  
Mutant DNAs were generated by PCR-based mutagenesis using the Quickchange mutagenesis 
kit (Stratagene, San Diego, CA, USA), purchased at Addgene and GenTech (Montreal, Canada). 
All constructs were verified by sequencing. Full-length human BAX and cBID and their variants 
BAX C62S, C126S, E6C, cBID C30S and BFL1∆C and its variants for fluorescent labelling were 
purified as described in the general material and method chapter and in (Bleicken et al, 2013a; 
Landeta et al, 2015; Landeta et al, 2011). cBID and BCLXLΔC (BCLXL lacking the C-terminal 
24 aminoacids) were expressed and purified as described earlier in the general materials and 
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methods chapter and (Terrones et al, 2004; Terrones et al, 2008). All protein preparations were 
>95% pure as assessed by SDS-PAGE and Coomassie staining. In a typical protein labelling 
reaction, AlexaFluor488/AlexaFluor647 dissolved in DMSO were added to a 1 ml sample containing 
25µM of BCL2 protein at a labelling reagent/BCL2 protein molar ratio of 10:1, samples were 
incubated overnight at 4 ºC, and subsequently eluted over a PD-10 column pre-equilibrated with  
100 mM KCl, 10 mM Hepes, pH 7.4 1 mM EDTA (KHE buffer). 
Circular dichroism.  
The CD spectra were collected using the following parameters a 1-nm step size over 260 to 200nm 
wavelength range, speed 50nm/min; response 1s; bandwidth 2nm in a spectropolarimeter Jasco 
J-810 (Jasco Spectroscopic Co. Ltd., Hachioji City, Japan) equipped with a JASCO PTC-423S 
temperature control unit. Each measurement was the average of 20 scans, which was background- 
subtracted. All samples were allowed to equilibrate for 10min prior to CD analysis. Secondary 
structure content was estimated from the far-UV spectra using CDPro software 
(http://lamar.colostate.edu/-sreeram/CDPro/main.html) (Sreerama & Woody, 2004a; 
Sreerama & Woody, 2004b). To assess the thermal stability of the BCL2 proteins studied, CD 
data was collected at 222nm wavelength every 1°C from 25°C to 90°C. The midpoint of the 
melting transition was estimated using the first derivative converter available in the software of 
the CD instrument with a window of nine data points and a 2nd degree polynomial smoothing. 
Protein concentration in all case was 3µM in PBS buffer. 
TIRF experiments. Supported lipid bilayers formation and data acquisition.  
LUVs were incubated with 0.5nM of BFL1∆Cg, BFL1∆Cg L21A and BFL1∆Cg R88D to be in 
the single-molecule regime, for 1h at room temperature. After the indicated incubation time, 
BFL1∆Cg-containing proteoliposomes were used to create SLBs on piranha-cleaned glass slides 
(0.13–0.16-mm thickness, Menzel) (for details see (Subburaj et al, 2015)) without any lipid 
dilution and the SLBs were immediately imaged. SLB were analysed using a modified Zeiss 
Axiovert 200M epifluorescence microscope using a 488 laser (Ichrome MLE-LFA multi laser, 
Toptica) equipped with a α Plan-Fluor 100x/1.46 oil objective (Zeiss), a Laser-TIRF 3 Imaging 
System (Zeiss) and a EM-CCD camera (iXon 897, Andor). Samples were illuminated for 35 ms 
with a delay time between frames of 25 ms (number of frames 1000) with an intensity of ~ 0.1 
kW/cm2.  
Stoichiometry analysis. The images acquired were used for the stoichiometry analysis based on 
the fluorescence intensity of the particles using an in-house algorithms implemented in Python 
(Python Software Foundation, https://www.python.org/). Bright spots were automatically 
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detected using an implementation of the Difference of Gaussians method (http://scikit-
image.org/docs/dev/api/skimage.feature.html) and thresholding. Selected particles were defined 
by a region of interest (ROI) of a defined pixel size (2x2) and fitted to two-dimensional (2D) 
Gaussians. Background subtraction was performed by defining a ROI around the particle´s ROI 
having a larger pixel size (3x3). Localized particles were discarded based on the distance and on 
the width of the 2D Gaussian, to avoid overlapping ROIs or multiple particles in the same ROI. 
This algorithm provided the brightness value for each spot. Stoichiometry counting was 
performed using the brightness analysis method as previously described (Subburaj et al, 2015). 
Briefly, the obtained brightness values were plotted as a probability density function or as a 
Gaussian distribution. Monomeric BFL1∆Cg particles were obtained by spreading BFL1∆Cg 
particles directly on a cleaned glass coverslip and selected by photobleaching analysis (Ulbrich 
& Isacoff, 2007) after smoothing of the signal with a median filter. For this purpose, individual 
particles with a single photobleaching step were detected via a threshold and their fluorescence 
intensity was estimated by fitting with a Gaussian. By convolution, the monomer brightness 
distribution was used to calculate the brightness distributions for higher oligomers. Finally, the 
overall brightness distribution was fitted by a linear combination of the N-mer contributions. The 
area under each curve was used to calculate the percentage of occurrence of each species, which 
was further corrected by taking into account that not all BFL1∆Cg molecules in a particle are 
labelled due to partial labelling. Correction for partial labelling efficiency was performed as 
previously described (Subburaj et al, 2015). Only proteins having > 60% labelling efficiency were 
considered for experiments and data collection. The graphs with the distribution of species 
correspond to the average values obtained from the different experiments, and the error bars 
correspond to the averaged errors in the individual experiments, as they were larger than the S.D. 
GUV preparation.  
GUV-type vesicles were prepared as described previously in the general materials and methods 
chapter and in (Bleicken et al, 2013a). Briefly, around 4 µl of the lipid mixture stock (1 mM) in 
chloroform was spread on the platinum wires of the electroformation chamber. After solvent 
evaporation, the wires were immersed in 200 mM sucrose buffer, and electric pulses of 10 Hz 
were provided for 2 h, followed by 2-Hz pulses for 30 min. Due to lower GUV stability relative 
to LUV/SUV-type liposomes, we used GUV with the following lipid compositions: 
PC60/PE30/PI10/CL0 (0% CL), PC35/PE30/PI10/CL25 (mol/mol) (25%CL), and CL (100% 
CL).  
GUV permeabilization and size determination experiments.  
BCL2 family proteins and Rho-4-kDa dextran/APC were mixed in LabTec chambers (NUNC) 
with 1,2-diphytanoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)-
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labelled GUV to a final volume of 400 µl (KHE buffer). After 2 h of incubation at room 
temperature, images   collected with a confocal fluorescence microscope (see microscope 
specifications below). The percentage of fluorescent probes internalization to the lumen of GUV 
was measured with ImageJ software as described previously (Bleicken et al, 2013a; Landeta et 
al, 2015) .Size determination was performed manually by using the measurement tool in the 
ImageJ. 
GUV Confocal Microscopy Analysis.  
Microscopy observations of protein recruitment to GUV, FCCS and two-focus SFCCS 
measurements in GUV were prepared as described previously (Landeta et al, 2015). In brief, for 
the observation of protein binding to GUV membrane fluorescently labelled proteins and 
liposomes were incubated together for 2 h at 22/37/43 °C. Fluorescence images were processed 
with ImageJ software using the plug-in “Radial profile,” where the protein bound to the GUV 
membrane was normalized to the values obtained in solution. FCCS measurements were 
performed at 22 °C using a ConfoCor3 module with attenuated excitation light from argon ion 
(488 nm) and helium-neon lasers (633 nm). Proteins were incubated in the observation chamber 
for 20 min before carrying out FCCS measurements.  
To obtain auto- and cross-correlation curves, raw fluorescence fluctuation data were fitted to a 
three-dimensional diffusion model with homemade software. For two-focus SFCCS 
measurements in GUV, the measurement time was 300 s, and the bin time was 2 µs. The 
autocorrelation and spectral and spatial cross-correlation curves were computed from the intensity 
traces, and irregular curves resulting from instability and distortion were excluded from the 
analysis. We fitted the auto- and cross-correlation functions with a nonlinear least-squares global 
fitting algorithm (2Dimensions 2Focus 2Color). As a result of the analysis of FCCS data, surface 
concentrations of single colour particles (Cr and Cg) and two-colour particles (CCrg) as well as 
their diffusion coefficients were determined. FCCS results were also corrected for fluorescence 
cross-talk and for protein labelling degrees (BFL1ΔCg WT, L21A and R88D 70-73-68% 
respectively, BFL1ΔCr 65-70-70% respectively, BAXr 60% and cBIDr 60%). Complex % values 
were calculated with respect to the amount of the green particles (CCrg X 100/Cg), being the 
percentage value between CCrg two-colour particles (the green and red complexed molecules) 
and the total green particles (the free and the complexed ones). The theoretical maximum of the 
%CC was calculated relative to the labelling efficiencies as described in (Bleicken et al, 2017; 
Ries et al, 2010). 
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Liposome preparation.  
MOM-like lipid mixtures were co-dissolved in chloroform/methanol (2:1), and organic solvents 
were removed by incubation under vacuum for 2h. Dry lipid films were resuspended in 100 mM 
KCl, 10 mM Hepes, pH 7.4 1 mM EDTA (KHE buffer), except in experiments were 20 mM KCl, 
10 mM Hepes pH 7.0, 1 mM EDTA, 12.5 mM ANTS and 45 mM DPX was used. Liposomes 
were then subjected to 10 freeze/thaw cycles, and subsequently extruded 10 times through two 
polycarbonate membranes of 0.2-µm pore size (Nucleopore, San Diego, CA) to obtain large 
unilamellar vesicles (LUVs).  
Lipid peroxidation assay.  
LUV of PC/PE/PI and PC/PE/PI/CL (3mM lipid mixture in EDTA-free ANTS/DPX buffer) were 
incubated at 37ºC after addition of CuCl2 (20µM) at zero time. Copper-induced oxidation was 
monitored at 245nm according to (Klein, 1970; Pinchuk et al, 1998; Schnitzer et al, 1998; 
Schnitzer et al, 2007) in a Uvikon 922 spectrophotometer (Kontron instruments, Groβ-Zimmen, 
Germany), using quartz cuvettes with absolute ethanol in reference cell. 
Steady-state fluorescence spectroscopy.  
Fluorescence intensity and spectral analyses were done in an 8100 Aminco-Bowman 
luminescence spectrometer (Spectronic Instruments, Rochester, NY), in thermostatically 
controlled 4x4-mm quartz cuvettes, at 25 °C. Trp spectra were recorded between 305 nm and 405 
nm at a scan rate of 1 nm/s, using an excitation wavelength of 295 nm (slits 4 nm). Release of 
LUV-encapsulated ANTS/DPX was monitored with λex=350 nm, and λem=520 nm (slits, 8 nm). 
The extent of marker release was quantified on a percentage basis, 10 min after cBID addition, 
according to the equation: (Ft-F0/F100-F0) x100, where Ft is the measured fluorescence of protein-
treated LUVs at time t, F0 is the initial fluorescence of the LUV suspension before protein 
addition, and F100 is the fluorescence value after complete disruption of LUVs by addition of 
C12E8 detergent (0.5 mM). Unless otherwise stated, BAX, cBID, BFL1, concentrations were 150 
nM. Lipid concentration was 150 µM.  
Size exclusion chromatography.  
BCL2 proteins (5µM) were incubated at 37ºC for 1h under continuous stirring in solution and in 
the presence pure CL LUV (500µM lipid in KHE). Then, liposomes were solubilized with 3% 
CHAPS final concentration for 30min at RT, and loaded in a pre-equilibrated (buffer B with 3% 
CHAPS) Superdex75. 
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Cyt c release assay in isolated mitochondria.  
BAX-/-/BAK-/-DKO human colon tumour (HCT) 116 cells were harvested by scrapping, and 
homogenized with a glass-Teflon Potter-Elvehjem homogenizer in mitochondrial isolation buffer 
(210 mM mannitol, 70 mM sucrose, 10 mM Hepes (pH 7.5), 1 mM EDTA, and protease 
inhibitors). After removing heavy membrane fractions by two consecutive centrifugations at 700 
g for 10 min at 4 oC, mitochondria-enriched fractions were pelleted by centrifuging the resultant 
supernatant at 14000 g for 10 min at 4 oC. Mitochondria (50 µg total protein) were incubated with 
recombinant BAX (100 nM) with or without cBID (10 nM) in release buffer (125 mM KCl, 5 
mM KH2PO4, 2 mM MgCl2, 1 mM DTT, and 10 mM HEPES-KOH, pH 7,4), for 30 min at 30 oC. 
Samples were then centrifuged at 14000 g for 10 min, and supernatant and pellet fractions were 
subjected to SDS-PAGE and immunoblotting analysis using anti-cyt c 7H8.2C-12 (BD-
Biosciences, San Jose, CA, USA) 
Cyt c release assay in semi-intact cells.  
Transfected BAX/BAK DKO HCT116 cells (106) were harvested by scrapping and resuspended 
in permeabilization buffer consisting of 120 mM KCl, 10 mM NaCl, 1 mM KH2PO4, 20mM 
HEPES-Tris (pH 7.4) supplemented with 0.025% w/v digitonin. Then, digitonized cells were 
were pelleted by centrifuging the resultant supernatant at 14000 g for 10 min at 4 oC.  Semi intact 
cells were incubated with recombinant BAX variants (100 nM) with or without cBID (50 nM) in 
release buffer for 30 min at 30 oC. Samples were then centrifuged at 14000 g for 10 min, and 
supernatant and pellet fractions were subjected to SDS-PAGE and immunoblotting analysis using 
anti-cyt c 7H8.2C-12 (BD-Biosciences, San Jose, CA, USA), and anti-GFP ChIP grade ab290. 
GFP-BCL2 proteins localization, cyt c release by immunoblotting and nucleus morphology 
analysis.  
BAX-/-/BAK-/- DKO and WT HCT 116 cells growing into a coverslip were transiently transfected 
with jetPRIME for 16h, thereafter, if necessary, were treated with 1µM rotenone/staurosporine 
(0, 4, 8 and 16h). Then, cells were incubated with Mitotracker (Red CMX Ros, invitrogen) 200nM 
at 37oC for 30min and washed twice with PBS before fixation with 3,8% paraformaldehyde. 
Next, coverslips were immunoblotted with a primary anti-cyt antibody (life technologies) and a 
secondary fluorescent anti-mouse 633 (life technologies) and finally nucleus, were dyed with 
Hoechst 33342 (Invitrogen). Samples were visualized in an inverted confocal microscope 
(TE2000 U, Nikon, Melville, NY) equipped for epifluorescence and with a Nikon D-eclipse C1si 
confocal spectral detector, using an X60, 1.45 numerical aperture, oil immersion objective. 
Images were processed by FiJi. 
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Apoptotic nuclei characterization in living cells.  
BAX-/-/BAK-/-DKO HCT 116 cells were growth and transfected as describe above, and then cells 
were treated with the toxicant (rotenone or staurosporine 1µM for 6h at 37oC with 5% CO2). 
Next, we substituted the media for a prewarmed media containing 1µM Hoechst 33342 and 3µM 
propidium iodide (Sigma) for 30 min. Subsequently, cells membrane integrity (PI containing 
cells) and nucleus morphology of transfected cells were analyse by using Leica DMI3000 and 
processed using Fiji. 
 
4.4 RESULTS 
4.4.1 BFL1 retrotranslocates BAX from mitochondria and 
mitochondria-like liposomes under nonapoptotic conditions 
through canonical, rather than non-canonical, interactions. 
BCLXL has been shown to maintain BAX inactive in healthy cells by continuously 
retrotranslocating BAX from the mitochondria into the cytosol. Thus, it was first analysed 
whether BFL1 shares with BCLXL this mode of action. GFP-BAX was ectopically expressed in 
BAX/BAK DKO HCT116 cells in the presence or absence of BFL1, and GFP-BAX 
retrotranslocation was analysed under nonapoptotic conditions using Fluorescence Loss In 
Photobleaching (FLIP) (Figure 4.1A)(Edlich et al, 2011a). To this aim, it was repeatedly bleached 
a region in the nucleus of a transfected cell (Figure 4.1B, white square), and the decay of GFP 
fluorescence in the targeted cell was followed by assigning regions of interest in the cytoplasm 
(Figure 4.1B, green circle) and on the mitochondria (Figure 4.1B, red and blue circles). GFP-
BAX readily crosses the nuclear envelope, and cytosolic GFP-BAX fluorescence of the targeted 
cell was rapidly bleached by FLIP, whereas the neighboring reference cell fluorescence (black 
circle) remained stable. After reducing the cytosolic GFP-BAX signal, the mitochondrial GFP-
BAX pool was readily apparent (Figure 4.1C, arrow). Consistent with previous reports, the decay 
of mitochondrial GFP-BAX fluorescence by FLIP occurred in a time frame of about 10 minutes 
following a first-order kinetic at a rate that is markedly slower than that of cytosolic GFP-BAX 
(Figures 4.1D and 4.1E). Importantly, BFL1 overexpression increased the FLIP rate of 
mitochondrial GFP-BAX without affecting the FLIP rate of cytosolic GFP-BAX (Figure 4.1D 
and 4.1E).  
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Figure 4.1. BFL1 retrotranslocates BAX from mitochondria. (A), Pictorial scheme of experimental 
design: (i) Before bleaching, GFP-BAX was localized in mitochondria and cytosol; (ii) FLIP bleaches 
cytosolic GFP-BAX; (iii) bleached GFP-BAX molecules translocate to the mitochondria while fluorescent 
GFP-BAX retrotranslocates into the cytoplasm; (iv) After continued FLIP, all GFP-BAX molecules are 
bleached. (B), GFP-BAX fluorescence monitorization in a typical FLIP experiment. Region marked as a 
white square was bleached 20 times at 488nm. GFP-BAX fluorescence variations on the mitochondria are 
detected in two areas (red circle and green circle, respectively), and changes in the cytosolic fluorescence 
(blue circle). Black circles indicate adjacent cells fluorescence, which serves as a control for cell-specific 
bleaching. Scale bars, 10µm. (C-D), Mitochondrial GFP-BAX fluorescence was monitored during 
fluorescence loss in photobleaching (FLIP) assay. (C), representative images showing time-dependent 
FLIP of GFP-BAX in the absence (top) and presence (bottom) of overexpressed BFL1.  Arrows denote 
mitochondria. Scale bars, 10µm (D), Average FLIP kinetics for multiple cells expressing only GFP-BAX 
(green line) and in the presence of BFL1 (blue line). (E), Average FLIP cytosolic kinetics for multiple 
cells expressing only GFP-BAX (green and black line) and in the presence of BFL1 (blue and black line). 
n>20 ROI for each condition of 3 independent experiments. Control represents GFP-BAX fluorescence in 
a neighbor cell. ***, p= <0.001. Error bars, S.D. 
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GFP-BFL1 also showed a dynamic localization between mitochondrial and cytosolic 
compartments in nonapoptotic HCT116 BAX/BAK DKO cells, and BAX overexpression 
increased the FLIP rate of mitochondrial, but not cytosolic, GFP-BFL1 (Figure 4.2A). These 
results strongly suggest that in intact nonapoptotic HCT116 BAX/BAK DKO cells BAX and 
BFL1 co-retrotranslocate together from the mitochondria into the cytosol, analogous to previous 
results obtained with BAX and BCLXL. Nevertheless, comparing these results with prior data it 
became apparent that BFL1 and BCLXL do not behave in an identical manner, since: (i) BFL1 
overexpression accelerates mitochondrial GFP-BAX retrotranslocation to a lower extent (44%) 
than BCLXL overexpression (83%), and (ii) GFP-BFL1 retrotranslocates from mitochondria with 
a higher FLIP rate (4.6 ± 0.2 X 10-3s-1) than GFP-BCLXL (1.4 ± 0.1 X 10-3s-1). Next, it was also 
examined the performance of a BAX variant which is predictably unable to heterodimerize with 
BFL1 through canonical BH3:groove and non-canonical BH4:BH4 interactions due to 
intramolecular tethering (GFP-BAX 1-2/L-6). The GFP-BAX 1-2/L-6 mutant displayed a very 
low mitochondrial retrotranslocation rate that did not detectably change upon BFL1 
overexpression (Figure 4.2B). 
 
Figure 4.2 BFL1 and BAX are in a codependent dynamic equilibrium between cytosol and the 
membrane. (A), Mitochondrial GFP-BFL1 fluorescence was monitored during fluorescence loss in 
photobleaching (FLIP) assay. Left, Representative images showing time-dependent FLIP of GFP-BFL1 
in the absence (top) and presence (bottom) of overexpressed BAX. Arrows denote mitochondria. Scale 
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bars, 10µm Right, Average FLIP kinetics for multiple cells expressing only GFP-BFL1 (green line) and 
in the presence of BAX (blue line). >20 ROI for each condition of 3 independent experiments. Control 
represents GFP-BFL1 fluorescence in a neighbor cell. ***, p= <0.001. Error bars, S.D. (B-Left), 
Representative images showing time-dependent FLIP of GFP-BAX 1-2/L6 in the absence (top) and 
presence (bottom) of overexpressed BFL1. Arrows denote mitochondria. Scale bars, 10µm (B-Right), 
Average FLIP kinetics for multiple cells expressing only GFP-BAX 1-2/L6 (redline) and in the presence 
of BFL1 (purple line). >20 ROI for each condition of 3 independent experiments. Control represents GFP-
BAX 1-2/L6 fluorescence in a neighbor cell. 
Then, it was examined whether the BFL1-mediated BAX retrotranslocation process observed in 
intact healthy cells can also be reproduced in minimalist systems (Bleicken et al, 2013a; Bleicken 
et al, 2013b; Landeta et al, 2015; Lovell et al, 2008). To this aim, BFL1ΔC26 lacking its TA motif 
(termed BFL1ΔC hereafter) was used because this construct can be obtained in a highly purified 
and homogeneous form, and also since a number of cellular studies showed that BFL1ΔC 
preserves the antiapoptotic function of BFL1 (Brien et al, 2009; Kucharczak et al, 2005). 
Unfortunately, FLIP methodology cannot be applied in this experimental system because the 
inter-GUV areas could not be bleached efficiently. Thus, as in a recent study with BCLXL and 
BAX (Bleicken et al, 2017), the  extent of binding of fluorescently-labelled BCL2 family proteins 
is quantitatively analysed to individual GUVs using confocal fluorescence microscopy. First, 
BFL1ΔC and BAX variants respectively were produced and subsequently labeled with Alexa 488 
and Alexa 647 fluorophores (termed BFL1ΔCg and BAXr hereafter), and it was confirmed that 
these proteins retain the basic structural and functional properties of their native unlabeled 
counterparts (Figure 4.3) (Bleicken et al, 2016).  
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Figure 4.3 BFL1∆Cg, BAXr, and cBIDr maintain structural and functional properties of native 
unlabeled counterparts. (A), Three-dimensional structures of BFL1∆C26 (PDB code 2VM6), BAX 
(PDB code 1F16), and BID (PDB code 1DDB) displaying as colored spheres the monocysteine residue 
where the Alexa-fluorophore is conjugated to generate BFL1∆Cg, BAXr, and cBIDr variants used in this 
study. (B), Percentage of ANTS/DPX permeabilized LUV in the presence or absence of the indicated 
BCL2 proteins (cBID(R)=150nM, BAX(R)=150nM and BFL1∆C(G)=450nM) at room temperature. Mean 
values ± S.D. (error bars) correspond to 3 independent experiments. (C), Effect of BCL2 proteins on the 
release of cytochrome c from mitochondria isolated BAX-/-/BAK-/- DKO HCT116 (BAX/BAK double 
knock out human colon carcinoma cells). (D), Percentage of ANTS/DPX permeabilized LUV as explained 
in (B) section but at 43oC. 
Next it was proceeded to the incubation of fluorescently-labelled proteins, alone or combined, 
with Mito-like GUVs containing different amounts of CL for 2h, and the increase of fluorescence 
intensity at the rim of the GUV membrane was visualized and quantified for multiple individual 
vesicles. As shown in Figure 4.4A-B, BFL1ΔCg and BAXr, alone or in combination, did not 
significantly bind to GUVs devoid of CL (0% CL GUVs). However, BAXr but not BFL1ΔCg, 
appreciably bound to GUVs containing CL levels that are typically found in mitochondrial contact 
sites (CS) under nonapoptotic conditions (25% CL). Importantly, co-incubation with BFL1ΔCg 
reduced by more than 70% the mean level of BAXr binding to 25% CL GUVs. By contrast, 
BFL1ΔCg and BAXr, each one alone, bound extensively to 100% CL GUVs emulating CL 
microdomains described in apoptotic cells, and co-incubation with BFL1ΔCg did not significantly 
reduce BAXr binding to this type of GUVs. These results suggest that BFL1 lacking its TA motif 
can retrotranslocate BAX from Mito-like GUVs under healthy-, but not apoptotic-like, conditions. 
 
Figure 4.4. BFL1∆Cg/BAXr binding profile in GUVs. Alexa488-labelled BFL1∆C (BFL1∆Cg) and 
Alexa647-labelled BAX (BAXr) were incubated at 37oC with GUV containing different amounts of CL 
followed by analysis of protein localization by confocal fluorescence microscopy. (A), Representative 
GUV images. (B), The ratio of maximum normalized integrated intensity values in membrane (IF 
membrane) and solution (IF solution) fluorescence obtained from radial profiles was measured for 
BFL1∆Cg (100 nM) and BAXr (100 nM) in GUVs of the indicated lipid compositions: 
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55PC/30PE/10PI/0CL mol/mol (0CL), 35PC/30PE/10PI/25CL mol/mol (25CL), and (100CL). In this box 
chart and raw data (dots) representation, the box represents the 96% confidence interval; inside the box, 
the media and median are represented by the small square and the line, respectively; and the errors 
correspond to 80% of the data. For each condition, at least 10 GUV were analysed from 3 independent 
experiments. 
In order to further confirm this possibility additional experiments were performed. To this aim, 
BAXr was incubated first with 25% CL GUVs for 2 hours in the absence or presence of two well-
established BAX-activating proapoptotic factors (cBID and mild heat, Figure 4.3B-D), followed 
by subsequent incubation of these mixtures with unlabeled BFL1ΔC for 2 more hours, and 
quantitative determination of the degree of BAXr binding to the liposomal membrane using 
confocal fluorescence microscopy. BFL1ΔC diminished the amount of BAXr bound to the GUVs 
in the absence of BAX activators, but not in their presence (Figure 4.5C). Next, it was examined 
the implication of canonical and BH4-mediated non-canonical BFL1ΔC:BAX interactions in the 
BAX retrotranslocation process reconstituted in vitro under healthy-like conditions.  
To this aim, the behavior of two single-residue BFL1ΔC mutants was analysed: (i) BFL1ΔC 
R88D, showing a charge reversal in the strictly conserved Arg residue of the BH1 motif that is 
critical to establish canonical BH3:groove interactions, and (ii) BFL1ΔC L21A, affecting a Leu 
residue localized in the BH4 motif of BCL2, BCLXL, and BFL1, and whose equivalent Leu-Ala 
mutation in BCL2 blocks the interaction between the BH4 motif of BCL2 and BAX and 
diminishes the antiapoptotic function of BCL2 (Barclay et al, 2015) (Figure 4.5D). Preliminary 
studies showed that the two BFL1ΔC point mutants preserve the structural folding of the native 
protein (Figure 4.5A). Importantly, the non-canonical BFL1ΔC L21A mutant completely retained 
the ability of BFL1ΔC to inhibit the release of cytochrome c induced by BAX from isolated 
HCT116 BAX/BAK DKO mitochondria, whereas the canonical BFL1ΔC R88D variant 
completely lost this capacity (Figure 4.5B-left). Moreover, ectopically expressed BFL1 L21A, 
but not BFL1 R88D, behaved as BFL1 inhibiting the cytochrome c release elicited by BAX in 
semi-intact HCT116 BAX/BAK DKO cells (Figure 4.5B-right). Similarly, BFL1ΔC L21A acted 
as its native counterpart inhibiting the BAX retrotranslocation process reconstituted in vitro, while 
BFL1ΔC R88D totally lost this capacity (Figure 4.5C). Prompted by these observations, the effect 
of a BCLXL construct lacking its TA motif in our minimalist system (BCLXLΔC24, termed 
BCLXLΔC hereafter) was examined in this CS-like membranes.  Unlike BFL1ΔC, BCLXLΔC 
did not reduce the level of BAXr binding to 25% CL GUVs under healthy-like conditions. This 
is in accordance with previous reports showing that BCLXL requires non-canonical interactions 
mediated by its TA motif to retrotranslocate mitochondrial BAX in nonapoptotic cells (Andreu-
Fernandez et al, 2017; Bleicken et al, 2017; Todt et al, 2013). 
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To summarize, this set of experiments demonstrated that in healthy cells BFL1 retrotranslocates 
BAX from the mitochondria to the cytosol in a similar, but not identical, manner to BCLXL. 
BFL1-mediated BAX retrotranslocation can be reconstituted in a minimalist system under 
healthy-, but not apoptotic-like like conditions, and this process requires canonical, rather than 
non-canonical, interactions between BFL1 and BAX.  
 
Figure 4.5. BAX retrotranslocation can be recapitulated in vitro with recombinant BFL1ΔC and 
model membranes. Structural and functional characterization of BFL1ΔC canonical/non-canonical 
mutants. (A-left), Representative Trp fluorescence spectra of BFL1∆C WT and mutants, (middle) thermal 
denaturation assay and (right) circular dichroism spectra. (B), Assessment of cyt c release inhibition by 
BFL1∆C mutants (left) and GFP-BFL1 mutants (right) in isolated mitochondria of BAX/BAK DKO 
HCT116 cells respectively. Protein concentration were cBID (50nM) and BAX (100nM). (C), In vitro 
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reconstitution of BAXr membrane retrotranslocation. BAXr (150 nM) was incubated with CS-like GUV 
at 37 oC (-/+ cBID, 20nM) and 43 oC for 2h. Then, samples are incubated 2h at RT (25oC) in the 
presence/absence of 450nM of BFL1ΔC WT, L21A and R88D and BCLXLΔC. Finally, binding profile 
was measured and represented as explained above. (D), Structural representation of BFL1ΔC (PDB:2vm6) 
in grey, depicting specific residues mutated, L21 (located in the BH4, colored cyan) and R88 (located in 
the canonical groove, colored in red). BAX BH3 domain is illustrated in dark blue. 
 
4.4.2 FCCS experiments reveal that BFL1ΔC forms canonical 
heterodimers or non-canonical homodimers in mitochondria-like 
membranes depending on CL levels 
To obtain quantitative information on the capacity of BFL1 to form stable complexes in solution 
and in mitochondria-like membranes are used point and scanning FCCS, respectively. FCCS is a 
technique with single molecule sensitivity that measures fluctuations in fluorescence intensity 
over time of individual particles labeled with spectrally different dyes as they diffuse through the 
detection volume of a confocal microscope. The resulting fluorescence intensity traces are 
temporally auto-correlated and cross-correlated to generate auto-correlation (AC) and cross-
correlation (CC) curves, respectively. The amplitudes of AC curves (red and green lines in Figure 
4.6A) are inversely proportional to the total concentrations of fluorophores, while the amplitudes 
of the CC curves (blue lines in Figure 4.6A) are directly proportional to the fraction of molecules 
forming complexes. The percentage of complex formation (% CC) is estimated by referring the 
amount of complex to the total concentration of protein (Figures 4.6B-E). 
In line with previous work, FCCS experiments were performed using physiological protein 
concentrations and after incubating the mixtures for 2h to ensure equilibrium conditions. Based 
on background CC levels obtained with free and membrane-bound dyes, mean CC values above 
2% and 9% indicated protein complex formation in solution and at the GUV membrane, 
respectively [(Figure 4.7) and (Bleicken et al, 2017; Ries et al, 2010)]. For the BFL1ΔCg/cBIDr 
pair, in solution, CC curves with positive amplitudes and CC levels in the 4-11% range were 
obtained (Figure 4.6A Left, and Figure 4.6B). By contrast, insignificant CC was obtained for the 
BFL1ΔCg/BAXr pair under the same experimental conditions (Figure 4.6A, Left, and Figure 
4.6D). Thus, these data indicate that in solution BFL1ΔC displays some capacity to form hetero-
complexes with cBID, but not with BAX. 
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Figure 4.6. FCCS analysis of BFL1∆Cg:BAXr and BFL1∆Cg:cBIDr heterodimerization in solution 
and in CL-containing membranes. (A-C), FCCS analysis of BFL1∆Cg:BAXr and BFL1∆Cg:cBIDr 
complex formation in solution, and CS-like liposomes (35PC/30PE/10PI/25CL mol/mol (CL25) GUV and 
CL100 GUV. (A), Dots represent raw data; straight lines, fitted autocorrelation curves (green and red), 
and cross-correlation curves (blue). B and D, quantification of canonical and non-canonical BFL1 
mutations in BFL1:cBID (B) and BFL1:BAX (D) complex formation in solution and in GUVs. C and E, 
percentages of BFL1:cBID (C) and BFL1:BAX (E) complex formation were represented on a 3D plot as 
a function of individual protein concentrations (molecules/µm2). Protein concentrations for FCS in 
solution were 200 nM of each protein. In SFCCS experiments; BFL1g (50 nM), BAXr (50 nM) and 
Alexa647-labelled cBID (cBIDr, 20 nM) in CS-like GUV and 20nM of each protein in 100CL GUV. Data 
correspond to 5–6 independent experiments, with more than 30GUV analysed for each condition. ***, p= 
<0.001. Error bars, S.D. Box chart and raw data (dots) representation as described in Figure 4.4. In B and 
D, red lines indicate the minimum (dashed lines) and the maximum (dotted lines) %CC considering dimer 
formation and the degree of labelling. 
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Figure 4.7 Negative controls for FCS and SFCCS analysis of BFL1∆Cg:BFL1∆Cr complex 
formation. As FCS negative controls we measured the %CC between BFL1ΔCg (200nM) and Alexa647 
and BFL1ΔCr (200nM) and alexa488 in solution. SFCCS controls were %CC between BFL1ΔCg (20nM) 
and DID, BFL1r (20nM) and DIO, and BFL1ΔCg(20nM):BFL1ΔCr(20nM): BFL1ΔC(60nM) in 100CL 
GUV. Box chart and raw data representation of complex formation, further experimental details were 
described in Fig 4.4. 
For membrane experiments, a unique advantage of scanning FCCS is that only the contributions 
of membrane-bound proteins to the fluorescence signal are considered in the data analysis, 
because the FCCS signal is acquired by a linear scanning across the membrane plane of the GUV. 
Thus, scanning FCCS allows quantifying the ability of BFL1ΔC to form stable protein complexes 
at the membrane level, without interference of membrane-to-solution retrotranslocation 
processes. In experiments with 25% CL GUV, they could not be performed scanning FCCS 
studies using BFL1ΔCg/BAXr because the levels of protein bound were very low under these 
experimental conditions (Figure 4.4). So that, in this section the interactions between BFL1ΔCg 
and cBIDr and between BFL1ΔCg and heat activated BAX (43o) are examined, because these 
protein combinations showed proper capacity for binding to 25% CL GUV. Here, CC curves with 
positive amplitudes were obtained for both BFL1ΔCg/cBIDr and BFL1ΔCg/activated-BAXr 
mixtures in 25% CL GUVs (Figure 4.6A, middle). CC levels were notably higher for 
BFL1ΔCg/cBIDr than for BFL1ΔCg/activated-BAXr. Thus, in 25% CL membranes, BFL1ΔC 
forms stronger hetero-complexes with the BAX activator cBID than with activated BAX itself. 
Moreover, in 25% CL GUVs, at all protein concentrations measured, the BFL1ΔCg/cBIDr pair 
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displayed % CC values close to the maximum level expected for heterodimeric complexes 
(Bleicken et al, 2017; Ries et al, 2010) (Figures 4.6B-E). Of note, CC levels for BFL1ΔCg/cBIDr 
were much lower in solution than in 25% CL GUVs indicating that hetero-interactions between 
BFL1ΔC and proapoptotic partners are enhanced in this type of membranes.  
Next, the contribution of canonical and non-canonical interactions between BFL1ΔC and 
proapoptotic partners in the formation of stable hetero-complexes was analysed in 25% CL 
GUVs. While the non-canonical BFL1ΔCg L21A mutant interacted with both cBIDr and 
activated-BAXr in a manner indistinguishable from that of BFL1ΔCg, the canonical BFL1ΔCg 
R88D mutant virtually lost all the capacity of the native protein to form complexes with either 
cBIDr or activated-BAXr (Figures 4.6B-E). Thus, at the membrane level, BFL1 forms stable 
hetero-complexes with both cBID and activated BAX via canonical BH3:groove interactions, 
without requiring BH4- or TA-mediated non-canonical interactions. Then, it was also analysed 
BFL1ΔC hetero-interactions in apoptotic-like 100% CL GUVs. The BFL1ΔCg/cBIDr pair 
showed CC curves with small positive amplitudes and low but significant CC levels, whereas the 
BFL1ΔCg/BAXr pair showed CC curves and CC percentages that were indistinguishable from 
background (Figure 4.6A Right, Figures 4.6B-E). This occurred despite the fact that all proteins 
efficiently bound to 100% CL GUVs (Figure 4.4 and 4.8). 
 
Figure 4.8 cBIDr promotes BFL1∆Cg binding to the membrane. BFL1∆Cg and cBIDr were incubated 
with GUV containing different amounts of CL followed by analysis of protein localization by confocal 
fluorescence microscopy. (A), Representative GUV images. (B), The ratio of maximum normalized 
integrated intensity values in membrane (IF memb.) and solution (IFsol.) fluorescence obtained from radial 
profiles was measured for BFL1∆Cg (100 nM) and cBIDr (30 nM) in GUVs. Vesicles compositions and 
box chart and raw data representation as described in Figure 4.4. 
Next, FCCS was used in order to assess the capacity of BFL1ΔC to form homo-complexes in 
solution and membrane environments. Of note, appropriate scanning FCCS experiments could 
not be performed in 25% CL GUVs due to the low level of BFL1ΔC binding to these vesicles 
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(Figure 4.4). FCCS analyses revealed that BFL1ΔCg and BFL1ΔCr form homo-complexes in 
100% CL GUVs, but not in solution nor in the presence of an excess of non labelled BFL1ΔC 
(Figure 4.9A-B and 4.8). CC levels for the BFL1ΔCg/BFL1ΔCr pair were similar at all protein 
concentrations measured and were not distant from maximum values expected for BFL1ΔC 
homodimeric complexes based on (Bleicken et al, 2017; Ries et al, 2010). BFL1ΔC R88D 
behaved as BFL1ΔC forming homo-complexes in 100% CL GUVs (Figure 4.9A-B), which is in 
stark contrast to the dramatic loss in hetero-complex formation observed for this mutant in 25% 
CL GUVs (Figures 4.6B-E). Furthermore, the non-canonical BFL1ΔC L21A mutant partially lost 
the capacity of BFL1ΔC to form homo-complexes in 100% CL GUVs (Figure 4.9A), unlike the 
equivalent abilities shown by this mutant and the native protein to form hetero-complexes in 25% 
CL GUVs.  
To further examine the quaternary structure of BFL1 homo-complexes in different environments 
Total Internal Reflection (TIRF) and size-exclusion chromatography (SEC) were used. TIRF 
experiments with single-molecule sensitivity revealed that in 0% CL membranes the majority of 
BFL1ΔC exists as a monomeric species, while in 100% CL membranes BFL1ΔC predominantly 
adopts a dimeric conformation (Figure 4.9C). Consistent with scanning FCCS results, the 
canonical BFL1ΔC R88D mutant homodimerized as efficiently as BFL1ΔC, while the non-
canonical BFL1ΔC L21A variant only retained the homodimerization capacity of its native 
counterpart in part. SEC analyses showed that in the absence of membranes BFL1ΔC elutes as a 
monomeric protein (Figure 4.9D, discontinuous black line), whereas in the presence of 100% CL 
liposomes the protein elutes as larger particles (Figure 4.9D, continuous black line) that may 
correspond to mixed micelles containing CL and dimeric BFL1ΔC or to BFL1ΔC complexes of 
higher stoichiometry. As observed in FCCS and TIRF studies, the canonical, but not the non-
canonical BFL1ΔC mutant, reproduced the behavior displayed by BFL1ΔC in the SEC assay 
(Figure 4.9D). Additional SEC experiments showed that unlike BFL1ΔC, BCLXLΔC fully retains 
its monomeric nature in the presence of 100% CL liposomes, while BAX mostly elutes in the 
void volume of the column (Figure 4.9D).    
To summarize, based on these collective set of results can be conclude that (i) in solution and in 
mitochondrial-like membranes, BFL1ΔC generally forms stronger hetero-complexes with cBID 
than with activated BAX; (ii) membranes with a healthy-like mitochondrial lipid composition 
(25% CL) enhance formation of stable hetero-complexes between BFL1ΔC and proapoptotic 
partners through a canonical BH3:groove interaction mechanism; and (iii) apoptotic-like 100% 
CL membranes promote formation of non-canonical BFL1ΔC homo-complexes, a feature that is 
not shared by BCLXLΔC. 
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Figure 4.9 BFL1∆C forms non-canonical homo-oligomers in pure CL liposomes. (A), Homo-
oligomerization (BFL1∆Cg:BFL1∆Cr complex formation) of BFL1∆C WT and its canonical and non-
canonical mutants in solution, and pure CL GUV (100CL) analysed by FCCS and SFCCS. Left, Box chart 
and raw data representation and right, 3D plot as a function of individual protein concentrations 
(molecules/µm2). Other experimental details as described in Figure 4.4 and Figure 4.6B/D. Red lines 
indicate the minimum (dashed lines) and the maximum (dotted line) %CC considering dimer formation 
and the degree of labelling. (B), Analysis of BFL1ΔC quaternary structure by Total Internal Reflection 
(TIRF) in (0CL) and pure CL (100CL) supported lipid bilayers (SLB). BFL1∆Cg analysis with 0CL SLB 
also included 1% DGS-NTA(Ni) lipids. Representation of the percentages of the quaternary structures of 
BFL1Cg or its canonical and non-canonical mutants in pure CL SLB (100CL). Monomers and dimers 
were calculated from the averaged distributions of species from 3 different experiments, after correction 
for partial labelling. The error bars correspond to the average error for each species. Inset plot, 
fluorescence intensity distribution of BFL1Cg or its variants particles bound to SLB. Approximately 
1000 particles were analysed. The resulting histograms were fitted with a linear combination of two 
Gaussians to estimate the occurrence of particles containing one (orange) and two (green) labelled 
molecules. The cumulative fit is shown in black. The area of the fitted Gaussians is proportional to the 
fraction of each species. (C), Quaternary structure study of BFL1∆C and its variant by size-exclusion 
chromatography (SEC) in solution and in pure CL GUV (100CL). Proteins were incubated in the absence 
(dashed lines) or in the presence of 100CL LUVs (solid lines) followed by 3%CHAPS addition, and 
Superdex-75 chromatography. Analysed proteins were BFL1∆C (black lines), BFL1∆C L21A (cyan 
lines), BFL1∆C R88D (red lines), BCLXL∆C (dark green lines) and BAX (dark blue lines). Protein 
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standards were: ribonuclease A (13.7 kDa), Carbonic anhydrase (29 kDa), Conalbumin (75 kDa) and 
Aldolase (158 kDa).  
 
4.4.3 BFL1ΔC adopts different conformations in CL-containing 
membranes and in pure CL membranes 
To test whether membrane CL levels affect specifically to BFL1 conformation, NBD-based 
fluorescence mapping strategy was used. To this aim, a set of monocysteine BFL1ΔC variants 
spread along the whole protein structure were produced and tested that maintain structural and 
functional properties of the native protein (Figure 4.10). Next, BFL1ΔC monocysteine mutants 
were site-specifically labelled with NBD, an environmentally sensitive fluorescent dye, followed 
by analysis of NBD fluorescence properties in the monocysteine BFL1ΔC variants and combining 
them with lipids containing doxyl groups as explained in the previous chapter, we were able to 
stablish BFL1 membrane topology at different lipid compositions. 
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Figure 4.10. Structural and functional characterization of NBD-labelled monocysteine BFL1ΔC 
mutants. (A), Primary structure of BFL1 indicating specific residues mutated to Cys for subsequent 
labelling with the environmentally sensitive NBD fluorophore (black circles). (B), Structural representation 
of BFL1ΔC26 (2vm6) depicting specific residues mutated to Cys for subsequent labelling with NBD (black 
spheres). (C), Representative Trp fluorescence spectra of NBD-labelled monocysteine BFL1 mutants. (D), 
Secondary structure assessment of BFL1ΔC monocysteine mutants by circular dichroism. E, Thermal 
denaturation assay for the set of BFL1 monocysteine mutants. (F), Assessment of cyt c release inhibition 
by BFL1ΔC mutants in BAX/BAK DKO MEF isolated mitochondria. Protein concentration: cBID (50nM) 
and BAX 100nM, and 1µM of each monocysteine BFL1ΔC mutant. 
 
As shown in Figure 4.11A-B, all monocysteine BFL1ΔC mutants underwent minimal changes in 
NBD fluorescence in the presence of CL-containing LUVs. Co-addition of BAX together with 
CL-containing LUVs did not produce further spectral changes in any NBD-labelled monocysteine 
BFL1 mutant. However, co-addition of cBID together with CL-containing LUVs produced a 
prominent increase in the fluorescence intensity of BFL1ΔC S43C-NBD, accompanied by a ∼4 
nm blue-shift in the λmax(em) of this variant (Figure 4.11A). Of note, the S43 residue is localized 
at the BH3-binding-groove of BFL1 supporting the notion that cBID and BFL1 form canonical 
BH3-in-groove complexes, which apparently maintain the global BFL1 solution fold. Moreover, 
NBD-quenching experiments with doxylated lipids showed insignificant effects for all BFL1 
variants, including residues in the hydrophobic core (α5-α6), in the absence or presence of cBID 
or BAX, strongly suggesting, in contraposition to reported for other BCL2-type antiapoptotic 
proteins, that cBID:BFL1 complex formation does not lead to BFL1 membrane insertion (Billen 
et al, 2008; Dlugosz et al, 2006; Lovell et al, 2008; Shamas-Din et al, 2013; Zhang et al, 2004). 
Next, the behaviour of the same set of NBD labelled monocysteine BFL1ΔC mutants was 
analysed in the presence of pure CL LUVs, with or without proapoptotic proteins (Figure 4.11B). 
Remarkably, all BFL1ΔC monocysteine mutants underwent substantial changes in NBD 
fluorescence in the presence of pure CL LUVs alone, and co-addition of cBID or BAX did not 
produce further changes in the NBD fluorescence intensity of any BFL1ΔC mutant examined 
(Figure 4.11B-left). Furthermore, in the presence of pure CL LUVs all NBD-labelled BFL1ΔC 
mutants displayed substantial quenching by doxylated lipids, suggesting that multiple BFL1 
regions insert into the membrane lipid bilayer under these conditions (Figure 4.11B, right).  
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Figure 4.11. Analysis of BFL1 membrane topology by NBD fluorescence mapping. (A), Representative 
NBD fluorescence emission spectra of indicated monocysteine BFL1 mutants incubated with or without 
MOM-like LUV (15CL) and proapoptotic proteins. In all cases, NBD fluorescence was normalized to the 
peak intensity of the NBD spectrum in buffer alone. Protein/lipid concentrations: 150nM of each BCL2 
protein and 150µM lipid. B, C Left, Average NBD fluorescence intensity ratios(+LUV/-LUV) of 
monocysteine BFL1 mutants incubated with MOM-like (45PC/30PE/10PI/15CL, termed CL15) (B) and 
CL100 (C) LUVs. Right, Dox5-quenching of NBD-BFL1 mutants in MOM-like (B) and 100 CL (C) LUVs. 
n= 3-4 independent experiments. Error bars, S.D. 
Complementarily, BFL1 membrane topology was studied by the Single Cysteine Accessibility 
Method (SCAM).  Here, BFL1ΔC monocysteine mutants were treated with PEG-5kDa, and 
PEGylated proteins were identified by SDS-PAGE analysis of protein migration patterns. SCAM 
                                                                               Chapter 4: CL-dependent BFL1 membrane activities    
 
 
187 
 
 
analysis of PEG-5kDa exposure of all monocysteine residues, confirmed that BFL1 maintains its 
global structure in CL-containing, but not in pure CL LUVs (Figure 4.12)  
 
Figure 4.12. Analysis of BFL1 membrane topology by single cysteine accessibility method (SCAM) 
(I). (A) Average 5kDaPEGMAL-exposure pattern of monocysteine BFL1ΔC mutants under above-
mentioned conditions (CL15 or CL100 /SOL). (B), Representative coomassie blue stain of CYS exposure 
pattern of S43C and R105C monocysteine mutants of BFL1ΔC assessed by using 5kDaPEGMAL in the 
presence/absence of proapoptotic cBID, in solution, CL15 and CL100 liposomes. *PEG-mal labelled BFL1 
monocysteine mutant (n=3). All LUV experiments 150µM lipid and 150nM of each protein. (C), 
Representative CYS exposure pattern of GFP-BFL1 S43C and R105C BFL1 FL at the MOM of digitonized 
BAX/BAK DKO MEF cells assessed by anti-GFP WB (n=3). 
Further SCAM experiments were performed with selected GFP-BFL1ΔC mutants (S43C, 
canonical-groove and R105C, hydrophobic core) expressed in BAK/BAX DKO MEFs. Both 
mutants showed a similar behaviour at the mitochondria level and with CL-containing liposomes 
(Figure 4.12C-D). 
 
To summarize, BFL1 membrane topology analyses showed that BFL1 interacts with cBID in CL-
containing LUVs through canonical BH3-in-groove interactions that maintain the global solution 
fold of the protein. By contrast, in pure CL LUVs, BFL1 undergoes a massive structural 
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rearrangement with extensive membrane insertion of the protein, thereby disrupting its BH3-
binding groove and abolishing its capacity to interact with proapoptotic partners 
 
4.4.4 BFL1ΔC forms non-canonical proteolipidic pores in pure CL 
membranes 
Next, it was examined the impact of BFL1ΔC on membrane permeability. In a first set of assays, 
spectrofluorimetry and LUVs encapsulating the small-sized dye/quencher ANTS/DPX (m.w. 
<1kDa) were used as a model membrane system. As shown in Figure 4.13A, the impact of 
BFL1ΔC on liposome membrane permeability correlated well with the capacity of BFL1 to form 
hetero- and homo-complexes (Figs 4.6 and 4.9). Thus, in 25% CL LUVs, BFL1ΔC inhibited the 
ANTS/DPX release elicited by cBID-activated BAX, and this inhibitory function on membrane 
permeabilization was also observed with the non-canonical BFL1ΔC L21A mutant, while it was 
totally lost in the case of the canonical BFL1ΔC R88D mutant. By contrast, BFL1ΔC itself elicited 
the release of ANTS/DPX from pure CL LUVs, and this autonomous membrane-permeabilizing 
function of BFL1ΔC was efficiently reproduced by the canonical BFL1ΔC R88D mutant, but not 
by the non-canonical BFL1ΔC L21A (Fig 4.13B). 
 
Figure 4.13. BFL1∆C displays opposing effects on membrane permeability depending on CL (I). (A), 
Dose-dependence of extents of vesicular contents release (ANTS/DPX release) inhibition elicited by 
BFL1∆C WT and its canonical/non-canonical mutants in 35PC/30PE/10PI/25CL mol/mol (25CL) LUV. 
(n = 3) Error bars, S.D. (B), ANTS/DPX release elicited by BFL1∆C WT (black) and its 
canonical(red)/non-canonical (cyan) mutants in pure CL LUV (100CL). Protein concentration: Dotted bars 
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(60nM), Dashed bars (120nM) and filled bars (180nM). C, Representative images of 100CL GUV after 
the incubation with BCL2 proteins in the presence of 4kDa dextrans and the fluorescent protein 
allophycocyanin (APC, 104kDa). Scale bars, 10µm. D, Percentage of permeabilized GUV measured by 
filling of externally added FITC-4-kDa dextran and APC (104kDa). E, GUV size normalized to the control 
n>50 of 3 independent experiments. ***, p= <0.001. Error bars, S.D. Box chart and raw data (dots) 
representation as described in Figure 4.4. 
Next, was explored the size of the membrane perturbation created by BFL1ΔC in pure CL 
membranes. Here, it was simultaneously analysed the internalization of FITC-4KDa and APC-
104kDa into pure CL GUVs by confocal fluorescence microscopy. In pure CL GUVs, BFL1ΔC 
elicited more extensive internalization of FITC-4 kDa than APC-104 kDa, while BAX produced 
similarly extensive internalization of both fluorescent markers, and cBID and the antiapoptotic 
BCLXLΔC did not allow internalization of any of them. Consistent with spectrofluorimetry 
results obtained in LUVs, the canonical BFL1ΔC R88D mutant permeabilized pure CL GUVs 
similarly to BFL1ΔC, while the non-canonical BFL1ΔC L21A variant showed diminished active 
(Fig. 4.14A and B). 
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Figure 4.14. BFL1∆C displays opposing effects on membrane permeability depending on CL (II). 
(A), Representative images of 100CL GUV after the incubation with BCL2 proteins in the presence of 
4kDa dextrans and the fluorescent protein allophycocyanin (APC, 104kDa). Scale bars, 10µm. (B), 
Percentage of permeabilized GUV measured by filling of externally added FITC-4-kDa dextran and APC 
(104kDa). (C), GUV size normalized to the control n>50 of 3 independent experiments. ***, p= <0.001. 
Error bars, S.D. Box chart and raw data (dots) representation as described in Figure 4.4. 
Accumulating evidence indicates that BAX-type proteins permeabilize membranes by forming 
proteolipidic pores (Salvador-Gallego et al, 2016; Terrones et al, 2004). BAX-induced 
proteolipidic pore formation in CL-containing GUVs has been linked to a reduction of GUV 
diameter that can be inhibited by BCLXL (Bleicken et al, 2016). Consistent with this, it was 
observed that heat-activated BAX significantly permeabilize (Figure 4.15A) and reduced the 
diameter of CL-containing GUVs (Figure 4.15B). This process was inhibited by BFL1ΔC and its 
non-canonical L21A variant, but not by its canonical R88D variant (Figure 4.15A-B). In stark 
contrast, BFL1ΔC and its canonical R88D variant, but not its non-canonical L21A variant, 
reduced the diameter of pure CL GUVs (Figure 4.14C). Complementarily, taking into account 
that oxidized CL (CLox) accumulates in apoptotic cells it was also examined the impact of CLox 
in BFL1ΔC pore-forming activity. Indeed, substitution of CL by CLox exacerbated ANTS/DPX 
release from LUVs by BFL1ΔC (Figure 4.15C). BFL1ΔC canonical R88D variant, but not 
BFL1ΔC non-canonical L21A mutant, preserved BFL1ΔC´s pore-forming activity in CLox 
LUVs. 
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Figure 4.15. Effects of BFL1∆C variants in heat-activated BAX in CS-like GUV. (A), Percentage of 
APC (104kDa) internalization upon the incubation of BCL2 protein(s) in CS-like GUV at 43oC.  (B), 
BFL1∆C inhibits both membrane remodeling activities elicited by its proapoptotic counterparts in 25CL 
GUV. Box chart and raw data representation of GUV size normalized to the control upon the incubation 
of BCL2 protein(s) in CS-like GUV at two different temperatures (RT and 43oC). Other experimental 
details were described in Figure 4.4. (C), Oxidized-CL increases the proapoptotic activity of BFL1∆C. 
Left, Kinetics of copper-induced oxidation of 60PC/30PE/10PI (0CL) and 35PC/30PE/10PI/30CL (25CL) 
LUV. Right, Extents of ANTS/DPX release elicited by BFL1∆C WT and its canonical/non-canonical 
mutants in 0CL LUV (gray bars), 25CL (dotted bars), and oxidized-25CL (black bars). Protein/lipid ratio 
was (1:300). 
Based on this set of results, can be concluded that BFL1ΔC oligomerizes via non-canonical 
interactions to form proteolipidic pores in pure CL and CLox-containing membranes.  
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4.4.5 BFL1, but not BCLXL, promotes BAX/BAK-independent 
apoptosis when stimulated by CL-externalizing drugs. 
Prompted by the results obtained in minimalistic in vitro reconstituted systems, we decided to 
examine whether BFL1 oligomerizes and/or increases membrane permeability in a more 
physiological environment. To this purpose, GFP-BFL1- and GFP-BCLXL-transfected HCT116 
cells were treated with the apoptosis-inducing agent rotenone at a suboptimal dose that induces 
mitochondrial CL externalization and oxidation, followed by immunofluorescence analyses of 
cytochrome c release and GFP-BFL1/GFP-BCLXL visualization(Jiang et al, 2008; Kagan et al, 
2004; Kagan et al, 2005). As shown in Figure 4.16A, sub-optimal rotenone treatment produced 
cyt c release and clustering in cells expressing GFP-BFL1, but not GFP-BCLXL.  
 
 
Figure 4.16. Rotenone-mediated CL oxidation induces BFL1 clustering and mitochondrial cyt c 
release in HCT 116 cells. (A), Representative images of GFP-BFL1 and GFP-BCLXL cellular 
distribution (in green), cyt c localization (in blue) and mitotracker intensity (red) in the presence/absence 
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of rotenone (1µM,4h) in HCT 116 cells. Scale bars, 10µm. (B), Kinetics of apoptotic cluster formation 
(left) and MOMP (cyt c release) (middle) in transfected cells at different times. Error bars, S.D. Right, 
quantification of the percentage of cyt c release in cluster presenting transfected cells. and *, p= <0.05. 
Error bars, S.D.  
Suboptimal rotenone treatment did not produce cytochrome c release or clustering in HCT 116 
cells transfected with GFP or Mito-GFP (Figure 4.16B-right and 4.17). zVAD did not reduce 
rotenone-induced cytochrome release or BFL1 clustering, indicating both processes are caspase-
independent (Figure 4.16B-right). In coherence with previous results, in cells transfected with the 
non-canonical GFP-BFL1 L21A mutant, but not the canonical GFP-BFL1 R88D variant, 
cytochrome c release and GFP-BFL1 clustering were partially reduced (Figure 4.16B-right).  
 
Figure 4.17. Rotenone-mediated CL oxidation does not induce any GFP or Mito-GFP clustering nor 
mitochondrial cyt c release in HCT 116 cells. (A), Representative images of GFP and Mito-GFP cellular 
distribution (in green) and cyt c localization (in blue) in the presence/absence of rotenone (1µM,4h) in 
HCT 116 cells. Scale bars, 10µm. (B), Kinetics of cluster formation and MOMP (cyt c release) for GFP 
(left) and for Mito-GFP (right) in the presence/absence of rotenone (1µM,4h) in transfected cells at 
different times. Error bars, S.D. 
Chapter 4: CL-dependent BFL1 membrane activities     
 
 
 
194 
 
 
Next, various apoptotic features were examined in rotenone- and staurosporine-treated 
BAX/BAK DKO HCT166 cells with or without ectopic expression of GFP-BAX, GFP-BFL1 and 
GFP-BCLXL. As shown in Figure 4.18A-B, rotenone and staurosporine treatment induced 
clustering, cytochrome c release, and pyknotic nuclei in GFP-BAX and GFP-BFL1 expressing 
cells, but not in GFP-BCLXL expressing cells. GFP-BAX had more pronounced effect than GFP-
BFL1.  
 
Figure 4.18. Rotenone- and staurosporine-mediated CL oxidation induces BFL1 clustering, 
mitochondrial cyt c release and apoptotic nuclei formation in BAX/BAK DKO HCT 116 cells. A and 
B, Left, Representative images of GFP-BAX, GFP-BFL1 and GFP-BCLXL cellular distribution (green), 
cyt c localization (in dark blue) and nuclear morphology (cyan) in the presence of rotenone (1µM,6h) (A) 
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or staurosporine (1µM,6h) (B) in BAX/BAK DKO HCT 116 cells. Scale bars, 10µm. Right, Quantification 
of cluster- (green bars), MOMP- (dark blue bars) and apoptotic nuclei- (cyan bars) presenting cells of total 
transfected cells in the presence of rotenone (1µM,6h) (A) or staurosporine (1µM, 6h) (B) in BAX/BAK 
DKO HCT 116 cells. 
Of note, the levels of cytochrome c release and BFL1 clustering were lower in rotenone-treated 
BAX/BAK DKO HCT 166 relative to rotenone-treated normal HCT 166 cells, despite GFP-BFL1 
was equally expressed in wt and BAX/BAK DK HCT116 cells (Figure 4.19A-B). The relative 
clustering levels of GFP-BFL1 and its canonical and non-canonical mutants were maintained in 
rotenone-treated BAX/BAK DKO HCT 166 cells (Figure 4.19-C).  
 
Figure 4.19. (A), GFP-BAX, GFP BFL1 and GFP-BCLXL expression levels in BAX/BAK DKO HCT116 
and HCT 116 WT cells assessed by western blotting anti-GFP. Loading control was determined by anti-
TOM antibody. (B), Comparison of total cluster formation of GFP and GFP-BFL1 in both cells lines (-/+) 
1µM rotenone treatment for 4h. (C), quantification of the percentage of cyt c release in cluster presenting 
transfected cells after rotenone treatment (1µM, 6h). **, p= <0.025. Error bars, S.D. 
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Based on this collective data, it is proposed that rotenone and staurosporine treatment unleashes 
a lethal clustering and MOMP activity of BFL1 that is not mediated via canonical BH3:groove 
interaction mechanism, and which is not present in the antiapoptotic BCLXL (Figure 4.20). 
 
Figure 4.20. Schematic representation of all three inhibition modes carried out by BFL1 upon a 
canonical BH3-into groove interactions: MODE 0 at healthy conditions (left), MODEs 1 and 2 at low 
apoptotic conditions (middle) and ProDeath MODE of BFL1 but not BCLXL at high apoptotic pressure 
conditions (right). 
 
4.5 DISCUSSION 
BFL1 has recently emerged as an important factor for oncogenesis and chemoresistance. 
However, our current mechanistic knowledge for BFL1 is much more limited than for BCL2 and 
BCLXL (Fan et al, 2010; Haq et al, 2013; Mahadevan et al, 2005; Moldoveanu et al, 2014; 
Placzek et al, 2010; Westphal et al, 2014b) (Huhn et al, 2016; Schenk et al, 2017; Tuzlak et al, 
2017). In this chapter, it was performed a multidisciplinary approach applied to a variety of in 
vitro and in celullo systems to gain new insight into the modes of action of BFL1, particularly in 
the membrane environment.  These results support the view that BFL1 possesses three 
antiapoptotic modes described before for BCLXL that are mediated via canonical BH3:groove 
interactions, as well as a BAX-like proapoptotic mode mediated by non-canonical interactions 
that can be unleashed by cardiolipin.  
On the one hand, different lines of evidence indicating that BFL1 can inhibit apoptosis via three 
distinct mechanisms are provided. First, it is shown that BFL1 shares with BCLXL (Edlich et al, 
2011a), the capacity to accelerate BAX shuttling from the mitochondria into the cytosol, 
designated as MODE 0 or retrotranslocation inhibitory mechanism. A mutant of BAX that is 
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unable to expose its BH3 domain (Edlich et al, 2011a) only displayed slow retrotranslocation 
rates. Thus, BFL1 may exert this retrotranslocation function through canonical BH3-in-groove 
interactions with BAX. Importantly, this phenomenon can be recapitulated using recombinant 
BAX and BFL1ΔC proteins and CS-like liposomes under healthy-, but not apoptotic-like 
conditions. Moreover, several evidences were provided to assert that the TA motif of BFL1 is not 
required to retrotranslocate BAX from the membrane, which is unlike the situation found for 
BCLXL. However, these results do not exclude the possibility that the TA domain of BFL1 
participates in BAX retrotranslocation in cellulo.  
Using minimalist systems and SFCCS, was also successfully reproduced the formation of stable 
BFL1ΔC:cBID (active BID) and BFL1ΔC:BAX (heat-activated BAX) complexes corresponding 
to MODE 1 and MODE 2 inhibitory mechanisms, respectively. In this context, these data clearly 
support the notion that BCL2-type (BCLXL, BFL1) proteins inhibit apoptosis, while maintaining 
the global solution fold via canonical BH3 into groove, neutralizing BH3-only and BAX-type 
proteins, rather than only one of these two classes of proapoptotic molecules. Of note, the 
existence of membrane-associated complexes between BFL1 and activated BAX has not been 
conclusively shown before. It is also noteworthy that protein-titration and protein-mutagenesis 
studies performed with this minimalist systems indicate that BFL1ΔC:cBID complexes display 
higher affinities than BFL1ΔC:BAX complexes while both interactions are based on canonical 
BH3-in-groove interactions. This is in concordance with previous results (Bleicken et al, 2017; 
Landeta et al, 2014) but in apparent contradiction with previous work proposing that all 
mitochondria-associated BCL2-type proteins display higher affinities for BAX-type proteins than 
for BH3-only proteins since non-canonical interaction surfaces hold tighter the former but not the 
latter proapoptotic proteins to their antiapoptotic counterparts (Llambi et al, 2011). Although the 
possibility that BFL1 interactions taking place at the mitochondria may differ from those captured 
in our minimalist systems cannot be excluded. It should be mentioned here that the main 
conclusions of that study were based on results obtained with BCLXL, BCL2, and MCL1, while 
BFL1 was left largely unexplored. 
Importantly, it was also shown by SFCCS that BFL1ΔC loses the capacity to form hetero-
complexes with BAX and cBID in membranes containing pure CL, while it gains the ability to 
homo-oligomerize under these conditions. The homooligomerization of BFL1ΔC in liposomes 
seems to be driven, at least in part, by a non-canonical interaction surface involving the BFL1ΔC 
BH4 motif, rather than the canonical BH3:groove interaction. This notion was further supported 
by using TIRF and SEC analyses, where BFL1ΔC and the canonical mutant R88D, but not the 
non-canonical L21A mutant, dimerized in pure CL membranes. Of note, some evidence indicates 
that in addition to canonical interactions, non-canonical interactions can participate in the BCL2 
interaction network (Andreu-Fernandez et al, 2017; Barclay et al, 2015; Gavathiotis et al, 2008). 
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Moreover, BFL1 is quite peculiar as it is one of the few BCL2 proteins lacking a conserved BH3 
domain. 
A remarkable and often overlooked property of BCL2-type proteins is their capacity to switch 
from an antiapoptotic to a proapoptotic phenotype (Basanez et al, 2001; Landeta et al, 2014; 
Megyesi et al, 2016). Here, it was observed that pure CL or oxidized CL unleash a non-canonical 
pore forming activity in BFL1 that presents similarities and dissimilarities with that of BAX. On 
the one hand, as observed with BAX, the BFL1 pore is associated with homo-complex formation 
(Figure 4.9), sallow membrane insertion (Figure 4.11) and membrane remodeling (Figure 4.14). 
On the other hand, BFL1 forms complexes and pores of smaller sizes than BAX in liposomal 
membranes. In addition, the basis for BFL1 homodimerization is not the canonical BH3-in-groove 
interactions, which is unlike the case of BAX. Importantly, it is also given the physiological 
relevance of the findings in minimalist systems. Specifically, it is shown that exposure/oxidation 
of mitochondrial CL by rotenone and staurosporine triggers non-canonical BFL1 clusterization, 
cytochrome c release and pyknotic nuclei formation, independent of BAX and BAK. Despite the 
exact relationship between BFL1 clusterization and cytochrome c release remains to be 
determined, it is noteworthy that BAX and BAK also form clusters during apoptosis which 
purportedly act as the crucial effectors of MOMP.  
Thus, taking all this information into account, can be proposed that CL or CLox accumulated at 
the mitochondria under apoptotic conditions triggers a phenotypic switch in BFL1. Consequently, 
BFL1 shifts from an antiapoptotic molecule capable to neutralize activated BAX and cBID at the 
MOM through three different canonical heterodimerizing interactions (MODE 0, 1 and 2), to a 
proapoptotic factor which homo-oligomerizes via non-canonical interactions (ProDeath MODE) 
to form proteolipidic pores at the MOM that breach its permeability barrier. Despite not being as 
potent as BAX-induced cell death, this mechanism could be important in a high apoptotic pressure 
scenario, where BFL1 helps the cell to die with its buried proapoptotic activity. Alternative 
mechanisms such as calpain cleavage or alternative splicing may also unleash the pore-forming 
capacity of BFL1 triggering its conversion into a proapoptotic factor (Valero et al, 2012). Further 
studies are warranted to assess whether the BFL1 phenotypic switch unveiled here can be 
triggered by other apoptosis-related lipids, as well as to determine whether this ProDeath -mode 
of action is specific for BFL1 or can be extended to other BCL2-type proteins. Finally, the 
potential therapeutic use of the findings described in this study should not be dismissed.
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5 General discussion, relevance and final conclusions 
Tissue homeostasis is defined as the equilibrium between cell death and proliferation, thus, its 
dysregulation could end in pathological situations, such as cancer or neurodegenerative diseases. 
Apoptosis or cell suicide is a kind of programmed cell death, considered as the main regulator of 
this cellular balance. Apoptosis can occur through two main pathways: the “extrinsic” or death 
receptor pathway and the most frequent “intrinsic” or mitochondrial pathway (Czabotar et al, 
2014). Concerning the mitochondrial pathway, BCL-2 family proteins are the main modulators 
of apoptosis which primarily act by regulating the breaching of the mitochondrial outer membrane 
(MOM) permeability barrier via an apoptotic pore that allows for the release of multiple 
apoptogenic mitochondrial factors into the cytosol (Westphal et al, 2014b).  
During the last decades, crucial advances have been made in our mechanistic and structural 
understanding of BCL-2 family proteins. We now know that different BCL-2 family members 
can be classified in three main groups, based on apoptosis-related functional and structural criteria 
(Czabotar et al, 2014; Gimenez-Cassina & Danial, 2015; Westphal et al, 2014a): (1) BAX-type 
proapoptotic proteins, which once activated, directly form the mitochondrial apoptotic pore; (2) 
BH3-only proapoptotic proteins, which trigger functional activation of BAX-type proteins; and 
(3) BCL-2-type antiapoptotic proteins, which inhibit proapoptotic partners and the mitochondrial 
apoptotic pore. Importantly, under certain conditions, this subgroup could exhibit a bifunctional 
phenotype that could contribute to breach permeability barrier (Basanez et al, 2012; Basanez et 
al, 2001; Cheng et al, 1997; Landeta et al, 2014). We also know that many BCL-2 family proteins 
are amphitropic proteins that shuttle between a cytosolic conformation and a membrane-
associated conformation depending on the physiological status of the cell (Edlich et al, 2011a; 
Lindsay et al, 2011; Schellenberg et al, 2013; Todt et al, 2015; Todt et al, 2013). Moreover, BCL-
2 family proteins can also perform functions unrelated to mitochondrial apoptotic pore regulation 
in healthy cells (Doghman-Bouguerra & Lalli, 2017). 
High-resolution X-Ray crystallography and solution NMR studies revealed that all BAX-type and 
BCL-2-type proteins share a common helical globular fold (Czabotar et al, 2013; Herman et al, 
2008; Moldoveanu et al, 2013; Muchmore et al, 1996). A remarkable feature of these solution-
based protein structures is the presence of a hydrophobic groove in BCL-2-type and BAX-type 
proteins, that can act in a receptor-like manner to engage BH3 domains of binding partners. 
Complementarily, other non-canonical surfaces have been proposed to participate in BCL2 
interactoma (Andreu-Fernandez et al, 2017; Barclay et al, 2015; Gavathiotis et al, 2008). Largely 
based on this structural information as well as in binding studies in lipid-free environments, a 
number of models have been put forward to explain how different BCL-2 family proteins regulate 
MOM permeabilization via protein:protein interactions (Chen et al, 2015; Korsmeyer et al, 1993; 
Llambi et al, 2011). More recently, the importance of the MOM and its lipid composition in the 
mode of action of several BCL-2 family members has also been recognized (Cosentino & Garcia-
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Saez, 2017; Leber et al, 2007; Subburaj et al, 2015). However, most of these models do not 
appropriately integrate the fact that BAX and BCLXL constantly shuttle on and off the 
mitochondria, nor the capacity of BCL2-type proteins to reverse their antiapoptotic phenotype 
under certain physiological conditions. 
Understanding the structural changes driving BAX-type proteins from an apoptosis-inactive 
conformation to a fully activated structure responsible for MOMP has been considered the “holy 
grail” of the apoptosis research (Youle & Strasser, 2008). These events, are usually encompassed 
in the following subsections: 1) Early activation steps (N-terminal and BH3 exposure), 2) 
Membrane insertion, 3) Oligomerization and 4) Pore formation. Moreover, in the last years, 
several groups have reported that the formation of BAX supramolecular assemblies, in the form 
of semi-arcs, rings and clusters are directly linked with apoptotic phenotype, being fundamental 
to form a pore, enabling the release of mitochondrial content (Grosse et al, 2016; Nechushtan et 
al, 2001; Salvador-Gallego et al, 2016; Uren et al, 2017). However, two main aspects of BAX 
activation process remain obscure: i) the exact topology that BAX adopts in the membrane and 
ii) the minimal BAX subunits required to permeabilize the MOM.   
In addition, as BCL2 family proteins play their biological role in the membrane, the lipid 
component is gaining attention. Concretely, the mitochondrial specific lipid CL, has been hailed 
as one of the key regulators of apoptosis. Indeed, CL content, distribution and redox state are 
reported to be fundamental for BAX-type proteins activities in model membranes and in vivo 
(Jiang et al, 2008; Kagan et al, 2004; Kagan et al, 2005). Moreover, during apoptosis selective 
ROS-mediated CL peroxidation is required for mitochondrial cyt c release (Osman et al, 2011). 
Furthermore, CL clusters can stabilize highly curved regions such as and those CL-formed lipid 
domains could act as signalling platforms for BCL2 proteins (Garofalo et al, 2005; Garofalo et al, 
2003; Malorni et al, 2007; Sorice et al, 2009). However, not all the studies ascribe fundamental 
role to CL in BCL2 protein family function, and the exact function of the CL and other 
mitochondrial lipids in the activation of BCL2 family proteins remains ill defined.  
 
Figure 5.1 Schematic representation of the BCL2 family interaction network. (A) The BCL2 family 
can be divided into three classes: the proapoptotic BAX-type proteins, the proapoptotic BH3-only proteins 
and the prosurvival proteins. The prosurvival proteins inhibit the activity of the proapoptotic members of 
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BCL2 family. The BH3-only proteins activate BAX and BAK either directly (activation) or indirectly 
(derepression). The BAX-type proteins breach MOM permeability barrier. (B) Inhibition by prosurvival 
proteins may occur via three MODEs. During MODE 0, prosurvival proteins bind to peripheral BAX at the 
mitochondria and retro-translocate it to the cytosol. During MODE1 inhibition the antiapoptotic proteins 
sequester BH3-only proteins to stop them to activate BAX. During MODE 2 the antiapoptotic proteins form 
a complex with activated BAX to prevent MOMP.  
 
The main aim of this Thesis is to advance in our understanding of the molecular mechanisms of 
action of BCL2 family proteins at the membrane level. Our focus is in the proapoptotic BCL2 
family member BAX, and in the antiapoptotic BFL1. 
In order to fulfil the general objective, the following specific aims were proposed: 
Specific Aims: 
1- To gain insight into inactive and active BAX membrane conformations. 
2- To elucidate the mechanism by which BFL1 inhibits apoptosis, by analysing three 
putative modes of action: (1) retrotranslocation of inactive BAX from the membrane into 
the cytosol (MODE-0), (2) heterodimerization with and neutralization of cBID at the 
membrane level (MODE-1), and (3) heterodimerization with and neutralization of 
activated BAX at the membrane level (MODE-2) 
3- To understand the role of the cardiolipin as a modulator of BFL1 and BCLXL membrane 
activities. 
In this Thesis, several quantitative biophysical techniques were applied on model membranes and 
cellular systems. The inherent complexity of the apoptotic process makes very challenging to 
obtain detailed information about the mechanism of action of specific members of BCL2 family 
proteins in the native cellular context. Fortunately, several groups, including ours, have reported 
that is possible to mimic the basic mechanisms of action of this family of proteins, in vitro using 
model membranes and recombinant purified proteins. Of note, in this Thesis in cellulo 
experiments were combined with the in vitro studies to gain more insight into BAX and BFL1 
modes of action. 
In the first part of my Thesis, the study of both active and inactive membrane topologies of BAX 
was carried out by using a multidisciplinary approach and recombinant proteins. Fluorescence 
mapping revealed that fully active BAX adopts a BH3-in-groove dimeric conformation in MOM-
like membranes, with BAX α4-α5 helices belonging to its core domain inserting deeper into the 
membrane lipid bilayer than BAX α6-α8 helices belonging to its latch domain. Moreover, in our 
reconstituted systems, antiapoptotic BCLXL formed canonical heterodimeric BH3-in-groove 
complexes with BAX, and blocked membrane insertion of BAX core α4-α5 helices, but not BAX 
latch α6-α8 helices. Furthermore, poly(ethylene glycol) (PEG) conjugation (PEGylation) at 
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multiple individual sites along the BAX core, but not latch domain, potently inhibited BAX pore-
forming activity. Additional combined computational and experimental evidence revealed that 
the BAX core α5 helix displays a bilayer-destabilizing membrane interaction mode that is absent 
in BAX latch α6-α8 helices.  
Then, it was characterized the inactive BAX membrane conformation (in the absence of apoptotic 
stimulus) using SCAM (Single Cysteine Accessibility Methodology). Specifically, the exposure 
pattern of more than twenty monocysteine mutant was analysed in solution and upon membrane 
interaction from isolated mitochondria and model membranes. According to PEGylation exposure 
pattern, inactive-BAX adopts a globular folding in the membrane, leading its C-terminal BAX 
α7-α9 helixes. Moreover, additional changes were observed in residues within the BAX BH3 
domain and canonical groove, suggesting that interactions with the MOM lipid bilayer alone 
favour partial rearrangement of these two regions of the protein. Such localized BAX structural 
reorganization may explain the different affinities described for BCL2 interactoma in solution 
and in the membrane.  
Overall, we propose that in the absence of apoptotic stimulus, BAX preserves its overall globular 
folding but experiences localized changes at the C-terminal, canonical groove and BH3 regions, 
leading to what we term the “lipid-primed” monomeric BAX conformation. By contrast, when 
BAX becomes fully activated by cBID, the protein undergoes extensive conformational changes 
implicating multiple different regions necessary for BAX oligomerization and extensive 
membrane insertion. Importantly, we also showed that membrane interactions of the BAX core 
(α4-α5), but not latch domain (α6-α8), is critical for BAX apoptotic pore formation. 
 
Figure 5.2. Schematic representation of inactive BAX (left) and activated BAX (right) membrane 
topology. The α-helixes are represented as follows: α1 (grey), α2 (green), α3 (dark-orange), α4 (dark-blue), 
α5 (red), α6 (light-orange), α7-α8 (cyan) and α9 (purple). CL: cardiolipin and PL: phospholipid. 
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As a continuation of these studies, in the second part of my Thesis the modes of inhibition of 
BFL1 were analysed in a lipid membrane context. Using FLIP, it was shown that BFL1 is able to 
retrotranslocate inactive-BAX from the membrane and applying SFCCS, I demonstrated that 
BFL1 forms high affinity complexes with cBID and less prominently with BAX in contact site 
(CS) like membranes (25CL), via a canonical BH3-into-groove interaction. In stark contrast, in 
solution or in pure CL (100CL) vesicles BFL1 dramatically diminished its capacity to 
heterodimerize with its proapoptotic counterparts.  
Then, SFCCS and TIRF studies indicated that BFL1 homodimerizes in membranes containing 
high CL concentration. The homooligomerization of BFL1 is driven by a non-canonical 
interaction surface, apparently involving the N-terminal (BH4 domain) of the protein. Of note, 
despite the canonical BH3:groove interaction represents the dominating interaction for 
heteromeric and homomeric complex formation involving BCL2 family proteins, non-canonical 
interactions between different BCL2 family proteins have also been identified (Andreu-Fernandez 
et al, 2017; Barclay et al, 2015). 
Next, in order to provide more structural and mechanistic details, the previously described 
methodology for BAX was adapted for BFL1. Thus, a fluorescence mapping of several BFL1 
monocysteine mutants was performed in the presence or absence of proapoptotic partners and in 
membranes containing different lipid composition. In CS-like membranes BFL1 preserves the 
solution globular folding and inhibition capacity, but in pure CL vesicles, BFL1 undergoes a 
profound reorganization leading to BFL1 shallow membrane insertion. Further experiments 
confirm that CL-mediated groove disruption and membrane insertion of BFL1 unearths the pore 
forming activity of BFL1. Importantly, the antiapoptotic BCLXL in the presence of pure vesicles 
of this mitochondrial specific lipid, is not able to form a pore, suggesting that this process is very 
dependent on the nature of the “antiapoptotic” protein. 
Taking all this into account, we propose that BFL1 exhibits a multimode antiapoptotic 
mechanism, and that BFL1 reverses its functional phenotype shifting into a proapoptotic mode at 
high apoptotic pressure reflected by high membrane CL content. 
Finally, in the last part of my Thesis, I studied the proapoptotic phenotype of BFL1 using model 
membranes and in a cellular system. In the former system, I showed that BFL1 perforates CL-
rich membranes and also reduces the average liposome size consistent with a BAX-type 
proteolipidic BFl1 pore. However, combining GUV and recombinant proteins with fluorescently 
labelled probes I showed that the BFL1 forms pores of smaller size than BAX. Then, I analysed 
the effect of CL-externalizing drugs such as rotenone and staurosporine in the behaviour of BFL1. 
Despite not being as potent as BAX, BFL1 wt formed clusters, induced MOMP, and elicited 
apoptotic nuclei in BAX-/-/BAK-/- DKO HCT 116 cells. All these activities were substantially 
reduced in the non-canonical BFL1 mutant, and were completely absent in BCLXL. 
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This mechanism could be operative in a high apoptotic pressure scenario, where BFL1 may 
accelerate the apoptotic cell death process through its pore-forming activity linked to MOMP. 
Since overexpression of BFL1 can contribute to chemotherapeutic resistance of certain cancer 
cells, the reversion of BFL1 proapoptotic phenotype could be helpful in the fight against specific 
types of cancer. 
 
Figure 5.3 Schematic representation of all three mode of inhibition of BFL1 plus its CL-mediated 
proapoptotic phenotype. BFL1 (green), BAX (grey), cBID (red) and BCLXL (blue). CL: cardiolipin and 
PL: phospholipid. 
 
The specific conclusions of this Thesis are: 
- Inactive BAX is peripherally associated to MOM and MOM-like membranes, producing 
localized structural changes particularly in the C-terminal region, and leading to the 
“Lipid-Primed” conformation of BAX. 
 
- Active BAX homodimerizes in the membrane by a BH3-into groove mechanism 
promoting membrane tension and pore formation by inserting its core, but not latch 
domain. 
- We succeed to recapitulate all three inhibitions modes described for BCL2 antiapoptotic 
proteins for BFL1, in different physiologically-relevant systems. Moreover, using site-
specific point mutations we conclude that BFL1 interacts with its proapoptotic 
counterparts mainly, if not solely, via a BH3-into-groove canonical mechanism. 
 
- Membrane CL content modulates BFL1 heterodimerization with both BAX and cBID, as 
well as BFL1´s non-canonical homodimerization and pore forming activity. In 
concordance, CL-externalizing drugs, such as rotenone and staurosporine, promote a 
BFL1 specific, BAX/BAK independent, apoptotic activity in mammalian cells. 
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6 Resumen de la Tesis y conclusiones finales 
La homeostasis de tejidos es considerado como el equilibrio entre la muerte y proliferación 
celular, y es por ello que su desregulación a menudo está asociada a diversas situaciones 
patológicas, tales como enfermedades neurodegenerativas o el cáncer. Este equilibrio, se 
encuentra regulado principalmente por un mecanismo denominado apoptosis o suicidio celular. 
Este tipo de muerte celular programada es activado mediante dos rutas co-dependientes: (i) la ruta 
extrínseca donde median los receptores de muerte y la ruta intrínseca o mitocondrial la cual 
constituye la forma más común de muerte celular por apoptosis (Czabotar et al, 2014). En cuanto 
a la ruta mitocondrial, la familia de proteínas BCL2 se erige como pieza clave en la regulación de 
esta vía, principalmente, a nivel de la permeabilización de la membrana externa mitocondrial 
(MEM). Este proceso, es considerado como el punto de no retorno de la vía, en el cual se forma 
un poro en la MEM que permite la liberación de material ocluido en la mitocondria al citosol y 
una vez allí este desencadena la muerte celular por apoptosis (Westphal et al, 2014b). 
En las últimas décadas, se han realizado avances de notoria importancia en el conocimiento sobre 
los mecanismos de acción de la familia de proteínas BCL2 (Czabotar et al, 2014; Westphal et al, 
2014b). Actualmente las BCL2 se clasifican en tres subgrupos basándose criterios funcionales y 
estructurales (Gimenez-Cassina & Danial, 2015): (i) proteínas proapoptóticas multidominio o tipo 
BAX, las cuales una vez activadas, forman un poro en la membrana mitocondrial externa, (ii) las 
proapoptótica de único dominio BH3 o BH3-only, las cuales activan a las tipo BAX y (iii) las 
antiapoptóticas o tipo BCL2, las cuales inhiben a ambos tipos de proapoptóticas y por 
consiguiente la formación del poro apoptótico. Sin embargo, han sido descritas ciertas 
condiciones fisiológicas donde este último subgrupo sufre una reversión total de su fenotipo 
antiapoptótico y adquiere una actividad formadora de poro o proapoptótica (Basanez et al, 2012; 
Basanez et al, 2001; Cheng et al, 1997; Landeta et al, 2014). Además, se sabe que la localización 
celular de las proteínas de esta familia es de importancia capital para su actividad. 
Interesantemente, muchas de las proteínas de la familia son anfitrópicas (localización dual, 
citosólica y membranal) la cual varía en función de las condiciones celulares y el estímulo 
apoptótico (Edlich et al, 2011b; Lindsay et al, 2011; Schellenberg et al, 2013; Todt et al, 2015; 
Todt et al, 2013). Por otra parte, cabe la pena destacar que la familia de proteínas BCL2 posee 
múltiples y muy diversas funciones en la célula no relacionadas con la muerte celular programada 
o apoptosis (Doghman-Bouguerra & Lalli, 2017). 
Estudios de resolución atómica, tales como la cristalografía rayos X y la resonancia magnética 
nuclear, han puesto de manifiesto que las proteínas tipo BCL2 o antiapoptóticas y las tipo BAX 
o proapoptóticas multidominio, poseen una estructura globular similar a pesar de presentar 
funciones contrapuestas (Czabotar et al, 2013; Herman et al, 2008; Moldoveanu et al, 2013; 
Muchmore et al, 1996). Atendiendo a las estructuras resueltas, esta familia de proteínas se 
caracteriza por poseer una estructura globular compuesta por una α-hélice hidrofóbica central 
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rodeada por varios pares de hélices anfipáticas. Además, tanto las proteínas multidominio, 
antiapoptóticas como las proapoptóticas, poseen un bolsillo hidrofóbico el cual actúa como 
receptor para el dominio BH3 (dominio universal de la familia) que actúa como ligando, 
conformando una interacción canónica comúnmente denominada como BH3 en el groove. De 
manera complementaria, durante los últimos años se han sugerido numerosas superficies de 
interacción alternativas o no-canónicas (Andreu-Fernandez et al, 2017; Barclay et al, 2015; 
Bleicken et al, 2017), lo cual agrega un grado extra de complejidad a las interacciones entre los 
miembros de la familia BCL2. La información estructural recopilada a lo largo de más de una 
década ha permitido el desarrollo de numerosas teorías sobre los modos de interacción proteína: 
proteína entre los miembros de la familia (Chen et al, 2015; Korsmeyer et al, 1993; Llambi et al, 
2011). Sin embargo, estas proteínas realizan su función biológica en la membrana y es por tanto 
para la comprensión de su interactoma, su estudio a nivel de membrana se antoja indispensable. 
Recientemente, el componente lipídico y la membrana han cobrado importancia, por lo que su 
papel regulador en las interacciones entre los diferentes miembros de la familia está siendo objeto 
de estudio intensivo (Cosentino & Garcia-Saez, 2017; Leber et al, 2007; Subburaj et al, 2015).  
Sin embargo, a pesar de tener diversos modelos de interacción, estos no han sido capaces de 
integrar: (i) el mecanismo de inhibición conocido como retrotranslocación o MODO 0 de 
inhibición, por el cual las proteínas antiapoptóticas son capaces translocar desde la MEM al 
citosol a las proteinas tipo BAX y (ii) la reversión del fenotipo antiapoptótico de las proteínas tipo 
BCL2. 
En este contexto, el entendimiento de los cambios estructurales mediante los cuales la proteína 
BAX, pasa de una estructura globular inactiva, a una estructura activa en membrana responsable 
de la permeabilización de la MEM, se ha considerado como el santo grial en la investigación de 
las BCL2 (Youle & Strasser, 2008). La activación de la proteína proapoptótica BAX se asocia a 
1) cambio en su segmento N-terminal y dominio BH3, 2) inserción en membrana, 3) 
oligomerización y 4) formación del poro apoptótico. Recientemente, varios grupos han 
demostrado que la formación de estructuras supramoleculares de las proteínas tipo BAX en forma 
de semi-arcos, anillos y clúster están relacionadas con el fenotipo apoptótico, siendo estas 
estructuras fundamentales para la liberación del citocromo c mitocondrial ocluido en este 
orgánulo (Grosse et al, 2016; Nechushtan et al, 2001; Salvador-Gallego et al, 2016; Uren et al, 
2017). Sin embargo, dos importantes aspectos del proceso de activación se encuentran vagamente 
descritos: (i) la disposición estructural exacta que la proteína BAX adopta en membrana y (ii) la 
cantidad mínima de subunidades de BAX necesarias para la formación del poro. 
Como se mencionaba anteriormente, puesto que la membrana conforma el locus biológico de 
estas proteinas, el estudio del componente lipídico y de la propia membrana se encuentra 
actualmente en boga. Concretamente, el lípido especifico de la mitocondria, cardiolipina (CL), se 
ha erigido como uno de los moduladores claves de la apoptosis. Tanto es así, que el contenido, la 
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distribución y el estado redox de este lípido han sido contenido de estudio en las actividades de 
membrana de las proteínas tipo BAX encargadas de la formación de poro apoptótico (Jiang et al, 
2008; Kagan et al, 2004; Kagan et al, 2005). Ademas, diversos grupos han descrito que durante 
la apoptosis, la peroxidación de la CL mediada por la formación de ROS, es necesaria para la 
liberación del citocromo c de las crestas mitocondriales, y por ende en la consecución del fenotipo 
apoptótico (Osman et al, 2011). También, las peculiaridades físico-químicas de este lípido, le 
permiten la formación de clúster capaces estabilizar zonas de mucha curvatura, las cuales han 
sido descritas como potenciales plataformas de interacción de las BCL2 (Garofalo et al, 2005; 
Garofalo et al, 2003; Malorni et al, 2007; Sorice et al, 2009). Sin embargo, a pesar de su 
importancia, la función exacta de la CL en particular y de los lípidos en general, en las actividades 
de membrana de las BCL2, se encuentra vagamente descrita. 
 
Figura R.1. Representación esquemática de la red de interacciones de la familia de proteínas BCL2. 
(A) La familia de proteínas BCL2 puede ser dividida en tres subclases: las proapoptóticas multidominio o 
tipo BAX, las proapoptóticas tipo BH3 solo y las antiapoptóticas o tipo BCL2. Las antiapoptóticas inhiben 
la actividad de ambos subgrupos de proteínas proapoptóticas. Las tipo BH3-solo activan a las tipo BAX 
directamente o indirectamente, mediante el desplazamiento de la antiapoptótica unida. (B) Las proteínas 
antiapoptóticas inhiben mediante tres modos de actuación. En el MODO 0, las proteínas antiapoptóticas se 
unen a las tipo BAX unidas periféricamente a la membrana y la retrotranslocan desde la MEM hasta el 
citosol. En el MODO 1, las antiapoptóticas se unen a las BH3 solo en membrana, inhibiendo por tanto la 
activación de estas a las tipo BAX. En el MODO 2 las antiapoptóticas forman complejo con las tipo BAX 
activas para así prevenir la permeabilización de la MEM. 
 
El objetivo de esta Tesis Doctoral ha sido avanzar en la comprensión de los mecanismos de acción 
de la familia de proteínas BCL2, así como de los factores reguladores que modulan su actividad 
durante la apoptosis. Concretamente, nos centramos en dos miembros de la familia: la 
proapoptótica multidominio prototípica BAX, y la poco estudiada proteína antiapoptótica BFL1. 
Para la consecución de estos objetivos, se han realizado estudios a nivel de membrana tanto en 
sistemas modelo como en células, mediante diversas técnicas biofísicas cuantitativas.  
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A fin de materializar el objetivo general, se plantearon los siguientes objetivos específicos: 
1. Caracterizar la conformación en membrana de BAX tanto en su forma activa como 
inactiva. 
2. Dilucidar el modo de acción de BFL1, centrándonos en los tres modos de inhibición 
descritos para las proteínas tipo BCL2 (1) retrotranslocación de las proteínas tipo BAX 
(MODO-0), (2) heterodimerización con las proteinas BH3 solo (MODO-1) y (3) 
formando un complejo de membrana con una BAX activa. 
3. Establecer el rol de la cardiolipina como modulador de las actividades de membrana de 
las proteínas BFL1 y BCLXL. 
 
Dada la complejidad inherente al proceso apoptótico, resulta intrincado obtener información 
detallada acerca del modo de acción de miembros específicos de la familia BCL2 utilizando 
sistemas celulares completos. Afortunadamente, diversos grupos, incluyendo el nuestro, han 
comprobado que es posible reproducir los mecanismos básicos de acción de los diferentes 
subgrupos de la familia BCL2 in vitro. En esta Tesis, se han realizado estudios mecanísticos sobre 
las BCL2 y sus factores reguladores utilizando diversos sistemas reconstituidos compuestos por 
proteínas recombinantes purificadas y membranas modelo. Sin embargo, a fin de otorgar una 
mayor fisiologicidad a los resultados in vitro, gran parte de estos estudios se complementaron con 
ensayos celulares, validando y robusteciendo nuestras conclusiones. 
En la primera parte de la Tesis, se estudió la topología de la proteína BAX a nivel de membrana 
en presencia y ausencia de activadores de la misma, utilizando para ello proteína recombinante, 
sistemas modelo que mimetizan las condiciones mitocondriales y mitocondrias aisladas. 
Mediante el uso de diversos mutantes monocisteína cuidadosamente seleccionados a lo largo de 
la estructura de la proteína, conjugados con la sonda sensible a la polaridad del ambiente, y 
analizando de la fluorescencia de estos residuos, concluimos que BAX completamente activa 
adopta en membrana una conformación dimérica tipo “BH3-intro groove”. Además de confirmar 
que BAX activo adopta una conformación donde el dominio BH3 de un monómero de BAX se 
introduce en el groove de otro monómero, se ha demostrado que lo hace insertando su dominio 
“core” (hélices α4-α5), pero no su dominio “latch” (hélices α6-α8) en membranas modelo que 
imitan a la MEM.  
También, en nuestro sistema reconstituido hemos podido comprobar que la proteína 
antiapoptótica BCLXL forma heterodímeros con BAX mediante la interacción canónica “BH3-
intro groove” y que impide la inserción del dominio core responsable de la formación del poro. 
Ademas, utilizando estos mismos mutantes de monocisteína y conjugándolos con el compuesto 
polyethilene glycol (PEG, 0.5kDa) se ha podido constatar que la unión de este compuesto a los 
residuos del dominio core, pero no del dominio latch, capaban la actividad formadora de poro de 
la proteína BAX. Estudios complementarios de computación y evidencias empíricas utilizando 
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péptidos de diversas hélices de la proteína, confirmaron que la hélice α5 del dominio core, pero 
no la α6 perteneciente al dominio latch, era capaz de desestabilizar la membrana. 
A fin de caracterizar el proceso de la activación de la proteína BAX, se estudió su conformación 
a nivel de membrana en su estado inicial inactivo o en ausencia de activador. En este caso se 
continuó con la conjugación del PEG-5kDa a múltiples mutantes de monocisteína, esta vez in situ 
en la propia membrana mitocondrial de células deficientes para BAX. Concretamente, analizamos 
el grado de exposición al PEG de las cisteínas de los diversos mutantes, estableciendo un patrón 
de exposición en solución y en membrana. De esta manera, concluimos que BAX inactivo, no es 
capaz de liberar citocromo c, adopta una estructura globular similar a la que tiene en solución, 
pero apoyando su C-terminal α7-α9. Este patrón muestra también, pequeños cambios en residuos 
cercanos al bolsillo hidrofóbico que permite la dimerización con el resto de miembros de la 
familia. Significativamente, estos pequeños cambios en el receptor canónico universal de las 
BCL2, podrían explicar las diferentes afinidades mostradas por lo miembros de la familia BCL2 
en solución y en membrana. 
Considerando todo referente a la topología de BAX en membrana, concluimos que en ausencia 
de estímulo apoptótico BAX adopta una estructura globular apoyando su C-terminal en la 
membrana, conformación a la cual hemos denominado “lipid primed”, ya que el lípido parece 
favorecer la exposición del bolsillo hidrofóbico que actuará como receptor en el proceso 
apoptótico. Sin embargo, una vez activada, BAX adopta una configuración BH3 into groove 
donde la inserción del dominio core, pero no del dominio latch, se antoja indispensable para la 
formación del poro apoptótico. 
 
Figure R.2. Representación esquemática de la topología a nivel de membrana de BAX inactive (izq.) 
y active (dcha.). Las hélices α están representadas como sigue: α1 (gris), α2 (verde), α3 (naranja oscuro), 
α4 (azul oscuro), α5 (rojo), α6 (naranja claro), α7-α8 (cian) and α9 (morado). CL: cardiolipina and PL: 
fosfolípido. 
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Como continuación de estos estos estudios, en la segunda parte de la tesis analizamos los modos 
de inhibición de BFL1 en el contexto de la membrana. Mediante el uso de FLIP (fluorescencce 
loss in photobleaching), se mostró como BFL1 es capaz de retrotranslocar a BAX desde la 
membrana hasta el citosol. Utilizando SFCCS (scanning fluorescene cross correlation 
spectroscopy), se demostró que BFL1 forma complejos de alta afinidad vía canónica o BH3-into-
groove, con la proteína BH3-solo cBID y en menor medida con BAX en membranas de 
composición que imita a las zonas de contacto que encontramos en las mitocondrias.  
Por el contrario en membranas con alto contenido en cardiolipina, las cuales imitan los 
microdominios de este lípido descritos en condiciones apoptóticas, BFL1 no solo pierde la 
capacidad de formar heterodímeros con los miembros proapoptóticos, sino que también es capaz 
de homodimerizar vía una superficie no descrita previamente situada en el dominio BH4 de la 
proteína. Además, estudios de TIRFm (Total internal reflection fluorescence microscopy) y de 
tamizado molecular confirmaron que BFL1 es capad de dimerizar vía una superficie no canónica. 
Esta capacidad de homodimerización de BFL1, no se promueve ni en solución ni en membranas 
con una composición lipídica característica de condiciones celulares no apoptóticas. 
Resumiendo, la capacidad inhibitoria de BFL1 es vía canónica, donde el BH3 de las proteínas 
proapoptóticas se introduce en el bolsillo hidrofóbico de BFL1. Sin embargo, en membranas 
apoptóticas enriquecidas en CL, BFL1 forma homodímeros mediante una interacción no canónica 
que implica su dominio BH4 (α1-α2). Este hallazgo, aunque inesperado, puede explicarse 
estructuralmente ya que BFL1 es una de las pocas proteinas de la familia BCL2 que no posee un 
dominio BH3 canónico, lo cual en principio explicaría que el homodímero formado por BFL1 no 
implicase a este dominio, hecho que confirmamos mediante el uso de mutantes específicos y las 
técnicas anteriormente descritas. 
Intentando aportar detalles tanto estructurales como mecanísticos, adaptamos para BFL1 la 
metodología aplicada en la resolución de la topología a nivel de membrana de BAX. Por tanto, 
realizamos un mapeo de fluorescencia de diversos mutantes de monocisteína conjugados con 
NBD, en presencia/ausencia de los miembros proapoptóticos en membranas de diferentes 
composiciones lipídicas. A través de los datos obtenidos de los espectros de los diferentes 
mutantes de monocisteína, podemos concluir que en membranas de bajo contenido en CL, BFL1 
adopta una conformación globular que mantiene su bolsillo hidrofóbico y por ende su capacidad 
de interaccionar con los miembros proapoptóticos. Sin embargo, en membranas de CL, BFL1 se 
reorganiza totalmente, perdiendo su estructura globular e insertando periféricamente la totalidad 
de sus alpha-hélices en la membrana. Seguidamente, comprobamos que esta reorganización e 
inserción de contenido proteico en la membrana, generaba una tensión en la misma capaz de 
formar un poro.  Merece la pena destacar el diferente comportamiento que exhibe la proteína 
antiapoptótica BCLXL, ya que ésta en presencia de membranas de CL, no es capaz de perturbar 
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la membrana ni formar un poro, por lo que el efecto que ejerce la CL sobre BFL1 parece ser 
especifico del tipo de proteína antiapoptótica.  
Teniendo en cuenta todo lo arriba mencionado, concluimos que BFL1 posee un mecanismo de 
acción multimodal (Modos 0, 1 y 2) y bifuncional (fenotipo antiapoptótico y proapoptótico) 
regulado por la cantidad de CL en la membrana. 
En el tercer periodo de la tesis doctoral, se trató de caracterizar la naturaleza del poro formado 
por BFL1, tanto en membranas modelo como en sistemas celulares con mayor fisiologicidad. 
Primeramente, en sistemas in vitro observamos que BFL1 no solo formaba un poro en la 
membrana, sino que también parecía reducir el diámetro de las vesículas, lo cual sugeriría que la 
naturaleza del poro formado por BFL1 en liposomas de CL es proteolipídica (Bleicken et al, 
2016). También, analizando la permeabilización en GUV (giant unilamellar vesicles), pudimos 
concretar que a diferencia de lo que sucede con BAX, BFL1 forma un poro de pequeño tamaño. 
Posteriormente, analizamos el efecto de dos drogas externalizadoras de CL como son la rotenona 
y la estaurosporina sobre la actividad BFL1. En coherencia con resultados previos, la 
externalización de CL en células de mamífero, estimula un fenotipo proapoptótico en BFL1, 
menos predominantemente en el mutante no-canónico y totalmente ausente en el caso de BCLXL, 
el cual es capaz de formar un poro en la MEM independientemente de BAX y BAK. 
A pesar de que la reversión fenotípica de BFL1, ésta no induce una muerte celular tan marcada 
como la proteína proapoptótica BAX. Por lo que se plantea un escenario donde debido a 
pronunciados estímulos apoptóticos que conllevan la externalización de CL, BFL1 es capaz de 
promover/facilitar la muerte celular por apoptosis. En este punto cabe mencionar que la 
sobreexpresión de las proteínas antiapoptóticas es la principal causa de resistencia a la 
quimioterapia, por lo que su reversión fenotípica plantea una alternativa valiosa en la lucha contra 
el cáncer. 
 
Figura R.3. Representación esquemática de los tres modos de inhibición de BFL1 y el fenotipo 
apoptótico mediado por CL. BFL1 (verde), BAX (gris), cBID (rojo) and BCLXL (azul). CL: cardiolipina 
and PL: fosfolípido. 
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Las conclusiones específicas de la Tesis son: 
 
- La proteína BAX inactiva se encuentra periféricamente asociada a la MEM y a 
membranas que imitan su composición lipídica, produciendo cambios estructurales 
localizados predominantemente en el C-terminal, en una configuración denominada 
como “Lipid-Primed”. 
 
- La proteína BAX activa homodimeriza en le membrana vía la interacción canonical BH3-
into-groove, insertando su dominio core pero no su dominio latch, produciendo una 
tensión en la membrana y formando un poro. 
 
- Se han logrado recapitular los tres mecanismos de inhibición descritos en las proteinas 
tipo BCL2 para BFL1, en diferentes sistemas fisiológicamente relevantes. Además, 
mediante el uso de mutantes puntuales concluimos que BFL1 interacciona con los 
miembros proapoptóticos es predominantemente, sino únicamente, mediante una 
interacción canónica tipo BH3-into-groove. 
 
- El contenido de CL de la membrana modula la heterodimerización de BFL1 con tanto 
BAX como con cBID, además de una actividad intrínseca de BFL1 para su 
homooligomerization no-canónica y formadora de poro. En concordancia, las drogas 
externalizadoras de CL, rotenona y estaurosporina, promueven en células de mamífero 
esta actividad específica de BFL1 para formar un poro en la MEM de manera 
independiente de BAX y BAK. 
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